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ABSTRACT 
Haemophilus influenzae type b (Hib) is a major cause of serious invasive disease in 
children worldwide. Before the introduction of a vaccine in 1992 in Australia, it was the 
commonest cause of serious bacterial infections in children under the age of five years 
and the incidence of Hib disease was reported to be the highest in the world in 
Aboriginal populations. It is not clear what characteristics, if any, of the bacterium are 
associated with its epidemiology and little is known about its diversity in Australia. This 
thesis describes a study that used pulsed field gel electrophoresis (PFGE) to analyse the 
overall molecular genetic characteristics of 213 pre-vaccine Aboriginal and non-
Aboriginal isolates of Hib from varied rural and urban regions in Australia and 20 post-
vaccine isolates from an Aboriginal community. The objectives were to examine the 
genetic diversity of Hib to determine whether distinctive types are associated with its 
epidemiology and virulence and to generate baseline data that would permit assessment 
of the effects of vaccination on the genetic diversity and population structure of Hib. 
Among the pre-vaccine isolates 69 different types of Smal-RFLP patterns with 17 or 
fewer fragments were well resolved by PFGE. Closely related and more distantly related 
genomic types were easily discriminated. Two types, designated F2a and A8b, 
accounted for 43% of the sample and include almost one-half of the Aboriginal isolates 
and over one-third of the non-Aboriginal isolates, respectively. The types fell into 7 
major clusters in a tree-like dendrogram that is consistent with a clonal population 
structure, as is the presence of two predominant types. The results reveal a clonal 
population structure and extend the geographical range over which the clonality of Hib 
has been demonstrated. 
Two highly divergent groups comprising 7 types that represent 50 (66%) Aboriginal 
isolates and 6 ( 4%) non-Aboriginal isolates and another genetically distinct group 
comprised of 3 9 types representing 7 (9%) Aboriginal isolates and 106 (77%) non-
Aboriginal isolates revealed a deep genetic divergence between the majority of 
Aboriginal and non-Aboriginal isolates. Overall, relatively fewer and more diverse types 
were found among the Aboriginal isolates compared to those from non-Aboriginals . A 
single clone predominated in each of the urban and rural areas studied except one where 
two predominant clones were identified. 
V 
The genetic distance separating the important major lineages ranged from a similarity of 
20% to 50% yet there is apparently an equivalent ability to cause disease among them. 
No association between RFLP type and age, sex, date of collection, or disease 
manifestation was found. Because of the lack of Aboriginal isolates from urban areas 
and non-Aboriginal isolates from rural areas the association, if any, between geographic 
location and type could not be determined. However, there is a strong association ( chi 
square, p>0.001) between the origin of isolates from Aboriginal children and RFLP type 
F2a and the origin of isolates from non-Aboriginal children and RFLP type A8b. 
Important information about the dynamics of Hib strain diversity in the pre- and post-
vaccine periods was revealed. Pre-vaccine PFGE types were found to be circulating 
several years after the introduction of vaccines in a remote Aboriginal community. Of 8 
Smal-RFLP types found among 20 post-vaccine isolates 5 are indistinguishable from 
types found among the pre-vaccine isolates. The same type (F2a) predominates in both 
the pre- and post-vaccine samples. The three post-vaccine types not found in the pre-
vaccine sample are closely related to two of the pre-vaccine types. This divergence may 
suggest a shift in population structure but because of the relatively low number of 
isolates studied it cannot be ruled out that less frequent types were not recovered in the 
pre-vaccine sample. 
The validity of the PFGE results was substantiated by several comparative analyses. 
Enterobacterial repetitive intergenic consensus (sequences)-PCR RFLP analysis and the 
results of cap locus, P2 and OMP26 hybridisation studies did not contradict the overall 
genetic relationships revealed among Hib isolates using PFGE. Differences found 
between Aboriginal and non-Aboriginal Hib types using PFGE demonstrate its practical 
discriminatory power for analysing large numbers of Hib isolates. Analysis of the huge 
similarity matrices required for large samples has been facilitated by the availability of 
computer programs and, with standardisation of PFGE methods, the database developed 
here will allow inter- and intra-laboratory comparison of results. This will improve 
surveillance by increasing the capacity to detect new strains of Hib and monitor the 
presence of old strains. This methodology will be useful in monitoring future Hib 
isolates from children in whom the vaccine has failed, unimmunised children, and 
adults. 
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1. 1 Introduction 
Haemophilus influenzae type b (Hib) is a bacterium that causes life threatening invasive 
disease in children, particularly among those under 5 years of age. Before the 
establishment of widespread Hib vaccination in Australia its epidemiology was 
characterised by an extremely high incidence of invasive disease among Aboriginal 
children compared to non-Aboriginal children (Hanna and Wild, 1991; Hanna, 1992; 
Hanna, 1995), a lack of epiglottitis among Aboriginals (Hanna, 1992), and significant 
differences in the incidence of epiglottitis between urban areas (Gilbert et al., 1990; 
McIntyre et al., 1991; Hanna et al., 1992; McGregor et al., 1992). The reasons for the 
unique epidemiology of Hib remain largely unknown and there is little information 
about its population structure and genetic diversity in Australia. 
The project presented in this thesis was initiated to assess the genetic diversity of 
isolates of Hib in order to answer questions concerning its epidemiology and population 
structure in Australia. The advent of the technology that allows us to examine bacterial 
genetic diversity at a molecular level occurred during the same time as the development 
of the Hib conjugate vaccines. For the first time ever, the opportunity exists to monitor 
the effects of immunization by examining, not only, the change in the incidence of 
disease, but also, the change, if any, in the molecular genetic diversity of the population 
structure of the target microorganism. The overall purpose of this study has been to 
analyse the molecular genetic characteristics of clinical isolates of Hib to determine 
whether distinctive types are associated with its epidemiology and to develop a typing 
system for monitoring H. influenzae isolates from children in whom the vaccine has 
failed, unimmunised children, and adults. The introduction that follows presents the 
general characteristics of Hib, an overview of typing methods used to study Hib and a 
review of our current understanding of the population structure and genetic diversity of 
H. influenzae. It concludes with a description of the aims of the study. 
1.2 Haemophilus influenzae: Historical Portrait of a Bacterium 
The bacterium known as H. influenzae was first seen by Robert Koch in 1883 when he 
found small Gram-negative bacilli in the pus of patients with conjunctivitis. It was 
separately discovered and initially cultured from similar material in 1886 by John 
Weeks and came to be known as the Koch-Weeks bacillus and then H. aegyptius . It was 
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only much later in the 1970s that we learned from Mogens Killian to include H. 
aegyptius in a biotype of H. influenzae (Turk, 1982a). The name H. influenzae is based 
on Rickard Pfeiffer's erroneous suggestion during the influenza pandemic of the 1890s 
that the 'influenza bacillus' he cultured from the sputa and lungs of patients was the 
cause of the disease (Pfeiffer, 1893). The American Association of Bacteriologists 
proposed the name Haemophilus influenzae for Pfeiffer's bacillus in 1920 long before 
the viral origin of influenza was determined in 1933. By this time the variability in the 
pathogenicity of H influenzae was recognised and Margaret Pittman had established the 
significance of a capsule in the increased pathogenicity of cerebrospinal fluid isolates 
(Pittman, 1931 ). While it seems likely that in at least some outbreaks of influenza there 
may be a virus-Haemophilus synergism, aside from Pfeiffer's association of it with the 
pandemic of the late 1800s and recognition of its presence in the 1918 pandemic 
(apparently as a secondary invader), H. influenzae has done little since to earn its 
species name (Turk, 1982b; Willett, 1988). 
The true picture of the range of pathogenic activities of H. influenzae became clearer in 
the period 1930-1960 (Turk, 1984) and knowledge of its epidemiology, pathogenicity, 
and genetics grew dramatically in the 25 years before and since the 1993 centenary of 
its cultivation by Pfeiffer. One of the important early observations was the description 
of the relationship between a high incidence of Hib meningitis and the low bactericidal 
power of serum in children 2 months to 3 years of age (Fothergill and Wright, 1933). 
The recognition that this reflected a lack of serum antibody capable of providing 
protection against invasive disease led to the development of a first generation vaccine 
consisting of the purified capsular polysaccharide of Hib, polyribosylribitol phosphate. 
This vaccine proved to be successful in older children but not in those under 2 years of 
age, the age group with the highest burden of disease. The conjugation of capsular 
polysaccharide to protein was a vital leap in technology that resulted in Hib vaccines 
capable of protecting infants (Heath, 1998). The effectiveness of the conjugate vaccines 
is such that in most areas where they have been introduced the incidence of Hib disease 
has been significantly reduced and its clinical significance diminished. Hib continues, 
however, to be a serious pathogen in populations where the vaccine is not available and 
the challenge remains to implement worldwide vaccination in areas where 
epidemiological studies warrant its use. 
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In early 1995 the determination of the complete sequence of a bacterial genome was 
accomplished for the first time ever when the final piece of sequence data was slotted 
into the circular chromosome of Haemophilus influenzae Rd KW20 (Fleischmann et al. , 
1995). Little known for being the strain from which one of the first DNA restriction 
enzymes were purified (Smith and Wilcox, 1970), this further honour was bestowed on 
H. influenzae Rd KW20 largely due to the its relatively small size (1.8 Mb). 
Remarkable achievements in the last two decades have deeply changed our 
understanding of the epidemiology, clinical significance and laboratory research of H. 
influenzae. The dramatic effect of the conjugate vaccines in preventing invasive disease 
and the publication of the H. influenzae genome sequence are just two of the 
extraordinary scientific achievements that, not only, shed light on our complex and long 
standing relationship with H. influenzae, but, illuminate our vision of the microbial 
world in general. 
1.3 The Genus, Haemophilus 
Haemophilus organisms are among the smallest of bacteria. The genus is restricted to a 
group of bacteria <1 µm in width and 1-1.5 µm in length. They are chemoheterotrophic, 
non-motile, non-spore forming aerobic or facultatively anaerobic, oxidase-positive 
(rarely negative), catalase-positive (rarely negative), Gram-negative rods that sometimes 
form threads and show marked pleomorphism (primarily when recovered from 
cerebrospinal fluid or broth cultures) but they are most often found in a uniform rod 
shape. The curved ends of the short bacilli makes many appear round and, hence, they 
are referred to as coccobacilli. Almost all haemophili require preformed growth factors 
present in blood, particularly X and V factor (I(illian and Biberstein, 1984) as shown in 
Table 1.1. X factor is actually a group of heat stable compounds provided by several 
iron-containing pigments and · V factor is nicotinamide adenine dinucleotide or 
nicotinamide adenine dinucleotide phosphate. The very name of the genus comes from 
the requirement for these accessory growth factors found in blood and is derived from 
the Greek words meaning "blood loving". The genus is currently classified in the family 
Pasteurellaceae that includes members of the genera Pasteurella and Actinobacillus 
(Killian and Biberstein, 1984). 
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Haemophili occur as obligate parasites on the mucous membranes of both humans and 
animals and, with the possible exception of H. parainfluenzae, are host specific (Killian 
and Biberstein, 1984). The ten human species and six animal species currently listed in 
the genus in Bergey's Manual of Determinative Bacteriology (Holt et al. , 1994) are 
shown in Table 1.1. The human species are found almost exclusively as members of the 
normal microbial flora of the oropharynx and they possess varying propensities for 
causing disease. They are also found, but much less frequently, in the normal flora of 
the genital tract with the exception of H. ducreyi which is a primary pathogen of the 
genital tract. 
Table 1. 1 Growth factor requirements of Haemophilus species isolated from humansa 
H. influenzaeb 
H. aegyptiusc 
Species 
H. parainfluenzae 
H. haemoly ticus 
H. parahaemoly ticus 
H. aphrophilus 
H. p araphroph ilus 
H. p araphrohaemoly ticus 
H. segnis 
H. ducrey{1 
Factor Requirement 
X V 
+ + 
+ + 
+ 
+ + 
...L 
I 
+ 
+ 
+ 
+ 
Data obtained from Kilian, M. and Bilberstein, E.L. in Bergey's Manual of Systematic Bacteriology, 1984. 
a animal species include H. pleuropneumoniae, H. haemoglobinophilus, H. parasuis, H. paragallinarium , 
H. paracuniculus, H. avium (changes in classification are found in Bergeys' Manual of Determinative 
Bacteriology, 9th edition, 1994) 
b includes 6 encapsulated types, and non-typeable H influenzae 
c now classified as H. influenzae biogroup aegyptius 
d evidence is accumulating that H. ducreyi may be only distantly related to the genus (Dewhirst et al., 1992) 
1.4 The Species, Haemophilus influenzae 
Haemophilus influenzae is the most important pathogen among the species that colonise 
the human host. With the occasional exception of the human genital tract, the human 
nasopharynx is the sole ecological niche occupied by this organism. It is not found in 
the environment and does not colonise or cause disease in other animal species. 
It may make one of six chemically distinct capsular polysaccharides designated types a-
f, but among the six capsule producing strains of Haemophilus influenzae only type b 
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isolates commonly cause systemic disease. Those strains of H. injluenzae that do not 
produce a capsule and are serologically non-reactive in capsular antisera are referred to 
as non-encapsulated or non-typeable H. injluenzae (NCHi or NTHi). The NCHi include 
a subset of a genetically distinct group described as a cryptic genospecies that is 
distantly related to H. injluenzae and H. haemolyticus (Quentin et al., 1993). 
Strains of H. injluenzae can be separated into biotypes (biovars) using a battery of 
biochemical tests. Kilian's system of biotyping based on indole production and 
omithine decarboxylase and urease activities (Kilian, 197 6) is currently used to divide 
H. injluenzae into biotypes I-VIII as shown in Table 1.2. The usefulness of biotyping 
for epidemiological purposes or for studying population structure is limited but 
valuable. 
It has been reported recently that the presence of active copper- and zinc-containing 
superoxide dismutase in isolates of the cryptic genospecies (non-capsulate strains of 
biotype IV and to a lesser extent biotype II), responsible for urogenital, neonatal, and 
mother-infant infections, can be used as a biochemical marker to discriminate them 
from H. injluenzae sensu stricto strains (Langford et al., 2002). 
/ 
Table 1. 2 Biotypes of Haemophilus injluenzaea 
Biotype Indole Production Ornithine Decarboxylase U rease Activity 
Activity 
Ib 
+ + + 
II + + III 
+ 
IV + + V + + 
VI + 
VII + 
VIII 
Modified from Kilian, M. 1991. Haemophilus. In Balows, A., et al. editors: Manual of clinical microbiology, 5th 
edition, American Society for Microbiology. 
afound among both encapsulated and non-encapsulated isolates 
bmost Hib isolates fall into this biotype 
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1.5 Pathogenesis and Clinical Significance of Hib 
Prior to the introduction of effective vaccines, disease caused by Hib was a worldwide 
problem of major importance in both developing and developed countries (Turk and 
May, 1967; Turk, 1982a). In areas where the vaccine has been introduced, primarily in 
developed countries, Hib disease has been virtually eradicated (Peltola et al. , 1992; 
Adams et al. , 1993). However, in those areas of the world, such as, in Asia and Africa, 
where Hib vaccines are not routinely used, Hib disease is still a significant cause of 
childhood morbidity and mortality, with devastating effects on the most vulnerable of 
all, babies and small children (Neuzil, 2000). Currently, less then 2% of Hib diseases 
worldwide are prevented because some 80% of the 215 countries reporting to the World 
Health Organisation (WHO) are not using Hib vaccines in their national immunisation 
programs (Peltola, 2000). Subsequently, some 175 countries and 118 million children 
are without protection against life-threatening Hib infections. According to the WHO, 
Hib still causes 3 million cases of serious disease and 400,000 to 700,000 deaths per 
year in young children worldwide (Peltola, 2000). 
Implementation of universal coverage of Hib vaccines will require overcoming 
obstacles of titanic proportions for which the outlook is currently quite gloomy. These 
include perceptions of low disease burden due to underestimates of Hib disease, limited 
availability and the high cost of vaccines, and motivation for vaccine programs (Neuzil, 
2000). Thus, despite the widespread use of Hib vaccines making the goal to eliminate 
Hib disease feasible (Heath, 1998; Campos, 2001) , it remains a major global infectious 
disease challenge for the foreseeable future. 
1.5.1 Clinical manifestations of Hib disease 
A wide variety of Haemophilus infections may occur in humans, ranging from 
infections that are frequent and easily managed ( e.g. , conjunctivitis and otitis media) to 
those that are potentially life threatening and less frequent or rare ( e.g., meningitis, 
pericarditis, and Brazilian purpuric fever) (Campos, 1995). Haemophilus injluenzae is 
the species that most frequently causes infection and invasive diseases are usually 
caused by Hib, the H. injluenzae strains possessing the type b capsule. In most 
industrialised countries in the pre-vaccine era, Hib was a frequent cause of invasive 
diseases in previously healthy children under the age of 5 and was the most common 
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cause of meningitis in children between 1 month and 3 years of age. This disease 
pattern is linked to the time after maternal antibody is lost and before the developing 
immune system is capable of protecting the infant. The other encapsulated strains ( types 
a, c, d, e, and f) and non-encapsulated H. influenzae may also cause invasive disease but 
Hib has been shown to cause approximately 90% of the systemic Haemophilus 
infections in industrialised societies (Jordens and Slack, 1995). 
While meningitis is the most common manifestation of invasive Hib disease, worldwide 
studies in the 1970s to 1990s showed that over 90% of Hib infections manifested as six 
"classical" entities: meningitis, epiglottitis, bacteremic pneumonia, septicemia, 
cellulitis, and osteoarticular infections (more often septic arthritis than osteomyelitis) 
(Peltola, 2000). Other clinical manifestations constituted only 3% of the total number, 
whereas multifocal cases were diagnosed in 6%. Table 1.3 shows the distribution of Hib 
diseases taken from data for 3,391 patients in 21 studies from various parts of the world. 
Table 1. 3 Worldwide spectrum of all classical Hib diseasesa 
Diagnosis % 
Meningitis 52 
Pneumoniab 12 
Epiglottitis 10 
Septicemia 8 
Cellulitis 5 
Osteoarticular 4 
Others 3 
Multifocal 6 
Table modified from Peltola, 2000. 
adata obtained in the l 970s-90s for 3,391 pati ents in 21 studies from various parts of the world 
bnon-bacteremic pneumonia excluded 
A clinical review of Hib disease in the pre-vaccine era in Melbourne, Victoria in 
Australia showed that three-quarters of the patients presented with either meningitis or 
epiglottitis (Gilbert et al. , 1995). It is of interest that epiglottitis accounts for 40% of 
invasive Hib disease in Victoria and that this is twice that found in Sydney (McIntyre et 
al. , 1991) or Western Australia (Hanna et al. , 1992) and is four times that found 
worldwide (Peltola, 2000). This difference in incidence, as well as, age related issues 
are discussed in the section of this chapter on epidemiology. Except for epiglottitis, the 
distribution of the classical Hib disease manifestations was roughly the same wherever 
it was studied (Peltola, 2000). In Victoria, aside from the increased incidence of 
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epiglottitis with a concomitant reduction in Hib meningitis, the distribution of Hib 
disease was similar to the worldwide distribution. The distribution of primary diagnoses 
in 235 patients in Victoria is shown in Table 1.4. 
Table 1. 4 Primary diagnoses in 235 children from Victoria, Australiaa with 
invasive Hib disease showing an increased incidence of epiglottitis and a 
concomitant reduction in meningitis as compared to the worldwide distribution of 
Hib disease 
Diagnosis n % 
Epiglottitis 94 40 
Meningitis 84 36 
Pneumonia 20 9 
Cellulitis 16 7 
Bacteremia 14 6 
Arthritis/osteomyelitisb 6 3 
Pericarditis 1 0.4 
Table modified from Gilbert, 1995 . 
aPatients admitted to the Royal Children 's Hospital, Melbourne, Victoria between 1 February 1988 and 
31 January 1990 were included in the study. 
bTwo additional patients who presented with meningitis developed arthritis after admission. 
Specificity of certain bacteria for certain species, even certain tissues, and even certain 
cells is one of the most amazing of all biological phenomena. For example, the polio 
virus kills only the anterior horn cells of the spinal cord of humans (and occasionally 
other primates). Similarly, the ability of Hib to infect the epiglottis is characteristic as 
epiglottitis in children is rarely attributed to other microorganisms (Hanna et al. , 1992). 
It is not known why this is so and the specificity of Hib for the skin and subcutaneous 
tissue of the epiglottis remains an extraordinary trademark of Hib, particularly, in light 
of its specificity for humans. 
1.5.2 Pathogenesis of invasive Hib disease 
Most children exposed to Hib will experience no overt disease at all, since the majority 
will only harbor the organism as a harmless commensal in the throat (Michaels et al., 
197 6). Disease, when it occurs, appears to occur within a short period (less than three 
days) after the initial encounter (Ryan and Falkow, 1994). It is not known why some 
individuals and not others develop Hib disease and the precise mechanism by which Hib 
gives rise to invasive disease is not fully understood. Nonetheless, many significant and 
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exciting developments in the past 25 - 30 years have increased our understanding of the 
pathogenesis of Hib disease and H injluenzae disease in general. 
The accepted pathogenesis of invasive Hib disease can be said to involve three basic 
sequential stages: 1) colonisation of the nasopharynx, 2) bacteremia and survival in the 
blood stream, and 3) central nervous system invasion ( although direct invasion of the 
meninges via contiguous spread from the nasopharynx is not precluded, clear evidence 
has been presented to show the meninges are invaded by a hemato genous route (Mox on 
and Murphy, 1978)). Pathogenesis begins with the pharynx as the portal of entry once 
penetration of the mucosal barrier has occurred. There is some evidence to suggest that 
there is a complex regulatory cascade coordinating capsular biosynthesis and adherence 
factors that act cooperatively in establishing the microbe within susceptible hosts (Ryan 
and Falkow, 1994). 
Bacteremia with Hib is thought to result from direct invasion of the sub-mucosal blood 
vessels, rather than to develop via the regional lymph nodes (Rubin and Moxon, 1983). 
The probability of developing meningitis has been shown to be directly related to the 
magnitude of bacteremia (Moxon and Ostrow, 1977) and other types of Hib disease, 
such as epiglottitis, are thought to represent metastatic disease evolved from bacteremia 
(Kristensen, 1999). The organism has been observed to occasionally exhibit highly 
invasive behaviour in an in vitro adhesion invasion assay and it was proposed that 
sporadic invasivness may correlate with the unknown events that precede Hib 
bacteremia (Johnson et al. , 1996). To reach the bloodstream, this non-motile bacterium 
must pass through the basement membrane and sub-epithelial tissue, and enter the 
endothelium of a blood vessel. The manner by which this occurs remains under 
investigation. 
The infant rat model of H. injluenzae meningitis has been used to study the early 
pathogenic events of Hib disease and has played a substantial role in the identification 
of Hib virulence factors . Infant rats less than three weeks of age contracted meningitis 
after intranasal challenge with Hib (Maxon et al., 1974) and an age dependent 
susceptibility to meningeal invasion and bacteremia was found (Maxon and Ostrow, 
1977). The incidence of bacterial meningitis was directly related to the intensity of 
bacteremia regardless of the age of the rat (Maxon and Ostrow, 1977). 
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Evidence obtained in both animals and humans suggests that a preceding or concurrent 
respiratory infection may facilitate invasion of the bacterium. In experimental studies 
influenza A virus has been shown to increase both the frequency and the magnitude of 
Hib bacteremia on challenge with Hib in infant rats and the number of Hib organisms 
needed to produce invasive disease in rats were 100 fold reduced when infection with 
influenzae A virus was established (Kristensen, 1999). Moreover, family members of 
children with Hib disease reported symptoms of respiratory infection in the preceding 
four week period before onset of Hib infection significantly more often than controls 
(Kristensen, 1999). 
A microbial pathogen is now recognised as a highly adapted microorganism that may 
cause disease ( overt damage to a host) because its survival strategy includes a 
requirement for infection (persistence, usually by multiplication on or within another 
living organism) (Falkow, 1990). Disease can thus be seen to be an inadvertent outcome 
of a microbe's strategy for survival in the host (Falkow, 1994). Untreated Hib 
meningitis and epiglottitis are fatal in most cases. Since death of the host terminates 
transmission and propagation of organisms and, thus, is disadvantageous to the infecting 
bacterium, vascular invasion by Hib may be circumstantial or accidental rather the 
result of evolutionary advantage (Barbour, 1996). 
1.5.3 Virulence factors of Hib 
In the past two decades a revolution has occurred in our understanding of the basic 
pathogenic mechanisms of microorganisms including many developments made in the 
understanding of the molecular genetics of the pathogenesis of H. injluenzae. It is now 
clear that mechanisms used by patho genie bacteria that cause infection and disease are 
numerous and diverse and usually include a co-regulated group of complementary 
genetic properties that are suited for the interaction of a particular microorganism with a 
particular host (Falkow, 1990). The complex mechanisms that cause disease that are 
used by both encapsulated and non-encapsulated H. injluenzae strains have now been 
broadly studied and valuable insight has been gained on the road of discovery towards 
understanding why Hib causes disease. Recently, Marrs et al. (2001) presented an 
excellent review of the current understanding of the molecular genetics of the factors 
that may be involved in the virulence of H. influenzae (Marrs et al. , 2001 ). This section 
(1.5.3) includes a brief description of the factors that are currently considered to be 
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among the putative virulence factors of Hib. These include the polysaccharide capsule, 
adhesion factors , lipooligosaccharide, heme uptake, haemocin, peptidoglycan, IgA 
proteases, H. influenzae genetic island 1, tryptophanase, antibiotic resistance and 
metabolic and physiologic factors. A list of the putative virulence factors with 
references is found in Table 1.5. 
1.5.3.1 Capsule 
The polysaccharide capsule and, particularly, the type b capsule has traditionally been 
considered the most important virulence factor of H influenzae (Turk, 1984). Animal 
studies of isogenic strains transformed with capsule associated DNA confirmed earlier 
observations that type b strains were more virulent than type a strains, which were more 
virulent than other capsular types (Zwahlen et al., 1989). 
The capsular polysaccharide of Hib is a linear polymer of ribose, ribitol, and phosphate 
(Crisel et al. , 1975) called polyribosylribitol phosphate (PRP). The host's immune 
system is targeted against PRP and considerable evidence indicates that antibody to 
PRP is a principal protective host factor (Granoff and Munson, 1986). Consequently, 
this is the basis of an effective vaccine. 
The bacterial capsule aids colonisation as it mediates resistance to complement and 
protects against phagocytosis which is advantageous for its invasivness (Moxon and 
Vaughn, 1981; Sutton et al. , 1982; Zwahlen et al. , 1989; Moxon and Kroll, 1990; Noel 
et al. , 1992). Interestingly, it has also been shown to impede interactions with epithelial 
cells in vitro (St. Geme and Falkow, 1991 ). 
All encapsulated strains possess the cap genetic locus, a segment of ~ 17 kb comprised 
of a region that shows serotype specificity flanked by regions sharing homology among 
all capsular types. In Hib, with very few exceptions, the cap locus contains an unstable 
direct repeat of the ~ 17 kb segment flanking an ~ 1 kb bridge region containing the gene 
bexA (Kroll, 1992). The tandem duplication of the cap locus in type b strains is 
characterised by a mutation in the bexA gene of one copy of the duplication. This results 
in an unstable gene region, with relatively high potential for recombination events . 
During recombination of the cap locus, mutants may be formed that possess a single 
copy of the cap locus containing the bexA mutation that results in non-encapsulated 
mutants. Thus, reduction to a single copy state renders the organism capsule deficient 
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and poorly able to survive in vivo compared to capsule proficient organisms (Preston 
and Apicella, 1999). On the other hand, such a recombination event may generate 
mutants possessing additional (n) copies of the cap locus with n-1 copies of bexA. Such 
mutants are hyper-encapsulated and show increased pathogenicity in the infant rat 
model (Kroll and Maxon, 1988). 
A significant number ( ~35%) of invasive type b clinical isolates contain amplified 
capsule gene sequences possessing three, four, or even five copies of the Cap b repeat 
(Hoiseth et al., 1992; Com et al., 1993). The biologic significance of amplified capsule 
genes remains speculative but as the capsule probably facilitates the survival of the 
organism, it is plausible that an increase in production of capsular polysaccharide would 
enhance the virulence of Hib. Extra copies of the repeat can be lost on a single 
subculture suggesting the amplified state is a disadvantage for growth in vitro; lacking 
positive selection for increased capsule production, the biosynthesis of excess PRP may 
be unfavourable because it places an excessive energy burden on the organism (Com et 
al., 1993). The fact that most clinical isolates do not appear to be amplified implies that 
two copies of the Cap b repeat, the tandem duplication, are sufficient to cause invasive 
disease. 
1.5.3.2 Adhesion factors 
Successful pharyngeal colonisation, the first vital step in the disease process of Hib after 
exposure, requires that an organism overcome the mucociliary escalator of the 
respiratory tract. One strategy employed by H. influenzae to surmount mucociliary 
clearance involves attachment to the respiratory epithelium. Both pilus and non-pilus 
attachment factors appear to facilitate this. In 1982, Guerina, et al. (1982) and 
Pichichero, et al. (1982) independently reported the presence of long peritrichous pili in 
isolates of Hib (Guerina et al., 1982; Pichichero et al., 1982). Both groups noted 
piliation was correlated with an increased attachment to oropharyngeal epithelial cells 
and was also associated with a capacity to agglutinate human erythrocytes . It has been 
shown that pili expression is regulated by reversible phase variation believed to be 
roughly 10-3 to 10-4 in both directions (Farley et al., 1990). Generally, strains isolated 
from invasive disease do not express pili, while those colonising the nasopharynx do 
(Marrs et al., 2001). 
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At least 14 serological groups of hemagglutinating pili have been distinguished among 
both Hib and non-capsulate isolates (St. Geme, 1994). While the majority of Hib 
isolates express pili belonging to one serotype (serotype 4 ), non-capsulate isolates 
exhibit considerable diversity in this respect (St. Geme, 1994 ). In one study, sera 
prepared against purified pili from 2 strains of Hib did not recognise any of 12 piliated 
non-capsulate strains (Gilsdorf et al., 1992). Most strains of Hib contain a pilus gene 
cluster composed of five genes, hifABCDE (van Ham et al., 1994; Marrs et al., 2001). 
Several studies suggest the presence of adhesins distinct from hemagglutinating pili 
among type b isolates but the identity of a second adhesin of Hib remains obscure while 
at least two adhesive high-molecular-weight proteins (HMWl, HMW2) expressed by 
non-capsulate isolates have been described (St. Geme, 1994). H. influenzae pili have 
been recently reviewed (Gilsdorf et al., 1997). 
Other factors shown to be involved with Hib adherence include fibrils, outer membrane 
proteins P2, PS and PS-related fimbrin, and lipooligosaccharide (Marrs et al., 2001 ). 
Additionally, fibrils and protein species designated Hia, Hap, and PE-binding adhesin 
have been found in NCHi (Marrs et al., 2001 ). 
1.5.3.3 Lipooligosaccharide (endotoxin 1) 
Lipooligosaccharide (LOS), an essential outer membrane component, has been shown 
by several independent investigations to be a major contributory factor to the 
pathogenicity of H influenzae (Kimura and Hansen, 1986; Zwahlen et al., 1986; 
Maskell et al., 1992). Structurally, LOS has a core of oligosaccharide but lacks the 0-
antigen side chains characteristic of the enterobacterial lipopolysaccharide. 
Oligosaccharides are exposed on the surface and are antigenic and they differ both 
within and between strains. Other characteristics of H. influenzae LOS include its 
endotoxic effects (Flesher and Insel, 1978), strain (Inzana, 1983) and phase variability 
(Kimura and Hansen, 1986; Weiser et al., 1990) and an ability to stimulate an 
inflammatory reaction (Marrs et al. , 2001). 
1 Historical Note Rickard Pfeiffer, the discoverer of H influenzae, was one of two scientists 
(Eugenio Centanni was the other) who independently studied the same heat stable toxin in the 
late 1800s. Pfeiffer noticed that Vibrio cholerae synthesised a heat resistant substance that was 
not actively extruded by the bacterium. He added the Greek word for 'within' to toxin and 
named his discovery endotoxin. While the term is still in use, it was shown that endotoxin 
resides on the surface of bacteria, not in the interior. (Rietschel and Brade, 1992) 
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A wide variety of glyco-modifications to the core LOS molecule have been detected and 
individual strains can also dynamically alter the expression of these terminal 
consitutents by phase variation of genes (liclA , lic2A , lic3A , Ig tC) within chromosomal 
loci that encode LOS biosynthetic pathway enzymes; this is presumably an adaptive 
strategy for subverting the immune system (Marrs et al. , 2001 ). Molecular mimicry of 
LOS to common eukaryotic glycolipid structures confers an ability to adhere to 
epithelial cells and as such would represent an important virulence determinant (High et 
al. , 1993). It has been shown that both serotypable and non-serotypable strains have the 
capacity to express LOS glycoforms with terminal sialic moieties that confer a relative 
resistance to the bactericidal activity of normal human serum (Marrs et al. , 2001 ). 
Studies to identify H influenzae modulins or immunomodulators have focused on LOS. 
Though endotoxemia is not a prominent feature of Hib disease (Ryan and Falkow, 
1994 ), there is in vivo evidence for the involvement of LOS in the activation of the 
immune system and the development of inflammation (Marrs et al. , 2001 ; Miyazaki et 
al. , 200.1 ). Its role in generating cerebrospinal fluid leukocytosis, protein influx, and 
blood-brain barrier permeability is well-characterised (Burroughs et al. , 1993). 
1.5.3.4 Heme uptake 
H. influenzae is nearly unique among human pathogens in its absolute requirement for 
exogenously supplied heme (a term used here to describe all iron-protoporphyrin 
complexes). The ability to circumvent the iron-withholding tactics of the human host by 
competing effectively for heme in vivo, is , presumably, an important determinant of the 
virulence of Hib. Initial studies on heme acquisition systems identified several cell 
envelope components that 1nay be involved in its uptake while providing evidence that 
multiple iron uptake systems are used by Hib (Hanson et al. , 1992; Hanson et al., 1992; 
Lee, 1992). Molecular genetic studies have shown that at least two cell surface proteins, 
Tbp 1 and Tbp2, encoded by the genes tbpA and tbpB , respectively, are needed for 
transferrin binding capacity; three genes (hitA/jbpA, hitB/jbpB , hitC/jbpC) are 
necessary for the utilisation of iron bound to transferrin or iron chelates; heme bound to 
hemopexin is utilised via the huxABC operon; and, four proteins (HgpA, HgpB, HgpC, 
HhuA) have been described that bind either hemoglobin or hemoglobin-haptoglobin 
complexes (Marrs et al. , 2001). A functional TonB protein has been shown to be a 
requirement for both heme utilisation and virulence (J arosik et al., 1994; J arosik et al. , 
1995). 
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1.5.3.5 Haemocin 
Over 90% of Hib strains produce the bacteriocin haemocin. Haemocin is toxic to 
virtually all non-type b strains of H influenzae (LiPuma et al., 1990). The notable 
absence of haemocin production by NCHi or other encapsulated types suggests that it 
may play a role in the pathogenesis of infections (Murley et al., 1998). It is thought that 
haemocin may contribute to the ability of Hib strains to effectively compete with NCHi 
strains in nasopharyngeal colonisation, an important early event in the pathogenesis of 
invasive Hib disease (LiPuma et al., 1990). The gene encoding haemocin immunity, 
hmcl, and several genes in the hmc locus that have been cloned and sequenced are 
specific to type b strains (Murley et al., 1997; Murley et al. , 1998). 
1.5.3.6 Peptidoglycan 
Despite sterilisation of the cerebrospinal fluid permanent neurologic sequelae, such as, 
deafness and seizures occur in many children surviving Hib meningitis. Thus, bacterial 
killing is not sufficient to assure a favorable outcome. Bacterial components released 
during antibiotic-induced killing transiently enhance the inflammatory response in the 
subarachnoid space, and down modulation of this inflammatory burst improves outcome 
(Burroughs et al., 1993). Peptidoglycan, a major cell wall component, has been studied 
in regard to its contribution to this pathology of Hib meningitis. Hib peptidoglycan was 
shown to cause profound increases in blood-brain barrier permeability and cerebrospinal 
fluid white blood cell counts in an adult rat model (Roord et al. , 1994). Significant brain 
edema and protein influx with little leukocytosis was shown in a rabbit model of 
meningitis (Burroughs et al. , 1993; Roord et al., 1994). 
1.5.3.7 lgA proteases 
The production of IgA proteases (Kilian et al., 1979) is thought to facilitate invasion 
through the mucosal barrier (Plaut, 1983). Both non-typeable and serotypeable H. 
influenzae express type l and type 2 IgA 1 proteases and cleavage products can be 
detected in nasopharyngeal secretions (Marrs et al., 2001 ). Vitovski, et al. (2002) have 
very recently shown that IgAl protease activity is higher in disease isolates of NCHi 
than in carriage isolates and their results provide quantitative evidence that IgAl 
protease activity is an important virulence factor in NCHi mediated pathogenicity 
(Vitovski et al. , 2002). However, the role of IgA proteases in Hib virulence has not been 
established (Marrs et al., 2001 ). 
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1.5.3.8 HiGl1 
A 16 kb genetic locus, designated Haemophilus influenzae genetic island 1 (HiGil ), has 
been found to be conserved in Hib strains and absent from the majority of other strains 
studied (Chang et al., 2000). That it is flanked by direct repeats, has regions different in 
G-C content from the rest of the genome, and evidence suggests that it may have 
resulted from phage-mediated transfer raise the potential that HiGil may be a virulence 
associated region (Chang et al., 2000). Studies are under way to test the hypothesis that 
HiGil is a virulence determinant. 
1.5.3.9 Tryptophanase 
Among strains of Haemophilus influenzae, the ability to catabolise tryptophan has long 
been correlated with pathogenicity (Kilian, 1976). To begin to address the question as to 
whether this identifies tryptophanase as a virulence factor, the putative tryptophanase 
operon of Hib (strain Eagan) has been sequenced (Martin et al., 1998). The Hib tna 
genes are not in the H. influenzae Rd KW20 genome, are flanked by direct repeats of an 
uptake signal sequence and appear to have been inserted as a mobile unit resembling a 
pathogenicity island (Martin et al., 1998). Studies using gene disruption are currently 
being used to investigate if the tnaA gene in the tna operon is a virulence determinate. 
1.5.3.10 Antibiotic resistance 
The emergence of multi-resistant phenotypes is a crisis in the medical management of 
Hib infections and contributes to its virulence. During the last two decades problems 
with antimicrobial resistance in invasive Hib has increased substantially and worldwide, 
though, it varies considerably between areas and is ameliorated in those areas where 
widespread vaccination has caused a significant decrease in the incidence of Hib 
(Kristensen, 1999). 
1.5.3.11 Metabolic and physiologic factors 
In contrast to the study of classic virulence factors, an effort has also been made to 
determine which metabolic and physiologic bacterial factors are essential for the 
survival and growth of H. influenzae in vivo. In particular, a genome-scale phenotypic 
analysis made possible by the availability of the complete genome sequence of H. 
influenzae Rd KW20 led to an estimate that 3 8% of H. influenzae genes are critical for 
growth or viability of colonies on rich medium (Akerley et al. , 2002). A comprehensive 
Table 1. 5 Putative virulence factors of H. influenzae type b 
Factor 
Polysaccharide capsule 
Lipooligosaccharide 
(the term 
lipopolysaccharide was 
used originally) 
Hemagglutinating pili 
/Fimbriae 
IgA 1 proteases 
Porin 
including OMP P2 
OMPP5 
Peptidoglycan 
TonB protein 
Ciliotoxin 
Haemocin 
Haemophilus 
injluenzae genetic 
island 1 (HiGil) 
Tryptophanase 
Antibiotic resistance 
Virulence Associated Action(s) 
Mediates adherence to host cells; inhibits 
phagocytosis and complement mediated lysis 
Mediates adherence to host cells; diverse 
types mimic common eukaryotic glycolipids 
and inhibit host immune defenses; antigenic 
phase variable expression inhibits host 
immune defenses; has toxic effect on ciliated 
respiratory cells; induces cerebrospinal fluid 
leukocytosis, protein influx and blood-brain 
pem1eabili ty 
Mediate adherence to host cells, however, 
subsequent reversion to a non-piliated state 
may promote invasivness 
Inactivates the predominant secretory IgA 
species, IgAl (Note: the role of IgA proteases 
in Hib virulence has not been established) 
Contributes to the signalling of the 
inflammatory cascade in the rat brain; 
mediates adherence to host cells 
Mediates adherence to host cells; diversity 
contributes to antigenic drift; targetting of the 
carcinoembryonic antigen family of cell 
adhesion molecules may be of primary 
significance in colonization 
Promotes inflammatory reaction; its most 
potent effect is a profound increase in blood-
brain permeability and the induction of brain 
edema 
Promotes heme uptake and virulence 
express10n 
Toxic effect on host 
Toxic effect on other bacteria, including, most 
all NTHi and non-type b encapsulated bacteria 
HiGil is conserved in Hib strains ; studies are 
underway to test the hypothesis that HiG 1 is a 
virulence determinant 
Ability to catabolize tryptophan is correlated 
with pathogenicity; studies are underway to 
test the hypothesis that the H. influenzae tnaA 
operon is a virulence determinant 
The emergence of multi-resistant phenotypes 
has occurred worldwide 
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list of factors that are essential in vitro under standard growth conditions have been 
identified from this work and these results provide information that be used to identify 
genes that are also essential during infection (Akerley et al. , 2002). An in vitro 
transposition system has also been described for identifying essential genes of H. 
influenzae (Reich et al., 1999). 
1.6 Epidemiology 
In recent years there has been much progress in our understanding of the epidemiology 
of disease caused by Hib in developed countries. The quality of the data on the 
incidence of Hib infections in low- and middle-income countries varies but a broader 
picture is emerging of worldwide geographic and population differences in the 
incidence of Hib disease. 
Before widespread immunisation against Hib the epidemiology of invasive Hib disease 
showed considerable variation through out the world (Table 1.6). In particular, rates of 
Hib disease 10-20 times that found in Western Europe (Takala et al. , 1989; Anderson et 
al. , 1995) and the United States (Murphy et al., 1987; Shapiro and Ward, 1991) 
occurred in certain high risk populations, such as, Alaskan Eskimos (Ward et al. , 1981 ), 
native American Indians (Losonsky et al. , 1984) and Australian Aboriginals (Hanna, 
1990). The estimates of disease incidence that are available from developing countries 
show that the incidence of invasive Hib disease can be similar to or more or less than 
that reported in industrialised areas but in general the incidence of Hib is greater in 
developing countries than in industrialised countries. 
A remarkable finding is the huge differences reported with respect to age distribution of 
disease. At least 85% of all Hib infections occur in children less than 5 years of age and 
more than 65% occur in children less than 2 years of age. In non-industrialised areas 
and in native populations, children with Hib disease tend to be younger than in W estem 
Europe, the United States, or Australian urban populations with a large proportion of the 
infants with Hib disease in these areas being younger than six months. 
Major differences in mortality have also been recorded. Case fatality rates from Hib 
meningitis of 26-43%, 37%, and 57%, respectively, have been reported from Nigeria, 
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Gambia and Egypt while in W estem Europe and the United States and Australia the 
mortality rate was around 2% (Campagne et al. , 1999; Kristensen, 1999). 
The two most common manifestations of Hib disease are meningitis and epiglottitis in 
children. Though differing significantly in clinical presentation both diseases are life 
threatening and may cause harmful sequelae in survivors. In W estem communities and 
indigenous populations it is striking that these infections tend to occur at different ages 
that vary according to the risk of Hib disease in the population. In populations where the 
incidence of Hib disease is high, epiglottitis is rare and meningitis predominates and 
occurs most often before 6 months of age. In contrast, where the incidence of Hib 
disease is lower epiglottitis is more common and usually occurs in children over 2 years 
of age and meningitis tends to occur predominantly in children over the age of 12 
months. In developing countries where the incidence of Hib disease is high and most 
disease occurs before 6 months of age, pneumonia is commoner than meningitis and 
epiglottitis is not seen (Mulholland et al., 1997). 
1.6.1 Epidemiology of carriage 
Carriage rates in different populations vary. In developed countries H. influenzae has 
been found to be carried by up to 80% of the population studied (Kuklinska and Kilian, 
1984). Only a small percentage of the carriage strains are encapsulated and of these 2-
4% are type b (Maxon, 1986). Most surveys in industrialised countries agree that 
nasopharyngeal or throat cultures recover Hib in 3% to 5% of young children with age 
being a prominent determinant of Hib carriage rates (Barbour, 1996). Higher rates up to 
15% have been found in American Indian and Alaskan native populations and in some 
developing countries, such as, the Dominican Republic and the Gambia (Gomez et al., 
1998). On the other hand, the prevalence of Hib colonisation in children in Beijing, 
China has been reported to be 2% (Levine et al., 2000). In Hong Kong, where there is 
an apparently low incidence of Hib disease, the carriage rate of Hib was zero in 621 
Chinese children and 1.3% in 300 Vietnamese refugees (Lau et al. , 1998). 
Table 1. 6 A selection of incidence and mortality data of invasive Hib disease from 
different worldwide areas 
Incidence /100,000 Children 
Country, Area or Population < 5 years old/year Mortality Reference 
Meningitis Epiglottitis All 
(%) 
Australia: Sydney 20 13 40 2.0 (McIntyre et al ., 1991) 
Australia: Central Australia 273 0 991 8.3 (Hanna, 1990) 
Aborigines, NT 
England and Wales not stated not stated 29 2.4 (Anderson et al. , 1995) 
Finland 26 13 52 1.8 (Takala et al., 1989) 
USA: Minnesota 45 not stated 67 2.8a (Murphy et al. , 1987) 
USA: Dallas County, TX 67 not stated 109 2.8a (Murphy et al., 1987) 
USA: Apaches 254 not stated not not stated (Losonsky et al., 1984) 
stated 
USA: Alaskan Eskimos 409 0 491 6.0 (Ward et al. , 1981 ) 
USA: Alaskan Natives 282 8 601 3.1 b (Ward et al., 1986) 
(Indians and Eskimos) 
USA: Alaskan non-Natives 69 16 129 3 .1 b (Ward et al., 1986) 
France: Central and Southwest 15 2 21 2.8 (Reinert et al. , 1993) 
Ireland not stated not stated 25.4 not stated (Fogarty et al. , 1995) 
Israel 18 not stated 34 2. 1 (Dagan, 1993 ) 
Greece not stated not stated 12 not stated (Tsoha et al., 1998) 
Spain: Barcelona not stated not stated 15.4 not stated (Beni et al., 1999) 
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Spain: Catalonia not stated not stated 6.4 not stated (Dominguez et al. , 1999) 
Brazil: Campinas region not stated not stated 17 not stated (Weiss et al., 2001 ) 
Hong Kong not stated not stated 2.7 not stated (Lau et al., 1995) 
Singapore not stated not stated 3.3 not stated (Lee et al., 2000) 
Korea not stated not stated similar not stated (Lee, 1998) 
to USA 
Japan not stated not stated 4.7 not stated (Kamiya et al., 1998) 
China: Hefei City not stated not stated 10.4 not stated (Yang et al. , 1998) 
Nigeria: Niamey not stated not stated 179 43 (Campagne et al., 1999) 
West Gambia 60 not stated 45 37 (Bijlmer et al., 1990) 
3
combined mortality for Dallas County and Minnesota 
bcombined mortality for Alaskan natives and non-natives 
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Under crowded circumstances or 1n a closed population carnage rates may be 
substantially higher than in open populations (Barbour, 1996). Prior to the introduction 
of the Hib vaccine, carriage of Hib in infants in an Aboriginal population in which the 
organism is highly endemic was found to be at least 48% by age 6 months (Smith-
Vaughan et al., 1998). 
Since most patients with Hib disease have not had contact with a person who had 
invasive disease, and the organism has no known reservoir outside humans, 
asymptomatic carriers have been recognised as the major source of Hib infection 
(Barbour, 1996). Carriage of Hib lasting more than six months has been reported 
(Michaels et al. , 197 6; Michaels and Norden, 1977). 
Pharyngeal carriage of Hib is important, not only, in the transmission of Hib, but also, 
in the pathogenesis of Hib disease (Moxon et al. , 1974) and the development of 
immunity to the bacterium (Bradshaw et al. , 1971 ). The remarkable success of current 
vaccination programs against Hib has been due in part to the effect of conjugate Hib 
vaccines in decreasing carriage of Hib (Peltola et al., 1992; van Alphen et al., 1994; 
Barbour et al., 1995; Muhlemann et al., 1996). 
There is some evidence that the population structure of nasopharyngeal Hib is different 
from that of invasive Hib (Leaves et al., 1994). And, organisms isolated from the 
pharynx appear to lack certain virulence attributes found in organisms that have 
disseminated into the blood stream of patients with invasive disease (Weiser, 1993 ). 
1.6.2 Epidemiology of Hib disease in Australia (Table 1.7) 
Before the introduction of conjugated vaccines, Hib had been the most important cause 
of meningitis in young children in Australia and similar industrialised countries. Among 
Caucasian populations in major urban areas of Australia the reported incidence of Hib 
disease ranged from 25 to 63.5 cases per 100,000 children under the age of five . Few 
cases were attributed to other encapsulated types or non-encapsulated H. influenzae. 
As with North American Indians and Eskimo children in the pre-vaccine era Aboriginal 
children had very high incidence rates of H. influenzae infection, young ages at disease 
occurrence, and a spectrum of disease characterised by the absence of epiglottitis and 
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predominance of meningitis and pneumonia. A striking difference between North 
American Indian children and Aboriginal children is that, whereas, virtually all cases in 
the former group of children are caused by type b strains, 15% of the infections in 
Aboriginal children in the Northern Territory are not caused by type b strains (Hanna, 
1990). In this regard, the epidemiology of invasive H. injluenzae infections in 
Aboriginal children is similar to that in children in some developing countries where 
Hib predominates in meningitis in young children but encapsulated types other than b 
and NCHi are frequently found as pathogens (Gratten et al. , 1994). 
In Australia, epiglottitis comprises 30-40% of the cases of invasive Hib disease in non-
Aboriginal children and meningitis comprises around 50% (Gilbert et al., 1990; 
McIntyre et al., 1991; McGregor et al., 1992) but, in Aboriginal children epiglottitis is 
virtually unknown (Hanna et al., 1992). The absence of epiglottitis among Aborigines 
corresponds to the striking characteristic of age-related variation in the incidence of Hib 
disease. The higher the overall incidence of Hib disease is, the earlier the median age of 
illness and the greater relative frequency of meningitis. Aboriginal populations have a 
very high incidence of Hib disease that occurs at a mean age of 6 months. 
Correspondingly it has been found that epiglottitis rarely if ever occurs in these 
populations (Clements and Gilbert, 1989). Another pattern of Hib disease in Australia 
before the introduction of Hib vaccines was a significant difference in the incidence of 
epiglottitis among urban populations. The incidence of epiglottitis in Victoria (Gilbert et 
al., 1990) and the Australian Capital Territory (McGregor et al., 1992) was twice that in 
Sydney (McIntyre et al., 1991) and Western Australia (Hanna et al., 1992). 
The intriguing issues concerning the epidemiology of Hib disease have prompted 
numerous studies to examine host factors and the characteristics of bacterial strains 
associated with Hib meningitis and epiglottitis (Takala et al., 1987; Johnson et al., 
1993; Johnson et al., 1996). Despite such efforts no evidence has emerged that provides 
definitive answers to the questions raised. It has been reported that some Hib outer 
membrane protein (OMP) subtypes are more likely to cause meningitis than epiglottitis 
(Takala et al., 1987) but this finding has not been substantiated by later studies (Takala 
et al., 1989; Clements et al., 1992). To date no finding has defined the characteristics of 
Hib, if any, that are associated with its unique epidemiology. 
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Table 1. 7 Incidence of Hib disease in Australia before the introduction of vaccines 
Incidence /100,000 Children 
< 5 years old/year 
Geographic Area Years Reference Meningitis Epiglottitis All 
NON-ABORIGINAL 
ACT 1984-1990 31 20 63.5 (McGregor et al. , 
1992) 
Victoria 1985-1987 25.4 22.7 58.5 (Gilbert et al. , 1990) 
Sydney 1985-1987 20 1/3 of 38.5 (McIntyre et al. , 1991) 
Hib disease 
Queensland 1990-1993 not stated not stated 36.4 (Scott, 1993) 
South Australia 1988-1991 25 not stated 25 (El Saadi and 
Cameron, 1993) 
Western Australia 1984-1988 26.9 13.5 36.8 (Hanna and Wild, 
199 1) 
Top End, NT 1985-1988 53 2 cases 59 (Hanna, 1990) 
Central Australia, NT 1985-1988 215 2 cases 215 (Hanna, 1990) 
ABORIGINAL 
Queensland 1990-1993 not stated not stated 116.6 (Scott, 1993) 
Western Australia 1984-1988 149.6 no cases 261.8 (Hanna and Wild, 
1991) 
Top End, NT 1985-1988 159 no cases 237 (Hanna, 1990) 
Central Australia, NT 1984-1988 273 no cases 991 (Hanna, 1990) 
1.7 Hib Vaccines 
Most individuals acquire protective immunity in the first few years of life without ever 
having developed invasive Hib disease. This naturally acquired immunity probably 
develops as a result of pharyngeal colonisation with Hib, as well as, colonisation of the 
gut with normal enteric flora that are antigenically cross-reactive with Hib (Shapiro and 
Ward, 19 91). 
About seventy years ago it was recognised that inadequate levels of a 'protective 
bactericidal activity in the blood' in young children played a major role in the 
development of disease (Fothergill and Wright, 1933). It was later shown that 
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antibodies to the type b capsular polysaccharide mediated this immune response (Turk, 
1981 ). We now know that transplacental anti-capsular antibodies in the newborn are lost 
within the first few months of life but reappear later in older children and adults , 
probably as a result of exposure to Hib or to other microbial antigens that engender 
cross-reactive antibodies. Loss of transplacental antibodies in the early months of life is 
coincident with the marked increase in the risk of Hib disease. The premise underlying 
the administration of vaccines during the first 6 months of life is to eliminate the 
window of age-related susceptibility between about 6 months ( earlier in indigenous 
populations) and 2-4 years of age. 
Although natural immunity to Hib undoubtedly involves immunity to several surface 
antigens of the organism, antibody to the type b polysaccharide, polyribosylribitol 
phosphate (PRP), appears to be of primary importance and the protection afforded by 
anti-capsular antibodies have been exploited in the development of Hib vaccine. PRP 
was purified for use as a vaccine immunogen in 1970 and vaccination against Hib was 
first attempted in a large field trial in Finland in 1974 (Peltola et al., 1977). From this 
study several important conclusions were drawn: 1) adverse effects were minor, 2) 
antibodies were induced only in children above 18 months of age, 3) no booster effect 
was seen, 4) protective efficacy was 90% in children above 24 months and nil in 
children below 18 months, and 5) protection was related to the level of antibody against 
Hib capsular polysaccharide (Kristensen, 1999). 
Like most polysaccharide vaccines, purified PRP is a relatively poor immunogen and 
does not provide immunologic memory in young children, hence, its inability to induce 
protective antibodies in children below 18 months. Subsequently, second generation 
vaccines have been developed in which PRP has been conjugated with various proteins 
to convert it to a thymus dependent antigen that is immunogenic in younger children 
and induces immunologic memory and an amnestic response to subsequent doses 
(Clements and Gilbert, 1989). 
Four basic types of conjugate vaccines have been licensed in various countries. They are 
polysaccharide conjugated to diphtheria toxoid (PRP-D: 'ProHIBit', Connaught 
Laboratories), non-toxic oligosaccharide mutant diphtheria toxin (HbOC: 'HibTITER', 
Praxis-Lederle Biologics), outer membrane protein complex of Neisseria meningitidis 
(PRP-OMP or PRP-OMPC: 'PedvaxHIB', Merck, Sharp and Dahme), or tetanus toxoid 
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(PRP-T: Pasteur-Merieux). They differ, not only, in their carrier proteins, but also, in 
the structure and length of the polysaccharide molecule(s) bound to the protein, in the 
method of coupling the protein to the carbohydrate and in the ratio of protein to 
carbohydrate. All four are highly immunogenic in adults and older children but differ 
markedly in the immune responses they stimulate among infants and these differences 
appear to be predictive of efficacy, such that some vaccines might be more suitable in 
certain populations (Decker and Edwards, 1998). Decisions about conjugate Hib 
vaccines for the Australian schedule were based on local epidemiological data and 
extrapolation from studies in comparable populations elsewhere (Guthridge et al. , 
2000). This led to the choice of PRP-OMPC for Aboriginal children and HbOC for 
non-Aboriginal children. 
The conjugate Hib vaccines were introduced in Australia in 1992 and 1993 and a 
nationally funded program of infant vaccination was begun in July 1993. Since then, as 
in other areas where widespread immunisation has been introduced, the incidence of 
invasive disease has dropped dramatically and surveillance systems have noted a 
greater than 70% decline in invasive Hib disease in Australian children under the age of 
5 years (Herceg, 1997; Bower et al., 1998). In fact, where ever conjugate Hib vaccines 
have been introduced a dramatic reduction in Hib disease has been observed (Peltola et 
al. , 1992; Adams et al., 1993; Booy et al., 1994; van Alphen et al. , 1994). The 
impressive impact of Hib vaccines has led to the speculation that in areas where 
vaccination has been introduced, particularly where the vaccine coverage is high, it is 
now likely that Hib disease can be eliminated (Heath, 1998). 
The process of eliminating Hib disease is helped by the eradication of Hib from the 
nasopharynx, a finding unique among bacterial infections (Peltola, 1993). That Hib 
conjugate vaccines protect against the acquisition of carriage has been established in 
epidemiologic terms, however, molecular knowledge about the mechanism by which 
conjugate vaccines reduce mucosal colonisation and the role of mucosal IgA antibodies 
in host defense against Hib is limited (Barbour, 1996). It is also not clear how large the 
impact of decreased carriage is among unvaccinated children for whom a reduced 
incidence of Hib disease has been observed (Madore, 1996). 
While it is clear that Hib vaccination confers protection, as Hib disease incidence has 
plummeted where it is available, the picture emerging is not that simple. Reports of 
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increased carnage rates and the re-emergence of Hib after the introduction of 
vaccination and evidence of replacement disease contribute to the need to monitor 
vaccine efficacy, H. injluenzae epidemiology and the distribution of genetic types of 
Hib. Continued high carriage rates averaging 9.3% but, as high as 22%, reported among 
Alaskan Natives in remote villages is postulated to have caused a resurgence in Hib 
disease in Alaska (Galil et al., 1999). A sharp decline in incidence after the introduction 
of Hib conjugate vaccine PRP-OMP was observed in Alaskan Natives, however, after 
switching to a different Hib conjugate vaccine, DTP-HbOC, a re-emergence of Hib 
disease occurred suggesting continued transmission of Hib despite widespread 
vaccination (Galil et al., 1999). 
A different scenario has emerged in another Native American population. In a group 
who have historically had a very high rate of Hib disease, the Navajo Indian population 
in the USA, incidence rates have remained about 20 times higher than in the general 
USA population despite dropping tremendously (Scheifele, 2001). However, in a two 
year period only 1 Navajo child out of 380 was colonised with Hib and the locus and 
reservoir of colonisation remains unknown (Scheifele, 2001 ). 
In Australia, pnor to the introduction of vaccination, the carriage rates among 
Aboriginal infants in a remote community were at least 42.8% by age 6 months; these 
rates fell during the first 6 months of vaccine use and reached zero in 1994; but, 
subsequently, Hib carriage rates in infants in the same population have risen (Smith-
Vaughan et al., 1998). This is of some concern, particularly, in light of the re-
emergence of Hib disease in Alaskan Natives. Relatively lower serologic responses to 
PRP-OMP vaccine in Aboriginal infants compared to Caucasian infants may contribute 
to the persistance of Hib colonisation (Guthridge et al., 2000). The data also suggest 
that Aboriginal children may have a disproportionate proportion of reported deaths and 
vaccine failures (Herceg, 1997). 
There was concern that as reduction of Hib disease progressed there would be 
replacement disease or replacement carriage with other types of capsulate or non-
capsulate Haemophilus and that other serotypes might acquire additional virulence traits 
and emerge as important pathogens (Slack, 1995; Muhlemann et al. , 1996). It has also 
been speculated that the broad use of Hib vaccines may lead to an increase in invasive 
disease due to non-capsulated mutants of Hib since they are not susceptible to antibody 
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elicited by the vaccine (Kroll et al., 1991). It is still not well known how the widespread 
use of vaccines influence the distribution of Hib subtypes. 
Until recently evidence of replacement has not been observed (Barbour et al. , 1995) 
(Melville et al. , 1994; Madore, 1996), though, slight increases in NCHi disease have 
been reported (Muhlemann et al., 1996). The predominant circulating Hib clones were 
shown to have disappeared during mass vaccination in Finland (van Alphen et al. , 
1992). Then an unusual cluster of 5 cases of severe disease that resembles the clinical 
and epidemiologic features of Hib disease but was caused by H. influenzae type a 
occurred in a 10 month period in 1998-1999 in Utah (Adderson et al., 2001). Three 
cases were attributable to a unique strain that possesses a deletion mutation associated 
with invasive strains of Hib but not normally found in non-invasive strains (Adderson et 
al., 2001). The evidence of the possibility of the emergence of a new, virulent strain of 
H. influenzae with the virulence characteristics of Hib is of some concern. 
Besides the issues noted here, it must be remembered that vaccine failures do occur 
(Scheifele et al., 1996; Booy et al., 1997; Breukels et al., 2001) and that H. influenzae 
remains a common pathogen in adult patients in whom at least half of invasive 
infections are caused by Hib and other encapsulated types (Strausbaugh, 1997). 
Investigation of carriage rates and the possible re-emergence of Hib disease will require 
long term surveillance of Hib disease. The need to monitor Hib isolates for the potential 
effects of the vaccine on clone selection or the replacement of Hib with other cap types 
is warranted. Such monitoring should include the genetic characterisation of carriage 
isolates, vaccine breakthrough strains and all strains from serious disease. To do this , 
techniques able to distinguish between Hib and the other serotypes and between capsule 
deficient type b and truly non-capsulate strains are essential. 
1.8 Phenotypic and Genotypic Methods Used to Characterise Hib 
Many questions about the epidemiology and population structure of Hib will be 
answered as we increase our understanding of the diversity that exists among Hib 
isolates. This section describes the variety of phenotypic and genotypic methods listed 
in Table 1. 8 that have been used to characterise Hib and the general usefulness of the 
information derived from them for surveillance, epidemiological and population 
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structure studies. Discussion on the population structure and genetic diversity of Hib 
derived from studies using these methods is located in section 1. 9. 
Table 1. 8 Some Typing Systems Used to Characterise H. influenzae and Hib 
Traditional Phenotypic Systems 
Biochemical reactions (biotyping) 
Capsular serotyping 
~-lactamase production 
Antibiotic sensitivity patterns 
More Powerful Phenotypic Systems 
Outer membrane protein typing 
Lipooligosaccharide typing 
Whole cell polypeptide typing 
Multilocus enzyme electrophoresis typing 
Molecular Typing Systems 
Plasmid profiles 
Polymerase chain reaction based methods: 
PCR-restriction fragment length polymorphism 
Randomly amplified polymorphic DNA 
Enterobacterial repetitive intergenic consensus 
sequences 
Long-PCR-ribotyping 
DNA restriction fragment length polymorphism 
patterns derived from: 
Plasmid restriction endonuclease analysis 
Chromosomal restriction endonuclease analysis 
Pulsed field gel electrophoresis 
Ribotyping 
Southern hybridization 
DNA sequencing of a particular locus 
Whole genome sequence typing - has begun 
Multilocus sequence typing -future 
1.8.1 Classic phenotypic typing systems 
Traditionally, methods used to discriminate among bacterial isolates 1n the 
epidemiological analysis of outbreaks of pathogenic bacteria have relied on what we 
now refer to as the traditional or classic phenotypic typing systems (Table 1.8). These 
systems detect characteristics expressed by microorganisms, such as, antibiotic and 
phage susceptibility patterns and biochemical and immunological reactions. 
Because phenotypic typing systems detect characteristics of isolates that cannot be 
related to allelic variation at specific gene loci, it cannot be concluded that isolates 
sharing one or more phenotypic features are from the same or a closely related clone. 
Conversely, random mutations may also cloud interpretation of phenotypic data among 
variants derived from a single clone that exhibit different phenotypes due to a random 
mutation but that are otherwise genetically similar. 
For these reasons using a single phenotypic characteristic as a critical determinant in 
any identification system is particularly hazardous. Usually several characteristics are 
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evaluated but this does not overcome the significant limitations in the use of phenotypic 
characteristics. They do not provide the information needed for the study of population 
structure because they are not able to detect the great diversity inherent in bacterial 
species and do not identify genotypes. Nonetheless, phenotypic methods are still very 
important in the primary identification of bacteria and can be useful in epidemiology 
studies . 
1.8.1.1 Primary identification of Hib 
The primary identification of Hib is based on the observation of typical colonial 
morphology on chocolate agar, gram stain morphology, and a characteristic mousy 
odor. The standard work-up for an isolate that exhibits microscopic and colonial 
properties suggestive of Haemophilus species is to determine the organism's X and V 
factor requirements (Table 1.1 ). Porphyrin-based testing methods (which detect strains 
of Haemophilus capable of synthesising heme, a property not shared by strains requiring 
exogenous X factor) represent the most reliable means for identifying Haemophilus 
species (Munson et al., 2002). Key biochemical tests can be used to identify 
Haemophilus to the species level. Specifically, H. influenzae will ferment glucose but 
not sucrose, lactose, or mannose. It will not hemolyse horse blood agar and is catalase 
positive. Capsular serotyping techniques or capsular genotyping techniques are used to 
determine the capsular type. 
1.8.1.2 Biotyping using Kilian's system 
As previously mentioned in section 1.2, Kilian's system of biotyping based on indole 
production, and urease and omithine decarboxylase activities is used to subdivide H. 
influenzae into eight biotypes (Table 1.2). The data that have accumulated from 
biotyping studies suggest that H. influenzae is biochemically heterogenous and initially 
it was thought that there might be a relationship between biotype and ability to cause 
invasive disease. However, this possibility is probably no more than a reflection of the 
unequal distribution of type b strains among the biotypes (Turk, 1984). Eighty-nine 
percent of Hib strains, the most frequent cause of the more serious H. influenzae 
diseases, are biotype I (Granoff et al. , 1982) whereas the majority of clinical NCHi fall 
into biotypes I, II, III, and IV (Barenkamp et al. , 1982; Butt et al. , 1990). 
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Biotyping may be useful in providing presumptive evidence for the epidemiology of 
Haemophilus influenzae disease as certain biotypes have been shown to be associated 
with different types of infections, sources of isolation, antigenic properties, and 
antimicrobial resistance patterns (Koneman et al., 1988). The sensitivity of biotypes to 
strain variation, however, is limited since only eight biotype categories are defined and 
some biotypes are found infrequently. Consequently, biotyping of Haemophilus 
influenzae strains has relatively poor discriminatory power and is not useful in 
population genetic studies. Among Hib strains, most of which are biotype I, the 
discriminatory power is very poor and biotyping is not very useful for determining 
genetic diversity in epidemiological studies. 
1.8.1.3 Capsular serotyping 
Capsular serotyping is most useful 1n the pnmary identification of H. influenzae 
isolates. Slide agglutination utilising serotype specific antiserum has been the most 
widely used method to determine serotypes but this method has been shown to be prone 
to error (Murphy and Apicella, 1987). A common pitfall appears to be serotyping a non-
capsulate isolate as a typeable one. This may be due to strains of NCHi 
autoagglutinating and the 'halo error' of high expectation that an isolate from blood or 
cerebrospinal fluid will be type b, especially when type b antiserum is the primary 
reagent used (Murphy and Apicella, 1987). False negatives due to technical error may 
also occur. Reports of infections due to non-typeable strains falling over 30% since the 
introduction of Hib vaccines in England suggest that some reported N CHi are really 
type b (Melville et al. , 1994). In addition, serotyping cannot detect cap b- mutants that 
do not express capsular polysaccharide. They are mistakenly identified as non-typeable. 
Serotyping has little discriminatory power because most invasive strains are type b. The 
use of genotypic capsular typing systems has contributed to the precise identification of 
capsular and non-capsular H. influenzae, as well as, to the elucidation of genetic 
variation among Hib strains (Kroll et al., 1991; Falla et al. , 1994). 
1.8.1.4 Antibiotic susceptibility and p-lactamase production 
Antibiotic sensitivity patterns and P-lactamase production may be helpful in 
discriminating isolates in outbreak situations but tend to be of limited use in studies of a 
large number of epidemiologically unrelated isolates. Furthermore, antibiotic 
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susceptibility patterns can change rapidly as an organism may become resistant and, 
conversely, lose resistance by multiple genetic mechanisms. The identification of new 
or unusual antibiotic sensitivity patterns among isolates from multiple patients may be 
the first clue to an outbreak but offers little utility for epidemiology studies (Arbeit, 
1995). Molecular characterisation of antimicrobial resistance determinants and plasmids 
has contributed to our understanding of the epidemiology of antimicrobic resistance and 
the genetic relatedness of multiply resistant H. influenzae (Mendelman et al., 1985; 
Campos et al. , 1989; Levy et al. , 1993). 
1.8.2 More powerful phenotypic typing systems 
In the last 25 years there have been substantial developments in the ability to assess 
microbial diversity through the study of proteins. Though relying on the expression of 
genetic information, protein and other chemical profiling techniques have proven to be 
useful methods for discriminating bacterial isolates and have been developed as marker 
systems for epidemiology studies and to investigate genetic diversity. The most 
common protein analyses include outer membrane protein typing, whole cell 
polypeptide typing, and multilocus enzyme electrophoresis. Multilocus enzyme 
electrophoresis, in particular, has been used effectively for analysing population 
structure. Various types of lipid, carbohydrate and other chemical profiling have also 
proved useful in detecting diversity. The more po{verful phenotypic systems used in the 
analysis of Haemophilus influenzae are described here. 
1.8.2.1 Outer membrane protein typing 
Useful phenotypic and epidemiologic information can be obtained from companng 
outer membrane protein (OMP) profiles. The OMPs are isolated from the cell in 
insoluble fractions and the identification of principle proteins is established by 
determining their molecular weights on stained electrophoretic gels. A selective 
solubility of the cytoplasmic membrane proteins in a particular detergent is exploited in 
the isolation of OMPs. The conditionally insoluble membranes contain integral and 
likely some peripheral proteins which are released by relatively small changes in pH or 
ionic strength and are referred to as outer membrane proteins, and more appropriately, 
detergent insoluble membrane proteins (Carlone et al. , 1986). Sodium dodecyl sulphate-
polyacrylamide gel electrophoresis of OMP preparations of Hib resolve a number of 
proteins that have been used to develop sub-classification schemes (Loeb and Smith, 
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19 8 O; B arenkamp et al. , 19 81; van Alp hen et al. , l 9 8 3). Among both encapsulated and 
non-capsulate H. influenzae the outer membrane protein component contains up to 36 
proteins of which 6 represent the major protein content (Loeb and Smith, 1980). The 
major proteins have molecular weights between 50,000 and 15,000 and are labelled P 1 
to P6 or a to fin order of decreasing molecular mass (Foxwell et al. , 1998). Overviews 
of the characteristics of major and minor proteins are found in Foxwell, et al. (1998) 
and Gilsdorfs reviews on H influenzae (Foxwell et al. , 1998; Gilsdorf, 1998). 
The usefulness of OMP subtyping varies . Initially, Granoff, et al. (1982) identified 21 
distinctive OMP subtypes among Hib isolates from 256 patients in 22 states in the USA. 
They found that three subtypes accounted for nearly three-quarters of the isolates and 
six subtypes were responsible for 89% of infections (Granoff et al. , 1982). That a 
limited number of types accounted for most of the isolates suggested a small number of 
distinctive clones were responsible for Hib disease. In contrast, studies in the 
Netherlands showed that a single OMP subtype predominated in Western Europe (van 
Alphen et al. , 1983 ; van Alphen et al., 1987). Similarly, a single OMP subtype was 
responsible for 83% of Hib infections in Victoria (Clements et al., 1992) and 76% in 
Western Australia and the Northern Territory (Hansman and Lawrence, 1993). Thus, 
OMP subtyping in those regions is of limited value for epidemiological purposes. 
While OMP typing indicates that there is considerable genetic diversity of Hib in some 
populations it does not measure the extent of variation in the genome and it has a 
limited ability to discriminate among Hib unless an infrequent subtype is involved. In 
order to answer questions about genetic relatedness a more powerful typing method is 
needed. Despite technical and practical limitations OMP subtyping is frequently used to 
distinguish Hib isolates and its widespread use has contributed to our understanding of 
the diversity of Hib. 
1.8.2.2 Whole cell polypeptide typing 
The technique of whole cell polypeptide typing characterises the molecular weights and 
mobility of the whole cell polypeptide contents in a stained electrophoretic gel using 
sodiun1 dodecyl sulphate-polyacrylamide gel electrophoresis. It has been assessed to be 
more discriminatory than biotyping and outer membrane protein typing for examining 
the genetic diversity of Hib and NCHi because of the large number of bands found 
among the isolates studied; in two reports the average number of bands found per 
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isolate was 39 and 48 (Paterson et al. , 1987; Pennington and Freebaim, 1989). While 
the large number of markers, a feature necessary for the analysis of population structure, 
increases the discriminatory power of whole cell polypeptide typing, it makes it difficult 
to compare large numbers of isolates. Thus, whole cell polypeptide typing is probably 
best suited for small-scale epidemiological studies. The disadvantages of any 
polyacrylamide gel technique are inherent in the whole cell polypeptide analysis, the 
most notable being problems associated with inter-gel variability. The study of the 
genetic diversity of Hib and NCHi in North East Scotland resulting in the identification 
of clones and the estimation of the total number of clones existing in that geographical 
region with comparison to isolates from England, Sweden, the Nether lands, and the 
USA is the primary body of work that has been reported for H. influenzae using whole 
cell polypeptide typing (Paterson et al. , 1987; Pennington and Freebaim, 1989; Bruce 
and Jordens, 1991; Bruce and Pennington, 1991). 
1.8.2.3 Lipooligosaccharide typing 
Characterisation of Hib lipooligosaccharide (LOS) by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis revealed micro-heterogeneity among the LOS 
molecules of different Hib strains, which permitted the development of a limited system 
for subtyping Hib strains based on their LOS profile (Kimura and Hansen, 1986). The 
antigenic heterogeneity results primarily from differences in lipid A as well as 
differences in its core polysaccharide or short carbohydrate side chains (Gilsdorf, 1998). 
Originally 11 LOS types were described (Inzana, 1983). However, a paucity of 
heterogeneity among the cell surface exposed antigenic determinants of Hib LOS was 
confirmed in several studies including those by van Alphen, et al. (1 983) who reported 
finding 4 different LOS serotypes among 80 strains of Hib in the Netherlands and 
Gulig, et al. (1984) who described four antigenic groups among 126 strains in the USA 
(Kimura and Hansen, 1986). Due to the limited LOS antigenic diversity, LOS profiles 
have been used most often in conjunction with other typing systems to characterise the 
genetic variation of Hib. NCHi strains exhibit a more heterogenous population with 
respect to LOS demonstrating no fewer than 14 groups based on LOS composition 
(Foxwell et al. , 1998). 
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1.8.2.4 Multilocus enzyme electrophoresis 
Multilocus enzyme electrophoresis (MLEE) is a robust technique that has been used to 
estimate genetic diversity and structure in natural populations of a variety of species of 
bacteria by the analysis of up to 25 or more different metabolic enzymes per isolate 
(Selander et al., 1986). Basically, the number of shared ( or identical) enzyme variants 
between pairs of isolates is used to determine their relatedness. Water soluble cellular 
enzymes are extracted and electrophoresed on a non-denaturing starch gel or cellulose 
acetate sheets followed by staining of the enzymes. Each electrophoretic variant is 
assigned a numeric score and each unique combination of scores 1s called an 
electrophoretic type (ET). 
Because the rate of migration of a protein during electrophoresis is determined by its 
amino acid sequence, mobility variants can be directly equated with alleles at the 
corresponding structural gene locus. A large proportion of amino acid substitutions can 
be detected by this method. But, because some substitutions do not affect 
electrophoretic mobility, electromorphs may be sequentially heterogenous and at the 
level of the nucleotide sequence of the gene itself, there is even greater heterogeneity, 
owing primarily to silent substitutions (Selander et al. , 1986). Thus, it must be 
understood that the alleles recognised may actually be groups of isoalleles. Post-
translational modification is a potential source of error in the application of MLEE but 
there is no evidence that post-translational modification of enzymes occurs frequently 
enough in any organism to seriously bias the estimates of genetic variation derived from 
the electrophoresis of proteins (Selander et al. , 1986). 
Criticisms of MLEE are that: 1) it assays the genotype indirectly, so that much variation 
at the nucleotide level may go undetected because nucleotide substitutions do not 
necessarily change the amino acid composition; 2) changes in amino acid composition 
do not necessarily change the electrophoretic mobility of the protein and, as a 
consequence, alleles that are considered to be the same protein alleles from different 
individuals may represent different gene alleles, and 3) selection may be acting on the 
polymorphisms, so that anonymous DNA markers may give a very different picture 
from allozyme markers , presumably because the former are neutral and the latter are 
under some sort of selection (Taylor et al. , 1999). In other words only a minority of 
mutations are detected (those that alter the electrophoretic mobility of the enzyme), and 
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enzymes with the same electrophoretic mobility can be encoded by very different gene 
sequences. 
As MLEE can be used to detect genetic changes that accumulate slowly and are likely 
to be selectively neutral it is suitable for long-term and global epidemiology studies 
(Yakubu et al., 1999). MLEE offers limited applicability for epidemiological analysis of 
clinical isolates and, for practical considerations alone, the cost, relative labor intensity 
and complexity of the method has restricted its application to primarily large scale 
population structure studies carried out in research laboratories. In fact, the context in 
which we now view bacterial population structure is based largely on studies conducted 
using MLEE. MLEE data have been used to estimate the levels of single locus and 
multilocus genotypic variation in populations as well as the extent of genetic exchange 
within a population (Selander et al., 1987). A comprehensive analysis of the genetic 
structure of H. influenzae based on 2,209 isolates from six continents has been carried 
out using this method (Musser et al., 1990). 
1.8.3 Genotypic typing systems 
The shortcomings of phenotypically based typing methods have led to the development 
of genotypic typing systems that mine the tremendous variation found in bacterial DNA. 
In the past twenty-plus years there has been a virtual explosion in techniques used to 
analyse nucleic acids. Phenotypic methods are now broadly supplemented by 
genotyping methods that allow a more refined and detailed differentiation of closely 
related microorganisms on the DNA level. 
Molecular techniques, such as, polymerase chain reaction derived methods, restriction 
enzyme digestion methods, Southern blot analysis, and DNA sequencing methods have 
become routine procedures in the study of genetic diversity. Ever more innovative 
molecular techniques are continuously being added to the molecular typing palette often 
displacing first generation genotypic methods. Plasmid profile analysis, probably the 
first DNA based technique used in epidemiology studies, falls into the category of 
traditional typing methods that are still useful but have been largely supplanted by the 
newer genotypic methods of discrimination. 
52 
It should be noted that the explosion of molecular techniques has revolutionised the 
application of the differentiation of microorganisms. The techniques that involve direct 
DNA-based analyses of chromosomal or extra-chromosomal genetic elements have 
proven to be powerful tools for discriminating bacterial isolates. Their use has directly 
contributed to the growth of several major fields of microbiological research. 
Taxonomy, population genetics, the study of evolutionary dynamics and phylogenetic 
relationships, and microbial epidemiology all rely on the ability to discriminate among 
genotypes. Many areas of applied microbiological research also depend on the 
1neasurement of genetic diversity, including, for example, the investigation of outbreaks 
of infectious disease or measuring genetic diversity in relation to pathogenicity, drug 
resistance or biodegradation. 
Substantial complexities in interpreting the results of genotypic methods and applying 
the data to epidemiologic studies remain, as does, the challenge of standardising 
methods and establishing a common nomenclature. Great strides have been made in 
each of these areas and it is certainly an exciting time in what can be called "the era of 
burgeoning bioinformatics". 
The utility of molecular typing methods vanes. Each method has its technical and 
nucleic acid target-dependent limitations that should be taken into account with the 
choice of method depending on the nature of the questions to be answered. It is 
commonly recommended that "polyphasic" systems incorporating both different 
molecular targets and additional analytical procedures be employed in a molecular 
identification system (Harmsen et al., 2001). 
In the following sections (1.8.3.1 - 1.8.3.6) a number of representative genotypic 
methods including a comprehensive overview on pulsed field gel electrophoresis are 
described. The usefulness of these methods in discerning the genetic diversity of Hib is 
discussed in section 1. 9. 
1.8.3.1 Restriction fragment length polymorphism analysis 
Restriction fragment length polymorphism (RFLP) analysis is a powerful method for 
detecting sequence dissimilarities by analysis of size and number of fragments 
generated by endonuclease digestion of DNA. Methods using direct visualisation of 
stained fragments involve digestion of total DNA with a suitable restriction enzyme, 
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followed by electrophoresis in agarose or acrylamide gels or by PFGE. The DNA 
molecule is sampled for . sequences that are cleaved by a particular restriction 
endonuclease; fragments of the same length and number are generated from genomes of 
identical or similar sequence, but fragments of different length and number are 
generated when the genomic sequences are different. The proportion of fragments that 
have identical sizes provides an estimate of the sequence similarity between DNA 
molecules. The patterns, provided they are not excessively complex, can then be 
subjected to numerical analysis, such as, Dice coefficients and dendrograms, to give 
statistical estimates of sequence similarity. 
The reliability of numerical analyses and associated graphical representations based on 
RFLP data has been questioned because each restriction fragment does not represent a 
separate distinct characteristic; rather, each fragment is defined by two restriction sites, 
each comprising 4, 6, or 8 nucleotides (Arbeit, 1995). For PFGE profiles, which 
represent the entire circular chromosome, the creation or loss of a single restriction site 
affects two fragments. Moreover, fragments of the same molecular size cannot be 
assumed to represent the same chromosomal DNA and may differ because of the 
insertion or deletion of extrachromosomal DNA ( e.g., bacteriophages) (Arbeit, 1995). 
This has led to questions about the relationship between isolates with similar restriction 
patterns, in particular, whether it is valid to relate restriction fragment length 
conservation with overall DNA sequence conservation in bacteria (Hall, 1994 ). Despite 
these theoretical concerns the use of RFLPs to determine genetic relatedness is well 
accepted and in practice has been shown to produce reliable data concerning relatedness 
(Dr Adrian Gibbs, personal communication). In a study of 29 epidemiologically distinct 
Hib isolates PFGE RFLPs reflected evolutionary divergence consistent with that 
identified with MLEE (Arbeit et al., 1990). The issue requires additional investigation 
but currently numerical analysis of RFLPs is widely used to determine genetic 
relatedness. See interpretation of PFGE RFLPs in this section. 
1.8.3.2 Chromosomal restriction endonuclease analysis 
Chromosomal restriction endonuclease analysis (REA) involves companson of the 
number and the size of fragments produced by digestion of DNA with a frequent cutting 
restriction endonuclease that cuts DNA at a constant position within a specific 
recognition site usually composed of 4-6 bp. A limitation of REA of whole 
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chromosomes is the generation of a large number of fragments. The separation by 
conventional gel electrophoresis leads to a smear-like appearance of the DNA on the gel 
and the resulting band patterns are too complex to be properly compared. To master this 
problem, the method is combined with nucleic acid probes ( e.g, ribotyping). The use of 
pulsed field gel electrophoresis and rare cutting endonucleases overcomes this problem 
as the number of fragments generated can be limited to a manageable number due to the 
ability of PFGE systems to separate relatively large pieces of DNA. 
The advantages of REA are that it is universally applicable (in principle all isolates may 
be typed by REA), sensitive because the whole genome is sampled, and relatively easy 
to perform. Its major disadvantage is the complexity of the band patterns. Forbes, et al. 
overcame this problem by dividing the fingerprints into sections on the basis of the size 
range of fragments and then comparing the fragments in a number of sections to 
establish similarities or differences (Forbes et al. , 1991). 
1.8.3.3 Pulsed field gel electrophoresis 
Conventional agarose gel electrophoresis is capable of separating DNA fragments with 
sizes up to 40-50 kilo bases (kb) in length (Maniatis et al., 1989). In the early 1980s 
Schwartz and co-workers developed an electrophoretic technique capable of resolving 
DNA molecules in excess of 2,000 kb (2.0 Mb) (Schwartz and Cantor, 1984) and in 
doing so ushered in pulsed field gel electrophoresis (PFGE), an advance in DNA 
technology of great significance; and, as the analysis of megabase sized DNA molecules 
has become routine the use of PFGE has become increasingly common. 
PFGE utilises the ability of alternating electric fields to separate relatively large 
fragments of DNA up to megabases in size. The significance of this is that entire 
bacterial genomes can be digested using rare cutting endonucleases, which cut 
infrequently, and the resulting few large fragments can be separated using a PFGE 
system. So, theoretically, entire genomes can be compared by analysing restriction 
fragments . It has become a technique of central importance in the mapping and 
sequencing of entire genomes, prokaryotic or eukaryotic, as well as , a method of choice 
for discrimination of bacterial isolates in epidemiological studies. Because PFGE has 
been shown to be superior to most other methods for biochemical and molecular typing, 
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it is often considered to be the "gold standard" of molecular typing methods (Olive and 
Bean, 1999). 
The term 'pulsed field gel electrophoresis' is a genenc term referring to gel 
electrophoresis systems in which the electric field is switched, usually in a controlled, 
pulsatile fashion between two different directions with pulse times ranging from 0.1 to 
1000 seconds or more. The variation is applied most commonly to field direction, but 
the pulsing may also be in field strength. By forcing DNA molecules to reorient 
periodically from one electric field direction to another PFGE overcomes the size 
limitations of conventional electrophoresis where all linear double stranded DNA 
molecules that are larger than about 40-50 kb migrate through agarose gels at the same 
rate. In PFGE systems, the larger the DNA molecule, the longer it takes to reorient. 
Shorter molecules can reorient more quickly and can therefore move through the gel 
faster than longer molecules. As a result mobility becomes a function of size and 
fragments ranging from 0.1 to 10 megabases can be efficiently separated. 
A consistent and generally accepted theoretical basis for DNA behaviour during PFGE 
has yet to be described. Probably the most popular conceptual framework is described 
in Sambrook and Russell's third edition of Molecular Cloning: A Laboratory Manual 
(Sambrook and Russell, 2001 ). It proposes that the effect of alternating fields can be 
explained by considering that a DNA molecule stretches out or elongates and orients 
parallel to an electric field. It can then be moved through successive pores in the agarose 
gel by reptation (the movement of large molecules believed to assume an 'end-on' 
configuration to the gel matrix as they wriggle in a reptile-like mode through the gel 
interstitial spaces). When the field direction changes, the DNA molecule must reorient 
before it can move in the new direction. As the field direction regularly changes, the 
DNA must regularly change directions. The larger the molecule, the more time required 
to reorient and tum comers, leaving proportionately less time (within each pulse) 
available to move in the new direction. 
A variety of different types of apparatus have been used successfully for PFGE. All are 
based on the approach to find the optimum electrode geometry which, coupled with 
appropriate pulses, would give reliable separation of large DNA molecules . Several of 
the more popular designs are described in Molecular Cloning: A Laboratory Manual 
(Sambrook and Russell, 2001). 
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Contour-clamped homogeneous-field (CHEF) electrophoresis is the most common type 
of PFGE now used. In CHEF PFGE the electrode configuration and the electrical 
switching are controlled in such a way as to generate electric fields that are 
homogeneous. The electrode arrays are hexagonal giving a field orientation, which is 
pulse-switched by 120°. The DNA molecules migrate with linear trajectories and 
fragment sizes can be compared accurately across multiple lanes in a gel so that size 
identity can be established. It also allows the accurate indexing of gel bands to 
transferred fragments on membrane filters in DNA hybridization analysis. And specific 
DNA molecules can be isolated by cutting gel bands from individual lanes. 
There are five major practical determinants that must be considered in optimising the 
resolution of large DNA molecules on gels: pulse time, field strength, alternating field 
angle, gel concentration (and agarose quality), and temperature (Stewart et al. , 1994). 
In addition, special consideration must be given to DNA preparation, the use of 
molecular weight markers and restriction enzymes. These parameters are 
interdependent and require careful exploration to generate a successful PFGE. A great 
deal of this exploratory work has been done and is reported in accounts of PFGE but it 
is worth understanding the functional significance of variation of these parameters. 
Pulse times should be greater for larger molecules. As a starting point from which to 
explore individual protocols for bacterial studies, pulse times of 1-2 seconds for <50 kb, 
10 seconds for 50-200 kb, 60 seconds for 200-800 kb, 120 seconds for up to 1400 kb 
have been suggested (Stewart et al., 1994). The use of ramped switching permits greater 
resolution of DNA fragments within a given size range. In ramping, the switch time at 
the beginning of the electrophoresis run is different from that at the end of the run. The 
resolution of a broad size range of fragments on a single gel can be optimised by 
programming consecutive blocks ( each with a customised ramp of initial switch time, 
final switch time, and run time) for the electrophoresis run. Ramping and using a series 
of blocks of varying ramps is possible on most commercial CHEF systems. 
Field strength or voltage, measured as V/cm, determines the rate of migration of 
charged particles through a gel. While increasing the field strength increases the size of 
the largest material resolved, there is a limit to the speed with which PFGE separations 
can be carried out because knotting and irreversible pinning of molecules to gel matrix 
fibers occurs at high voltages (Sambrook and Russell, 2001). Voltage effects are 
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particularly important for resolution of >2000 kb for which long, slow pulse times of 
30-90 minutes at ~ 1-2 V/cm are required. For smaller fragments , typical of the 
fragments produced when bacterial genomes are digested with infrequent cutting 
enzymes, pulse times of 1-90 seconds at 6 V/cm are usually optimal. 
Alternating field angle should be somewhere between 90° and 180° with 120° a 
common setting. In many systems this is an invariant parameter. It has been shown that 
decreasing the included angle from 120° to 94° increases the velocity of the DNA, with 
the mobilities of the large DNAs (> 1 Mb) affected to a greater degree than the smaller 
DNAs (< l Mb) (Bio-Rad, 1992). 
Gel concentration and agarose quality are similar to those now used in conventional 
electrophoresis. Gel concentrations around 0.8-1.2% provide good band sharpness. The 
quality of agarose is important and the highest quality ultra-pure agaroses should be 
used. Agaroses with ultra-low electroendosmosis used with low ionic strength buffers 
can increase the mobilities of DNA molecules in PFGE by as much as 50% (Lai, 1991 ). 
It might be noted that it was the advent of PFGE with its requirement for contaminant 
free agarose and a reduction in its long run times that has led to the quality of agaroses 
that are now available for electrophoresis. 
Temperature influences the rate at which DNA molecules relax and adopt new 
configurations when the electric field changes. DNA migrates faster at higher 
temperatures; however, higher temperatures also cause trapping at lower fragment sizes 
and significant band broadening (Sambrook and Russell, 2001). So, unlike conventional 
agarose electrophoresis, which is generally carried out at room temperature, PFGE is 
generally run at 4- l 5°C with temperatures of 12-14 °C appearing to be optimal in 
increasing relaxation rates while at the same time avoiding band and lane distortion due 
to heat build-up (Stewart et al. , 1994 ). 
DNA preparation for PFGE cannot be accomplished using standard procedures for 
DNA isolation in solution. Instead, to preserve the integrity of the large DNA molecules 
required for PFGE, DNA isolation is done by embedding live cells in agarose (Schwartz 
and Cantor, 1984). To prevent shear damage, procedures have been developed for 
extracting DNA from the cells embedded in small plugs (also called inserts) of low 
melting temperature agarose. The cells are lysed and other cellular macromolecules 
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(proteins, RNA, lipids) are degraded or solubilised by enzymatic digestion and 
detergent treatment directly in the agarose plugs. The 'cleaned' DNA embedded in the 
agarose plugs is subjected to buffer washes and digestion procedures for the restriction 
enzyme of choice and, subsequently, loaded into the loading wells of the gel. Prior 
quantitation of cells is an important criterion in plug production to ensure the amount of 
DNA on the gel is optimal because the mobility of DNA in PFGE is more sensitive to 
concentration than in conventional electrophoresis. Amounts must be restricted to <1-2 
µg per lane (Sambrook and Russell, 2001 ). 
Molecular weight markers of a high molecular weight are required for PFGE as size 
standards are critical for estimating sizes of fragments, particularly, in the comparison 
of RFLPs on different gels whether by visual inspection or with commercial software 
packages. The use of A concatemers has become the standard for bacterial PFGE work. 
A series of markers evenly spaced over a wide range of molecular weights is obtained 
by the ligation of bacteriophage A DNA into a nested series of concatemers. The 
principle behind the formation of the concatemers is as follows. The viral DNA is 
readily ligated by virtue of the 12 bp sticky ends of cos sites that occur at both ends of 
the bacteriophage genome. Lambda will connect to themselves at these cos sites and 
form multimers of its 48.5 kb monomer; thus the individual concatemers are multiples 
of this length. Digested bacterial isolates with known fragment sizes, such as, the Smal 
digest of the chromosome of S. aureus ATCC 8325 used by Pattee to define the 
physical map of S. aureus are excellent size standards and preparation of the DNA 
serves as a useful quality control for the whole procedure (Maslow et al. , 1993 ). 
Restriction endonucleases with infrequently occurring recognition sites are essential to 
exploit the resolving power of PFGE. Due to the non-random arrangement of base pairs 
in a genome, certain restriction sequences may be substantially under-represented and 
the base composition and/or sequenced DNA from a genome can be used to predict 
which restriction sequences will be rare. Often the selection of endonucleases is a matter 
of trial and error guided by the nucleotide composition (G+C content), size of the 
genome and the purpose of the PFGE. Two practical points to keep in mind when 
selecting restriction enzymes are: one, DNA of low G+C will cut infrequently when 
treated with an enzyme with a G+C rich recognition site and two, enzymes with 8 bp 
recognition sequences will cut less frequently than comparable 6 bp cutters. Restriction 
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enzymes that generate between 15-25 fragments with a broad size distribution are 
optimal. 
Interpretation of PFGE restriction patterns. Analysing the restriction digest patterns 
resolved by PFGE to identify and differentiate strains is based on comparing the size 
and number of fragments between pairs of isolates. Tenover et al. have suggested and it 
is generally accepted that strains with identical PFGE patterns are considered to be the 
same strain and clonal. Strains with one or two band shifts consistent with a single 
genetic event ( e.g., a point mutation resulting in the loss or gain of a restriction site, an 
insertion, a deletion, or a chromosomal inversion) are also considered to be closely 
related. If there are a very limited number of band shifts ( 4-6) which are not explained 
by a single genetic event, the strains are considered to be possibly related but distinct. 
Strains that differ at six or more bands are considered to represent independent strains, 
although strains with multiple or distinctive similarities may have a common ancestry 
(Maslow et al. , 1993; Tenover et al. , 1995). 
Gel results can be photographed and the data can be stored by using one of several 
commercially available digital systems. Data analysis can be accomplished by using any 
of a number of commercially available software packages. With the aid of gel scanning 
and analysis software it is theoretically possible to create data banks of PFGE patterns 
for all organisms, enabling the creation of reference databases to which any new strain 
could be compared for identifying its phylogenetic relationship to similar strains (Olive 
and Bean, 1999). At this time inter-laboratory standardisation has not reached a level to 
allow the use of common type nomenclature or direct DNA pattern exchange to be used 
on a regular basis. However, surveillance networks are being been set up now using 
PFGE. These networks will serve as models for more extensive use of such 
standardisation. Several examples are noted here. 
The most prominent PFGE network is PulseNet, an early warning system for outbreaks 
of foodborne diseases set up in 1996 by the Centers for Disease Control and Prevention 
(CDC). It consists of a national network of laboratories that performs PFGE on bacteria 
that may be foodborne. The network identifies and labels each PFGE pattern and 
permits rapid comparison of these patterns through an electronic database at CDC. The 
subsequent inclusion of PFGE analysis of other bacteria, such as Neisseria meningitidis, 
to PulseNet demonstrates its wider usefulness (Popovic et al. , 2001). Another network 
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is the Pneumococcal Molecular Epidemiology Network established in 1997 under the 
auspices of the International Union of Microbiological Societies with the aim of 
standardising the nomenclature and classification of resistant pneumococcal clones. 
This system identifies worldwide clones using PFGE with two other techniques (McGee 
et al. , 2001 ). A third example is the rapid standardised PFGE protocol for 
macrorestriction analysis of methicillin resistant Staphylococcus aureus (MRSA) that 
has been developed in Canada which allows for inter-center comparisons of MRSA 
fingerprints for national surveillance studies (Mulvey et al. , 2001) 
Disadvantages of PFGE. Originally extensive use of PFGE was prevented by the long 
and tedious procedures required for isolating and cutting the genomic DNA by the 
agarose plug method, the requirement for large quantities of expensive enzymes and 
reagents, the complexity of experimentally optimising the electrophoretic conditions 
and the need for specialised equipment much more expensive than that required for 
PCR or southern hybridisation (Swaminathan and Matar, 1993 ). That is not the case 
now. New developments in instrumentation (CHEF DR™III, Bio-Rad) and 
simplification of the protocol address some of these problems (Matushek et al. , 1996; 
Gautam, 1997; Chang and Chui, 1998; Benson and Ferrieri, 2001). 
Advantages of PFGE. PFGE is a highly reproducible and discriminating tool. It has 
been successfully applied to a broad range of different Gram-negative and Gram-
positive organisms in epidemiological studies and outbreaks (Matushek et al. , 1996). 
These include Escherichia coli, Neisseria meningitidis, Pseudomonas aeruginosa, 
Listeria monocy togenes , Bordetella pertussis, Legionella pneumophila, Staphylococcus 
aureus and enterococcal isolates (Gautam, 1997). Its discriminatory power has been 
shown to be better than MLEE, ribotyping, and RAPD-PCR (refer to section 1.8 .3.4) 
methods and is best used to identify the micro-variation that is required to distinguish 
between strains; it is suitable for typing both highly clonal and less clonal populations 
(Struelens, 1998) 
Highly variable regions of the genome or individual loci can be identified and 
appropriate restriction enzymes chosen (Yakubu et al. , 1999). From a theoretical 
perspective PFGE is considered to be appropriate for detecting replication errors 
resulting from point mutation, recombination, and inversion and for detecting 
acquisition of extraneous elements through transformation, phage transduction or 
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infection and transposons (van Belkum et al. , 2001). The sensitivity of PFGE to detect 
genomic rearrangements makes appropriate interpretation of minor pattern differences a 
key to its correct application (Struelens, 1998). 
Criticisms of PFGE. PFGE is now the "gold standard" for epidemiological typing and 
calculation of restriction pattern similarity coefficients and graphical display of pattern 
relatedness as dendrograms is also useful for interpretation, particularly for large scale 
studies (Struelens, 1998). Although this analysis has been criticised as invalid for 
phylogenetic inferences because DNA restriction fragment pattern variation is not due 
to independent events, it is supported by population analysis, e.g. , of Pseudomonas 
aeruginosa (Musser et al. , 1995; Struelens, 1998). It is also a concern that fragments of 
the same size cannot be assumed to represent the same chromosomal region and, 
conversely, that restriction fragments of different sizes may represent the same 
chromosomal DNA. While it is worth remembering that because we don 't know if 
fragments are homologous does not mean that they are not, this issue requires 
investigation. The debate seems to reflect the 'purist' vs 'pragmatist' approach. On that 
note I would like to share a comment by Adrian Gibbs, developer of the RAPDistance 
Programs, who told me that using RFLPs for phylogenetic inferences might be 
considered by some as following a "suck it and see" approach with the result 
determining its worth. It remains to be determined precisely what is the 'margin of 
error' for determining the true relationships among bacteria that is inherent in RFLP and 
other molecular typing methods that sample only a portion of the genome. And it 
remains to be determined in each instance what the significance of such error is to our 
understanding of epidemiology or population structure. For example, subtle differences 
in the genome of strains may identify differences that are not epidemiologically 
significant. Until sequencing complete genomes is inexpensive, rapid and commonplace 
the use of a polyphasic approach to identification will help to resolve some of the 
uncertainty. Indeed in the last 10 years using multiple molecular typing systems that 
complement each other has become increasingly more common. Despite theoretical 
criticisms, PFGE (and other RFLP data) are currently used extensively (and often in 
conjunction with other typing methods) to make phylogenetic inferences that are 
improving our understanding of relatedness among bacteria, viruses, and fungi. 
PFGE and H. influenzae. CHEF PFGE, now a well-established methodology in many 
pathology laboratories, is most often employed to analyse relatively small sets of 
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isolates related to outbreaks of disease. Its use in the analysis of H. injluenzae began in 
the early 1990s when it was used to construct a physical map of Hib strain Eagan and to 
characterise ten genetically heterogenous Hib isolates previously typed by MLEE 
(Butler and Maxon, 1990). It has also been used to study insertion mutations in the 
transferrin binding system of Hib (Curran et al., 1994) and other types of PFGE have 
been used to estimate its genome size (Kauc, 1992). Results of PFGE of 29 
epidemiologically unrelated Hib isolates demonstrated evolutionary divergence 
consistent with that of multilocus enzyme electrophoresis (Arbeit et al., 1990). Until the 
last several years in which a number of studies have been completed, PFGE, had not 
been applied to the study of a large number of clinical isolates of Hib in population 
genetic studies. In conjunction with mathematical analysis the RFLPs generated by 
PFGE in this study were used to provide numerical estimates of genetic diversity among 
213 isolates to construct a dendrogram and to assess the correlation of genetic types 
with the epidemiology of Hib. 
1.8.3.4 Polymerase chain reaction based methods 
The polymerase chain reaction (PCR) is an in vitro DNA procedure that can, in a matter 
of hours, isolate and amplify a specific segment of DNA by as much 108-fold. The 
overall ease of performance and the speed of PCR methods are well established and 
PCR is commonly used in the genetic typing of bacteria. The components are 
conceptually simple: target DNA to be amplified, oligonucleotide primers, temperature-
stable DNA polymerase, nucleotides, and appropriate buffer and salts. The power of 
PCR is in its theoretical twofold amplification during each cycle, a cycle being defined 
by temperature shifts in which DNA is serially denatured, annealed to primers, and 
enzymatically extended. Despite these operational simplicities, users must contend with 
unique problems of optimising individual assays ( e.g., determining optimal primer 
design and temperature conditions). Since contamination with even one copy of target 
DNA can produce a false positive result, some workers recommend physically separate 
work areas for preparing the samples and for performing the reactions. Speed, lower 
costs, the need for only a small sample, and a protocol with fewer steps are advantages 
offered by PCR. While PCR has proven to be an extremely important typing tool, one 
must be aware that the level of reproducibility and the discriminatory ability vary 
considerably among PCR methods. 
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The various kinds of PCR-based methods now used to discriminate bacteria are too 
numerous to mention in entirety here. Three that have been used in the study of H. 
injluenzae are described, namely, PCR-RFLP, RAPD/AP-PCR and ERIC. 
Polymerase chain reaction-restriction fragment length polymorphism. Polymerase 
chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis involves 
amplifying a known sequence, cutting it with restriction enzymes, and comparing 
restriction fragments of the amplified DNA from different strains. It offers advantages 
over the conventional DNA restriction analyses because no southern blotting or probing 
is necessary and problems with DNA base modification (methylation) are not 
encountered. Virulence genes and ribosomal operons have been targeted for PCR-
RFLP subtyping. 
Randomly amplified polymorphic DNA-PCR. Randomly amplified polymorphic DNA-
PCR (RAPD-PCR) (also referred to as arbitrarily primed PCR analysis (AP-PCR)) is 
similar to RFLP analysis. The process involves randomly amplifying a segment of the 
target DNA by using a single short primer ( ,.._,6-10 bp) that does not have any known 
homology to the target sequence. It assays DNA sequence variation in short regions, but 
instead of analysing restriction endonuclease recognition sequences, it focuses on PCR 
priming regions. RAPD analyses are technically simple and often detect variation 
among isolates that are invariant with conventional RFLP analysis. Criticisms focus on 
reproducibility problems and incomplete comparison with the powers of other 
techniques. 
Enterobacterial repetitive intergenic consensus-PCR. Enterobacterial repetitive 
intergenic consensus (ERIC) sequences are conserved regions of DNA dispersed 
throughout the genomes of Gram-negative enteric bacteria (Pettigrew et al., 2002). Such 
sequences are typically present at many sites around the bacterial chromosome; when 
two sequences are located near enough to each other (within a few kilobases) the DNA 
fragment ( called the inter-repeat fragment) between those sites is amplified. The 
distribution of ERIC sequences varies between strains and ERIC-specific primers have 
been used to produce fingerprints of bacterial genomes based on the size and numbers 
of the inter-repeat fragments. The technique appears to have excellent reproducibility 
and moderate discriminatory power (Arbeit, 1995). A number of PCR techniques 
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utilising interspersed repetitive elements as pnmers for the amplification of regions 
between neighbouring repetitive elements is collectively called rep-PCR. 
1.8.3.5 Ribotyping/Southern hybridization 
The evolutionary conservation of ribosomal RNA makes it applicable as a universal 
bacterial probe. Ribotyping or ribosomal DNA RFLP is a method that probes restriction 
fragments of genomic DNA with cloned probes that contain all or part of the l 6S and 
23S rRNA genes. It is the most versatile and the most widely used strategy of Southern 
blot analysis of bacterial genome polymorphism. Patterns are easy to interpret because 
of a limited number of hybridised fragments (usually 7-12), and the ribotypes are stable 
and reproducible after subculture of the same organism. Genes coding for rRNA are 
highly conserved and most bacteria have multiple ribosomal operons. Thus, probing 
permits inter-species and intra-species discrimination (Stull et al., 1988). The method 
can be used for long-term epidemiological studies since the ribotype is stable. Its 
discriminatory power is lower compared to PFGE (Busch and Nitschko, 1999), and at a 
level equal to or inferior to that of MLEE (Struelens, 1998). This is related to the fact 
that ribosomal operons cover less than O .1 % of chromosomal length and tend to cluster 
in one particular region of the genome (Struelens, 1998). Ribotyping has been shown to 
easily distinguish Hib isolates, however, it cannot be used to reliably cluster apparently 
related patterns because differences in any two ribotypes, despite being stable, may not 
be representative of the majority of the genome; indeed, rRNA operons are clustered 
and cannot be considered to be a random representation of the bacterial genome (Leaves 
and Jordens, 1994). 
1.8.3.6 Sequence typing 
Ultimately all molecular genetic methods for distinguishing organisms are based on 
differences in the DNA sequence. Logically, then, DNA sequencing would appear to be 
the best approach to differentiating subtypes. But, while DNA sequencing remains the 
most sensitive method of detecting polymorphism within a gene, there are practical 
constraints on its use. The major limitation to its use is the size constraints of the DNA 
that can be practically sequenced. A very small region of the chromosome should be 
targeted for sequencing and this region must meet several structural criteria ( e.g., it must 
consist of a variable sequence flanked by highly conserved regions) before it can be 
used for strain differentiation. Further, it should not be horizontally transmissible to 
other strains of the species. Unfortunately for bacteria, few sequences meet these criteria 
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(Olive and Bean, 1999). Thus, the development of sequence typing hinges on 
identifying appropriate genomic targets of interest and determining their sequence 
variability (Yakubu et al., 1999). To optimise the use of genomic sequencing within 
and beyond the research laboratory, simplified, automated sequencing methods need to 
be more generally available. 
DNA sequencing of a particular locus. By using PCR to amplify a known DNA 
segment and automated techniques to sequence the PCR product, it is now feasible to 
compare multiple isolates by sequencing each one at the same locus. In most cases for 
diagnostic purposes, the following genomic structures are chosen as a target: 1) DNA 
sequences bearing the code for toxic or pathogenic factors, 2) DNA sequences of 
specific antigens, 3) specific DNA plasmid sequences, 4) DNA sequences bearing 
rRNA codes, and 5) small sequences, mostly species specific, that are non-coding 
(Harmsen et al., 2001 ). 
Since the early 1980s molecular techniques have been used to determine the nucleotide 
sequence of ribosomal RNA (rRNA) from various prokaryotes. According to 16S rRNA 
analyses , life on earth has been classified into three domains: the Bacteria, the Archaea, 
and the Eucarya (Woese, 1987). Because certain ribosomal sequences are highly 
conserved across the bacterial kingdom, primers that will amplify ribosomal sequences 
from essentially any bacteria can be defined. By sequencing the amplified PCR product 
and analysing the nucleotide sequences at the relatively variable areas within the 
ribosomal operon, the bacterial family, genus and species can be identified. Since DNA 
is more easily isolated and manipulated, analysis of 16S rRNA gene sequence data (i .e. , 
rDNA) has subsequently become the most well used method of single locus typing. 
Single locus typing has been applied to analyses of bacterial populations (Dubose et al. , 
1988) (van Loo et al. , 1994), epidemiology studies (Swanson et al. , 1998) and outbreak 
situations (Hoe et al., 1999). 
Multilocus sequence tvping. Multilocus sequence typing (MLST) is based on the well 
tested principles of multilocus electrophoresis, but it assigns alleles at each site directly 
by nucleotide sequencing rather than indirectly from electrophoretic mobilities of their 
gene products in starch gels. It is based on direct sequencing of c. 4 70-bp PCR products 
of six housekeeping genes. Strain associations shown by MLST were consistent with 
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clonal groups previously established by MLEE (Maiden et al. , 1998). An important 
advantage of MLST over other typing methods, such as RFLP, RAPD, and PFGE is that 
the sequence data are truly comparable between laboratories (Maiden et al. , 1998). It 
permits comparison of results from different laboratories without the need to exchange 
or to take variations in electrophoretic techniques into account. Therefore, it is well 
suited to the construction of global databanks. Further, MLST is more amenable to 
quantitative analyses allowing the establishment of quantitative genetic relationships 
between isolates. Finally, MLST has proven to be especially suitable for studying 
longer-term and global epidemiology (van Loo et al. , 1994). 
Although MLST could well become the 'gold standard' method for study of the long-
term evolution and global epidemiology of bacteria, it is less sensitive to microevolution 
than PFGE which means that typing methods such as PFGE that are very sensitive to 
microevolution will continue to be used to reveal minor differences between related 
strains (Yakubu et al. , 1999). 
1.9 Genetic Diversity of Haemophilus influenzae 
It had been known for some time prior to the advent of molecular technology that there 
is diversity within the species of Haemophilus influenzae. Early on after its discovery it 
was noted that some strains of H. influenzae were encapsulated and others were not 
though it was some 30 years before Margaret Pittman's seminal work describing the six 
capsular serotypes was completed in the early 1930s (Pittman, 1931 ). It was another 40 
years before Magen Kilian's extensive taxonomic study clearly demonstrated the 
heterogeneity of H. influenzae that had been repeatedly suggested by strain specific 
differences in pathogenicity and various biochemical properties (Kilian, 1976). Kilian 
and several others noted a correlation between biotype and the source of H. influenzae 
isolates and it was reported t~at both antibiotic resistance and type b capsule production 
were associated with biotype I and II organisms (Albritton et al. , 1978). While revealing 
diversity among H. influenzae isolates this data provided limited insight into its scope 
and significance. Thus, by the late 1970s our understanding of the diversity of H. 
influenzae was still primitive with the body of research based on morphological, 
biochemical, serological and physiological characteristics. The next 25 years , however, 
were incredibly fruitful. A fundamental understanding of the population structure and 
diversity of bacteria, including H. influenzae and, in particular, Hib was acquired. This 
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was due primarily to developments in detecting proteins and nucleic acids . The data that 
has been acquired regarding the genetic diversity of H. influenzae and Hib must be 
considered in the context of what is known about the extent of genetic variability within 
the so called bacterial species and the structure of bacterial populations. 
1.9.1 Bacterial population structure 
The genetic structure of microbial populations has been the subject of growing interest 
and considerable activity since the early 1980s (after being largely ignored during the 
burgeoning of descriptive population genetics in natural populations during the 1960s 
and 1970s). The development of bacterial genetic population studies truly emerged 
when Selander and colleagues applied multilocus enzyme electrophoresis to the study of 
bacteria and our present knowledge of the bacterial population structure largely stems 
from work they published in the 1980s (Selander et al. , 1987). 
Population genetics is concerned with genetic variation (basically within and between 
species), its amount in nature, its distribution over time and space, the forces that affect 
it and its biological significance -- the raw stuff of evolution (Young, 1989). In other 
words, it can be considered to be the study of natural bacterial genetic diversity arising 
from evolutionary processes. It is now widely understood that the findings of population 
genetics research have important implications for understanding the origins and spread 
of microbial disease and can be useful in advancing our understanding of pathogenesis 
and epidemiology and in designing effective public health measures (Musser, 1996). 
Before continuing the discussion on bacterial population structure in section 1.9 .1.3 it is 
appropriate to review the current understanding of the terms ' species ' and ' clone' as 
they apply to bacterial populations. 
1.9.1.1 The species 
The biologic definition of species (traditionally the most important taxonomic category 
in biology) when applied to bacteria remains consistently controversial and is 
undergoing continuous refinement (van Belkum et al. , 2001 ). The basic issue is whether 
bacteria exist as a series of asexual clones or as promiscuous, freely intermixing 
populations. For more than 50 years the discussion on species definition has been 
dominated by that of Mayr and others who define species as "groups of actually or 
68 
potentially interbreeding natural populations, which are reproductively isolated from 
other such groups" (Pennington, 1994). It is generally accepted that a species is a 
population whose members freely and under natural conditions exchange genes with 
one another and that the members of a species cannot exchange genes with members of 
other species. This concept is, of course, only applicable to sexually reproducing 
organisms. Prokaryotes, which reproduce by binary fission, are asexual ( at least by the 
standard definition of sexual reproduction). Therein lies one problem in assigning the 
classic definition of species to bacteria. 
A second problem is that in contradiction to the asexuality of binary fission, bacteria 
possess a range of mechanisms for genetic exchange and rearrangement, which include 
conjugation, transduction and transformation, plasmids, phages and transposable 
elements and seem to share a wide gene pool that reaches beyond the species level. The 
apparent promiscuity of certain genetic elements begs the important questions as to 
whether bacterial populations are composed of reproductively isolated species and 
whether we should attempt to apply the traditional species concept to bacteria or should 
consider an alternative image for defining bacterial species. Maynard Smith posited 
whether is it better to take a wholly gene-centred view and consider the bacterial cell -
or rather its chromosome - as merely an alliance of genes, analogous to a football team, 
composed of players from many different countries, all liable to be to transferred at any 
time (Maynard Smith, 1990). 
In practice most systematists eschew reproductive isolation as a criterion and make 
inferences based on morphological, biochemical, serological, and cytogenic features 
(Pennington, 1994). Subjective judgment is certainly required. Consider, for example, 
that in Bergey' s Manual Staley and Krieg define a bacterial species as a collection of 
strains that share many features in common and differ considerably from other strains. 
They further state that a species consists of the type strain and all other strains that are 
considered to be sufficiently similar to it as to warrant inclusion with it in the species 
(Staley and Krieg, 1984). The imprecision of 'differ considerably' and ' sufficiently 
similar' represent the state of the dilemma. 
Sneath's ground breaking work in the 1950s in numerical taxonomy methods has been 
applied to quantitative analysis of traditionally phenotypic characteristics and it is now 
generally accepted that for an isolate to belong to a given species there must be at least 
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80-85% similarity among independent covariate characteristics (Janda and Abbott, 
2002). Sneath has remarked, however, that "good scientific judgment in the light of 
other knowledge is indispensable for interpreting the results of numerical taxonomy" 
(Pennington, 1994). 
The use of DNA hybridisation was the first maJor leap in the· use of molecular 
technology to define species. An ad hoc committee of the International Committee for 
Systematic Bacteriology concluded that the phylogenetic definition of a species would 
generally include those strains with 70% or greater DNA-DNA homology at a thermal 
stability within 4°C of that of homologous reassociated DNA (Wayne et al. , 1987). 
Consequently, species are defined on the basis of a primitive form of genetic typing: 
resemblance between genomes is arbitrarily characterised on the basis of a technology 
that superficially scans for genome identity (van Belkum et al. , 2001 ). 
16S rDNA sequencing (sequencing of the DNA that encodes the 16S RNA subunit) is 
the single most common molecular technique presently being used for bacterial species 
identification. While there are no consensus guidelines for its use, it is generally 
accepted that an unidentified isolate whose rDNA is <97% similar to those of the 
isolate's closest phylogenetic neighbours constitutes a new taxon (Janda and Abbott, 
2002). Despite its widespread and prolific use several concerns cloud the use of rDNA 
sequencing data for taxonomic relatedness. The lack of consensus on the cutoff point for 
relatedness ( one study suggests that it should be >99% similarity) is one such concern. 
Another is that l 6S rDNA relatedness may not be recognised by other genetic tests 
(three Edwardsiella species recognised as the same species by 16S rDNA with only 
0.19 to 0.65% divergence that were genetically distinct by DNA hybridisation and 
ecological niche has been reported) (Janda and Abbott, 2002). This is complicated by 
significant sequence variation among identical prokaryote species with multiple rDNA 
sequences deposited in public sequence databases (Kolbert and Persing, 1999). 
An alternative but more generally phylogenetic concept proposed by Cracraft defines a 
species as a "group with a common origin that is composed of the smallest diagnosable 
cluster of individual organisms within which there is a parental pattern of ancestry and 
descent" (van Belkum et al., 2001). It has been proposed that a microbial species should 
correspond to a discrete typing unit to be valid, in which case the species definition is 
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clear cut; or, on the other hand, species can be considered "condensed nodes" in an 
"otherwise cloudy, confluent taxonomic space" (van Belkum et al. , 200 l ). 
Dykhuizen and Green's proposal that gene trees can be used to create an operational 
definition of bacterial species is an attempt to define species from a biological approach 
(in contrast to the phenetic or phylogenetic approaches mentioned above); some of the 
difficulties and complications of this approach are discussed in their 1991 publication 
(Dykhuizen and Green, 1991). 
Current definitions, whether conceptualised by taxonomic, phylogenetic or biologic 
approaches, allow that the concept of species involves making subjective judgement and 
notably leave precise species boundaries unclear while simultaneous application of 
varied definitions is inconsistent and confusing. Perhaps now that bacterial population 
studies are expanding and variation in large samples of the population can be measured 
at multiple loci directly by nucleotide sequence determination further insight into what 
constitutes a bacterial species or even whether such an entity exists will be forthcoming. 
For now, because the term cannot be avoided the word ' species' is probably most often 
used to refer to assemblages of isolates defined as species by traditional microbiological 
criteria (Spratt and Maiden, 1999). 
1.9.1.2 The clone 
It has been noted that identification of clones must be based on thorough monitoring of 
several (molecular) markers of sufficient discriminatory power and that the definition of 
"sufficient" is sometimes the subject of intense debate (van Belkum et al. , 2001). Thus, 
the issue of precise boundaries also surrounds the definition of clone but there is a 
reasonable consensus on a working definition. 
The term was first used by Herbert John Weber in 1903 to designate a population in 
which all members have been derived from one and the same progenitor by non-sexual 
multiplication (Orskov and Orskov, 1983). In 1982 at a time when significant 
population studies were just beginning to emerge, investigators at an international 
workshop entitled "The Clone Concept in Epidemiology, Taxonomy, and Evolution of 
the Enterobacteriaceae and other Bacteria" agreed that "for the present the word clone 
will be used to denote bacterial cultures isolated independently from different sources, 
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in different locations, and perhaps at different times, but showing so many identical 
phenotypic and genetic traits that the most likely explanation for this identity is a 
common origin" (Orskov and Orskov, 1983). Clearly a more precise definition was 
needed. 
Milkman, noted for his pioneering work on bacterial population studies, defined a 
bacterial clone as a group of organisms or cells descended without recombination from 
a single ancestor (Milkman and Stolzfus, 1988). This is now the generally accepted 
definition of clone and it may be assumed that members of a clone are genetically 
identical descendants of a single ancestor whereby all evolutionary change through time 
is the result of the mutational process or other non-recombinant processes. In contrast, 
non-clonal or sexual evolution occurs by the horizontal transfer of genetic material 
between unrelated individuals through the process of recombination (Guttman and 
Dykhuizen, 1994). 
Spratt and Maiden's assertion that "asexual bacterial populations exist as assemblages 
of independent lineages (i.e. , distinct clonal lineages) which are stable, with 
evolutionary change occurring only by de nova mutation, although diversity may also 
arise by other mechanisms, e.g., the gain and loss of plasmids or the movement of 
insertion sequences" further clarifies the current definition popularly applied to the 
nature of bacterial clones (Spratt and Maiden, 1999). 
1.9.1.3 Clonality in bacterial populations 
The fact that, in some cases, bacterial pathogens represent widespread members of a 
single clone was first observed by Duguid and collaborators in the 1960s. They were 
struck by the uniform properties of so-called FIRN Salmonella typhimurium bacteria, 
which are non-fimbriate and cannot ferment rhamnose or inositol. They showed that 
three independent mutations leading to lack of piliation and an inability to ferment 
rhamnose were conserved in independent bacteria isolated worldwide and that the 
original strain had diversified sufficiently for 27 phage types and 22 biotypes to be 
recognised among FIRN isolates (Morgenroth and Duguid, 1968). 
In the mid-1970s the Orskovs concluded that enterotoxigenic strains of Escherichia coli 
represented a few distinct clones because of the association of diarrhoeal disease with 
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particular O:H serotypes that were otherwise exceedingly rare among the 20,000 E. coli 
isolates they had examined (Orskov et al. , 1976). By the early 1980s the clonal 
population structure of E. coli was demonstrated genetically by multilocus enzyme 
electrophoresis (MLEE) studies (Selander and Levin, 1980; Whittam et al. , 1983). The 
introduction of MLEE to the study of bacterial populations marks a turning point from 
which bacterial population genetics emerged as an area of considerable activity and 
interest. 
The most extensively studied bacterial population is that of Escherichia coli from which 
our present knowledge on the dynamics of the genetic structure of bacterial populations 
stems (Milkman, 1973 ; Selander and Levin, 1980; Whittam et al. , 1983; Hartl and 
Dykhuizen, 1984; Selander et al. , 1986). E. coli contains thousands of electrophoretic 
types (ETs ). The repeated isolation of certain ETs over decades and continents plus 
statistical analyses of the genetic distances between ETs led to the concept that E. coli is 
clonal. 
Haemophilus and Neisseria species have also been important in the early studies on 
bacterial populations (Musser et al., 1985; Olyhoek et al. , 1987; Caugant et al. , 1987a; 
Caugant et al., 1987b; Caugant et al., 1988; Musser et al., 1988). Data collected using 
MLEE showed that the amount of diversity that exists between independent isolates 
within species was less than would be expected if all alleles were randomly distributed. 
Thus, a non-random association of alleles (linkage disequilibrium) was characteristic of 
bacterial populations and it was concluded that many species of bacteria were clonal in 
structure. One mechanism that accounts for this structure is periodic selection, in which 
a rare generally favourable mutant allele rises in frequency, carrying the rest of the 
genome along as a passive hitchhiker (Milkman and Stolzfus, 1988). 
We need to remember that although bacteria are largely asexual, they possess a number 
of mechanisms for the horizontal exchange of chromosomal DNA. The three most 
important mechanisms, conjugation, transduction and transformation are properly called 
parasexual processes as none of them involves wholesale exchange of chromosomal 
genetic material. Rather, they permit the transfer of fragments of chromosomal DNA, 
and horizontal genetic exchanges lead to bacterial genomes being pocked by small 
chromosomal replacements from other lineages, a process that has been referred to as 
localised sex (Maynard Smith et al., 1991 ). Plasmids, prophages, transposons and 
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insertion sequences can also be transferred horizontally, providing mechanisms for 
mobilising DNA among distantly related bacteria. 
A clonal structure implies that recombination is a relatively rare event in these 
populations but it does not prove that members of a particular clone are identical at all 
gene loci (Maynard Smith, 1990). To explain the contradiction between clonality and 
recombination the idea of clonal segments (i.e., a chromosomal region not yet broken 
up by recombination) was introduced in which the bacterial chromosome is the stable 
clonal frame derived from a single common ancestor within which individual segments 
are inserted from a variety of sources (Milkman and Stolzfus, 1988; Maynard Smith et 
al. , 1991 ). This mosaic structure has been demonstrated in a number of genes but is not 
universal (Maynard Smith, 1993a) and is limited by the degree of homology between 
recombining DNA molecules. It has been estimated that homologous recombination 
requires as little as 70% nucleotide sequence identity between the recipient and donor 
bacteria. A consequence of this promiscuity is that bacteria can recruit variation from 
other members of the same species and, at lower frequencies from related species. 
As it is unlinked to reproduction, the frequency of recombination could vary from very 
low ( or zero) to very high. Localised sex (i.e., small chromosomal replacements from 
other lineages) can disrupt clonal population structure enabling mutations to escape the 
lineage in which they arose, thus , moderating the power of diversity-reducing events to 
purge the variation (through periodic selection) in a bacterial population. In other 
circumstances horizontal genetic exchange can be a cohesive evolutionary force, by 
enabling a variant allele to spread horizontally in a population, replacing other variants 
and reducing diversity (Spratt and Maiden, 1999). The extent and impact of 
recombination versus mutation on the diversification of bacterial clones is not clear but 
recent evidence suggests that in many species recombination contributes more greatly to 
clonal diversification than do point mutations (Spratt et al. , 2001 ). 
Maynard Smith et al. (1993b) statistically tested the extent of clonality and identified 
four types of bacterial populations. They argued 1) that only certain species 
(Escherichia coli , Salmonella spp. , and Haemophilus injluenzae) have clonal population 
structures where little recombination has occurred in the evolutionary history of the 
species, 2) that others (Neisseria gonorrhoeae) are panmictic or fully sexual with 
random association between loci owing to extensive genetic recombination, 3) that still 
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others (Neisseria meningitidis) only appear to be clonal owing to rapid epidemic spread 
of panmictic bacteria and, 4) that other Rhizobium-like populations are panmictic at the 
fine scale but do not recombine between populations (Maynard Smith et al., 1993b ). 
Over the short term, all these bacteria have a clonal population structure which can be 
obscured by recombination or amplified by spread, depending on the species and in 
some cases even on the specific clonal grouping; thus, the distinction between clonal, 
. panmictic and epidemic populations structures reflects different ratios of recombination 
to spread (Achtman, 1994). 
It is thought that the extremes of strictly clonal and non-clonal populations structures 
are rarely found in bacterial species, and that most bacterial populations occupy a 
middle ground where recombination is highly significant in the evolution of the 
population, but is not sufficiently frequent to prevent the emergence of clonal lineages 
(Spratt and Maiden, 1999). Further it has become increasingly clear that bacterial 
populations are complex and may not always be adequately described as being highy 
clonal, weakly clonal or non-clonal; for example, populations may be non-clonal in the 
longer term, although the emergence of unstable clones may be an important feature of 
the population (Spratt and Maiden, 1999). An important fact to consider is that bacterial 
populations do not seem to evolve toward a "single most fit clone" occupancy of a 
given niche. Even in a simple environment such as a stationary batch culture, bacteria 
appear to maintain an interactive polymorphic state (van Belkum et al. , 2001). 
1.9.2 Genetic diversity in H. influenzae populations 
As noted previously by the late 1970s our understanding of the diversity of H. 
injluenzae was still primitive with the body of research based on morphological, 
biochemical, serological and physiological characteristics. Since then many different 
typing schemes and hundreds of studies have added to a growing knowledge of the 
population structure of Hib. For example, besides biotyping, OMP subtyping, and 
MLEE, schemes used for subtyping Hib include plasmid analysis (Mendelman et al., 
1985), whole cell polypeptides (Pennington and Freebaim, 1989), DNA fingerprinting 
(Mencarelli et al. , 1993), ribotyping (Leaves and Jordens, 1994), cap region RFLP 
patterns obtained by digestion with EcoRI (Musser et al. , 1988), DNA sequencing and 
PCR fingerprinting (Falla et al. , 1994) and long PCR ribotyping (Smith-Vaughan et al. , 
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1998). Recently, RFLP analysis using PFGE has been used to analyse small samples of 
Hib (Tarasi et al., 1998; Mitsuda et al., 1999; Saito et al., 1999). In this section I will 
discuss OMP typing, the first method to provide data that seriously identified Hib 
diversity and MLEE, the method used to provide a population genetic framework for 
the analysis of variation in other characters and which was used in a seminal piece of 
work that revealed the clonal population structure of Hib. 
In the early 1980s OMP subtyping was found to be a useful technique for investigating 
the epidemiology of Hib and substantial gains were made in understanding its diversity 
(Barenkamp et al. , 1981; Loeb et al., 1981; Granoff et al. , 1982). The first report using 
OMP data in an epidemiological study provided information on the evolution of H. 
influenzae strains among which the presence of six serotypes itself suggests 
evolutionary divergence. This was supported by the lack of relatedness of Hib OMP 
patterns (8 were found among 28 isolates) with those of four other capsular serotypes 
(Loeb and Smith, 1980). In addition, considerable variation among NTHi strains left 
open the question of whether they evolved before encapsulated forms and subsequently 
gave rise to the various serotypes and/or whether they evolved from any of the 
erotypes (Loeb and Smith, 1980). 
The limited number of OMP subtyp·es found in initial studies suggested that a small 
number of distinctive clones were responsible for most Hib disease in the United States . 
Barenkamp, et al. described 9 subtypes among 50 isolates from patients at St. Louis 
Children ' s Hospital with just 5 types accounting for 92% of the strains (Barenkamp et 
al., 1981).2 The designation and proportion of these 5 types being: lL (14%), lH (31 %), 
2L (22%), 2H (10°/o), 3L (16%).. The remaining isolates had unique profiles different 
from the 5 predominant types and from each other. Subtype concordance was observed 
among epidemiologically related strains. Further study identified a total of 21 
distinctive OMP subtypes among isolates from 256 patients hospitalised in 22 states; six 
of these subtyp,es accounted for 89% of the isolates and three of these - lH, 2L, and 3L 
- were prevalent in all the tested regions (Granoff et al. , 1982) . Strains with the lH 
OMP pattern were most common representing 3 7% of all endemic cases and associated 
2ln the "Barenkamp'' system for OMP classification subtypes are designated 1, 2, 3 and so on, 
according to the pattern produced by proteins with a molecular weight of 25,000-40,000. An H 
(heavy) or L (light) category is assigned based on the apparent molecular weight of a heat-
modifiable protein of 50 kilodaltons (kDa) or 49 kDa, respectively. A few strains with a heat-
modifiable protein different from the H or L protein are designated U or unclassified . 
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with a tenfold increase in the secondary spread of disease in day-care centers that was 
not explained by increased transmissibility or by enhanced ability to colonise the 
nasopharynx (Barenkamp et al., 1981 ). 
Compared to the findings in the United States, a remarkable homogeneity among 80 
randomly selected Hib isolates from patients with meningitis was seen in the 
Netherlands showing that they were not strongly subject to genetic change (van Alphen 
et al. , 1983).3 67 of the 80 strains studied had identical OMP patterns designated 
subtype 1. Among the 13 other isolates 4 different patterns were seen. It was further 
revealed that 7 5% of the isolates were characterised by a particular OMP pattern 
(subtype 1), LPS serotype (type 1), and biotype (type I). The uniformity of the strains 
indicates that they are not strongly subject to genetic variation. The lack of uniformity 
among the isolates in the United States is likely caused by the distribution of various 
subtypes (among which is one that is predominant in the Netherlands) and is not simply 
a matter of geographic area because subtypes in the United States were nearly randomly 
distributed around the country (van Alphen et al., 1983). 
Examination of strains from other Western European countries (Denmark, Sweden, 
Finland, Iceland, Norway, France, Germany and the United Kingdom) showed that only 
a few subtypes of Hib predominated and that the distribution of these subtypes showed 
distinct geographic differences (van Alphen et al., 1987). The predominant subtype (OMP 
1, LPS 1, Biotype I) in the Netherlands was predominant in Western Europe except for 
Iceland where it was almost absent. A new type (OMP 2, LPS 9, Biotype I) not 
previously described comprised 83% of the isolates in Iceland. It was not found in other 
countries and was not found to be associated with a particular disease type. van 
Alphen's OMP subtype 2 is identical to Barenkamp's 2L but several American isolates 
of this subtype that were tested were not LPS serotype 9. The uniqueness of the 
"Iceland" subtype is difficult to explain. It may be that this type is present but was not 
found in the countries from which only a few isolates were studied. 
3The system used by van Alphen for 01'v1P classification assigns isolates to subtypes based on 
the position of the major outer membrane proteins, a, c, d, and e described by Loeb (Loeb et al. , 
1981). The predominant pattern was designated subtype 1. Patterns similar to subtype 1 that 
showed a difference in protein d were designated 1 a and 1 b. Two other patterns were designated 
subtype 2 and 3 based on differences in the mobility of proteins c and a, respectively. 
Comparison with Barenkamp's nomenclature revealed subtype 1 was identical to 3L, subtype la 
was unique, subtype 1 b resembled l 6L, subtype 2 was identical to 2L, and subtype 3 was 
identical to 6U. 
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Although the majority of infections worldwide are caused by just a few OMP subtypes 
(Musser et al., 1990), the predominant subtypes differ in different parts of the world. 
The subtypes found in the Far East (Weinberg et al. , 1989), the Gambia (Bijlmer et al. , 
1992) and among Aboriginal children in Australia (Gilbert and Clements, 1993 ; 
Hansman and Lawrence, 1993) differ from those found elsewhere in the world. Four 
unique OMP types (not previously described by either OMP system) were revealed in 
the Gambia with one of them accounting for 54% of the isolates; only one type, van 
Alphen's type 2 that corresponded with Barenkamp's type 2L, had been previously 
described among European and U.S. isolates (Bijlmer et al. , 1992). 
In Australia, 76% of 59 strains belonged to a single OMP subtype equivalent to subtype 
3L in the Barenkamp scheme; the remaining type b strains belonged to five other OMP 
subtypes (Hansman and Lawrence, 1993). The distribution of OMP subtypes from rural 
Aboriginal children and Caucasian children in Melbourne and Sydney differs. In the 
latter group 183 of 220 isolates were the same subtype and identical with the 
predominant European subtype (1 VA in Barenkamp's scheme); 3 additional isolates 
were of the almost identical subtype 3L (Barenkamp scheme) (Clements et al. , 1992). 
Together 1 VA and 3L represented 85% of isolates. By contrast only 13% of 55 isolates 
from aboriginal children were type 1 VA and none was subtype 3 L. The predominant 
subtype was an apparently unique local subtype, designated INT, that was almost 
identical with subtype lL (Barenkamp scheme) (Gilbert and Clements , 1993). It 
accounted for 82% of isolates from Aboriginal children compared with only 1 % of 
isolates from Melbourne and Sydney. Ten other unique subtypes were found among the 
urban and rural isolates. The marked discrepancy between OMP subtypes causing Hib 
disease in two major groups of children is intriguing and should be confirmed by testing 
isolates from Caucasian children in Western Australia or the Northern Territory 
In Melbourne the distribution of subtypes also varied in different age groups suggesting 
that less common subtypes of Hib are more likely to cause disease in younger children 
(<12 months old) in which the incidence of Hib disease is higher because of increased 
susceptibility or exposure ( or both) (Gilbert and Clements, 1993). 
Takala et al. (1987) reported that in Finland type b strains of OMP subtypes 1 and le 
(3L and lL, respectively in the Barenkamp scheme) are non-randomly associated with 
different types of invasive disease. The observation that strains of subtype 1 c caused 
proportionally more meningitis and less epiglottitis than did those of subtype 1 was 
78 
interpreted as evidence of a true difference in virulence between isolates expressing 
those subtypes . It was hypothesised that the subtype 1 c protein marks a clone with 
special virulence properties. To date no evidence has confirmed this but the results of 
OMP subtyping of 587 world wide Hib isolates were consistent with the interpretation 
that in Finland the type le OMP subtype frequently marks a subclone that is especially 
successful in invading the CSF (Musser et al., 1990). 
In the 1980s multilocus enzyme electrophoresis was first used to study 177 isolates of 
Hib, largely from the United States, and a basically clonal structure of Hib populations 
was revealed and they were marked by temporal and geographic variations (Musser et 
al., 1985). The use of MLEE in an extensive survey reported in 1990 of 2209 
encapsulated H. influenzae isolates from all over the world revealed that there are two 
primary phylogenetic divisions, designated I and II, within the encapsulated H. 
influenzae and that the population structure is tightly clonal. It was revealed that 
capsulated H. influenzae belong to twelve major lineages, designated A-L, each of 
which belongs to one of the two primary divisions. Division I contains all serotype c 
and d isolates studied, one lineage of serotype a isolates, and 95% of type b 
electrophoretic types. Division II contains all serotype f isolates studied, a second 
lineage of a isolates, and a second group of serotype b isolates. A serotype belongs to 
only one or a few lineages, and these lineages are not shared between serotypes (Musser 
et al., 1990). 
There is an interesting distinction between the capsule locus of division I and the 
capsule locus of division II type b isolates. In division I isolates, the ISJ OJ 6 element is 
associated with the capsule locus. In division II isolates, the element is present, but not 
associated with the capsule locus. ISJ OJ 6 is also found at either end of the capsule 
locus of type a-d strains that belong to division I, although the capsule loci are present 
as a single copy. Division II type b strains also contain a single copy cap locus. These 
strains are less virulent in an infant rat model of pathogenesis and are rarely responsible 
for invasive disease cases. Thus, it appears that the 1.2 kb deletion of the bridge region 
(refer to section 1.5 .3 .1) is an ancestral mutation that causes a selective pressure for 
maintenance of the duplicated capsule locus state (Preston and Apicella, 1999). 
Most of the invasive disease worldwide was caused by serotype b strains of 9 clones. 
Strong patterns of geographic variation on an intercontinental scale, in both the extent 
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of genetic diversity and the clonal composition of populations was noted. Only one 
situation was identified in which there was a statistically significant association of a 
clone with a particular syndrome - ET 21.8 in Finland with meningitis - but no other 
obvious associations of clones and invasive disease were revealed (Musser et al. , 1990). 
Musser et al's analysis suggests that the present distribution of Hib clones is, in part, 
related to patterns of racial or ethnic differentiation and historical demographic 
movements of the human host populations. Briefly, four phylogenetic lineages of clones 
of serotype b are highly distinctive in multilocus genotype, which means their 
phylogenetic relationships are relatively deep. Hence, the pattern of global geographic 
variation in clonal composition of populations that they revealed for Hib does not 
represent merely a transitional state in the relatively recent spread of new minor mutant 
variants. The degree of genetic differentiation indicates several of the lineages have 
long histories of differentiation (nucleotide substitutions have been estimated to 
accumulate at the rate of 1 % per million years); they are old. They proposed two 
hypotheses to account for this. First, it is suggested that a large component of the 
geographic variation in clonal composition of Hib seen today reflects an older pattern of 
differentiation that evolved in relative geographic isolation before the Age of 
Exploration (beginning about 450 years ago) and has not yet been completely obscured 
by recent demographic changes. Alternatively, a second hypothesis suggested that there 
are, in fact, no old human racial or ethnic correlates of the contemporary global pattern 
of distribution and abundance of the various clones or clone groups. Rather, all the 
major clonal groups have since earliest times been present in all major geographic 
regions and human populations. This hypothesis postulates the contemporary pattern of 
variation in the relative abundance of Hib clones in different geographic regions can be 
attributed to differential susceptibility to various clones on the part of human 
populations. A weakness of this hypothesis is that is seems unlikely that all the clones 
of Hib could have achieved and maintained global distribution while the human species 
was undergoing geographic differentiation in strong geographic isolation over the past 
50,000-100,000 years. For ethical reasons rigorous prospective testing of these two 
hypotheses is not possible. One critical test comes from an examination of isolates from 
native or other populations that have experienced very little immigration: hypothesis 
one explicitly predicts that these populations ( aboriginals or others) should have a 
distinctive set of Hib clones in a relatively high frequency, whereas hypothesis two does 
not. The bulk of the data favours hypothesis one. Study of isolates from regions of the 
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world not yet sampled, and especially strains recovered from additional human 
populations, such as, Australian Aboriginals, that have experienced little recent 
admixture, will provide critical data bearing on these hypotheses . 
Most of what we know about the genetic diversity of Hib in Australia is based on OMP 
studies that have been shown to be of limited value in detecting genomic variation 
because only a few OMP subtypes are responsible for most Hib infections. By 
exploiting the discriminatory power of PFGE we will increase our knowledge of the 
genetic diversity of Hib in Australia. Because we will be examining a large sample of 
Aboriginal isolates we will be able to provide some of the 'critical data' bearing on 
these intriguing hypotheses about the history of Hib clones and how humans may have 
contributed to their worldwide distribution. 
1.10 Aims and Strategies 
SIGNIFICANCE OF THE PROJECT 
It is not clear what characteristics, if any, of the Hib bacterium are associated with its 
epidemiology and little is known about its genetic diversity in Australia. The 
epidemiology of Hib has been studied in Victoria, Sydney, the Northern Territory, the 
Australian Capital Territory and Western Australia. There are similarities between the 
main urban centres, especially with respect to the incidence and age-distribution of the 
most important Hib disease, meningitis. There is greater variability in the epidemiology 
of the other major Hib disease, epiglottitis. Using the same criteria for diagnosis, three 
population-based studies in Victoria, Sydney, and Western Australia showed significant 
differences in the incidence of epiglottitis; in Victoria it was nearly twice that in either 
Sydney or Western Australia. In a smaller study in the ACT the incidence was similar to 
that in Victoria. These differences may be explained in part by socioeconomic and/or 
climatic factors. However, the possibility that they are related to differences in strains of 
Hib in these geographically separate areas has not been explored. 
The other major difference in the epidemiology of Hib disease in these Australian 
studies is between Aboriginal children and (mainly) non-Aboriginal children in 
metropolitan centres. The incidence of Hib disease in rural Aboriginal children is 
several times that in other Australian children, the disease occurs at a significantly lower 
age and epiglottitis is virtually unknown. Meningitis and pneumonia with bacteraemia 
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are the commonest manifestations and serotypes other than type b and non-capsulated 
strains are frequently recovered. This is similar to the epidemiology of Hib disease in 
other high-risk ethnic minorities and in developing countries . Socioeconomic and 
genetic factors have been implicated but there are likely to be other factors involved, 
including distribution of Hib strains in different populations . 
Understanding the population structure of pathogenic bacteria may provide insights into 
the pathogenesis of human infections. Currently, there is no practical typing system for 
monitoring Hib isolates from vaccine failures, adults and unimmunized children. 
GENERAL AIMS OF THE PROJECT 
To study the distribution of genetic subtypes of Haemophilus injluenzae type b among 
Hib isolates from Australian children (Caucasian and Aboriginal) and adults with 
invasive Hib disease and from carriers from different parts of the country, to determine 
whether particular genetic types are associated with different epidemiological and/or 
virulence factors and to establish methods of typing and identifying Hib for the 
surveillance of Hib disease following the introduction of Hib vaccines in Australia 
while generating the baseline data against which future distribution patterns of subtypes 
can be compared that would be necessary to assess the effects of vaccination on the 
genetic diversity and structures of populations of Hib. 
If time allowed this project aimed to investigate the genetic differences, if any, found 
among Hib isolates that may be related to epidemiological differences. The search will 
be for those parts of the genome which are invariably associated with the 
epidemiological characteristic being studied. 
SPECIFIC STRATEGIES OF THE PROJECT 
Assess the usefulness of pulsed field gel electrophoresis (PFGE) for detecting the 
genetic diversity of Hib isolates and acquire Hib isolates recovered from both Caucasian 
and Aboriginal children and adults from a variety of geographic areas in Australia. 
Use molecular genetic typing techniques to determine whether differences in the 
epidemiology of Hib disease in different geographical regions and ethnic groups in 
Australia are reflected in the distribution of genetic types of Hib by studying isolates 
from Caucasian and Aboriginal children and adults with invasive Hib disease and/or 
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upper respiratory tract carriage to answer the following questions and others about the 
genetic diversity of Hib: What is the degree of genetic diversity among Hib isolates in 
Australia? Is the clonality, which has been demonstrated for isolates in the USA and 
Europe characteristic of the isolates of Hib found in Australia? Are there molecular 
genetic differences among strains of Hib which will distinguish between: 1) invasive 
and non-invasive isolates, 2) isolates which cause epiglottitis and isolates which cause 
meningitis, 3) isolates recovered from patients living in different geographic regions, 4) 
isolates recovered from Aboriginal and non-Aboriginal children 
Using molecular genetic techniques establish a broad database of genetic subtypes of 
Hib for epidemiological surveillance of Hib disease to: 1) study changes in the 
distribution of genetic types, if any, after introduction of the Hib vaccines, 2) investigate 
suspected outbreaks of Hib disease, 3) investigate cases of Haemophilus influenzae 
disease in immunized and unimmunized children and, 4) screen non-typeable 
Haemophilus injluenzae isolates from children with invasive disease or upper 
respiratory tract carriage to test the hypothesis that some are capsule deficient Hib 
strains (and potentially more virulent than other NTHi). 
CHAPTER 2 
Methods 
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2. 1 Bacterial isolates (Appendices A. 1 - A. 6) 
A collection of 213 isolates of Haemophilus influenzae type b recovered from 
Aboriginal and non-Aboriginal children (n=208) and adults (n=5) from diverse rural 
and urban regions of Australia was obtained for this project. One hundred eighty-nine 
isolates were recovered from patients diagnosed with Hib diseases. Twenty-four isolates 
were from individuals who did not exhibit any sign of disease at the time the isolates 
were recovered. No follow-up information is available as to whether these children 
subsequently developed Hib disease and the isolates are considered to represent strains 
found among Hib carriers. 
Hib isolates recovered before the introduction of the first conjugate Hib vaccine (PRP-
D) for use in children 18 months and older in July 1992 comprise the majority of 
isolates studied. Seventeen isolates recovered in 1993 are included in the collection 
although by mid-1993 another three conjugate vaccines (PRP-OMP, HbOC and PRP-T) 
were available for use in children under 18 months and were free to all children under 
the age of 5 years (Herceg, 1997). The vaccine uptake rates were estimated to be 45-
50% in Sydney (McIntyre et al. , 1995) and Darwin (Mitchell and Krause, 1995) and 
exceeding 90% amongst rural Aboriginal children in the Northern Territory (Mitchell 
and Krause, 1995) by August -September 1993. 
The isolates were obtained from established collections through the generosity of the 
scientists who shared them. Thirty-four isolates from the Canberra region and 3 7 from 
Sydney were obtained from the Canberra Hospital, Australian Capital Territory 
(courtesy of Jan Bell and Dr Peter Collignon); 20 isolates from Melbourne and 10 from 
the Alice Springs region were obtained from the Royal Children's Hospital in 
Melbourne, Victoria ( courtesy of Professor Gwendolyn L Gilbert and Frances 
Oppedsidano ); 45 isolates from metropolitan Perth and rural areas of Western Australia 
were obtained from the Princess Margaret Hospital in Perth, Western Australia 
( courtesy of Professor G L Gilbert and Leoni Walpington); 10 non-Aboriginal isolates 
from the Alice Springs region were obtained from the Queensland Institute of Medical 
Research, Brisbane, Queensland ( courtesy of Dr Michael Gratten); 3 5 isolates from the 
Alice Springs Region originally from Dr M Gratten were obtained from the Westmead 
Hospital collection ( courtesy of Professor G L Gilbert and Helen Fuller); 19 isolates 
from Bathurst Island were obtained from the Menzies School of Health Research in 
Darwin, Northern Territory ( courtesy of Dr Amanda Leach) and 2 isolates were 
obtained from the Townsville General Hospital, Queensland ( courtesy of Chris Ashurst-
Smith). The geographic origin of the isolates is depicted in Figure 2.1. 
Figure 2. 1 Map of Australia showing the geographic locations from which Hib isolates 
were obtained 
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The collection used for this project ultimately included 137 isolates from non-
Aboriginals and 76 from Aboriginals comprising 95 isolates recovered from the 
cerebrospinal fluid of patients with meningitis, 3 7 isolates from the blood of patients 
with epiglottitis, and 39 from patients with other diagnoses including 13 isolates from 
the blood of patients for whom no clinical information was available and 24 isolates 
from healthy carriers. A breakdown of the distribution of the Hib isolates by geographic 
locaticn, Aboriginality, and disease association is shown in Table 2.1. 
The acquisition of previously collected Hib isolates for this study occurred over a period 
of 3 years. The isolates were not initially collected for a single purpose and the 
epidemiological data available varies. While it is not known how medical diagnostic 
models and detection systems used to recover the isolates may have varied, it is unlikely 
to be significant among the collections that were accessed. There is also no evidence to 
suggest that there are strains of Hib not readily recovered using standard specimen 
collection and culture procedures for Haemophilus injluenzae. Therefore, it is 
reasonably assumed that the Hib collection for this project represents a spectrum of 
isolates that can be considered representatjveof the overall diversity of Hib in Australia. 
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Table 2. I Geographic location and disease association of 213 Hib isolates recovered 
from Aboriginals and non-Aboriginals before the introduction of vaccines 
Number of isolates 
Group and geographic location 
Meningitis Epiglottitis Other Carrier Total 
Aboriginal 23 0 29 24 76 
Alice Springs region, Northern Territory 1 1 0 28a 6 45 
Bathurst Island, Northern Territory 0 0 lb 18 19 
Perth, Western Australia 5 0 0 0 5 
Rural Wes tern Australia 7 0 0 0 7 
Non-Aboriginal 72 37 28 0 136 
Canberra, Australian Capital Territory 20 14 0 0 34 
Melbourne, Victoria 10 10 0 0 20 
Sydney, New South Wales 21 1 15c 0 37 
Perth, Western Australia 12 8 5d 0 25 
Rural Western Australia 4 4 ld 0 9 
Townsville, Queensland 2 0 0 0 2 
Alice Springs region, Northern Territory 3 0 r 0 10 
Total 95 37 57 24 213 
aThese isolates were associated with pneumonia (n=9), gastroenteritis (n=9) , acute lower respiratory tract infections 
(n=4), cellulitis (n= I), febrile disease (n= I), conjunctivitis (n= I), otitis media (n= I), bronchiolitis (n= I) , and 
failure to thrive (n= I). 
6The isolate may be associated with otitis media. 
cThirteen invasive isolates recovered from blood (diagnoses unknown) and 2 isolates associated with cellulitis. 
dThe diagnoses for these isolates are unknown. 
elnvasive isolates recovered from blood (diagnoses unknown). 
A complete collection of the isolates used in this study is stored at -70°C in the 
Australian Capital Territory at the Gadi Research Centre, University of Canberra. A 
partial collection is stored at the Canberra Hospital. 
2.1 .1 Identification of bacterial isolates 
All of the isolates obtained for this study had previously been identified by conventional 
methods. These included identification by typical Gram stain results, colony 
morphology on chocolate agar, catalase production, X and V factor requirement, lack of 
haemolysis when grown on tryptic soy agar plates containing 5% horse blood and l % 
Iso VitaleX and biotyping. They were also previously tested for capsular type b antigen 
by either coagglutination or slide agglutination and were stored at - 70°C except for 46 
isolates from a collection in Western Australia that had been lyophilised. 
Upon receipt, frozen isolates were thawed and aliquots were subcultured to chocolate 
agar plates that were incubated overnight at 35°C at 5% CO2 . Individual colonies were 
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then subcultured to a second chocolate agar plate that was incubated under identical 
conditions. Typical colony types found on chocolate agar were tested for X and V factor 
requirements (Difeo). All the isolates were genotyped to confirm that they were 
capsular type b or a capsular type not type b or that they did not possess the cap locus. 
2.2 Pulsed field gel electrophoresis 
Isolates were independently digested and electrophoresed at least two times. When 
comparison of fragment size on different gels was questionable, another gel was run so 
those fragments could be compared in close proximity. Partial digests and lanes with 
any smearing due to DNAse contamination were repeated. A six day protocol using a 15 
well gel that included 12 isolates and 3 controls is summarised in Table 2.2. 
Table 2. 2 Timetable of a six day protocol for PFGE of Hib 
Day 
Day 1 
Day2 
Day 3 
Day4 
Day 5 
Day 6 
(Day 7 
Activity 
Primary isolation of bacterium with overnight incubation 
Subculture of bacterium with overnight incubation 
Preparation of DNA plugs with overnight incubation 
Wash and overnight digestion of DNA plugs 
Gel set up and overnight electrophoresis run 
Staining and photographing gel 
Evaluation and analysis of RFLPs 
Photographing gel after 24 hour destaining wash 
Time Required* 
< 1 hour 
< 1 hour 
2-3 hours 
5-6 hours 
< 2 hours 
< 2 hours 
Variable, > 8 hours 
< 1 hour) 
*Times estimates are based on what can be expected with experienced personnel using the methods 
described and does not include time required to prepare media and reagents or to clean glassware, etc. 
For many bacteria, particularly Gram-positives, a lysis step(s) that can require overnight 
incubation is needed to break up the cell wall prior to preparing DNA plugs. This was 
not necessary when working with Hib, a Gram-negative bacterium whose cell wall is 
disrupted in ESP solution. There are a number of other variations that can be applied to 
PFGE methods, particularly, reducing incubation times, that will decrease the time 
requirement. Rapid methods have been described for 3 day (Matushek et al., 1996) and 
24 hour (Gautom, 1997; Chang and Chui, 1998) protocols. 
2.2.1 DNA preparation 
The preparation of chromosomal DNA was performed by a modification of the method 
described by Bautsch (Bautsch, 1992). DNA was prepared in a 1: 1 ratio in an intact 1 % 
agarose (SeaPlaque® low gelling temperature agarose, FMC Bioproducts) matrix using 
cells harvested from an overnight growth on chocolate agar suspended in solution 21 
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(Lee and Smith, 1988) to an optical density of 1.8 at 650nm. The DNA-agarose plugs 
(lx8xl9 mm) were lysed in a solution ofproteinase K (lmg/ml) in 0.5M EDTA and 1 % 
sodium lauryl sarcosine and incubated overnight at 50°C. The plugs were rinsed for 2 
hours in TE (10 mM Tris, 1 mM EDTA, pH 8.0) and then stored in fresh TE at 4°C. 
2.2.2 Selection of enzymes 
H. injluenzae has a base composition of 37 mol¾ G+C. Therefore, enzymes recognising 
six-base-pair sequences comprising only G-C bases should produce a small number of 
distinct fragments. Smal (CCCt tGGG) and Apal (GtGGCCtC) were used. 
2.2.3 Restriction endonuclease digestion 
Washing of plugs and digestion of the DNA with endonucleases were performed as 
described by Inglis et al. (1993) (Inglis et al., 1993). Smal (Boehringer Mannheim) and 
Apal (Boehringer Mannheim) were used according to the manufacturer's instructions. 
For each analysis , one half of a DNA-agarose plug was digested overnight with 30 units 
of enzyme at 30°C (Smal) or 37°C (Apal). Smaller concentrations of enzyme resulted in 
partial digestions. Consistent clean cutting was obtained when 30 or more units of 
enzyme were used. 
2.2.4 PFGE analysis 
Separation of DNA fragments using a clamped homogeneous electric field device 
(CHEF DR™II, Bio-Rad) at 200 volts was carried out in 1 % agarose (Type II-A: 
Medium EEO, Sigma) gels made with .5X TBE (0.045 M Tris-borate, 0.001 M EDT A) 
in 0.5X TBE buffer at 12-14°C. Pulse parameters for both Smal and Apal digests 
included a ramp of pulses for 6-8 seconds for 7 hours followed by a ramp of 1-3 8 
seconds for 17 hours. Gels were stained for 30 minutes with ethidium bromide 
(0.5 µg/ml) in distilled water, then destained in distilled water for 1 or more hours and 
photographed (Polaroid 667) using a UV light source. The polaroid pictures of the 
RFLP patterns were scanned using an Astra UMAX 1200S Scanner, printed out on a 
Laser Jet 4000N printer and photocopied for inclusion in this thesis. 
2.2.5 Molecular weight standards 
The DNA molecular weight standards used were A phage concatemers (Lambda Ladder 
PFG Marker, New England Biolabs), Hind1ll phage A fragments (prepared by digesting 
phage A DNA with Hindlll), and the genomic fragments from Hib strain HS008 . This 
isolate came from the Canberra Hospital collection. It was recovered from a sputum 
specimen from a four year old female. It was chosen as a standard during the 
preliminary studies carried out in the process of setting up the PFGE protocol. The 
fragment sizes of RS008 were estimated using a plot of log molecular weight of A 
phage markers versus distance migrated. The estimated sizes of 15 Smal fragments of 
HS008 are shown in Table 2.3. 
Table 2. 3 Estimated size and schematic diagram of 15 Smal fragments* 
of Rib strain RS008 
Schematic Fragment kb 
diagram 
8.1 416 
8.2 256 
8.3d 209 
8.4d 209 
8.5 147 
8.6 107 
8.7 98.5 
8.8t 81 
8.9t 81 
8.l0t 81 
8.11 62 
K12 57 
8.13 43 
8.14 35 
8.15 33 
*Fragments are numbered from 1 ( according to size - largest to smallest) 
including each member of a double or triple. The name of the isolate (in this 
case, 8) followed by a full stop and then the number of the fragment is used to 
indicate the marker fragment. 'd' or 't' next to an isolate fragment means it is part 
of a doublet or triple. 
2.2.6 Fragment database for Haemophi/us influenzae type b 
A database of the distinct fragments found among the Rib isolates was compiled for 
each enzyme as a "reference set" of fragments to use in the interpretation of RFLPs. A 
total of 79 distinct Smal fragments were found among 213 isolates. Fifty-seven distinct 
Apa! fragments were found among 84 isolates. The presence or absence of each of the 
different fragments f6r the appropriate enzyme(s) was visually determined for each 
isolate in the numerical determination of genetic diversity. 
2.2.7 Estimation of genetic diversity between isolates and construction of 
dendrograms 
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In the analysis of the Hib isolates described here, RFLPs were determined for the entire 
genome, except for fragments present in such small amounts that they did not bind 
sufficient ethidium bromide to be visible, or so small ( <6 kb) that they ran off the end of 
the gel during electrophoresis; such fragments would account for a small proportion of 
the genome. 
The numbers and mobilities of fragments were determined by visual examination of the 
polaroid photographs of the stained gels. Initially, gel patterns were interpreted by two 
or more individuals and assignment of fragment size was determined by the use of 
several size standards, including lambda concatemers and the Smal digest of the 
chromosome of S. aureus ATCC 8325 used by Pattee to define the physical map of S. 
aureus. The complexity of visual examination of the large number of gels in this study 
was diminished by the use of multiple standards on each gel, namely, lambda 
concatemers and the Smal digest of Hib isolate HS008 (sized using lambda concatemers 
and S. aureus ATCC 8325 from the average estimate of 10 runs). Each gel was 
interpreted at different times on multiple occasions to confirm interpretation. As the 
number of typed isolates grew, interpretation was facilitated by the presence of patterns 
on gels that were indistinguishable from those in the database because they provided 
another point of reference. The use of a computerised program designed to interpret and 
store RFLP data would be helpful, though visual inspection, will always be needed to 
confirm such results. 
Numerical analysis of RFLP patterns was performed by identifying the proportion of 
fragments shared by pairs of isolates using the method of N ei and Li (N ei and Li, 1979) 
(also known as the Dice coefficient or coefficient of similarity) and calculated as F = 
2nx/(nx + ny), where nx is the total number of DNA fragments from isolate X, ny is the 
total number of fragments from isolate Y, and nxy is the number of fragments identical 
in the two isolates. 
A matrix of F values for all pairs of isolates was constructed and a dendrogram 
computed using the NJTREE program, i.e., the neighbour-joining method of Saitou and 
Nei (Saitou and Nei, 1987) and the TDRA W program. The programs used for 
mathematical calculations and construction of the dendrogram are accessible on the 
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package, RAPDistance Programs, distributed by J. Armstrong, et al. , Research School 
of Biological Sciences, Australian National University (Armstrong et al., 1994 ). 
The N ei and Li similarity matrix for one sample, the epiglottitis isolates from Western 
Australia, would not compute with the NJTREE program and Jaccard's algorithm found 
in the RAPDistance Programs was used to build a matrix from which a dendrogram 
could be constructed. Jaccard's similarity value is calculated as F = nx/(n-00), where 
nxy is the number of fragments identical in the two isolates, n is the total number of 
possible DNA fragments and 00 is the number of those fragments not present in x or y. 
2.3 Other methods 
Capsular typing using hybridisation Capsular type was confirmed by hybridisation 
of Southern blots of Smal DNA fragments separated by PFGE with 32P labelled pU082, 
a 1.9 kb BamHI/EcoRI portion of the 2.1 kb EcoRI fragment cloned into pBR322, 
which spans type b specific parts of the H. influenzae cap locus (Kroll and Moxon, 
1988). Hybridisation products were detected by autoradiography. If no signal was 
detected, isolates were reprobed with pU038, an 18 kb BamHI fragment from wild type 
Eagen subcloned from cosmid clone pSKH3 into pBR322, which spans serotype 
specific and non-serotype specific parts of the cap locus (Kroll and Moxon, 1988). 
Isolates which did not hybridise with pU082 were not included in the study. The probes 
were originally provided by Professor E. Richard Moxon to Professor G L. Gilbert. 
Only one isolate was found to be non-encapsulated and excluded from the study. 
P2 typing The P2 gene of H. influenzae encodes the outer membrane protein P2 that 
accounts for the major protein component of the outer membrane and functions as a 
porin protein. Hib strains have highly conserved P2 sequences (Munson et al., 1989). A 
P2 gene probe previously prepared by cloning a 7 kb fragment in the EcoRl site of 
pUC9 was obtained from the Royal Melbourne Hospital and used to screen 84 isolates 
(34 from Canberra and 60 from the Alice Springs region) for polymorphisms (if any) 
that would be detectable by hybridisation of Smal DNA fragments separated by PFGE. 
Southern blotting and hybridisation DNA fragments separated by PFGE were acid 
depurinated in 0.25 M HCl for 2 x 8 minutes followed by 2 x 8 minutes rinses in 0.4 M 
NaOH and then transferred onto Hybond-N nylon membranes (Amersham) in 10 mM 
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N aOH overnight. The membranes were prehybridised overnight at 70°C in a buffer 
containing 2X PE (PE= 0.133 M sodium phosphate, 1 mM EDTA), 7% SDS, and 1 % 
BSA. The probe consisted of 25 ng of pUO82 or pUO38 or P2 DNA labelled with a-
[32P]dCTP using the Megaprime labelling system (Amersham). The probe was 
incubated overnight with the membranes at 70°C in the same hybridization buffer. The 
membranes were then washed for 3 x 15 minutes in 2X SCC, 0.1 % SDS at RT and once 
in 5X SSC, 1 % SDS at 70°C and analysed using autoradiography. 
Chemiluminenscence probe Southern blot hybridisation with nonradioactive labelling 
using digoxigenin-11-dUTP was performed with pQE30/OMP26 according to the 
manufacturer's instructions (DIG-High Prime DNA Labelling and Detection Kit, 
Boehringer Mannheim). OMP26 is a 26-kDa protein isolated from NTHi-289 that has 
been investigated as a potential vaccine candidate; DNA sequences encoding OMP26 
were previously ligated into pQE30 (El-Adhami et al., 1999). pQE30/OMP26 was 
kindly provided by Dr Adam Smith, Canberra Centre for Mucosal Immunology. 
Chromosomal DNA preparation for PCR Total chromosomal DNA was harvested 
using the Genomic Tip 20/G kit (Qiagen) from overnight sBHI broth cultures inoculated 
with a single colony. The DNA concentration was estimated by comparing a small DNA 
sample with known amounts of bacteriophage lambda DNA on an ethidium bromide 
stained electrophoretic gel. The DNA was dissolved at a concentration of ~20 ng/µl in 
TE. 
PCR capsular typing A PCR method based on the protocol of Falla et al. (1 994) was 
also used to detect the cap b locus (Falla et al., 1994). Type b capsule specific primers, 
Bl and B2, (5'-GCGAAAGTGAACTCTTATCTCTC-3') and (5'-
GCTTACGCTTCTATCTC GGTGAA-3'), respectively, were used. The Taq PCR Core 
Kit (Qiagen) was used to prepare the reaction mix to a total volume of 50 µ1. It 
consisted of lX Qiagen PCR buffer, 3.5 mM MgCh, 200 µM (each) dNTP mix, 1 µM 
B 1 and 1 µM B2, 2.5 units Taq polymerase and 50 ng template DNA. Samples were 
overlaid with mineral oil and cycled 25 times at 94 °C for 1 min, 60°C for 1 min, and 
72°C for 1 min, followed by a final 10 min incubation at 72°C. PCR products were run · 
on 1.5% agarose gel containing 0.5 µg/ml ethidium bromide in lxTAE buffer for 1 hour 
at 80 V. A negative control, consisting of the same reaction mixture but with no DNA 
template, was included in each amplification procedure. A standard 1 kb ladder 
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(Fermentas) was included. The gel images were captured using the Gel Doc 1000 DNA 
gel analysis and photodocumentation system (Bio-Rad Laboratories, Hercules, CA). 
PCR fingerprinting Some of the isolates were PCR fingerprinted using pnmers 
directed to enterobacterial repetitive intergenic consensus (ERIC) sequences as 
described by van Belkum et al. (1994) (van Belkum et al. , 1994). The Taq PCR Core 
Kit (Qiagen) was used to prepare the reaction mix. The PCR reaction mix (final volume 
25 µl) consisted of 2.5 µl 1 OX Qiagen PCR buffer, 4 µl 25mM MgCh, 0.5 µl dNTP 
mix, 1 µl of25 µM ERICl (5'-ATGTAAGCTCCTGGGGATTCAC-3'), 1 µl of 25 µM 
ERIC2 (5'-AAGTAAGTGACTGGGGTGAGCG-3'), 0.2 µl Taq polymerase (1 unit per 
reaction), 10.8 µl distilled H2O, 5 µl template DNA (~100 ng). PCR samples were 
overlaid with mineral oil. Samples were cycled 3 5 times at 94 °C for 1 min, 25°C for 1 
min, and 74°C for 4 min, followed by a final 10 min incubation at 74°C. PCR products 
were run on 1.5% agarose gel containing 0.5 µg/ml ethidium bromide in lxTAE buffer 
for 3 hours at 50 V. A negative control, consisting of the same reaction mixture but with 
no DNA template, was included in each amplification procedure. A standard 1 kb ladder 
(Fermentas) was included. The gel images were captured using the Gel Doc 1000 DNA 
gel analysis and photodocumentation system (Bio-Rad Laboratories, Hercules, CA). 
The images were then pasted into Microsoft Powerpoint® for illustration and inclusion 
in this thesis. Relationship analysis of the fingerprints was performed as described for 
the PFGE RFLPs using the RAPDistance Programs. 
Plasmid analysis Minipreparations of plasmid DNA were prepared by the alkaline lysis 
method described by Maniatis et al. (Maniatis et al. , 1989) and electrophoresed in 1 % 
agarose in lx TAE electrophoresis buffer under standard electrophoresis conditions. 
Purified plasmid, pQE30/OMP26, was prepared using the Quantum Prep® Plasmid 
Miniprep Kit (Bio-Rad) by the protocol supplied by the manufacturer. 
Beta-lactasmase testing Beta-lactamase production was detected with nitrocefin-
impregnated paper discs (Cefinase discs ; BBL). 
Diplomo Diploma is an interactive co1nputer graphics application that uses the distance 
plot principle in an approach to phylogenetics analysis. Diploma compares different 
distance measures with each other by displaying them as a scatter plot. It then helps one 
identify individual comparisons within the plot. Many different questions can be 
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addressed with a DIPLOMO analysis and it was used here to determine whether 
distance matrices derived from Smal digestion of Hib DNAs varied from distance 
matrices derived from Apal digestion of Hib DNAs. Diploma is distributed by the 
Research School of Biological Sciences, Australian National University (Weiller and 
Gibbs, 1993). 
Simpson's index of diversity Simpson's index of diversity (D) is a numerical index of 
discrimination based on the probability that two unrelated strains sampled from the test 
population will be placed into different typing groups. This probability is calculated as 
s 
D = 1 - 1 L nj (nj-1) 
N (N-1) j=l 
where N is the total number of strains in the sample population, S is the total number of 
types described, and nj is the number of strains belonging to the jth type (Hunter and 
Gaston, 1988). The application of this index was used to assess the discriminatory 
power of Smal and Apa! PFGE. 
GenStat (Release 6.1) GenStat is a comprehensive statistical system developed by 
Rothamsted Experimental Station and distributed by the Numerical Algorithms Group, 
United Kingdom. In appropriate cases, average distances or chi square analysis was 
used. Random average distances between types associated with either meningitis or 
epiglottitis were determined to evaluate the association between type and disease 
manifestation. Pearson chi square values at p<.001 were calculated to evaluate the 
association between epidemiologic factors and RFLP type. Consultation and the use of 
GenStat was made available through the Statistical Consulting Unit, The Graduate 
School, Australian National University. 
METHODS ADDENDUM 
Bacterial isolates. Fifty Hib isolates collected after the introduction of vaccines in 
northern Australia were obtained through the courtesy of Heidi C. Smith-Vaughan at the 
Menzies School of Health Research. Twenty of these isolates have been PFGE 
genotyped and the results are included in Chapter 8. The gel images were captured 
using the Gel Doc 1000 DNA gel analysis and photodocumentation system (Bio-Rad 
Laboratories, Hercules, CA). 
CHAPTER 3 
Evaluation of Pulsed Field Gel Electrophoresis 
to Investigate the Genetic Diversity of 
Haemophilus influenzae type b 
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3. 1 Introduction 
Two of the most common manifestations of Hib disease are meningitis and epiglottitis 
in children. As described in Chapter 1 the following intriguing issues surround the 
epidemiology of these diseases: 
1) In Western communities and indigenous populations these infections tend to occur 
at different ages according to the risk of Hib disease in the population. The absence 
of epiglottitis among Aborigines corresponds to this striking characteristic of age-
related variation in the incidence of Hib disease (Clements and Gilbert, 1989). It is 
not known why an age related incidence of disease occurs. 
2) The ability of Hib to infect the epiglottis is characteristic as epiglottitis in children is 
rarely attributed to other microorganisms (Hanna et al. , 1992). It is not known why 
this is so or if specific strains of Hib are associated with epiglottitis. 
3) A pattern of Hib disease in Australia before the introduction of Hib vaccines was a 
significant difference in the incidence of epiglottitis among urban populations. The 
incidence of epiglottitis in Victoria (Gilbert et al., 1990) and the Australian Capital 
Territory (McGregor et al., 1992) was twice that in Sydney (McIntyre et al., 1991) 
and Western Australia (Hanna et al., 1992). Whether differences in the incidence of 
epiglottitis in different populations are related to different strains of Hib is not 
known. 
4) It is very rare for a child to develop concurrent Hib infections of the epiglottis and 
the meninges (personal communication, G. Gilbert). The reasons for this are 
unknown nor is it known why children develop epiglottitis instead of meningitis or 
why contacts of children with meningitis may develop epiglottitis. While it has been 
reported that some Hib outer membrane protein (OMP) subtypes are more likely to 
cause meningitis than epiglottitis (Takala et al., 1987) this finding has not been 
substantiated by later studies (Takala et al., 1989; Clements et al., 1992). To date 
no finding has defined the characteristics of Hib, if any, that are associated with its 
unique epidemiology. 
In order to investigate the possibility that bacterial characteristics may account for its 
unique epidemiology, I designed a preliminary study to examine the genotypic structure 
of Hib isolates in a sample of meningitis and epiglottitis isolates recovered from non-
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Aboriginal patients admitted to the Canberra Hospital during the period 1988-1990. 
When this study commenced in 1992, pulsed field gel electrophoresis was not well 
established and had not previously been used to characterise a large number of Hib 
isolates. It was necessary to establish the optimal conditions for use of PFGE and 
evaluate the methodology for use in examining Hib isolates. This chapter describes the 
results of the first attempt to study Hib isolates using PFGE in order to answer questions 
concerning its epidemiology and, specifically, to answer questions relating to isolate 
types associated with epiglottitis and meningitis. 
The following hypothesis concerning the methodology was tested: that PFGE of Hib 
genomic DNAs digested with the restriction endonucleases, Smal or Apal, would 
produce a limited number of well resolved fragments that could be used to reliably 
discriminate between closely related and more distantly related isolates of Hib. 
Two hypotheses concerning the bacterial isolates were tested: first, that genotypes 
associated with epiglottitis are not associated with meningitis and, secondly that 
genotypes associated with meningitis are not associated with epiglottitis. 
3.2 Methods 
This experiment was performed after an extended period spent developing the protocol 
and my proficiency in using PFGE. The particulars of the methods are described below 
and in more detail in Chapter 2. 
3.2.1 Bacterial isolates (Appendix A.1) 
A selection of 20 isolates recovered from patients with meningitis and 14 isolates 
recovered from patients with epiglottitis from the Canberra region were examined in a 
preliminary evaluation of the use of PFGE for characterising Hib. The 34 isolates were 
collected between November 1988 and September 1990 as part of a national 
collaborative study of the antimicrobial resistance in Australia among Haemophilus 
influenzae isolates from blood or cerebrospinal fluid (Collignon et al. , 1992). All of the 
isolates had previously been identified by conventional methods. 
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The meningitis isolates were designated Ml to M20 and the epiglottitis isolates were 
designated E 1 to E 15 excluding E8, an isolate that was subsequently found to have been 
recovered from a patient from Campbelltown, NSW. 
3.2.2 Restriction endonuclease digestion 
Initially, Smal (CCCt tGGG) and Apal (GtGGCCtC) were used. Washing of plugs 
and digestion of the DNA with endonucleases were performed as described in Methods. 
3.2.3 PFGE cond itions 
Separation of fragments using a clamped homogeneous electric field device was carried 
out as described in Methods. 
3.2.4 Estimation of genetic diversity between isolates and construction of 
dendrograms 
The numbers and mobilities of fragments were determined by visual examination of the 
polaroid photographs of the stained gels as described in Methods. A matrix of F values 
for all pairs of isolates was constructed and a dendrogram computed using the NJTREE 
program and the companion TDRA W program. 
3.2.5 Hybridisation with pU082 and P2 probes 
Hybridisation techniques were used to detect the presence of the cap locus and the P2 
gene using the Smal PFGE gels as described in Chapter 2. 
3.2.6 Correlation of data and determination of the discriminatory power of 
enzymes 
Visual analysis and computer analysis using the programs Diploma (Weiller and Gibbs, 
1993) and the RAPDistance Programs were used to evaluate the correlation of the two 
enzymes. Simpson's Index of Diversity (Hunter and Gaston, 1988) was used to 
determine their discriminatory power. 
3.2.7 Average distance calculations of RFLP type and disease association 
The distance matrix of the 26 SmaI-RFLPs types found among the 34 meningitis and 
epiglottitis isolates (Table 3 .9 in Appendix B) was tested using GenStat's average 
distances program for evidence of association of type to disease manifestation. 
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3.3 Results 
The results are presented in layers of information to illustrate the evaluation of the effect 
of sample size and selection and the effect of using the different enzymes. First, the 
analysis of the RFLP patterns by visual comparison is described for these subsets: the 
Smal-RFLP patterns, the Apal-RFLP patterns, and the RFLP patterns found when the 
Smal fragments and the Apal fragments of each isolate are combined. Each of these 
subsets is examined for the sample of meningitis isolates, the epiglottitis isolates, and 
the combined sample of meningitis and epiglottitis isolates. Secondly, the genetic 
diversity determined by numerical analysis of the fragment patterns and the construction 
of dendrograms is similarly described for each of the subsets. Table 3 .5 summarises the 
RFLP types found for each enzyme and diagnosis. 
RFLP types are designated by the restriction enzyme( s) and the lowest M then E 
numbered isolate found with that pattern. For example, Smal-MS includes isolates MS , 
Ml2, Ml 6, Ml 8, and E12. 
3.3.1 Hybridisation 
All 34 isolates hybridised with pU082. Hybridisation was detected on one or two DNA 
fragments per isolate on the Smal-PFGE gels. The same size fragment, corresponding to 
fragment 8.1 (,---416 kb) of HS008, of 21 types hybridised with pU082. Hybridisation 
was detected on two fragments of 13 types. Among sets of multiple types the same 
fragment or fragments hybridised and no further splitting of RFLP types was found 
from the capsular typing of the PFGE RFLPs. 
All the isolates hybridised with the P2 probe. Hybridisation was found on one fragment 
per isolate and for 21 types the same size fragment, corresponding to fragment 8.6 
(~107 kb) ofHS008, hybridised. A fragment corresponding to fragment 8.14 (~35 kb) 
of HS008 hybridised with four clonally related types, Ml , M3, M20 and El5. 
Hybridisation also occurred on an ~70 kb fragment of M13 , the most diverse isolate in 
the sample. No further splitting of RFLP types was found using the P2 probe. 
3.3.2 Visual analysis of Smal and Apal RFLPs 
Well resolved patterns were found among the isolates with both enzymes but the 
fragments of Smal digested DNAs were more distinct. All isolates were digested at least 
twice and usually three or more times in the development of the methodology to 
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confirm fragment size. The size range of the fragments found among the Smal-RFLP 
types was ,_,9--420 kb and ""'6-450 kb among the Apal-RFLP types. Two Smal fragments 
were shared by all the isolates . Neither of those shared fragments hybridised with 
p U082 or the P2 gene probe. Seven of the Apal fragments were found among all the 
isolates. Comparative data on the fragments is shown in Table 3 .1. Tables 3 .2-3 .4 
describe the fragment distribution among types found in each subset. The RFLP patterns 
were stable. When isolates were repeatedly subcultured, their DNAs yielded unchanged 
Smal and Apal fragment patterns. Isolate HS008 was most often subcultured and 
repeatedly digested and no variation was seen in its RFLP pattern. 
Table 3. 1 Comparative data on the PFGE fragments from Smal and Apal 
digestion of the DNAs of 20 meningitis and 14 epiglottitis isolates of 
Haemophilus influenzae type b 
Meningitis 
Smal Apal SmaV Smal 
ApaI 
Number of types 16 15 17 12 
Number of distinct 48 42 90 36 
fragmentsa 
Total number of 232 275 555 173 
fragmentsb 
Average number of 14.5 18.3 32.6 14.4 
fragments per type 
Epiglottitis 
Apal SmaV 
ApaI 
9 13 
31 69 
159 417 
17.7 32.0 
Meningitis and 
Epiglottitis 
Smal ApaI SmaV 
ApaI 
26 20 28 
49 44 97 
377 363 909 
14.5 18 .2 32.5 
a .b 
' Refers to fragments among the different types found in the subset (multiple isolates of the 
same type are not included) 
Meningitis Isolates: Smal-RFLPs (Figures 3.1-3.2, Table 3.2) Sixteen Smal-RFLP 
types were found among the 20 meningitis isolates. One type, Smal-M5 , comprising 4 
of the isolates, accounted for 20% of the sample. The distribution of the meningitis 
isolates among types was: 
Smal-RFLP type 
M5 
M3 
all others (n = 14) 
Number of isolates/type 
4 
2 
1 
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Epiglottitis Isolates: SmaI-RFLPs (Figures 3.2-3.3, Table 3.2) Twelve Smal-RFLP 
types were found among the 14 epiglottitis isolates . Two types , Smal-E2 and Smal-E9, 
each comprised 2 (14%) of the isolates . The distribution of epiglottitis isolates among 
Smal-RFLP types was: 
Smal-RFLP type 
E2 
E9 
all others ( n = 10) 
Number of isolates/type 
2 
2 
1 
Meningitis and Epiglottitis Isolates Combined: SmaI-RFLPs (Table 3.2) Twenty-
six Smal-RFLP types were found in the combined sample. Only 2 Smal-RFLP types 
were found in both disease groups. One of these, Smal-M5, accounted for 15% of the 
sample. The distribution of the combined sample of meningitis and epiglottitis isolates 
among the Smal-RFLP types was: 
Smal-RFLP type 
M5 
M8 
M 3 
E2 
E9 
all others (n=21) 
· Number of isolates/type 
5 
2 
2 
2 
2 
1 
Distribution of isolates/type/disease 
Meningitis Epiglottitis 
4 
1 
2 
l 
l 
2 
2 
Meningitis Isolates: ApaI-RFLPs (Figures 3.4-3.5, Table 3.3) Fifteen Apal-RFLP 
types were found among the 20 meningitis isolates . The RFLP type designated Apal-M5 
accounted for 30% of the sample. The meningitis isolates were distributed among the 
Apal-RFLP types as follows: 
Apa I-RFLP type 
M5 
all others (n = 14) 
Number of isolates/type 
6 
1 
Epiglottitis Isolates: ApaI-RFLPs (Figures 3.5-3.6, Table 3.3) Nine Apal-RFLP types 
were found among the 14 epiglottitis isolates. RFLP type ApaI-E6 accounted for 31 % of 
the sample. The isolates were distributed among the Apal-RFLP types as follows : 
ApaI-RFLP type 
E6 
E5 
all others (n=7) 
Number of isolates/type 
5 
2 
1 
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Meningitis and Epiglottitis Isolates Combined: ApaI-RFLPs (Table 3.3) Twenty 
Apar-RFLP types were found in the combined sample of meningitis and epiglottitis 
isolates. Four types were found in both disease groups. A predominant type,Apar-MS , 
comprised 32% of the sample. The combined meningitis and epiglottitis isolates were 
distributed among Apar-RFLP types as follows: 
ApaI-RFLP type Number of isolates Distribution of isolates/type/disease 
per type Meningitis Epiglottitis 
MS 11 6 5 
Ml5 3 1 2 
M8 2 1 l 
M20 2 l l 
all others (n= 16) 1 
Meningitis Isolates: Smal/ApaI-RFLPs (Table 3.4) The Smar and Apar fragments 
were combined for each of the meningitis isolates. Seventeen SmaI/Apar-RFLP types 
were found among the 20 meningitis isolates. SmaI/Apar-MS accounted for 20% of the 
sample. The distribution of the isolates among the types was: 
SmaVApaI-RFLP type 
M5 
all others (n = 16) 
Number of isolates/type 
4 
1 
Epiglottitis Isolates: Smal/ApaI-RFLPs (Table 3.4) The Smar and Apar fragment 
were combined for each of the epiglottitis isolates. Thirteen SmaI/Apar-RFLP types 
were found among the 14 epiglottitis isolates. Only one type, SmaI/Apar-E9 , with 2 
members represented multiple isolates. The distribution of isolates among types was: 
SmaVApaI-RFLP type 
E9 
all others (n= 12) 
Number of isolates/type 
2 
1 
Combined Meningitis and Epiglottitis Isolates: SmaI/ApaI-RFLPs (Table 3.4) 
Twenty-eight SmaI/Apar-RFLP types were found. SmaI/Apar-MS accounted for 15% of 
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the sample. The combined meningitis and epiglottitis isolates were distributed among 
the SmaVApaI-RFLP types as follows: 
SmaIJApaIRFLP Number of isolates/type Distribution of isolates/type/disease 
type Meningitis E pi gl o tti tis 
M5 5 4 l 
M8 2 l l 
E9 2 2 
all others (n=25) 1 
Table 3. 2 Number of Smal-RFLP types and number of fragments per type 
Meningitis isolates 
n=20 
Epiglottitis isolates 
n=l4 
Total number 
of types 
16 
(0.80: It 
12 
(0.86:lt 
Types 
Isolates 
Number of fragments per type 
13 14 15 16 
2 6 6 2 
n=5 n=7 n=6 n=2 
Types 2 5 3 2 
n=2 Isolates n=3 n=6 n=3 
A ll isolates 26b Types 3 c 11 8d 4 
n=34 (0.76:lt Isolates n=8 n=l3 n=9 n=4 
aRatio of the number of types found to the total number of isolates typed. 
bTwo Smal-RFLP types were found among both meningitis and epiglottitis isolates. Thus , the 
total number of different Smal-RFLP types found in the sample was 26 not 28 . 
cone of the 13 fragment SmaI-RFLPs was found among both groups of isolates. 
dOne of the 15 fragment SmaI-RFLPs was found among both groups of isolates. 
Table 3. 3 Number of Apal-RFLP types and number of fragments per type 
Total number Number of fragments per type 
of types 16 17 18 19 20 21 
Meningitis isolates 15 Types 5 3 5 l l 
n=20 (0.75: It Isolates n=JO n=3 n=5 n=l n=l 
Epiglottitis isolates 9 Types 1 3 3 2 
n=14 (0 .64: it Isolates n=l n=6 n=4 n=3 
All isolates 20b Types 1 6c 5d 6e 1 l 
n=34 (0.71:1? Isolates n=l n=l6 n=7 n=8 n=l n=l 
aRatio of the number of types found to the total number of isolates typed. 
bFour Apal-RFLP types were found among both meningitis and epiglottitis isolates. 
cTwo ofthel 7 fragment ApaI-RFLPs were found among both groups of isolates. 
done of the 18 fragment ApaI-RFLPs was found among both groups of isolates. 
eOne of the 19 fragment ApaI-RFLPs was found among both groups of isolates. 
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Table 3. 4 Number of Smal/Apal-RFLP types and number of fragments per type 
Total number Number of fragments per type 
of types 30 31 32 33 34 35 37 
Meningitis isolates 17 Types 2 1 6 4 2 l 1 
n=20 (0.90:lt Isolates n=5 n=l n=6 n=4 n=2 n=l n=l 
Epiglottitis isolates 13 Types 2 1 5 4 l 
n=l4 (0.93:lt Isolates n=3 n=l n=5 n=4 n=l 
All isolates 28b Types 3c 2 10d 8 3 1 1 
n=34 (0.71:lt Isolates n=8 n=2 n=ll n=8 n=3 n=l n=l 
aRatio of the number of types found to the total number of isolates typed. 
bTwo RFLP types were found among both meningitis and epiglottitis isolates. Thus, the total 
number of different SmaIJApaI RFLP types found in the sample was 28 not 30. 
cone of the 30 fragment RFLPs was found among both the meningitis and epiglottitis isolates. 
done of the 32 fragment RFLPs was found among both the meningitis and epiglottitis isolates. 
3.3.3 Genetic relationships determined by numerical analysis of fragment 
length polymorphisms 
As described in the Methods section in Chapter 2, in order to quantify the genetic 
relationships among the RFLP types similarity matrices were built using N ei and Li's F 
values obtained by comparing pairs of types. Figures 3. 7 to 3 .15 are the dendrograms 
generated from the matrices built in this study. 
The distance matrices are included in Appendix B to illustrate the data from which 
dendrograms are computed. When matrices are built for a limited number of isolates it 
is easy to pick out the most closely related and the most distantly related isolates from 
the data. However, as matrices enlarge owing to increasing numbers of isolates it 
becomes increasingly difficult to utilise them to visualise the genetic distance between 
pairs. The construction of dendrograms helps to overcome this problem. Table 3 .6 
summarises numerical data derived using N ei and Li's mathematical model. 
Meningitis Isolates: Smal-RFLPs (Figure 3.7, Table 3.7 in Appendix B) Table 3.7 
shows the distance matrix of 1-F values derived from the pairwise comparison of the 16 
types found among the 20 meningitis isolates and from which the dendrogram seen in 
Figure 3. 7 was constructed. The similarity among pairs ranged from 19% to 97%. RFLP 
type Smal-M5 comprising 4 of the isolates was clonally related to 6 other types (Smal-
M2, M3, M8, Ml 1, Ml 7, and M19) that comprised 7 isolates . 
. . . text continues after Figures 3.1 - 3. 6 
l o5' 
8 A-H A Ml M2 M3 M5 M6 M9 MlO M12 M13 M14 M18 M20 
kb 
250.0 
80.0 
30.0 
Figure 3 .1 Smal restriction fragments obtained by PFGE of the genomic DNAs of 12 
Hib isolates recovered from the cerebrospinal fluid or blood of meningitis patients from 
the Canberra region. Lanes labelled 8, A, and A-H contain fragment standards. 
A-H 8 M4 M7 M8Mll M15M16M17M19E14E15 8 
kb 
250.0 
80.0 
30.0 
Figure 3 .2 Smal restriction fragments obtained by PFGE of the genomic DNAs of 10 
Hib isolates recovered from the cerebrospinal fluid or blood of 8 meningitis patients and 
2 epiglottitis patients from the Canberra region. Lanes labelled 8 and A-H contain 
fragment standards. 
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8/ 
A-H El E2 E3 E4 E5 E6 E7 S37 XX E9 ElO El 1 El2 El3 
kb 
250.0 
80.0 
30.0 
Figure 3.3 Smal restriction fraginents obtained by PFGE of the genomic DNAs of 13 
Hib isolates recovered from the blood of epiglottitis patients from the Canberra region 
and 1 isolate from the Sydney region. The lane labelled 8/A-H contains fragment 
standards. The lane labelled xx is an isolate that is not part of this study. 
A-H 8 Ml M2 M3 M5 M6 M9 MlO Ml2 Ml3 Ml4 Ml8 M20 8 
kb 
250.0 
80.0 
30.0 
Figure 3.4 Apal restriction fragments obtained by PFGE of the genomic DNAs of 12 
Hib isolates recovered from the cerebrospinal fluid or blood of meningitis patients from 
the Canberra region. Lanes labelled 8 and A-H contain fragment standards. 
ten 
8 M4 M7 M8 Ml 1 Ml5 Ml6 Ml 7 Ml9 El4 El5 8 
kb 
250.0 
80.0 
30.0 
Figure 3.5 Apal restriction fragments obtained by PFGE of the genomic DNAs of 12 
Hib isolates recovered from the cerebrospinal fluid or blood of 8 meningitis and 2 
epiglottitis patients from the Canberra region. Lanes labelled 8 contain fragment 
standards. 
8/A-H El E2 E3 E4 E5 E6 E7 S37 XX E9 ElO El 1 El2 El3 
kb 
250.0 
80.0 
30.0 
Figure 3.6 Apal restriction fragments obtained by PFGE of the genomic DNAs of 12 
Hib isolates recovered from the blood of epiglottitis patients from the Canberra region 
and 1 epiglottitis isolate from the Sydney region. The lane labelled 8/A-H contains 
fragment standards. The lane labelled XX is an isolate that is not part of this study. 
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Thus, Smal-M5 and its clonally related types accounted for 55% of the sample. Smal-
M7, Smal-M9, and Smal~Ml3 defined the range of diversity within the sample relative 
to the predominant type. Each represented a single isolate that was less than 43 % 
(range 36-43%) similar to Smal-M5. 
Epiglottitis Isolates: SmaI-RFLPs (Figure 3.8, Table 3.8 in Appendix B) Table 3.8 
shows the distance matrix of 1-F values derived from the pairwise comparison of the 12 
Smal-RFLP types found among the 14 epiglottitis isolates and from which the 
dendrogram seen in Figure 3.8 was constructed. The similarity among pairs ranged from 
48% to 96%. One of the clonal groups included 4 types (Smal-E2 , Smal-E7, Smal-E9 , 
and Smal-E12) and comprised 6 members (43%) of the sample. Smal-E5 was the most 
genetically diverse type with F values ranging from 0.51 to 0.62 between it and the 
predominant clonal types. 
Meningitis and Epiglottitis Isolates Combined: SmaI-RFLPs (Figure 3.9, Table 3.9 
in Appendix B) Table 3 .9 shows the distance matrix of 1-F values derived from the 
pairwise comparison of the 26 Smal-RFLP types found among the 34 meningitis and 
epiglottitis isolates and from which the dendrogram seen in Figure 3 .9 was constructed. 
The similarity among pairs ranged from 19% to 97%. Six of the clusters at an F value > 
0.9 contained both meningitis and epiglottitis isolates; however only two RFLP types, 
Smal-M5 and Smal-M8, comprised both meningitis and epiglottitis isolates. 
Meningitis Isolates: ApaI-RFLPs (Figure 3.10, Table 3.10 in Appendix B) Table 
3 .10 shows the distance matrix of 1-F values derived from the pairwise comparison of 
the 12 types found among the 20 meningitis isolates and from which the dendrogram 
seen in Figure 3.10 was constructed. The similarity among pairs ranged from 43% to 
97%. RFLP type Apal-M5 and 3 clonally related types accounted for 45% of the 
sample. Apal-M13 representing a single isolate was the most genetically diverse type 
from the Apal-M5 type at an F value of 0.56. 
Epiglottitis Isolates: ApaI-RFLPs (Figure 3.11, Table 3.11 in Appendix B) Table 
3 .11 shows the distance matrix of 1-F values derived from the pairwise comparison of 
the 9 types found among the 14 epiglottitis isolates and from which the dendrogram 
seen in Figure 3.11 was constructed. The similarity among pairs ranged from 53% to 
97%. RFLP type Apal-E6 and 3 clonally related types accounted for 57% of the sample. 
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Table 3. 5 Summary of RFLP types* found per enzyme and diagnosis 
Meningitis RFLPs · 
n=20 
Epiglottitis RFLPs 
n=14 
SmaI Apal Small Smal Apal Small 
ApaI ApaI 
1 Ml Ml Ml El El El 
2 M2 M2 M2 E2d E2 E2 
3 M3a M3 M3 E3 E3 E3 
4 M5b M4 M4 E4 E4 E4 
5 M6 MSC MSb ES E5r ES 
6 M7 M7 M6 E6 E6g E6 
7 M8 M8 M7 E7 E7 E7 
8 M9 M9 M8 E9e El3 E9e 
9 MIO MIO M9 El 1 EIS El 1 
10 Mll Ml3 MIO El2 El2 
11 Ml3 Ml4 Mll El3 El3 
12 Ml4 MIS Ml3 EIS El4 
13 MIS Ml7 Ml4 ElS 
14 Ml7 Ml9 MlS 
15 Ml9 M20 Ml7 
16 M20 Ml9 
17 M20 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
3M3 andM4 eE9 and ElO 
b M5,Ml2,Ml 6,Ml 8 rE5 and El 1 
CM5,M6,Ml l ,Ml2,M16, gE6,E9 ,E 1 O,E 12,E 14 
Ml8 h M5,Ml2,M16,M18,El2 
ctE2 and E14 iM8 and E7 
Meningitis and 
Epiglottitis Combined 
RFLPs 
n=34 
Sm a I Apa I Small 
Apa! 
Ml Ml Ml 
M2 M2 M2 
M3a M3 M3 
M5h M4 M4 
M6 M5j M5h 
M7 M7 M6 
M8i M8i M7 
M9 M9 M8i 
MIO MIO M9 
Mll Ml3 MIO 
Ml3 Ml4 Mll 
Ml4 I M15k I Ml3 
MlS Ml7 Ml4 
Ml7 Ml9 MlS 
Ml9 M20' Ml7 
M20 El Ml9 
El E2 M20 
E2d E3 El 
E3 E4 E2 
E4 El3 E3 
ES E4 
E6 ES 
E9e E6 
El 1 E9e 
El3 El l 
EIS El3 
El4 
EIS 
1M5,M6,Ml l ,M12,Ml6, 
Ml 8,E6,E9 ,E 1 O,E 12, 
El4 
kMl 5,E5, Ell 
1M20 and E15 
*The designated RFLP type name represents the lowest number assigned to a meningitis isolate 
of that type or if no meningitis isolate represents the type then the lowest number assigned to an 
epiglottitis isolate of that type. The types in boldface represent multiple isolates. The boxed 
types represent types found among both the meningitis and the epiglottitis isolates. Note: In the 
text of this thesis Sm a I, Apa I or SmaIJ Apa I prefixes RFLP types as appropriate for clarification. 
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Meningitis and Epiglottitis Isolates Combined: ApaI-RFLPs (Figure 3.12, Table 
3.12 in Appendix B) Table 3.12 shows the distance matrix of 1-F values derived from 
the pairwise comparison of the 20 types found among the 34 meningitis and epiglottitis 
isolates and from which the dendrogram seen in Figure 3 .12 was constructed. The 
similarity among pairs ranged from 43% to 97%. Three of the clusters at an F value > 
0.9 and four types comprised both meningitis and epiglottitis isolates. Apal-MS and 
clonally related types accounted for 50% of the sample. Apal-Ml3 was the most 
diverse isolate from these types. 
Meningitis Isolates: Smal/Apal-RFLPs (Figure 3.13, Table 3.13 in Appendix B) 
Table 3 .13 shows the distance matrix of 1-F values derived from the pairwise 
comparison of the 17 Smal/Apal-RFLP types found among the 20 meningitis isolates 
and from which the dendrogram seen in Figure 3.13 was constructed. The similarity 
among pairs ranged from 36% to 97%. Only one type, SmaVApal-MS , with 4 members 
represented multiple isolates. 
Epiglottitis Isolates: SmaI/ApaI-RFLPs (Figure 3.14, Table 3.14 in Appendix B) 
Table 3.14 shows the distance matrix of 1-F values derived from the pairwise 
comparison of the 13 SmaVApal-RFLP types found among the 14 epiglottitis isolates 
and from which the dendrogram seen in Figure 3.14 was constructed. The similarity 
among pairs ranged from 55% to 97%. Only one type, SmaVApal-E9 that had two 
members, represented more than one isolate. 
Combined Meningitis and Epiglottitis Isolates: Smal/ApaI-RFLPS (Figure 3.15, 
Table 3.15 in Appendix B) Table 3 .15 shows the distance matrix of 1-F values derived 
from the pairwise comparison of the 28 Smal/Apal-RFLP types found among the 
combined meningitis and epiglottitis isolates and from which the dendrogram seen in 
Figure 3 .15 was constructed. The similarity among pairs ranged from 36% to 98%. 
Only 2 types comprised both meningitis and epiglottitis isolates, however, 6 of the 
clusters at an F value > 0.9 contained both meningitis and epiglottitis isolates . 
SmaVApal-MS was indistinguishable from 4 other isolates and found among both the 
meningitis and epiglottis isolates. It was closely or clonally related (F>0.90) to 11 
isolates in three clonal groups. Thus, M5 and isolates clonally or closely related 
accounted for 4 7% of the sample. 
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3.3.4 Genetic diversity and correlation to meningitis and epiglottitis 
Clustering of the RFLP types was not associated with either meningitis or epiglottitis. 
Isolates from patients with either disease type were represented by a diverse range of 
types and no single type was associated with a particular diagnosis. Chi square analysis 
did not reveal any association. In addition, no obvious association was found between 
age, sex, or date of collection. 
3.3.5 Correlation of Smal and Apal RFLP types 
Visual examination of the matrices, dendrograms, and the patterns of the RFLP types 
showed that overall relationships between isolates were similar using both enzymes and 
that both meningitis and epiglottitis isolates shared RFLP types. The correlation 
coefficient of the two enzymes determined using the computer program Diploma 
(Weiller and Gibbs, 1993) was 0.79 among the meningitis isolates (190 data points), 
0.74 among the epiglottitis isolates (91 data points), and 0.78 among the combined 
sample (561 data points). 
Specific differences in Smal versus Apal typing could be reliably ascertained only 
among the types with multiple isolates. In almost all cases typing differences were due 
to indistinguishable isolates being identified as clonal or closely related by the second 
enzyme. Examples of these typing differences are described in the box following and 
are illustrated in the summary of types shown in Table 3.5. 
3.3.6 Numerical index of the discriminatory ability of the typing system 
Simpson's index of diversity (D) was applied to the data to determine the discriminatory 
power of Smal and Apal PFGE. The use of Smal alone had an index of 0.974. This 
index indicates that if two strains were sampled randomly from the population, than on 
97 .4% of occasions, they would fall into different types. The index for Apal alone was 
0.890, a D value considered to be less desirable. Using the two enzymes together 
yielded an index of 0.978, marginally better than Smal alone. No correcting factor for 
the small sample size (n=34) was applied in determining D. 
3.3.7 Average distances calculation of RFLP type and disease association 
The distance matrix of the 26 SmaI-RFLPs (Table 3.9 in Appendix B) was tested for 
evidence of association of type to disease manifestation by determining average 
112 
distances between types. The average distance between meningitis isolates was 0 .34 7 5, 
between epiglottitis isolates it was 0.3000, and between meningitis and epiglottis 
isolates the average distance was 0.3160. Permutation test estimates from 199 permuted 
samples were 0.3245, 0.3275, and 0.3258, respectively. The results were well within 
the 9S% confidence level and, thus, no evidence was provided to suggest that any types 
were associated with disease manifestation. 
Smal vs Apal typing: Differences among types with multiple isolates 
Meningitis 
• M3 and M4, indistinguishable by Smal typing, were different though 
closely related by Apal typing. 
• Apal-MS, included all the isolates that fell in the Smal-MS type plus 2 
isolates that were closely and clonal related by Smal typing. 
Epiglottitis 
• E2 was indistinguishable from E 14 when typed using Smal. Apal typing 
distinguished them and indicated a close or clonal relationship. 
• By Smal typing E9 was indistinguishable from El0. Apal typing also 
showed E9 and E 10 to be indistinguishable and included E6, E 12, and 
E 14 in this type. As noted above E2 was indistinguishable from E 14 by 
Smal typing but it was shown to be clonally related to it by Apal typing. 
E9-E14 and E9-E12 were clonally related by Smal typing. But the Smal 
Fvalue of both E6-E9 and E6-El0 was 0.76 suggesting that they may not 
be closely related. F values >0.8 were found between E6-El2 and E6-
E14. 
Combined Sample 
• M15, ES, and El I were indistinguishable by Apal typing and fell into 
three different Smal types that were closely or clonally related. 
• M20 and EIS, indistinguishable by Apal typing, were different by SmaI 
typing but were found to have a clonal relationship . 
... text follows Figures 3. 7 - 3.15 and Table 3.6 
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Figure 3.7 Dendrogram showing the clustering of 16 Smal-RFLP types found 
among 20 meningitis isolates obtained from _patients in the Canb_erra region. The 
dendrogram was generated using the mathematical model of Nei and Li. Distances were 
calculated by the neighbor-joining method and the TDRA W program was used to 
_ produce the appropriate tree. The bar indicates a genetic value of 0.10. The sum of the 
numerical value of the length of the horizontal lines between pairs represents the genetic 
distance between the two types. 
Types that fell in 
clusters (n=3) at F ~ 0.5 
1) M13 
2) M7, M9 
3) All the other types 
Types that fell in the clusters or 
branches (n=12) atF~ 0.9 
1) M13 7) M6, M19 
2) M7 8) M3, Ml0 
3) M9 9) MS, Ml 1 
4) M14 10) Ml 7 
5) M15 11) M2 
6) M8 12) Ml, M20 
Pairs of types (n=l3) at_F~ 0.9 
Ml-M20 
M2-M5 
M3-M5 
M3-M6 
M3-M10 
M3-Ml 1 
M3-M19 
M5-M8 
M5-Ml 1 
M5-Ml7 
M5-Ml9 
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Figure 3.8 Dendrogram showing the clustering of 12 Smal-RFLP types found 
among 14 epiglottitis ~solates obtained from patients in the Canberra region. The 
dendrogram was generated using the mathematical model of Nei and Li. Distances were 
calculated by the neighbor-joining method and the TDRA W program was used to 
produce the appropriate tree. The bar indicates a genetic value of 0.10. The sum of the 
numerical value of the horizontal lines between pairs is an estimate of the genetic 
distance between the two types. 
Types that fell in 
clusters (n=2) at F::; 0.5 
1) ES , El 1 
2) All the other types 
Types that fell in the clusters or 
branches (n=6) at F ~ 0.9 
1) ES, El 1 
2) El 
3) El5 
4) E2, E7, E9, E12a 
5) E3, E4 
6) E6, E13 
a This type is indistinguishable from RFLP type Smal-MS . 
Pairs of types (n=9) at F ~ 0.9 
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Figure 3.9 Dendrogram showing the clustering of 26 Smal-RFLP types found 
among 34 meningitis (n 20) and epiglottitis (n=14) isolates obtained from patients 
in the Canberra region. The de1s.drogram was generated using the mathematical model 
of Nei and Li. Distances were calculated by the neighbor-joining method and the 
TDRA W program was used to produce the appropriate tree. The bar indicates a genetic 
value of0.10. The sum of the numerical value of the horizontal lines between pairs is an 
estimate of the genetic distance between the two types. 
Types that fell in Types that fell in the clusters or Pairs of types (n=34) atF~ 0.9 
clusters (n=3) at F ~ 0.5 branches (n=14) atF~ 0.9 
1) M13 1) M13 13) M15 , ES, El 1 Ml-M20 M5-M17 M15-El 1 
2) M7, M9 2) M7 14) El Ml-El5 M5-Ml9 Ml 7-E2 
3) All the other types 3) M9 M2-M5 M5-E2 Ml9-E3 
4) M3 , Ml0, E3 M3-M5 M5-E9 Ml9-E6 
5) E4 M3-M6 M6-M19 Ml9-E13 
6) M6, Ml 9, E6, El3 M3-Ml0 M6-E6 M20-El5 
7) Ml , M2, Ml5 M3-Ml 1 M6-El3 E2-E9 
8) M2 M3-Ml9 M8-E2 E3-E4 
9) Mll,M5,Ml 7 M3-E3 M8-E9 ES-El 1 
10) Ml7 M3 -El3 Ml0-Ml9 E6-El 3 
11) MS , E9, E2 M5-M8 Ml0-E3 
12) Ml4 MS-Ml 1 Ml l-E2 
- M9 
-
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M17 
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Figure 3 .10 Dendrogram s~owing the clustering of 15 Apal-RFLP types found 
among 20 meningitis isolat~s obtained from patients in the Canberra region. The 
dendrogram was generated using the mathematical model of Nei and Li. Distances were 
calculated by the neighbor-joining method and the TDRA W program was used to 
produce the appropriate tree. The bar indicates a genetic value of 0.10. The sum of the 
numerical value of the horizontal lines between pairs is an estimate of the genetic 
distance between the two types. 
Types that fell in 
clusters (n=2) at F ~ 0.5 
1) Ml3 
2) All the other types 
Types that fell in the clusters or 
branches (n=7) at F ~ 0.9 
1) Ml3 
2) Ml4 
3) M9 
4) Ml5 
5) MS, M8, Ml 7, Ml9 
6) M3, MIO, M4 
7) Ml, M2, M20 
Pairs oftypes (n=14) atF~ 0.9 
Ml-M2 
Ml-M20 
M2-M20 
M3-Ml0 
M4-M5 
M4-Ml0 
M5-M8 
M5-Ml0 
MS-Ml 7 
M5-M19 
M8-M19 
M10-M19 
M17-M19 
M19-M20 
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Figure 3 .11 Dendrogram showing the clustering of 9 Apal RFLP types found 
among 14 epiglottitis isolates obtained from patients in the Canberra region. The 
dendrogram was generated using the mathematical model of Nei and Li. Distances were 
calculated by the neighbor-joining method and the TDRA W program was used to 
produce the appropriate tree. The bar indicates a genetic value of 0.10. The sum of the 
numerical value of the horizontal lines between pairs is an estimate of the genetic 
distance between the two types. 
Types that fell in 
clusters at F ~ 0.5 
All the types fell in a 
single cluster 
Types that fell in the clusters or 
branches (n=6) at F z 0.9 
1) El 
2) ES 
3) E4, E63, E7, El3 
4) El5 
5) E3 
6) E2 
a This type is indistinguishable from RFLP typeApaI-MS. 
Pairs of types (n=8) at F z 0.9 
E3-E6 
E4-E6 
E4-E7 
E4-El3 
E6-E7 
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Figure 3.12 Dendrogram showing the clustering of 20 Apal-RFLP types found 
among 34 meningitis (n-20) and epiglottitis (n=14) isolates obtained from patients 
in the Canberra region. The dendrogram was generated using the mathematical model 
of Nei and Li. Distances were calculated by the neighbor-joining method and the 
TDRA W program was used to produce the appropriate tree. The bar indicates a genetic 
value of 0.10. The sum of the numerical value of the horizontal lines between pairs is an 
estimate of the genetic distance between the two types. 
Types that fell in 
clusters (n=2) at F:::; 0.5 
1) Ml3 
2) All the other types 
Types that fell in the clusters or 
branches (n=l 1) at F ~ 0.9 
1) Ml3 
2) Ml5 
3) El 
4) M7 
5) Ml4 
6) M9 
7) M8 
8) MS , Ml 7, Ml 9, E4, El3 
9) Ml , M2, M20a 
10) M4, E2 
11) M3 , MIO, E3 
aThis Apal-RFLP type included isolates M20 and E 15 . 
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Figure 3.13 Dendrogram showing the clustering of 17 Smal/Apal-RFLP types 
found among 20 meningitis isolates obtained from patients in the Canberra region. 
The dendrogram was generated using the mathematical model of Nei and Li. Distances 
were calculated by the neighbor-joining method and the TDRA W program was used to 
produce the appropriate tree. The bar indicates a genetic value of 0.10. The sum of the 
numerical value of the horizontal lines between pairs is an estimate of the genetic 
distance between the two types. 
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Figure 3.14 D~ndrograni showing the clustering of 13 Smal/Apal-RFLP types 
found among 14 epiglottitis isolates obtained from patients in the Canberra region. 
The dendrogram was generated using the mathematical model of Nei and Li. Distances 
were calculated by the neighbor-joining method and the TDRA W program was used to 
produce the appropriate tree. The bar indicates a genetic value of 0.1 0. The sum of the 
numerical value of the length of the horizontal lines between pairs represents the genetic 
distance between the two types. 
Types that fell in Types that fell in the clusters or Pairs of types (n=20) at F ~ 0.9 
clusters at F ~ 0.5 branches (n=7) at F ~ 0.9 
1) El E2-E12 E6-E14 
All the types fell in a 2) E5, El 1 E2-E14 E7-E9 
single cluster 3) E2 E4-E6 E7-El2 
4) b E7, E9, E12, El4 E4-E9 E7-E14 
5) E4, E6, E13 E4-E12 E9-El2 
6) E3 E4-El 3 E9-El3 
7) El5 E5 -E 11 E9-El4 
E6-E9 El2-El3 
E6-El2 E12-El4 
E6-E13 E13-E14 
aThis type was indistinguishable from RFLP type Smal/Apal-MS. 
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Figure 3 .15 Dendrogram showing the clustering of 28 Smal/Apal-RFLP types 
found among 34 meningitis (n 20) and epiglottitis (n=l4) isolates obtained from 
patients in the Canberra region. The dendrogram was generated us(ng the 
mathematical model of Nei and Li. Distances were calculated by the neighbor-joining 
method and the TDRA W program was used to produce the appropriate tree. The qar 
indicates a genetic value of 0.10. The sum of the numerical value of the horizontal lines 
between pairs is an estimate of the genetic distance between the two types. 
Types that fell in Types that fell in the Pairs of types (n=65) at F ~ 0.9 
clusters (n=2) at clusters or branches 
F~ 0.5 (n=JO) atF~ 0.9 
1) Ml3 1) M13 Ml-M2 M5-M6 M6-M19 Ml 1-E6 M20-E15 
2) All the other 2) El Ml-M20 M5-M8 M6-E4 Ml 1-E9 E2-E14 
types 3) Ml 5, ES, El 1 Ml-E15 MS-Ml 1 M6-E6 Ml 1-E13 E4-E6 
4) M7 M3-M4 M5-M17 M6-E9 Mll-E14 E4-E9 
5) M4,M9 M3-M10 M5-M19 M6-E13 Ml5-E5 E4-El3 
6) MS, MS, Ml 1, Ml 7, M3-M19 M5-E2 M6-E14 M15-Ell E4-E14 
E2,E9, El4 M3-E3 M5-E4 M8-Ml 1 Ml 7-E9 E5-El 1 
7) M2 M4-M5 M5-E6 M8-E9 Ml 7-E14 E6-E9 
8) Ml, M20, E15 M4-M6 M5-E9 M8-E14 M19-E4 E6-E13 
9) M6, M19, E4, E6, E13 M4-M10 M5-E13 M10-M19 Ml9-E6 E6-E14 
10) M3, M4, MIO, E3 M4-Ml 1 M5-El4 M10-E3 Ml 9-E9 E9-E 13 
M4-M19 M6-M8 Mll-Ml7 M19-El3 E9-E14 
M4-E3 M6-Ml 1 Mll-M19 Ml 9-El4 E13-El4 
Table 3.6 Summary of the PFGE analysis of the genetic relationships among the meningitis (n=20) and epiglottitis (n=l4) isolates recovered from 
patients in the Canberra region using the restriction endonucleases, Smal and Apa!, and N ei and Li's mathematical model 
Meningitis Epiglottitis Meningitis and Epiglottitis 
SmaI Apal SmaI!ApaI Smal ApaI Small A pal Smal Apal SmaI/ApaI 
Number of RFLP types a I 16 15 17 I 12 9 13 I 26 20 28 
Ratio of types to isolatesb 0 .80 0.75 0.85 0 .86 0 .64 0.93 I 0.76 0.59 0.82 
F value of the most closely related pairs of 0 .97 0.97 0 .98 0.96 0.97 0 .97 I 0.97 0.97 0.98 
the different typesc 
F value of the most diverse genetic 0 .19 0:4!:3 0 .36 I 0.48 0.53 0.55 I 0.19 0.43 0.36 
relationship among pairs of typesd 
Number of shared fragments among the most I 3 of28 8 of29 12 of 54 I 7 of22 9 of25 18 of 47 I 3 of28 8 of29 12 of 54 diverse pair of isolates and the total number 
of fragments among the paire 
Number of clusters among types at F <0.5 f I 3 2 2 I 2 1 1 I 3 2 2 
Nun1ber of clusters among types at F >0.9g I 12 7 10 I 6 6 7 I 14 11 10 
Number of pairs among types at F ~0.9h I 13 14 22 I 9 8 20 I 34 31 65 
a Smal discrimination yielded more RFLP types than Apal. eThis data correlates with the F value of the most diverse genetic relationship 
bThe ratio of Smal types to isolates is highest and the difference between using among pairs of types listed in the previous row. 
Smal alone versus Smal and Apal is not great. fSmaI discrimination produced more clusters at F <0.5 than Apal. 
cClosely related isolates were consistently identified by each of the enzymes. gSmaI discrimination produced more clusters at F >0.9 than Apal. 
d An inconsistency in genetic diversity among the most diverse pairs of types h Smal discrimination produced more pairs among types at F ~0. 9 than ApaI. 
ainong the meningitis isolates was found between Smal and Apal. 
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3.4 Discussion 
It has been shown that the Hib population is clonal, which implies that the number of 
different types will be limited (Musser et al., 1988). One practical implication of this is 
that, in general, non-specific procedures such as RFLP analysis can be used to identify 
bacteria in such populations (Porras et al., 1986). The aim of this study was to evaluate 
the use of PFGE for determining the genetic diversity of Haemophilus influenzae type b 
and to characterise a sample of clinical isolates of Rib. Because of its epidemiological 
significance a sample of 34 isolates from meningitis and epiglottitis patients from 
Canberra, a discrete geographical area, was selected for this study. 
The rare-cutting endonucleases, Smal and Apal, were chosen to digest the Rib DNAs, 
and 20 ApaI-RFLPs, 26 SmaI-RFLPs and 28 SmaI/ApaI-RFLPs were found. Identical, 
closely related, and distantly related isolates of Rib were distinguished and the 
correlation between the enzymes was very good. Both enzymes produced distinct, 
comparable patterns though Smal patterns were easier to interpret than Apal patterns . 
The average number of fragments per type ranged from 14 to 18, for Smal and Apal 
digests, respectively. This is a sufficient number for good discrimination with patterns 
produced that are not excessively complex. Repeat runs were necessary to confirm some 
observations particularly when comparing isolates on different gels. When necessary, 
the isolates in question were loaded into adjacent lanes and run together on a new gel. 
While the need to prepare repeat runs may not ever be entirely avoided, a high level of 
consistency in producing quality gels is necessary to facilitate comparison of patterns 
and to limit repeat runs. 
Correlation between the two enzymes was very good (r = 0. 78 with 561 data) but, not 
surprisingly, discrepancies were found. However, among types with multiple isolates 
typing differences were mostly due to pairs that were indistinguishable by Apal typing 
but distinguishable as clonally or closely related when typed with Smal. The most 
diverse Smal F value found between isolates that were indistinguishable using Apal was 
0. 7 6 when 7 of the 19 different Smal fragments found between E6-E9 were not shared. 
Even this difference, however, is not outside the bounds of potentially clonally related 
isolates (Thal et al., 1997). Thus, among types with multiple isolates, differences in 
typing between the two enzymes did not change the overall genetic diversity inferred 
from the results. 
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Among the RAPDistance Programs package is a program that identifies samples 
producing patterns that correlate worst with a distance matrix. When it was applied to 
the distance matrix of all the types, removal of up to 16 isolates was required to increase 
the correlation coefficient by just 0.04. After removing those 16 isolates no 
improvement in the correlation coefficient was attained. This suggests that no one 
isolate was responsible for decreasing the correlation of the enzymes and that typing 
differences between the two enzymes did not obscure the relationship of the isolates 
determined by PFGE using either enzyme. 
Calculation of Simpson's index of diversity (D) showed that Smal digestion was more 
discriminating than Apa! digestion. D = 0.974 for Smal, indicates a very high power of 
discrimination. The D value of Apa!, 0.890, is considered to be less desirable but is just 
within the range where results can be interpreted with confidence. The use of both 
enzymes together did not improve the power of discrimination significantly. Ideally, 
typing schemes should not be validated with small samples and a larger sample (n>l 00) 
should be used to confirm the D values. However, one would predict from the number 
of types found and the presence of multiple isolates per type that this typing system has 
a high level of discrimination. 
It was shown that Smal digestion results were similar to those found using Apa! 
digestion and that both are suitable for typing Hib isolates. The practical implication of 
this is that either of the enzymes alone could be used to examine the overall genetic 
diversity of Hib and its population structure with similar results . Since SmaI patterns 
had fewer fragments, were less complex and were easier to compare, I prefer its use 
from a technical point of view. In addition, Smal was more sensitive in detecting 
differences among closely related isolates. While the combination of patterns obtained 
with both enzymes will theoretically increase the power of a typing system, only two 
additional types were found by SmaIJApaI typing versus typing with SmaI alone. In 
each case indistinguishable isolates that were found to be different by the second 
enzyme were clonally related. Interestingly, a close genetic relationship determined by 
Smal typing was confirmed by Apa! typing among 78 Hib strains recovered from the 
cerebrospinal fluid of children with meningitis in Italy (Tarasi et al. , 1998). The data 
were not subject to cluster analysis. Estimates of genetic distance were based on the 
number of shared fragments between pairs without subjecting the data to numerical 
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analysis. The authors concluded that a combination of the enzymes would enhance the 
discriminatory power of PFGE but it was not clear to what extent this occurred. 
The dendrograms generated from the similarity matrices of each enzyme reflect the 
consistency of the overall relationships between types. The closely related isolates are 
consistently closely related and, while the more distantly related isolates tend to vary 
slightly in their location on the dendrograms, the overall close and distant relationships 
are not obscured. The entire sample typed by both enzymes was analysed for the effect 
of the fragment data on the numerical calculation used to determine the genetic distance 
values. The same clustering and distribution of types found using Nei and Li's F value 
was consistently observed when dendrograms were produced from the similarity 
matrices calculated using 15 different algorithms (RAPDistance Programs). 
The distribution of RFLP types indicates that the population of Hib in Canberra is 
clonal. None of the types was associated with beta-lactamase production, biotype, age, 
sex or disease state. The close genetic relationship among most of the isolates digested 
by Smal was confirmed following Apal digestion. One type, SmaVApaI-M5, and 
isolates clonally related to it accounted for almost 50% of the sample representing a 
clone endemic in the Canberra region. These data are in accordance with the results 
obtained with multilocus enzyme electrophoresis suggesting that H. injluenzae is 
basically clonal and that most diseases are caused by a very small number of clonal 
genotypes (Musser et al., 1990). 
The isolates in the predominant clone were almost evenly distributed among the 
epiglottitis and meningitis isolates. And, isolates from each disease group were found in 
6 of the 10 clusters at a similarity >0.90 and in the two clusters at a genetic distance of 
<0.50. It may well be that the failure to demonstrate clonal disease specificity was 
caused by the choice of enzyme. Other restriction enzymes that sample different areas 
of the genome may detect molecular differences that demonstrate clonal disease 
specificity but we did not detect such a relationship among the isolates in this study. It 
can also be argued that owing to the small sample size, more isolates must be studied to 
confirm the lack of association of PFGE types with epiglottitis. 
The epiglottitis isolates were less diverse than the meningitis isolates. The smallest F 
value (0.48) among them was 0.29 greater than the smallest value found among the 
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meningitis isolates (0.19). However, if isolate E8 had been kept in the sample the 
diversity of the epiglottitis isolates would have been similar to that of the meningitis 
isolates because E8 was clonally related to Ml3. Ml3 was the most diverse isolate in 
the sample and genetically distinct from all the other isolates . 
An interesting note is that the pattern of RFLP type Smal-MS was indistinguishable 
from the Smal pattern of a known OMP subtype 1 strain that we hold in a set of OMP 
reference isolates. OMP subtype 1 is the predominant European outer membrane protein 
subtype described by (van Alphen et al., 1983). It has been reported to be identical with 
that designated 3L among the North American isolates studied in the development of 
the system reported by Barenkamp et al. (Barenkamp et al., 1981). This subtype 
accounted for 83 % of 187 isolates recovered from children with invasive disease in 
Victoria (Clements et al., 1992). It was also found to account for 76% of 59 Hib isolates 
from Adelaide and one from Newcastle (Hansman and Lawrence, 1993). 
Furthermore, the profile of Smal-MS appears to be indistinguishable from the 
predominant pattern described among Italian isolates that matched a strain from the 
United Kingdom and was closely related to reference strain ATCC 10211 (Tarasi et al., 
1998). Computer generated graphic patterns of Smal-RFLP types of Hib recently 
reported among Japanese isolates were difficult to compare with the gel pictures from 
this study but it did not appear that any of those patterns matched Smal-MS (Mitsuda et 
al. , 1999). 
This study showed that PFGE can be used to explore the genetic diversity of Rib ' s 
population structure in Australia and has extended our knowledge on the range of its 
clonality. It showed that similar strains of Hib are associated with meningitis and 
epiglottitis and that a single type and its clonally related isolates predominate in the 
Canberra region. The correlation of the predominant RFLP type with OMP subtype 1 
suggests that this type may be predominant in other areas of Australia and that it may be 
of European origin. Further investigation using PFGE to study the diversity of Hib 
types, the range of the predominant clonal group, and the association of types with 
disease states is warranted. 
CHAPTER 4 
Characterisation of 104 Non-Aboriginal 
Meningitis and Epiglottitis Isolates of 
Haemophilus influenzae type b 
Using Pulsed Field Gel Electrophoresis 
128 
4. 1 Introduction 
The results described in Chapter 3 showed that PFGE would be useful for characterising 
genetic types among Hib isolates. To further investigate the variation of Hib types and 
the lack of association of types with meningitis and epiglottitis found in the preliminary 
study, meningitis and epiglottitis isolates from three other metropolitan areas were 
obtained for characterisation by PFGE. The isolates were recovered before the 
introduction of Hib vaccines from non-Aboriginal patients living in the urban areas of 
Melbourne, Sydney, and Perth. 
It has been shown that the incidence of epiglottitis in Victoria (Gilbert et al. , 1990), the 
Australian Capital Territory (McGregor et al., 1992), and Sydney (McIntyre et al., 
1991) was almost twice that found in Western Australia (Hanna et al. , 1992). An age 
difference was also found with 8 and 25% of the Western Australian and Victorian 
cases, respectively, occurring after 60 months of age (Hanna, 1990). The reason for the 
differing epidemiology is not known, but, it might be explained if there were differences 
in the strains of Hib isolated in the different regions. 
Unlike that of epiglottitis, the incidence of meningitis in children under the age of 5 
years was similar in these four cities. The annual incidence averaged around 25 
cases/I 00,000 (the range was 20-31 cases). The lowest incidence was found in Sydney 
and thought to be due to under-reporting (McIntyre et al., 1991 ). In addition, reports 
from South Australia (El Saadi and Cameron, 1993) and Queensland (Hanna and Wild, 
1991) showed similar rates of Hib meningitis though the incidence was slightly higher 
in Queensland. 
Isolates from Aboriginals were not found among the Canberra, Melbourne and Sydney 
Hib collections that we accessed. Thus, this sample was limited to non-Aboriginal 
isolates. In Canberra where Aborigines comprise only 0.5% (ABS, 1987) of the 
population, no patients of Aboriginal descent were identified in a seven year study 
period (McGregor et al., 1992). Similarly, the population of Victoria is predominantly 
white and only 0.3°/o Aboriginal (ABS, 1987). It is not known to what extent isolates 
from Aboriginal patients are identified in the Sydney metropolitan area but 
Aboriginality was not mentioned by McIntyre et al. ( 1991) in their study of the 
epidemiology of Hib disease in this metropolitan region. 
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This study was undertaken to further investigate the hypotheses that genotypes 
associated with epiglottitis are not associated with meningitis and vice versa. The lack 
of association of types with disease state among the 34 isolates in the preliminary study 
does not substantiate these hypotheses; but, a examination of a larger sample would 
confirm this. Furthermore, it is not known what types are associated with disease in 
other areas and whether they are the same as those found in the Canberra region. It 
would be interesting to determine whether the predominant clone found in the Canberra 
sample is found elsewhere. The purpose of this study was 1) to ascertain genetic types 
of Hib associated with different areas and compare them for similarity, and 2) to 
determine whether any types are associated with meningitis or epiglottitis among 
isolates sampled from different areas. 
4.2 Methods 
Preparation of DNA, restriction endonuclease digestion, PFGE conditions, 
determination of the numbers and mobilities of fragments, estimation of genetic 
diversity and construction of dendrograms were performed as previously described. 
Hybridisation, plasmid analysis and routine biochemical tests were also performed as 
previously described. 
4.2.1 Bacterial isolates (Table 4.1, Appendices A.1-A.4) 
The 104 isolates included 67 recovered from patients with meningitis and 3 7 recovered 
from patients with epiglottitis. All were collected between 1985 and 1990. Thirty-four 
isolates from Canberra (previously characterised by PFGE and described in Chapter 3) 
and 22 isolates from Sydney were obtained from the Canberra Hospital, Australian 
Capital Territory; 20 isolates were obtained from the Royal Children's Hospital, 
Melbourne, Victoria; and 28 isolates from were obtained from the Princess Margaret 
Hospital, Perth, Western Australia. A breakdown of the geographic location and disease 
association of the isolates is shown in Table 4.1. Appendices 1-4 describe the isolates 
in more detail. 
All of the isolates obtained for this study had been identified by conventional methods 
as described previously. They were stored at - 70°C or, in the case of the isolates from 
Western Australia, were lyophilised. Because of the strong correlation between types 
using Smal and Apal found in the preliminary study only one enzyme, Smal was used 
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for the analysis of RFLPs in this study. It was chosen because the number and size of 
fragments produced using SmaI were fewer and more distinct than those of Apal. 
Digestion with Apal was performed and the results were available for backup if needed. 
Table 4. 1 Geographic location and disease association of 104 Rib isolates 
recovered from non-Aboriginals diagnosed with meningitis or 
epiglottitis 
Number of isolates 
Geographic location 
Meningitis Epiglottitis 
Canberra, Australian Capital Territorya 
Melbourne, Victoriab 
Sydney, New South Walesa 
Perth, Western Australiac 
Total 
20 
10 
21 
16 
67 
14 
10 
1 
12 
37 
aFrom a collection held at Canberra Hospital, Woden, Australian Capital Territory 
bFrom a collection held at Royal Children's Hospital, Melbourne, Victoria 
cFrom a collection held at Princess Margaret Hospital , Perth, Western Australia 
The isolates were designated as follows: 
Source Meningitis Epiglottitis 
Canberra (n=34) M 1-20 (n=20) E 1-7, E 9-15 ( n = 14) a 
Victorian (n=20) V 1-1 0 ( n = 1 O) V 11-2 0 ( n = 1 O) 
Sydney (n=22)b S2, 5-9 
' 
11-12, 14, 16-18, S37 (n=l) 
20, 22, 24-25, 28-30, 35-36 
(n=21) 
Total 
34 
20 
22 
28 
104 
Perth (n=28)b WA14-17, 22, 24-25, 27, 29- WA18-21, 26, 28, 35-36, 40, 
31, 34, 41, 43-44, 47 (n=l6) 42, 45-46 (n= 12) 
aThe isolate designated E8 was excluded from the Canberra subset when it was found to be from 
Campbelltown, NSW, and subsequently was designated S37 
bBreaks in the numbering represent Hib isolates in our collection that were recovered from patients 
diagnosed with diseases other than meningitis or epiglottitis. These ' other' isolates were analysed 
and included in the study described in Chapter 6. 
4.3 Results 
4.3.1 Hybridisation 
All the isolates hybridised with pU082. Hybridisation was detected on one or two DNA 
fragments per isolate on the Smal-PFGE gels. For most types the same size fragment, 
corresponding to fragment 8.1 (--416 kb) of HS008, hybridised with pU082. Among sets 
of multiple types the same fragment or fragments hybridised and no further splitting of 
RFLP types was found from the capsular typing of the PFGE RFLPs. 
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4.3.2 Visual analysis of Smal-RFLPs 
Tables 4.2-4.4 describe the fragment distribution among types found in each subset. 
Fragment sizes ranged from ,__,9-500 kb which extended the size range found in the 
preliminary study. The increase in fragment size was due to just two isolates, S29 and 
S3 7. Most isolates were tested at least twice. 
Canberra isolates (Figures 3.1-3.3, Table 3.1) The analysis of these isolates is 
described in Chapter 3. In summary, 26 SmaI-RFLPs were found among 34 isolates. A 
predominant type and its clonally related types represented 47% of the sample. Only 
two types were found among both the meningitis and epiglottitis isolates. The most 
genetically distant pair of isolates shared just 3 of their 28 fragments (F 0.19). 
Victorian isolates (Figures 4.1-4.2, Table 4.2) Six types were found among the 10 
meningitis isolates. One accounted for 40% of the sample and was indistinguishable 
from the predominant type found among the Canberra isolates. One of the four types 
found among the 10 epiglottitis isolates was also indistinguishable from the 
predominant Canberra type. It accounted for 7 (70%) of the epiglottitis isolates. The 
distribution of isolates among types was: 
Meningitis isolates ( n = 10) 
Smal-RFLP type Number of 
isolates/type 
V2 (same as Vl 1 )* 4 
Vl 2 
V5 V7 V8 VlO 1 each 
Epiglottitis isolates ( n = 10) 
Smal-RFLP type 
Vl 1 (same as V2)* 
V14, Vl 8, Vl 9 
Number of 
isolates/type 
7 
1 each 
*indistinguishable from RFLP type Smal-MS that predominated in the Canberra sample 
When the meningitis and epiglottitis isolates were combined 9 types were found. The 
ratio of types to isolates was lower and the types were less diverse than those found in 
the Canberra sample. The type that was indistinguishable from the predominant 
Canberra type accounted for 55% of the sample. It was the only type found among both 
the meningitis and the epiglottitis isolates. The distribution of isolates among the 
combined meningitis and epiglottis types was: 
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Meningitis and epiglottitis isolates combined (n=20) 
Smal-RFLP Number of isolates Distribution of isolates/type/disease 
type per type Meningitis Epiglottitis 
V2* 1 1 4 7 
Vl 2 2 0 
all others (n= 72 1 each V52 V7l V82 VlO Vl42Vl8lV19 
*indistinguishable from RFLP type Smal-M5 that predominated in the Canberra sample 
Sydney isolates (Figures 4.2-4.6, Table 4.3) Eleven types were found among the 21 
meningitis isolates from Sydney. One of them was indistinguishable from RFLP type 
MS, the predominant type found in the Canberra and Victorian samples. It accounted for 
41 % of the sample. The only epiglottitis isolate in the sample was a unique type and the 
most diverse one. The distribution of isolates among types was: 
Meningitis and epiglottitis isolates combined (n=22) 
Smal-RFLP type 
S6* 
Sl6 
S2, 5, 8, 11, 12, 
14,20,29,37 
Number of isolates/type 
9 
2 
1 each 
*indistinguishable from RFLP type Smal-M5 that 
predominated in the Canberra sample 
Western Australian isolates (Figures 4.7-4.9, Table 4.4) Five types were found 
among the meningitis isolates from Perth. One was indistinguishable from RFLP type 
MS, the predominant Canberra/Melbourne/Sydney type. It accounted for 7 (44%) of the 
16 meningitis isolates and S ( 42%) of the 12 epiglottitis isolates among which 7 types 
were found. The distribution of isolates among types was: 
Meningitis isolates 
SmaI-RFLP type Number of 
isolates/type 
WA14(sameasWA18)* 7 
WA15 4 
WA16 2 
WA24 2 
WA17 1 
Epiglottitis isolates 
Smal-RFLP type 
WA18 (same as WA14)* 
WA19 
W A20,21,36,42,46 
Number of 
isolates/type 
5 
2 
1 each 
*indistinguishable from RFLP type Smal-M5 that predominated in the Canberra sample 
In the combined sample 9 types were found. The predominant type, that was 
indistinguishable from MS included 12 (43%) of the 28 isolates. It was clonally related 
. . . text continues after Tables 4. 2-4. 4 and Figures 4.1-4. 9 
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Table 4. 2 Number of Smal-RFLP types and the number of fragments found per 
type among 20 meningitis and epiglottitis Hib isolates from Victoria 
Total number Number of fragments per type 
of types 13 14 15 
Meningitis isolates 6 Types 3 1 2 
n=JO (0.60: It Isolates n=6 n=l n=3 
Epiglottitis isolates 4 Types 2 0 2 
n=JO (0.40: It Isolates n=8 n=O n=2 
All isolates 9b Types 4c 1 4 
n=20 (0.45:It Isolates n=l4 n=l n=5 
aRatio of the number of types found to the total number of isolates typed. 
bone Smal-RFLP type was found among both meningitis and epiglottitis isolates. 
cone of the 13 fragment types was found among both meningitis and epiglottitis isolates. 
Table 4. 3 Number of Smal-RFLP types and the number of fragments found per 
type among 22 meningitis and epiglottitis Hib isolates from Sydney, 
New South Wales 
Total number Number of fragments per type 
of types 13 14 15 16 
Meningitis isolates 11 Types 4 6 1 
n=21 (0.52: It Isolates n=l3 n=6 n=2 
Epiglottitis isolates 1 Types 1 
n=l Isolates n=l 
All isolates 12 Types 4 6 1 1 
n=22 (0.45: It Isolates n=l3 n=6 n=2 n=l 
aRatio of the number of types found to the total number of isolates typed. 
Table 4. 4 Number of Smal-RFLP types and the number of fragments found per 
type among 28 meningitis and epiglottitis Hib isolates from Western 
Australia 
Meningitis isolates 
n=16 
Epiglottitis isolates 
n=12 
Total number 
of types 
5 
(0.31: It 
7 
(0.58: it 
Number of fragments per type 
Types 
Isolates 
Types 
Isolates 
13 14 
3 2 
n=l3 n=3 
4 3 
n=9 n=3 
All isolates 9b Types 5c 4 ct 
n=28 (0.32: It Isolates n=23 n=5 
aRatio of the number of types found to the total number of isolates typed. 
bThree Smal-RFLP types were found among both meningitis and epiglottitis isolates. 
cTwo of the 13 fragment types were found among both meningitis and epiglottitis isolates . 
dOne of the 14 fragment types was found among both meningitis and epiglottitis isolates. 
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Figure 4.1 Smal restriction fragments obtained by PFGE of the genomic DNAs of I 0 
Hib isolates recovered from the cerebrospinal fluid or blood of meningitis patients from 
Victoria. Lanes labelled 8, A and A-H contain fragment standards; lane IL is a Hib 
isolate with OMP subtype IL from a set of OMP standards. 
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Figure 4.2 Smal restriction fragments obtained by PFGE of the genomic DNAs of I 0 
Hib isolates recovered from the blood of epiglottitis patients from Victoria and 2 
isolates from a meningitis patient (S36) and a patient with invasive disease from the 
Sydney region. Lanes labelled 8 and A contain fragment standards. 
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Figure 4.3 SmaI restriction fragments obtained by PFGE of the genomic DNAs of 10 
Hib isolates recovered from the cerebrospinal fluid or blood of meningitis (m) patients 
or patients with other ( o) infections from the Sydney region. Lanes labelled 8, A and A-
H contain fragment standards. 
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Figure 4.4 Sn1aI restriction fragments obtained by PFGE of the genomic DNAs of 10 
Hib isolates recovered from the cerebrospinal fluid or blood of meningitis (m) patients 
or patients with other ( o) infections from the Sydney region. Lanes labelled 8, A and A-
H contain fragment standards . 
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Figure 4.5 Snial restriction fragments obtained by PFGE of the genomic DNAs of 10 
Hib isolates recovered from the cerebrospinal fluid or blood of meningitis (m) patients 
or patients with other ( o) infections from the Sydney region. Lanes labelled 8, A and A-H 
contain fragment standards. 
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Figure 4.6 Smal restriction fragments obtained by PFGE of the genomic DNAs of 6 
Hib isolates recovered from the cerebrospinal fluid or blood of meningitis (m) patients 
or patients with other ( o) infections from the Sydney region and 5 Aboriginal meningitis 
isolates from Western Australia. Lanes labelled 8 and AIA-H contain fragment standards. 
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Figure 4.7 Smal restriction fragments obtained by PFGE of the genomic DNAs of Hib 
isolates recovered from the cerebrospinal fluid or blood of 6 patients with meningitis 
and 4 with epiglottitis from Western Australia. Lanes labelled 8 and AIA-H contain 
fragment standards; lane 1 L is a Hib isolate with OMP subtype 1 L from a set of OMP 
standards. The prefix for each isolate is WA. 
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Figure 4.8 Smal restriction fragments obtained by PFGE of the genomic DNAs of Hib 
isolates recovered from the cerebrospinal fluid or blood of 8 meningitis (m) and 3 
epiglottitis ( e) patients from Western Australia. Two isolates are from patients with 
other ( o) diagnoses. Lanes labelled 8 contain fragment standards. The prefix for each 
isolate is WA. 
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Figure 4.9 Smal restriction fragments obtained by PFGE of the genomic DNAs of Hib 
isolates recovered from the cerebrospinal fluid or blood of 4 meningitis (m) and 5 
epiglottitis ( e) patients from Western Australia. Four isolates are from patients with 
other ( o) diagnoses. Lanes labelled 8 contain fragment standards. The prefix of all the 
isolates is WA. 
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to 6 types (WA15, WA16, WA20, WA24, WA42, and WA46) and together these types 
comprised 89% of the isolates. Three types (WA14, WA15, and WA17) were shared by 
both the meningitis and epiglottitis isolates. The lowest ratio of types to isolates of all 
the urban areas was found in this sample. The distribution of isolates among types was: 
Meningitis and epiglottitis isolates combined 
SmaI-RFLP type Number of isolates/type Distribution of isolates/type/disease 
Meningitis Epiglottitis 
WA14* 12 7 5 
WA15 6 4 2 
WA17 2 1 1 
WA16 2 2 0 
WA24 2 2 0 
all others (n=4) 1 each WA20,21,42,46 
*indistinguishable from RFLP type SmaI-M5 that predominated in the Canberra sample 
All isolates from the four areas (Table 4.5) Thirty-two Smal-RFLP types among the 
67 meningitis isolates and 21 types among the 3 7 epiglottitis isolates were found. Over 
one third of the sample were members of the predominant type MS. The distribution of 
isolates among types is shown in Table 4.5. 
When all the isolates from all four urban regions were combined 4 7 types were found. 
The predominant type, MS (n=37), and its 18 clonally related types ( M2, M3 , M8 , 
Ml 1, Ml 7, M19, E2, E9, VS, Vl0, V14, V19, S2, Sl 1, S20, WA24, WA42 and WA46) 
comprised 67% of the sample. Twelve types had multiple members. Six of them were 
shared by both the meningitis and the epiglottitis isolates and 6 types had two or three 
members of only one disease state. But no one type was associated with meningitis or 
epiglottitis . 
The consistency in the ratio of types to isolates found in the different areas or in disease 
association varied. The ratios among urban areas and disease types was: 
Canberra 
Melbourne 
Sydney 
Perth 
All urban areas 
Ratio of SmaI-RFLP types to isolates 
Meningitis 
0.80 
0.60 
0.52 
0.31 
0.48 
Epiglottitis 
0.86 
0.40 
0.58 
0.57 
Combined 
0.76 
0.45 
0.45 
0.32 
0.45 
Canberra had the highest ratio of types to isolates among both meningitis and 
epiglottitis isolates. Western Australia had the lowest ratio among meningitis isolates 
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(and overall), while Victoria had the lowest ratio among epiglottitis isolates . In contrast 
to these observations, the ratio among Victoria's meningitis isolates was twice that 
found in Western Australia and the ratio of epiglottitis isolates in Western Australia was 
higher than that in Victoria. Overall the ratio of types to isolates in the entire sample 
was similar to that found in Victoria and Sydney but was less than that in Canberra and 
slightly more than in Western Australia. It is interesting that the two subsets that had the 
largest difference in ratios, Canberra and Western Australia, had the largest sample 
sizes. If the samples examined from Victoria and Sydney are smaller proportions of the 
total number of isolates in those areas than are the Canberra and Western Australian 
samples they may be less representative of the true diversity of Hib. This may explain 
the low ratios seen in these two areas. 
A breakdown of the distribution of types, multiple isolate types, and shared types in the 
entire sample is shown in Table 4.5. Only one type, Smal-M5 was found in all four 
urban areas. Six other types were found in more than one area. 
4.3.3 Genetic relationships determined by numerical analysis of restriction 
fragment length polymorphisms 
The range of similarity or genetic distance, identification of clonal relationships and 
identification of the most diverse relationships among types were determined from 
matrices produced using the mathematical model of N ei and Li except for the subset of 
epiglottitis isolates from Western Australia. In this case, Jaccard's algorithm was used 
because the TDraw program would not compute the Nei and Li matrix. 
Canberra isolates (Figures 3.9-3.11) The genetic analysis of these isolates is 
described in Chapter 3. Briefly, a wide range of similarity among the types was found 
in this sample. Three types were genetically distant from each other and the major 
clusters into which most of the types fell. Two of these, Ml 3-M7, had an F value of 
0.19. A predominant type, designated Smal-M5 , and 6 clonally related types accounted 
for 55% of the sample. 
Victorian isolates (Figures 4.10-4.12) The similarity among pairs of meningitis types 
ranged from 50 to 92%. The predominant type and 2 clonally related types represented 
60% of this subset. The most genetically distinct type had F values ranging from 0.50 to 
0.57 when compared to the other types. The epiglottitis types ranged in similarity from 
Table 4. S Summary of Smal-RFLP types 1 found among 104 non-Aboriginal 
meningitis and epiglottitis isolates of Haemophilus injluenzae type b 
RFLPs among 
meningitis isolates 
n=67 isolates 
Ml 
M2 
M3*a 
MS*b 
M6 
M7 
M8 
M9 
MIO 
Mll 
M13 
M14 
M15*c 
M17 
M19 
M20 
Vld 
vs 
V7 
V8 
VlO 
S2 
SS 
S7e 
S8 
S 11 
S12 
S16r 
S20*g 
S29 
WA17 
WA24h 
n=32 
aM3, M4, WA16, WA25 
bM5,Ml 2,M 16,M 18,V2, 
V3,V4,V6,S6,Sl 7, S18, 
S24,S25,S28,S30,S35, 
S36,WA14,WA22, 
WA27,WA29,WA30, 
WA44,WA47 (n=24) 
CM15, S 14 
dVl, V9 
RFLPs among 
epiglottitis isolates 
n=37 isolates 
RFLPs among combined 
meningitis and epiglottitis 
isolates 
El 
E21 
E3 
E4 
ES 
E6 
E7 
E13 
EIS 
V14 
Vl8 
V19 
S37 
Ml 
M2 
M3*a 
I MS*b,~ 
M6 
M7 
E9*j 
WA191 
WA21 
WA36 
WA42 
WA46 
I Msml 
M9 
MIO 
Mll 
M13 
M14 
El 1 
E12*k 
n=21 
M15*c 
eS7, S9 
rS16, S22 
gS20, WA15, WA31, 
WA34, WA43 
hWA24, WA41 
1E2, E14 
JE9, E10,WA20 
M17 
M19 
M20 
k E12,Vl l,V12,V13,Vl5, 
V16,Vl 7,V20,WA18, 
n= 104 isolates 
El 
I E2*4 
E3 
E4 
ES 
E6 
E9*j 
!Ell *0 1 
E13 
EIS 
Vld 
vs 
V7 
V8 
VlO 
V14 
V18 
V19 
S2 
SS 
S 11 
S12 
S16r 
I S20*g,~ 
S29 
S37 
twAI71 
WA21 
WA24h 
WA42 
WA46 
n=47 
WA26,WA28,WA40, 
WA45 (n=l3) 
1WA19, WA35 
mM8, E7 
nE2, E14, S8 
0El 1, S7, S9 
PWA17, WA36 
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1The designated RFLP type name represents the lowest number assigned to a meningitis isolate 
of that type or if no meningitis isolate represents the type then the lowest number assigned to an 
epiglottitis isolate of that type. Type names were assigned to Canberra isolates first, then new 
types found among Melbourne isolates, then Sydney, and finally Perth. The types in boldface 
represent those types with multiple isolates. The boxed types are the types found among both 
the meningitis and the epiglottitis isolates. 
*Found in more than one urban area; RFLP-M5 is the only type found in all four urban areas. 
79 to 93%. Three of the 4 types in this subset were clonally related and accounted for 
90% of the isolates. It is possible that the most diverse isolate, V 18 (F O. 79 when 
compared with Vl 1 and V14 and 0.80 when paired with V19), was clonally related to 
the others. When the meningitis and epiglottitis isolates were combined the predominant 
type and its clonally related types comprised 7S% of the sample. The most genetically 
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distinct type was no greater than 50% dissimilar from other types and overall this 
sample was more homogeneous than the Canberra sample. 
Sydney isolates (Figure 4.13) The meningitis types ranged in similarity from 55 to 
96%. The predominant type and 4 clonally related types accounted for 62% of the 
isolates. Another clonal group of 3 types comprising 4 members was 70% similar to the 
predominant type. 
The epiglottitis isolate was the most diverse in the combined sample and the largest F 
value, 0.27, was found when it was compared to S 11. This reduced the similarity range 
to a low of 27% for the combined sample. The large genetic distance between some 
types was similar to that found in the Canberra sample. 
Western Australian isolates (Figures 4.14-4.16) The similarity range of the 
meningitis types was 60 to 93%. The predominant type and clonally related types (n=4) 
accounted for 93% of the sample. Among the epiglottitis types a larger similarity range 
of 46 to 96% was found. Clonally related types including the predominant type 
represented 75% of the epiglottitis isolates. When combined the predominant type and 
its clonally related types comprised 89% of the sample. 
All isolates from the four urban areas (Figures 4.17-4.19) The range of similarity 
among all the meningitis types was determined by the diversity of the Canberra types 
and ranged from 19 to 97%. The predominant type and its clonally related types 
comprised 45 members and accounted for 67% of the meningitis isolates. Four 
meningitis types were less the 50% similar to the other 28 types. Ml3-M7 was the most 
diverse pair with an F 0.19. 
Most of the epiglottitis isolates fell into 2 closely related clusters. The predominant 
type and its clonally related types accounting for 68% of the sample represented twenty-
five isolates. S3 7, the most diverse type, was less then 40% similar to all the other 
types. S37-E4 was the most diverse pair of epiglottitis types with an F 0.20. 
When all the types were combined they fell into 7 maJor clusters in a tree like 
dendrogam. Three clusters fell at an F<0.50 and 25 branches fell at F?:.0 .90. Six types, 
Ml3 , S37, M7, Vl , M9 and WA21 represented the most diverse types and included 7 
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isolates. The predominant type, designated Smal-MS (n=37) and its 18 clonally related 
types accounted for 70 isolates or 67% of the entire sample. 
The distribution of RFLP type Smal-MS and its clonally related types among the areas 
and subsets was: 
Percentage of sample represented by Smal-M5 and clonally related types* 
Canberra 
Victoria 
Sydney 
W estem Australia 
All areas 
Meningitis 
20/55 
40/60 
43/62 
44/94 
36/67 
Epiglottitis 
7/43 
70/90 
42/50 
35/68 
All isolates 
15/47 
55/75 
41/59 
43/89 
35/67 
*the first nu1nber of a pair refers to the percentage of the predominant type 
alone; the second number refers to the percentage of the predominant type 
and its clonally related types. 
I<-+ 4 
V1,V9 
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Figure 4.10 Dendrogram showing the clustering of 6 Smal-RFLP types found 
among 10 meningitis isolates obtained from non-Aboriginal patients in Victoria. 
The dendrogram was generated using the mathematical model of Nei and Li. Distances 
were calculated by the neighbor-joining method and the TDRA W program was used to 
produce the appropriate tree. The bar indicates a genetic value of 0.10. The sum of the 
numerical value of the horizontal lines between pairs is an estimate of the genetic 
distance between the two types. 
. Types that fell in 
clusters (n=2) at F ~ 0.5 
1) Vl ,V9 
2) All the other types 
Types that fell in the clusters or Pairs of types (n=2) at F ~ 0.9 
branches (n=5) at F ~ 0.9 
1) V2\Vl0 V2-V5 
2) V5 V2-Vl0 
3) V8 
4) V7 
5 Vl ,V9 
aThis type was indistinguishable from Sma1-M5 , the predominant type found among the Canberra 
isolates. 
V18 
V19 
V11-13,V15-17,V20 
V14 
0.10 
Figure 4.11 Dendrogram showing the clustering of 4 Smal-RFLP types found 
among 10 epiglottitis isolates obtained from non-Aboriginal patients in Victoria. 
The dendrogram was generated using the mathematical model of Nei and Li. Distances 
were calculated by the neighbor-joining method and the TDRA W program was used to 
produce the appropriate tree. The bar indicates a genetic value of 0.10. The sum of the 
numerical value of the horizontal lines between pairs is an estimate of the genetic 
distance between the two types. 
Types that fell in 
clusters (n=l) at F ~ 0.5 
1) All the types 
Types that fell in the clusters or 
branches (n=3) at F z 0.9 
1) Vll\Vl9 
2) Vl4 
3 Vl8 
Pairs of types (n=2) at F z 0.9 
Vll-Vl9 
Vl l-Vl4 
aThis type was indistinguishable from Smal-M5, the predominant type found among the Canberra 
isolates. 
V1,V9 
-
V1 0 
-
~ V2,V3-4,V6,V11-1 3,V15-17,V20 
-
~ 
vs 
V19 
V 8 
- V14 
V7 
-
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Figure 4.12 Dendrogram showing the clustering of 9 Smal-RFLP types found 
among 20 meningitis and epiglottitis isolates obtained from non-Aboriginal 
patients in Victoria. The dendrograrn was generated using the mathematical model of 
Nei and Li. Distances were calculated by the neighbor-joining method and the TDRA W 
program was used to produce the appropriate tree. The bar indicates a genetic value of 
0.10. The sum of the numerical value of the horizontal lines between pairs is an estimate 
of the genetic distance between the two types. 
Types that fell in 
clusters (n=2) at F ~ 0.5 
1) Vl ,V9 
2) All the other types 
Types that fell in the clusters or 
branches (n=l) at F ~ 0.9 
1) V2\Vl9 
2) vs 
3) Vl0 
4) V8,Vl4 
5) V7 
6) Vl8 
7 Vl,V9 
Pairs of types (n=5) at F ~ 0.9 
V2-V5 
V2-Vl0 
V2-Vl4 
V2-V19 
V8-Vl4 
aThis type was indistinguishable from Smal-MS, the predominant type found among the Canberra 
isolates . 
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Figure 4.13 Dendrogram showing the clustering of 12 Smal-RFLP types found 
among 22 meningitis and epiglottitis isolates obtained from non-Aboriginal 
patients in the Sydney region. The dendrogram was generated using the mathematical 
model of Nei and Li. Distances were calculated by the neighbor-joining method and the 
TDRA W program was used to produce the appropriate tree. The bar indicates a genetic 
value of 0.10. The sum of the numerical value of the horizontal lines between pairs is an 
estimate of the genetic distance between the two types. 
Types that fell in 
clusters (n=2) at F ~ 0.5 
1) S37 
2) All the other types 
Types that fell in the clusters or 
branches (n=7) at F ~ 0.9 
1) S6\S2,S8 
2) S 11 
3) S5,S20 
4) S29 
5) S7,Sl4,Sl2 
6) Sl6 
7 S37 
Pairs of types (n=l 1) at F ~ 0.9 
S2-S6 
S2-S8 
S2-S20 
S5-S20 
S6-S8 
S6-S4 
S6-S20 
S7-Sl2 
S7-Sl4 
S8-S20 
S 12-S 14 
aThis type was indistinguishable from SmaI-M5, the predominant type found among the Canberra 
isolates. 
WA17 
-
WA16, WA25 
WA24, WA41 
WA 14,22,27,29,3 0,44,47 
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0.10 
WA 15,31,34,43 
Figure 4.14 Dendrogram showing the clustering of 5 Smal-RFLP types found 
among 16 meningitis isolates obtained from non-Aboriginal patients in Western 
Australia. The dendrogram was generated using the mathematical model of N ei and Li. 
Distances were calculated by the neighbor-joining method and _ the TDRA W program 
was used to produce the appropriate tree. The bar indicates a genetic value of 0. ro. The 
sum of the numerical value of the horizontal lines between pairs is an estimat'e of the 
genetic distance between the two types. 
Types that fell in 
clusters (n=l) at F ~ 0.5 
1) All the types 
Types that fell in the clusters or 
branches (n=4) at F?. 0.9 
1) WA14\WA15 
2) WA24 
3) WA16 
4 WA17 
Pairs of types (n=3) at F?. 0.9 
WA14-WA15 
WA14-WA16 
WA14-WA24 
aThis type was indistinguishable from Smal-M5, the predominant type found among the Canberra 
isolates . 
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- WA18,26,28,4 0,45 
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Figure 4.15 Dendrogram showing the clustering of 7 Smal-RFLP types found 
among 12 epiglottitis isolates obtained from non-Aboriginal patients in Western 
A ustralia. The dendro gram was generated using J accard' s mathematical model. 
-Distances were calculated by the neighbor-joining method and the TDRA W program 
was used to produce the appropriate tree. The bar indicates a genetic value of O .10. The 
sum of the numerical value of the horizontal lines between pairs is an estimate of the 
genetic distance between the two types. 
Types that fell in 
clusters (n=2) at F::; 0.5 
1) WA21,WA36 
2) All the other types 
Types that fell in the clusters or 
branches (n=6) at F ~ 0.9 
1) WA18\WA42 
2) WA19 
3) WA20 
4) WA46 
5) WA36 
6 WA21 
Pairs of types (n=l) atF~ 0.9 
WA18-WA42 
aThis type was indistinguishable from Smal-M5, the predominant type found among the Canberra 
isolates. 
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WA17m WA36e 
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-
WA21e 
WA16 m, WA25m 
WA46 e 
WA20e 
WA14 (n=12 m&e) 
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WA15 (n=6 m&e) 
WA42e 
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0.10 
WA24m, WA41m 
Figure 4.16 Dendrogram showing the clustering of 9 Smal-RFLP types found 
among 28 meningitis and epiglottitis isolates obtained from non-Aboriginal 
patients in Western Australia. The dendrogram ,was generated using the mathematical 
model ofNei and Li. Distances were calculated by the neighbor-joining method and the 
TDRA W program was used to produce the appropriate tree. The bar indicates a genetic 
value of0.10. The sum of the numerical value of the horizontal lines between pairs is an 
estimate of the genetic distance between the two types. An 'm' for meningitis or ' e' for 
epiglottitis is used to indicate the disease association of an isolate. 
Types that fell in 
clusters (n=2) at F ~ 0.5 
1) WA21 
2) All the other types 
Types that fell in the clusters or 
branches (n=6) at F ~ 0.9 
1) WA14a,WA156,WA42 
2) WA20 
3) WA24 
4) WA16,WA46 
5) WAI 7 
6 WA21 
Pairs of types (n=JO) atF~ 0.9 
WA14-WA15 
WA14-WA1 6 
WA14-WA20 
WA14-WA24 
WA14-WA42 
WA14-WA46 
WA15-WA42 
WA1 6-WA46 
WA20-WA42 
WA24-WA42 
aThis Smal-RFLP type included isolates WA14m, W A22m, W A27m, W A29m, WA30m, WA44m, 
WA47m, WAI 8e, W A26e, WA28e, WA40e and WA45e (n=l 2) and was indistinguishable from Smal-
M5 , the predominant type found among the Canberra isolates . 
bThis Smal-RFLP type included isolates WA15m, WA3lm, WA34m, WA43m, WA19e and WA35 e 
(n=6) . 
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Figure 4.17 Dendrogram showing the clustering of 32 Smal-RFLP types found 
among. 67 meningitis isolates obtained from non-Aboriginal patients in four urban 
regions. The dendrogram was generated using the mathematical model of Nei and Li. 
Distances were calculated by the neighbor-joining method and the TDRA W program 
was used to produce the appropriate tree. The bar indicates a genetic value of 0.10. 
Types that fell 
in clusters 
(n=3) at F ~ 0.5 
1) Ml3 
2) M7, M9 
and Vl 
3) All the 
other types 
Types that fell in the clusters or branches 
(n=17) atFz 0.9 
1) Ml,M20 10) M14 
2) M2,Vl0 11) S16 
3) M3 ,Ml0 12) Ml5,S7,WA17 
4) V8,Sll 13) S12 
5) M6,Ml9 14) S29 
6) M5\Ml l ,S8 15) V7 
7) M8 16) M7,M9,Vl 
8) S5,W A24 17) Ml3 
9) Ml 7,S2,VS ,S20 
Pairs of types (n=49) atFz 0.9 
Ml-M20 M5-Ml 7 Ml0-Sl I V8-Sl I 
Ml-VI0 M5-M19 Ml 1-S8 VI0-S8 
M2-M5 M5-V5 M15-S7 S2-S8 
M2-Vl0 M5-Vl0 Ml5-S12 S2-S20 
M3-M5 M5-S2 Ml5-WA17S5-S20 
M3-M6 M5-S8 Ml7-V5 S5-WA24 
M3-Ml0 M5-Sll M17-S20 S7-S12 
M3-Ml 1 M5-S20 Ml 7-S2 S7-WAl 7 
M3-Ml9 M5-WA24Ml7-S8 S8-S20 
M3-V8 M6-Ml9 Ml9-V8 S8-WA24 
M3-Sl 1 M6-Sl 1 Ml9-Sl 1 
M5-M8 M 8-V5 V5-S5 
M5-Ml 1 M8-S 8 V5-S20 
aThis type included isolates M5 , Ml 2, M6 , Ml 8, V2, V3 , V4, V6, S6 , Sl 7, S18 , S24, S25, S28 , S30, S35 , 
S36, WA14 , WA22, WA27 , WA29 , WA30, WA44, WA47 (n=24). 
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Figure 4.18 Dendrogram showing the clustering of 21 Smal-RFLP types found 
among 37 epigloffitis isolates obtained from non-Aboriginal patients in four urban 
regions. The dendrogram was generated using the mathematical model of Nei and Li. 
Distances were calculated by the neighbor-joining method and the TDRA W program 
was used to produce the appropriate tree. The bar indicates a genetic value of 0.10. 
Types that fell 
in clusters 
(n=2) at 
F~ 0.5 
1) S37 
2) All the 
other 
types 
Types that fell in the clusters or 
branches (n= I I) at F-:?. 0.9 
Pairs of types (n=JI) atF-:?. 0.9 
1) WA42,El2\E7,E9 9) WA21 E2-E7 E3-Vl4 E7-WA42 El2-WA46 
2) WA19 10) WA36 E2-E9 E3-WA46 E9-El2 El3-Vl4 
3) E2,Vl9 11) S37 E2-El2 E4-Vl4 E9-WA42 El3-WA46 
4) E3,E4 E2-Vl4 ES-El 1 El l-WA36 Vl4-WA42 
5) Vl4,WA46,E6,El3 E2-Vl9 E6-El3 El2-Vl4 Vl4-WA46 
6) El5 E2-WA19 E6-Vl4 El2-Vl9 Vl9-WA42 
7) Vl8 E2-WA42 E7-E9 El2-WA19 WA19-42 
8) E5,El 1 E3-E4 E7-El2 El2-WA42 
aThis type included isolates E12, Vl 1, V12, V13, Vl5, V16, Vl7, V20, WA18 , WA26, WA28 , WA40 
and WA45 (n=J 3) and was indistinguishable from Smal-M5, the predominant type among the Canberra 
isolates. 
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Figure 4.19 Dendrogram showing the clustering of 47 Smal-RFLP types found 
among 104 meningitis and epiglottitis isolates obtained from non-Aboriginal 
patients in four urban regions. The dendrogram was generated using the mathematica! 
model of Nei and Li. Distances were calculated by the neighbor-joining method and tµe 
TDRA W program was used to produce the tree. The bar indicates a genetic value of 
0.10. 
Types that fell in 
clusters (n =J) at 
F ~ 0.5 
1) Ml3,S37 
2) M7,Vl , 
M9 
3) All the other types 
Types that fell in the clusters or branches (n=25) Pairs of types (n=f 04) at 
at F ~ 0.9 F ~ 0.9 
1) Ml ,M2O,El5 14) El Not listed 
2) M2,VlO 15) V7 
3) M5\ WA42,M8 ,E9 16) Vl8 
4) M7 ,S2 17) S29 
5) V5 ,S2O,S5 ,W A24 18) Ml4 
6) E2,Vl9 19) S16 
7) Ml 1 20) Ml5 ,E5 ,El 1 
8) Vl4,WA46 21) WA17 
9) M3 ,MlO 22) WA21 
10) E3 ,E4 23 ) S12 
11) M6,Ml9,El3 24) M7,Vl,M9 
12) E6 ,S 11 25) Ml3,S37 
13 V8 
aThis type included isolates M5, Ml 2, M6, Ml 8, El 2, V2, V3 , V4, V6, Vl 1, Vl2, Vl3, Vl5, Vl6, Vl 7, 
V2O, S6, S17, S18 , S24, S25 , S28, S3O, S35 , S36 , WA14, WA18, WA22, WA26 , WA27, WA28 , WA29, 
WA3O, WA4O, WA44, WA45 , WA47 (n=37). 
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4.3.4 Numerical index of the discriminatory ability of the typing system 
Simpson's index of diversity (D) was 0.87 when applied to the data to determine the 
discriminatory power of Smal among the 104 meningitis and epiglottitis isolates. 
4.4 Discussion 
A large sample (n= 104) of meningitis and epiglottitis isolates from four distinct urban 
regions in Australia was obtained for characterisation by PFGE and hybridisation. It 
was striking that despite significant heterogeneity among some types, a single type 
found in all four urban areas and 18 types clonally related to it accounted for well over 
two-thirds of the isolates. It appears from our results that a group of closely related 
types accounted for most of the invasive Hib disease in non-Aboriginal Australians in 
the pre-vaccine era. 
These results correlate with findings from Victoria and other areas of the world where 
outer membrane protein subtyping revealed that the genetic diversity of Hib is relatively 
restricted in some populations (van Alphen et al., 1983; Takala et al., 1987; Clements et 
al., 1992; Urwin et al., 1995). It has also recently been reported that the same PCR 
ribotype was found among a majority of carrier Hib isolates from Aboriginal children 
living in a remote island community in the Northern Territory (Smith-Vaughan et al., 
1998). 
Interestingly, the extent to which the predominant type, designated Smal-M5, was 
present varied among both the metropolitan areas and the disease type subsets in this 
sample. Overall the predominant type alone accounted for one third of the meningitis 
isolates and one-third of the epiglottitis isolates. There was a difference in the number 
of epiglottitis isolates represented by the predominant type in the regional subsets. In the 
Canberra sample 7% of the isolates were the predominant type. Whereas in the 
Victorian sample of a similar size, 70% of the isolates were the predominant type. The 
proportion in W estem Australia was almost half that of Victoria but still six times that 
of Canberra. So while it appears that the Smal-M5 type was found equally among 
meningitis and epiglottitis isolates in the entire sample, anomalies were found among 
the urban subsets of epiglottitis isolates. One explanation is that the Victorian and 
Sydney samples were not representative proportions of the actual number of Hib types 
found in those areas. 
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There was less divergence in the representation of the predominant type in the subsets 
of meningitis isolates. It accounted for about 40% of the isolates in three of the urban 
subsets, the exception being the Canberra subset where it accounted for only 20%. The 
lower representation of the predominant type in the Canberra sample is not surprising as 
it was the most diverse of the urban subsets and had the highest ratio of types to isolates 
that was more than two times greater than that found in the Western Australian sample. 
The Victorian and Sydney ratios were similar and slightly higher than the Western 
Australian ratio of types to isolates. 
No other type predominated in the combined sample and in the Canberra subset no type 
was represented by more than 2 isolates. Thus, no other single type had been selected 
for and, subsequently, accounted for the low percentage of the Smal-M5 type in the 
Canberra sample. 
It is notable that in the Victorian sample of epiglottitis isolates, 3 of the 4 types found 
were clonally related. The fourth type was less closely related to the others at an F value 
of 0.20 that was not outside the bounds of potentially clonally related isolates (Thal et 
al., 1997). Thus, while 90% of the isolates were shown to belong to clonally related 
types, the entire sample was potentially clonally related. A similar homogeneity was 
not found in any other subset of epiglottitis isolates. However, a slightly greater 
homogeneity was found in the Western Australian subset of meningitis isolates where 
94% of the isolates fell in the predominant type and its clonally related types. Even 
though the subset sample sizes are relatively small, the data suggest that there is a 
stronger selection in these subsets for the predominant type and a small group of its 
clonally related types. It is puzzling that this appears to occur among the epiglottitis 
isolates in Victoria and among the meningitis isolates in Western Australia and not in 
any other subsets of the sample. 
The RFLPs of the 20 isolates from Victoria were compared with their previously 
determined OMP subtypes (Clements et al., 1992). Eleven of the isolates were members 
of the same RFLP type (indistinguishable from Smal-M5). Three OMP subtypes, IL, 
14L and 1 VA were found among them. The most genetically distinct type, Smal-Vl , 
had two members with the same OMP subtype, 3L. Of the other 7 isolates that fell into 
7 RFLP types, 6 were OMP subtype 1-VA and one was subtype 14L. As previously 
mentioned, when the fragment pattern of Smal-MS was compared to the Smal RFLP 
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patterns of an OMP reference set of 21 isolates obtained from European and North 
American collections it was identical to the pattern of OMP subtype l /3L called 1 VA by 
Clements, et al. It might also be noted that OMP subtypes IL and 14L had identical 
PFGE patterns that differed from the l /3L (1 VA) OMP subtype pattern by a two 
fragment difference. While the discriminatory ability of PFGE was significantly greater 
than that of OMP typing among the 20 Victorian isolates, in some cases at least, 
discrimination was better using both methods. The usefulness of correlating OMP 
subtyping with PFGE RFLP typing awaits further study. 
A genetic distance showing a similarity of less than 20% was found between four types, 
M7-Ml3 and S11-S37 had F 0.19 and 0.20, respectively. Five types, M7, M9, Ml3 , 
S3 7 and Vl , representing 6 isolates, were found to be consistently less than 60% similar 
to all other types and mostly even more dissimilar to each other with the exception of 
M 13 and S3 7 that were clonally related. In contrast the majority of the other types fell 
into closely related clusters. In fact, the predominant type and its clonally related types 
accounted for almost 70% of the sample. The presence of such diverse types in an 
otherwise relatively closely related group of types is intriguing. Do they represent 
endemic strains or strains recently brought into the region? Are they newly ansen 
strains or older strains from which the endemic clonal group has evolved? 
No evidence was found to suggest that a particular genotype was associated with one 
disease and not the other. The data show clearly that the predominant type found in all 
urban areas and its clonally related types are associated with both meningitis and 
epiglottitis. Isolates associated with epiglottitis were found in 9 of 11 major clusters, 
including the most distant cluster, of the dendrogram constructed from the similarity 
matrix of the entire sample. Meningitis isolates were found in all the major clusters . 
In summary, the population structure of Hib among meningitis and epiglottitis isolates 
from urban areas appears to be clonal. Typical of a clonal population, one type 
predominated and with its clonally related types accounted for almost 70% of the 
sample. A few distantly related types representing less then 6% of the sample were 
found. No association between RFLP type and disease state, age, sex, biotype, beta-
lactamase production or geographic location was found. Hybridisation of the Smal 
digested DNA fragments with pU082 did not split the types further than that found with 
PFGE alone. 
CHAPTER 5 
Investigation of the Genetic Diversity of 
7 6 Aboriginal Isolates of 
Haemophilus influenzae type b 
Using Pulsed Field Gel Electrophoresis 
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5.1 Introduction 
The pre-vaccine epidemiology of Hib disease among Aboriginal populations was 
markedly different from that found among non-Aboriginals in Australia. The incidence 
of disease was four to ten times higher, the age of onset of disease was earlier and while 
a spectrum of Hib diseases occurred, in particular, meningitis , pneumonia, and 
bacteremia, virtually no epiglottitis was found in Aboriginal populations (Hanna, 1992). 
Though generally kept low because the associated hospitalisation rates were very high, 
the case fatality rate was also higher (Hanna and Wild, 1991 ). This is similar to the 
epidemiology of Hib disease among other high-risk ethnic minorities, namely, 
American Indians (Losonsky et al., 1984), Alaskan Eskimos (Ward et al. , 1981) and 
Canadian Inuits (Shapiro and Ward, 1991 ). The reasons for these variations are not 
understood. Environmental factors and genetic predisposition have been implicated but 
there are likely to be other factors involved, including differences in the distribution of 
Hib strains in different populations. 
The annual incidence rate of Hib meningitis, the most precisely estimated disease 
incidence, was approximately 150 episodes per 100,000 Aboriginal children under five 
years of age per year in Western Australia and the Northern Territory (Hanna and Wild, 
1991 ). However, the point estimate was much higher in Central Australia at 273 cases 
per 100,000 children (Hanna, 1990). In contrast the incidence of Hib meningitis among 
children in non-Aboriginal populations in the same time period was around 25/100,000. 
As noted above, Central Australian Aboriginal children were found to have a 
significantly higher incidence of Hib disease then other Aboriginal children in the 
Northern Territory and Western Australia. In fact, the world's highest incidence of Hib 
disease was estimated to be a startling 991 cases per 100,000 Central Australian 
Aboriginal children and residence in Central Australia was identified as one of the 
major risk factors for invasive Hib disease (Hanna, 1990). Concurrently the incidence of 
meningitis in non-Aboriginal children in Central Australia was found to be four times 
greater than that estimated for Melbourne children (Hanna, 1990) reflecting the 
exceptionally high risk for Aboriginal children residing there. One of the factors that 
might explain the increased risk of invasive Hib infection in Central Australia is the 
possibility of the presence of a more virulent strain than that prevalent in other areas . 
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It can also be stated that Hib caused a substantial proportion of pneumonia and 
bacteraemia in young Aboriginal children and less common but severe infections such 
as septic arthritis , cellulitis and osteomyelitis. Not a single case of epiglottitis among 
Aboriginal children was documented in the years covered by the three major studies on 
the epidemiology of Hib disease among Aboriginal populations in Western Australian 
and the Northern Territory (Hanna, 1990; Hanna and Wild, 1991; Hanna et al. , 1992). 
There is little information about the diversity of Hib isolates among Aboriginals, but 
there is some intriguing evidence pointing to a difference among Aboriginal and non-
Aboriginal isolates. When outer membrane protein (OMP) subtyping was used to 
distinguish 220 non-Aboriginal isolates from Melbourne and Sydney and 55 rural 
Aboriginal isolates from the Northern Territory and Western Australia, a marked 
discrepancy between OMP subtypes causing Hib disease in the Aboriginal and non-
Aboriginal children was found (Gilbert and Clements, 1993). It appeared that the 
predominant subtype ( 1 NT) among Aboriginal children was similar, but distinguishable 
from, the predominant Victorian/Sydney subtype (1 VA) and that there was more 
variation in subtypes, some of which appeared novel among the Aboriginal isolates. 
To begin to unravel the mystery concerning the epidemiology of Hib disease among 
Aboriginal populations it would be particularly interesting to determine if: 
1) the difference between Aboriginal and non-Aboriginal OMP subtypes detected by 
Gilbert et al. (1993) is reflected in PFGE RFLP types, 
2) the Smal-RFLP type predominating in the non-Aboriginal meningitis and epiglottitis 
sample described in Chapter 4 is found among Aboriginal isolates or if other unique 
and potentially more virulent types predominate, and 
3) the Aboriginal isolates in Central Australia are different from those found in the Top 
End of the Northern Territory and Western Australia. 
The purpose of this study was to use PFGE to examine the molecular genetic 
characteristics of Hib isolates from Aboriginal patients living in distinct geographic 
regions to determine if there are genetically detectable differences between them and, 
subsequently, to determine of there are differences between Aboriginal and non-
Aboriginal isolates. 
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5.2 Methods 
Preparation of DNA, restriction endonuclease digestion, PFGE conditions, 
determination of the numbers and mobilities of fragments, estimation of genetic 
diversity and construction of dendrograms and hybridisation were performed as 
previously described. 
5.2.1 Bacterial isolates (Table 2.1, Appendices A.4-A.6) 
The sample comprised 76 isolates from Aboriginal patients and carriers living in the 
Alice Springs region, Bathurst Island, rural Western Australia and metropolitan Perth. It 
included 23 isolates recovered from patients with meningitis, 29 isolates from other 
diagnoses and 24 isolates recovered from carriers. No isolates associated with 
epiglottitis in Aboriginals were found. All the isolates were collected between 1985 and 
1993. Thirty-six were obtained from W estmead Hospital, W estmead, New South Wales 
from a collection originally obtained from Queensland Institute of Medical Research, 
Brisbane, Queensland; 9 were obtained from the Royal Children's Hospital, Melbourne, 
Victoria; 19 were obtained from the Menzies School of Health Research, Darwin, 
Northern Territory and 12 from were obtained from the Princess Margaret Hospital, 
Perth, Western Australia. A breakdown of the geographic location and disease 
association of the isolates is shown in Table 2.1. Appendices A.4-A.6 describe the 
isolates in more detail. 
All of the isolates obtained for this study had been identified by conventional methods 
as described previously. They were stored at -70°C or, in the case of the isolates from 
Western Australia, were lyophilised. Smal was used for the analysis of RFLPs in this 
study, however, digestion with Apal was also performed and the results were available 
if needed. 
The isolates were designated as follows: 
Source 
Alice 
Springs 
region 
(n=45) a 
Bathurst 
Island 
(n= 19) b 
Rural 
Western 
Australia 
(n=7) C 
Perth 
(n=5) C 
Designation 
Al-A50 
excluding Al 0, 
A24, A25,A30, 
A48 
Bl-B21 
excluding B9 
and Bl 7 
W A2, 3, 5, 6, 7, 
9, 10 
WAI, 4, 8, 12, 
13 
Reason for breaks in numbering of isolates 
Al 0 and A24 were from non-Aboriginal patients 
A25 was a nontypeable Haemophilus injluenzae 
A30 and A48 were each members of a pair of 
isolates from one patient with indistinguishable 
RFLPs. 
B9 and B 17 were non-viable on receipt. 
WAI, 4, 8, 12, and 13 are from metropolitan Perth; 
the designation WA 11 was excluded because the 
isolate was non-viable on receipt. 
WA2, 3, 5, 6, 7, 9, and 10 are from rural Western 
Australia. 
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aFrom collections held at Westmead Hospital, Westmead, New South Wales originally obtained from the 
Queensland Institute of Medical Research, Brisbane, Queensland (n=36) and Royal Children 's 
Hospital, Melbourne, Victoria (n=9) 
bFrom a collection held at Menzies School of Health Research, Darwin, Northern Territory 
cFrom a collection held at Princess Margaret Hospital, Perth, Western Australia 
5.3 Results 
Initially, 46 isolates were obtained from the Alice Springs region but one failed to 
hybridise with either pU038 or pU082 and was excluded from the study. All the other 
isolates in this study hybridised with pU082 but no further splitting of types was 
detected by cap polymorphisms. All the isolates from the Alice Springs region (n=45) 
hybridised with the P2 probe but no further splitting of types was detected. The visual 
analysis of the RFLP patterns is described first and then the numerical analysis is 
described. 
5.3.1 Visual analysis of Smal-RFLPs 
Tables 5 .1-5 .3 describe the fragment distribution among types found in each subset. 
Fragment sizes ranged from ,__,6 kb to 550 kb. While this extended the size range from 
that found among 104 non-Aboriginal isolates, the size of fragments was well within the 
ability of the system to detect them using the ramping configuration previously 
determined with non-Aboriginal isolates. There was no need to adjust methods to 
evaluate the Aboriginal isolates. 
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Alice Springs region, Northern Territory Aboriginal isolates (Figures 5.1-5.5, 
Table 5.1) The 45 Aboriginal isolates from the Central Australia Alice Springs region 
were associated with meningitis (n= 11) pneumonia (n=9), gastroenteritis (n=9) , acute 
lower respiratory tract infection (n=4), cellulitis (n= 1), febrile disease (n= 1), failure to 
thrive (n= 1), conjunctivitis (n= 1), bronchiolitis (n= 1) and otitis media (n = 1). Six 
isolates were recovered from children that did not exhibit any sign of disease. It is not 
known whether they subsequently developed Hib disease. 
Thirteen genetic types were found. One of them, A 1, accounted for 49% of the sample. 
A single isolate, A22, was indistinguishable from the predominant type (Smal-M5) 
previously found among non-Aboriginal urban isolates. The distribution of isolates 
among types was: 
Northern Territory Alice Springs region isolates ( n=45) 
Smal-RFLP type Number of isolates/type 
Al 
AS 
A23 
A2 
A3, A8, A21, A22*, A34, 
A41, A42, A45, A47 
22 
6 
5 
3 
1 each 
*indistinguishable from RFLP type Smal-M5 
The distribution of types among meningitis isolates, other diagnoses, and carriers was 
not restricted. The predominant type, Al, was found among the major disease states, 
meningitis (n=4), pneumonia (n=4) and gastroenteritis (n=4), and the less common 
serious diseases (n=6) and among the carrier isolates (n=4). The second most frequent 
type, AS, was found among the carrier isolates (n= 1) and meningitis (n= 1), pneumonia 
(n=2) , and acute lower respiratory tract infections (n= 1) but none was found among the 
9 gastroenteritis isolates. 
Pairs of isolates for each of four patients were included in this sample. Two pairs had 
members that shared the same RFLP type. The two other pairs each had members with 
different RFLPs; but, in each case the RFLPs of a pair with different types were closely 
related differing by only 2 or 4 fragments. The distribution of the types among the 4 
pairs was: 
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RFLP typing of paired isolates from a single patient 
Diagnosis Pair Source Type Fragments shared 
Meningitis A21 blood A21 24 of 28 
A22 csf A22 
Meningitis A34 blood A34 30 of 32 
A35 csf Al 
Pneumonia A29 blood Al 32 of 32 
A30 pleural fluid Al 
Meningitis/ A47 not known A47 32 of 32 
otitis media A48 not known A47 
Bathurst Island, Northern Territory Aboriginal isolates (Figures 5.6-5.7, Table 
5.2) This sample consisted of 1 isolate recovered from an ear discharge in an infant and 
18 recovered from the nasopharynx of infants who were not exhibiting symptoms of 
Hib disease. Six RFLP types were found. No single type predominated, but two types 
had 7 and 6 members each. One of these, Smal-B6, was indistinguishable from Smal-
Al, the predominant type in the Alice Springs region. The predominant type (Smal-M5) 
found among the urban isolates was not represented in this sample. The distribution of 
the isolates among the types was: 
Northe1n Territory Bathurst Island isolates (n= 19) 
Smal-RFLP type 
B2 
B6 
B8 
Bl, BS, B13 
Number of isolates/type 
7 
6 
3 
1 each 
The type designated B 13 represented the isolate recovered from an ear discharge. It was 
clonally related to type B2 (n=7) sharing 28 of 30 fragments found between them. 
Three sets of 2 isolates recovered at different times from three children and one set of 3 
isolates collected on the same date from one child were included in the sample. The 
RFLPs found were indistinguishable in each respective set. The date of collection and 
distribution of types among these sets was: 
Date of 
Collection 
14 April 92 
14 April 92 
14 April 92 
21 July 92 
02 Dec 92 
Set 
B2 
B3 
B4 
B6 
B7 
Source Type 
nasopharynx B2 
nasopharynx B2 
nasopharynx B2 
nasopharynx B6 
nasopharynx B6 
02 Dec 92 
10 Feb 93 
10 Aug 93 
20 Sept 93 
B14 
B15 
B18 
B19 
nasopharynx 
nasopharynx 
nasopharynx 
nasopharynx 
B6 
B6 
B2 
B2 
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Western Australian Aboriginal isolates (Figures 4.6, 5.8, Table 5.3) Twelve 
meningitis isolates from Aboriginal children living in metropolitan Perth (n=5) and 
rural Western Australia (n= 7) were examined. The rural isolates were from a relatively 
large geographic area including the Kimberly, Midlands, Central and Southeast Western 
Australia. 
Five RFLP types were found. Seventy-five percent of the sample was represented by 
two clonally related types, WA4 and WAI, that shared 30 of 32 fragments between 
them. W A4 was indistinguishable from the predominant type, A 1, in the Alice Springs 
region. It comprised 7 ( 64 % ) of the sample including 3 urban isolates and 4 rural 
isolates while W A2 comprised 2 rural isolates. One type, WA 1, representing a single 
isolate was indistinguishable from Smal-M5. The distribution of isolates to types was: 
Metropolitan Perth isolates (n=5) 
Smal-RFLP type 
WA4 
WA1* , WA12 
Number of 
isolates/type 
3 
1 each 
Rural Western Australia isolates (n= 7) 
Smal-RFLP type 
WA4 
WA2 
WAS 
Number of 
isolates/type 
4 
2 
1 
*indistinguishable from RFLP type Smal-M5 
All Aboriginal isolates (Table 5.4) A total of 19 types were found among the 76 
Aboriginal isolates. One type, designated Al (n=36) , predominated and was the only 
one found in all three subsets. It was clonally related to A34 (n= 1), BS (n= 1) and A23 
(n=7). These related types accounted for 59% of the sample. Five other types had 
multiple members. Type AS was the most diverse type and most distantly related to Al 
with whom it shared only 2 of 31 fragments. A summary of the distribution of types is 
shown in Table 5.5. 
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Table 5. 1 Number of Smal-RFLP types and the number of fragments found per 
type among 45 Aboriginal isolates of Hib from the Alice Springs region 
Total number Number of fragments per type 
of types 13 14 15 16 17 
Meningitis isolates 7 Types 2 1 2 2 
n=l l (0.64: it Isolates n=2 n=l n=3 n=5 
Other isolates 9 Types 0 1 4 3 1 
n=28 (0.32: It Isolates n=O n=l n=6 n=20 n=l 
Carrier isolates 3 Types 0 1 l 1 
n=6 (0.50:lt Isolates n=O n=l n=l n=4 
All isolates 13 Types 2 1 5 4 1 
n=45 (0.29: It Isolates n=2 n=3 n=JO n=29 n=l 
aRatio of the number of types found to the total number of isolates typed. 
Table 5. 2 Number of Smal-RFLP types and the number of fragments found per 
type among 19 Aboriginal carrier isolates of Hib from Bathurst Island 
Total number Number of fragments per type 
of types 14 15 16 
All isolates 6 Types 1 3 2 
n=l9 (0.32: It Isolate n=l n=l l n=7 
aRatio of the number of types found to the total number of isolates typed. 
Table 5. 3 Number of Smal-RFLP types and the number of fragments found per 
type among 12 Aboriginal isolates of Hib from Western Australia 
Total number Number of fragments per type 
of types 13 14 15 16 
Rural isolates 3 Types 0 1 0 2 
n=7 (0.64: it Isolates n=O n=l n=O n=6 
Perth isolates 3 Types 1 1 0 1 
n=5 (0.60: It Isolates n=l n=l n=O n=3 
All isolates 5 Types 1 2 0 2 
n=12 (0.42:lt Isolates n=l n=2 n=O n=9 
aRatio of the number of types found to the total number of isolates typed. 
A-H 8 Al A2 A3 A4 AS A6 A7 A8 A9 NTlO Al 1 Al2 8 
kb 
250.0 
80.0 
30 .0 
Figure 5.1 Smar restriction fragments obtained by PFGE of the genomic DNAs of 11 
Aboriginal Hib isolates and 1 non-Aboriginal isolate from the Alice Springs region. 
Lanes labelled 8 and A-H contain fragment standards. 
A-H 8 Al3 Al4 Al5 Al6 Al7 Al8 Al9 A20 A21 A22 A23 NT9 8 
kb 
250.0 
80.0 
30.0 
Figure 5 .2 Smar restriction fragments obtained by PFGE of the genomic DNAs of 12 
Aboriginal Hib isolates from the Alice Springs region. Lanes labelled 8 and A-H contain 
fragment standards. 
NTHi NTHi 
A-H A 1 A26 A27 A28 1 A26 A27 A28 A 
kb 
250.0 
80.0 
30.0 
Figure 5.3 S,nal restriction fragments obtained by PFGE of the genomic DNAs of 3 
Aboriginal Hib isolates and 1 nontypeable H. influenzae isolate from the Alice Springs 
region. Lanes labelled A and A-H contain fragment standards. 
A-H 8 A29 A30 A31 A32 A33 A34 A35 A36 A37 A38 A39 A40 8 
kb 
250.0 
80 .0 
30 .0 
Figure 5 .4 Smal restriction fragments obtained by PFGE of the genomic DNAs of 12 
Aboriginal Hib isolates from the Alice Springs region. Lanes labelled 8 and A-H contain 
fragment standards. 
A-H 8 A4 A41 A42 A43 A44 A45 A46 A47 A48 A49 A50 8 A-H 
kb 
250.0 
80 .0 
30 .0 
Figure 5.5 S,nal restriction fragments obtained by PFGE of the genomic DNAs of 11 
Aboriginal Hib isolates from the Alice Springs region. Lanes labelled 8 and AIA-H 
contain fragment standards. 
A-H A 8 B5 B6 B8 Bl2 Bl3 Bl4 Bl6 Bl9 B21 -8 
kb 
250.0 
80.0 
30 .0 
Figure 5.6 Smal restriction fragments obtained by PFGE of the genomic DNAs of 9 
Aboriginal Hib isolates from Bathurst Island. Lanes labelled 8, A and A-H contain 
fragment standards. 
8 Bl B2 B3 B4 B7 BlO Bl 1 Bl5 Bl8 B20 8 
kb 
250.0 
80.0 
30.0 
Figure 5.7 Smal restriction fragments obtained by PFGE of the genomic DNAs of 10 
Aboriginal Hib isolates from Bathurst Island. The lane labelled 8 contains fragment 
standards. 
"A,/ 
A-H 8 WA5 WA6 WA7 WA8 WA9 WAlO Al 8 
kb 
250.0 
80.0 
30 .0 
Figure 5.8 Snial restriction fragments obtained by PFGE of the genomic DNAs of 6 
Aboriginal Hib isolates from W estem Australia and 1 from the Alice Springs region. 
Lanes labelled 8, A and A-H contain fragment standards. 
5.3.2 Genetic relationships determined by numerical analysis of restriction 
fragment length polymorphisms 
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The range of similarity or genetic distance, identification of clonal and the most diverse 
relationships among types and construction of dendrograms were determined from 
matrices produced using the mathematical model of N ei and Li as previously described. 
Alice Springs region, Northern Territory Aboriginal isolates (Figure 5.9) 
Similarity among the types found in this sample ranged from 13-96%. Only 4 clonal 
pairs were among them. The predominant type, Al (n=22) , was clonally related to A34 
(n = 1) and A23 (n=5). Together this cluster of related isolates accounted for 62% of the 
sample (n=45). Interestingly no types in this cluster were closely related to other types. 
Their similarity ranged from 13-39% when compared to the other types in the sample. 
RFLP type AS was the most genetically diverse. It was less then 21 % similar to all other 
types and as low as 13% similar when compared to Al, A23, A34 and A47. 
Bathurst Island, Northern Territory Aboriginal isolates (Figure 5.10) The range of 
similarity among these types was 27 to 94% with two clonal pairs among them. No one 
type predominated but two distinct types that differed at F < 0.50 accounted for 79% of 
the isolates. One of these, B6 (n=6), was clonally related to BS (n= 1) and together they 
comprised 37% of the sample (n=19). The other, B2 (n=7) was clonally related to B13 
(n= 1) and they accounted for 42% of the sample. 
Western Australian Aboriginal isolates (Figure 5.11) The range of similarity among 
the five types in this sample was 33-94%. RFLP type WA4 (n=7) was clonally related 
to W A2 (n=2). They comprised 75% of the sample and were the only clonally related 
pair of types found. They were genetically distinct from the other three types differing 
from them at an F value< 0.41. One of these types, WAl (n= 1), was indistinguishable 
from Smal-MS. 
All Aboriginal isolates (Figure 5.12, Table 5.4) The 76 Aboriginal isolates fell into 4 
major clusters two of which were genetically distinct from each other and the other two 
clusters at F < 0.45. The range of similarity was 13-96% with a 0.25: 1 ratio of types to 
isolates . The predominant type, Al (n=36) was clonally related to A34 (n=l ), A23 
(n=7) and BS (n=l) and together they comprised 59% of the sample. The most 
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genetically distinct type, AS (n=6), was found only in the Alice Springs region subset 
but otherwise there was no obvious restriction of types within the major clusters though 
only type Al was found in all three subsets. Only 6 clonal pairs were found among the 
19 types and four pairs (AS-Al, AS-A23, AS-A34, AS-47) were the most genetically 
diverse with an F O. l 3. A summary of the distribution of types is shown in Table S .4. 
Table 5. 4 Summary of Smal-RFLP types* found among 76 Aboriginal isolates 
Alice Springs 
n=45 
Ala A23d 
A2b A34 
A3 A41 
ASC A42 
A8 A45 
A21 A47 
A22 n=l3 
aA1,A4,A6,A9,Al l,Al3, 
A14,Al5,Al 7,A18,A20, 
A26,A27,A29,A31,A35, 
A36,A38,A39,A43,A46, 
A50 (n=22) 
bA2,A12,A32 
Bathurst Island W estem Australia 
n=l9 n=l2 
Bl WAI 
B2e WA2h 
BS WA4i 
B6r WAS 
B8g WA12 
B13 n=5 
n=6 
CA5,A16,Al 9,A37,A40 
d A23,A28,A33,A44,A49 
eB2,B3 ,B4,B 16,B 18,B 19, 
B20 
f B6,B7,Bl l,B14,Bl5,B21 
gB8,B 1 0,B 12 
All isolates 
n=76 
Al a,r,i 
A2 
A3 
ASC 
A8 
A21 
A22 
A23d,h 
A34 
A41 
A42 
A45e,j 
A47 
Bl 
B5 
B8g 
B13 
WAS 
WA12 
n=l9 
~WA2,WA3 
1WA4,WA6,WA 7,WA8, 
. WA8,WA10,WA13 
1A45 
*The designated Smal-RFLP type name represents the lowest number assigned to an isolate of 
that type found among the Alice Springs isolates first, then new types found among the Bathurst 
Island isolates, and finally new types found among the Western Australian isolates. The types in 
boldface represent types with multiple members. The boxed type represents the one type found 
among all the subsets. 
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Figure 5.9 Dendrogram showing the clustering of 13 Smal-RFLP types found 
- among 45 isolates obtained from Aboriginal patients and carriers in the Alice 
Springs region, Northern Territory. The dendrogram was generated using the 
mathematical model of Nei and Li. Distances were calculated by the neighbour-joining 
method and the TDRA W program was used to produce the appropriate tree. The bar 
indicates a genetic value of 0.10. The sum of the numerical value of the horizontal lines 
between pairs is an estimate of the genetic distance between the two types. 
Types that fell in 
clusters (n=3) at F ~ 0.5 
1) A5 
2) Al, A34, A23 
3) All the other types 
Types that fell in the clusters or Pairs of types (n=4) at F~ 0.9 
branches (n= 10) at F ~ 0.9 
1) Al 8, A34 6) A2, A41 
2) A23b 7) A3 
3) A8 8) A45 
4) A21, A42 9) A47 
5) A22c 10) A5d 
Al-A23 
Al-A34 
A2-A41 
A21-A42 
aThis Smal-RFLP type included isolates Al, A4, A6, A9 , Al 1, Al 3, Al 4, Al 5, Al 7, Al 8, A20, A26, 
A27, A29, A3 l, A35, A36, A38, A39, A43, A46 and A50 (n=22). 
bThis Smal-RFLP type included isolates A23 , A28, A33, A44 and A49 (n=5). 
cThis type was indistinguishable from Smal-M5, the predominant type found among 104 non-Aboriginal 
isolates . 
<lThis SmaI-RFLP type included isolates A5, A7, Al 6, Al 9, A37 and A40 (n=6). 
B5 
B6 (n=6) 
81 
88,81 0,812 
~ 82(n=7 ) 
I I 
0.10 
813 
Figure 5.10 Dendrogram showing the clustering of 6 Smal-RFLP types found 
among 19 isolates obtained from Aboriginal children from Bathurst Island, 
Northern Territory. The dendrogram was generated using the mathematical model of 
·Nei and Li. Distances were calculated by the neighboc,r-joining method and the 
TDRA W program was used to produce the appropriate tree. The bar indicates a genetic 
value of 0.10. The sum of the numerical value of the horizontal lines between pairs is an 
estimate of the genetic distance between the two types. 
Types that fell in 
clusters (n=2) at F ~ 0.5 
1) B5, B6 
2) All the other types 
Types that fell in the clusters or Pairs of types (n=2) at F ~ 0.9 
branches (n=4) at F ~ 0.9 
1) B5 , B6a 
2) Bl 
3) B8 
4 B2b 
B2-B 13 
B5-B6 
aThis Smal-RFLP type included isolates B6, B7, Bl 1, B14, B15 and B21 (n=6) . 
bThis Smal-RFLP type included isolates B2, B3, B4, B16, B18, B19 and B20 (n=7). 
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Figure 5.11 Dendrogram showing the clustering of 5 Smal-RFLP types found 
among 12 isolates obtained from Aboriginal patients in Western Australia. The 
dendrogram was generated using the mathematical model of Nei and Li. Distances were 
calculated by the neighbour-joining method and the TDRA W program was used to 
produce the appropriate tree. The bar indicates a genetic value of 0.10. The sum of the 
numerical value of the horizontal lines between pairs is an estimate of the genetic 
distance between the two types. 
Types that fell in 
clusters (n=2) at F ~ 0.5 
1) WA2, WA4 
2) All the other types 
Types that fell in the clusters or 
branches (n=4) at F ~ 0.9 
1) WA2, WA4a 
2) WA12 
3) WAlb 
4 WAS 
Pairs of types (n=I) atF~ 0.9 
WA4-WA2 
~his SmaI-RFLP type included isolates WA4, WA6, WA7, WA8, WA9, WAl0 and WA13 (n=7) . 
bThis typ~ was indistinguishable from Smal-M5, the predominant type found among 104 non-Aboriginal 
isolates. 
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Figure 5.12 Dendrogram showing the clustering of 19 Smal-RFLP types found 
among 76 isolates obtained from Aboriginal patients in the Northern Territory and 
Western Australia. The dendrogram was generated using the mathematical model of 
Nei and Li. Distances were valcufated by the neighbor-joining method and the TORA W 
program was used to produce the appropriate tree. The bar indicates a genetic value of 
0.10. The sum of the numerical value of the horizontal lines between pairs is an estimate 
of the genetic distance between the two types. 
Types that fell in 
clusters (n=3) at F ~ 0.5 
1) A5 
2) Al, A34, B5, A23 
3) All the other types 
Types that fell in the clusters or 
branches (n= 14) at F ~ 0.9 
1) Al\ A34 8) Bl 
2) B5, A23b 9) A2, A41 
3) WAS 10) A3 
4) A21 , A42 11) A45ct, B 13 
5) A22c 12) B8 
6) A8 13) WA12 
7) A47 14) A5e 
Pairs of types (n=6) at F ~ 0.9 
Al-A23 
Al-A34 
Al-B5 
A2-A41 
A21-A42 
A45-B13 
arrhis SmaI-RFLP type included isolates Al, A4, A6, A9, Al 1, A13, A14, Al 5, Al 7, A18, A20, A26, 
A27, A29, A31, A35, A36, A38, A39, A43, A46, A50, B6, B7, B 11, B14, B 15, B21, WA4, WA6, 
WA7, WA8, WA9, WAI0 and WA13 (n=36). 
bThis Smal-RFLP type included isolates A23, A28, A33, A44, A49, W A2 and WA3 (n=7). 
crhis type was indistinguishable from Smal-M5, the predominant type found among 104 non-Aboriginal 
isolates. 
ctThis SmaI-RFLP type included isolates A45, B2, B3, B4, B 16, B 18, B 19 and B20 (n=8). 
eThis Smal-RFLP type included isolates A5, A7, A16, Al 9, A37 and A45 (n=6). 
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5.3.3 Numerical index of the discriminatory ability of the typing system 
Simpson's index of diversity (D) was 0.75 when applied to the data to determine the 
discriminatory power of SmaI among the Aboriginal isolates. No correcting factor for 
the small sample size (n=76) was applied in determining D but the poor discriminatory 
power seen here is due to the relatively few types found among the sample. 
5.4 Discussion 
Seventy-six isolates from Aboriginal patients and carriers living in three geographically 
distinct rural regions of Australia were obtained for this study. An outstanding feature 
of the genetic characterisation of these isolates was the predominance of a single type 
that was found in each geographical area. It was genetically distinct (F 0.34) from 
SmaI-M5 that predominated in the non-Aboriginal meningitis and epiglottitis sample 
and was designated SmaI-Al. Interestingly SmaI-Al was indistinguishable from RFLP 
type SmaI-S37, that represented the single epiglottitis isolate in the Sydney sample and 
subsequently, provided evidence that this type can be associated with epiglottitis. 
Among the Aboriginal isolates SmaI-Al was recovered from both healthy carriers and 
sick children including those with meningitis, pneumonia, gastroenteritis, cellulitis, 
bronchiolitis, and acute lower respiratory tract infections. 
Smal-Al was the predominant type in the Alice Springs and Western Australian subsets 
but it was one of two types that appear to be endemic clones circulating in the Bathurst 
Island population. Even when the same types found among multiple isolates from the 
same child are counted as one member of a type the population structure of 2 endemic 
clones remains. A second major endemic type found among the Bathurst Island isolates 
was exclusive to this group except for one isolate from the Alice Springs region. It may 
represent a local clone that has spread to Central Australia. 
The sample of Aboriginal isolates was further distinguished by the relatively large 
genetic distance between most types compared to that found among the non-Aboriginal 
isolates. The large genetic distances suggest that some types may have been long 
established in the communities in which they were found and are not the result of recent 
genetic changes. At least one member of a clonal pair is a type most likely to be due to 
recent genetic changes and there are few clonal pairs among the Aboriginal types. 
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Another distinguishing feature of the Aboriginal sample was its smaller ratio of types to 
isolates compared to that found among the 104 non-Aboriginal meningitis and 
epiglottitis isolates. Ratios of O .25: 1 and O .45: 1 were found among the Aboriginal 
isolates and the non-Aboriginal isolates, respectively. Thus, there were almost 50% 
more isolates per type in the Aboriginal sample. This observation raises questions that 
cannot be answered at this time. Does the isolation of the rural populations contribute to 
fewer endemic types? Or does the rate of transmission among Aboriginal populations 
result in a few endemic types? On the other hand, do the types contribute to increased 
transmission rates? 
Small population groups among Aboriginals, overcrowded living conditions, poor 
hygiene and heavy colonisation rates may explain the presence of a few types exploiting 
an environment that supports a high rate of transmission. In contrast, non-Aboriginals 
who live in larger population groups but with less contact and lower colonisation rates 
are not as efficient in the transmission of Hib strains. This may result in the presence of 
more strains that are not transmitted as easily. It also suggests that the predominant non-
Aboriginal clone may be more transmissible than others found in this population group. 
PFGE typing has provided a remarkable glimpse into the structure of Hib populations in 
these two epidemiologically distinct groups. Further study is needed to answer the 
questions it raises. 
This study provided evidence that two genetic types of Hib can be present in individuals 
with Hib disease. An isolate, A22, that was recovered from the cerebrospinal fluid of a 
four month old child with meningitis from Hermmansburg, Northern Territory had an 
RFLP pattern that was indistinguishable from the predominant non-Aboriginal RFLP 
type, Smal-M5. (Only one other isolate of this type was found and it was in the subset 
from metropolitan Perth.) A22 was also closely or clonally related to a second isolate, 
A21 , that was recovered from the blood of this same child. There was a 4 fragment 
difference between the two types and they shared 24 of 28 fragments found between 
them. 
Another pair of isolates, A34 and A35, recovered from the blood and cerebrospinal 
fluid, respectively, of a five month old child with meningitis were also found to be 
different types but were clonally related. A35 , the isolate from the cerebrospinal fluid 
was the predominant Aboriginal type, Smal-Al. In contrast each of two other pairs of 
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isolates from a child with pneumonia and a patient (age unknown) with meningitis and 
otitis media were types with RFLPs that were indistinguishable. 
It has been established that a significant number ( ~ 3 5%) of invasive type b clinical 
isolates contain amplified capsule gene sequences and may possess three, four or even 
five copies of the cap B repeat (the capsule genes of Hib are arranged as a duplication 
of an 18 kb DNA segment (Hoiseth et al., 1986)) and that Smal does not cut within the 
18 kb repeats but just outside the cap B locus (Com et al. , 1993). The recombinational 
event leading to the amplification of cap B sequences should add DNA in 18-kb 
increments. Thus, it might be possible to detect capsule amplification when probing the 
Smal fragments with pU082 if the cap locus was located on a fragment whose size 
increase could be detected by its decreased migration on the gel. Examination of the 
southern blot of SmaI fragments probed with pU082 showed that the cap locus was 
located on the largest fragment ( ~420 kb) of A22 and on two fragments ( ~420 kb and 
~ 120 kb) of A21. This suggests that a genetic event may have resulted in the insertion 
or creation of a Smal site within the cap locus but this needs further study to confirm. 
The cap locus was found on the largest fragment of A3 5 ( ~620 kb) and the largest 
fragment of A34 (~640 kb) which are shown on Figure 5.4. Keeping in mind that 
estimation of fragment size using a plot of log molecular weight versus distance 
migrated is affected by the non-linear migration patterns of DNA found with PFGE, the 
difference in size between the fragments that hybridised was found to be approximately 
18 kb. It seems possible that A35 represents an amplified state of A34. Another 
explanation is that an insertion occurred in another portion of the fragment that has 
nothing to do with the cap locus but I found the former explanation an intriguing 
speculation. Among others it raises the perhaps philosophical question as to whether or 
not an amplified state represents a different clone and thus, as one would interpret with 
this typing system (if fragment differences result between an amplified state and an 
unamplified state), a different genetic type. However, an attempt to demonstrate 
increased amplification product of the cap b locus in A3 5 was unsuccessful. 
Note: To investigate if isolate A35 represents an amplified state of isolate A34 
detection of type b specific capsular genes using PCR typing was performed as 
described in Chapter 2 in the methods section. Total chromosomal DNA 
concentration was estimated by comparing a small DNA sample with known 
amounts of bacteriophage lambda DNA on an ethidium bromide stained 
electrophoretic gel and template DNA was carefully standardised. A35 was not 
observed to produce excess amplification product. 
1 2 3 4 5 6 7 PCR amplification products: 
Lanes 1 and 7 are 1 kb size marker 
Lane 2 is Hib control 
Lane 3 is NTHi control 
Lane 4 is reaction control with no 
DNA template 
Lane 5 is A34 
Lane 6 is A35 
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It should be noted that one isolate provided for this study that was previously identified 
as Hib was shown to be a nontypeable Haemophilus influenzae because it did not 
hybridise with pU082. On examination, its RFLP pattern (Figure 5.3) was not similar to 
those found among the Hib isolates. This reminds us that false positives ( and false 
negatives) are associated with conventional serotyping (Murphy and Apicella, 1987) 
and that capsular genotyping is necessary to confirm the presence of the cap locus in 
Haemophilus influenzae isolates. When H. influenzae serotyping is undertaken slide 
agglutination results should be interpreted within 30 seconds of mixing the reactants in 
order to avoid misclassification of non-encapsulated strains because of 
autoagglutination. This problem is exacerbated when the expectation is that capsular 
type b isolates are the most commonly recovered invasive H. influenzae. Occasional 
strains of H. influenzae may be non-typeable on initial isolation because of glycocalyx 
formation (Gratten and Montgomery, 1991). Glycocalyces are lost on serial subculture 
and antibody binding sites are re-exposed. Multiple subcultures, however, may 
encourage the loss of capsular material and hence type specificity. 
In summary, the evaluation of 76 Aboriginal isolates using PFGE showed the 
population structure of Hib among Aboriginals is clonal and a single type predominates, 
not unlike the structure found in other studies of Hib populations. However, the 
predominant type is distinct from that found among non-Aboriginals in urban areas and 
overall the types are more diverse and fewer were found per isolate than among non-
Aboriginals. These results follow in the footsteps of others. We first learned about a 
marked discrepancy between OMP subtypes causing Hib disease in the two major 
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groups of Australian children from Gilbert and Clements in 1993 . This difference has 
now been confirmed using a genotypic typing system and these results show that two 
Hib types can be simultaneously present in a patient with Hib disease. 
CHAPTER 6 
Pulsed field gel electrophoresis used 
to investigate the genetic diversity of 
Haemophilus influenzae type b 
shows differences between 
Aboriginal and non-Aboriginal isolates 
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6. 1 Introduction 
The purpose of this chapter is to describe the genetic characteristics determined by 
combining all the Hib isolates studied previously in this project with additional isolates 
that have not formerly been evaluated. The additional isolates are from non-Aboriginal 
patients diagnosed with meningitis or invasive disease from the Alice Springs region 
and Townsville, Queensland and from patients with infections other than meningitis and 
epiglottitis from the Sydney region and Western Australia. 
6.2 Methods 
Preparation of DNA, restriction endonuclease digestion, PFGE conditions, 
determination of the numbers and mobilities of fragments, estimation of genetic 
diversity and construction of dendrograms and hybridisation were performed as 
previously described. 
6.2.1 Selection of isolates for examination 
One hundred-eighty isolates characterised by PFGE as described in Chapters 3-5 were 
included in the sample. Thirty-three non-Aboriginal isolates were added to them. Ten 
were isolates from non-Aboriginals living in the Alice Springs region, five of whom 
were diagnosed with meningitis and 5 with invasive disease. Two meningitis isolates 
were from Townsville, Queensland and a further 15 non-Aboriginal isolates from 
Sydney and 6 from Western Australia that were associated with diseases other than 
meningitis or epiglottitis, were included. The breakdown of these isolates according to 
disease association is shown in Table 2.1. Appendices A.1-A.6 describe all the isolates 
in more detail. 
6.3 Results 
All the additional isolates in this study hybridised with p U082 but no further splitting of 
types was detected by cap polymorphisms. All the non-Aboriginal isolates from the 
Alice Springs region (n= 12) hybridised with the P2 probe and but no further splitting of 
types was detected. 
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6.3.1 Analysis of restriction fragment length polymorphisms 
Non-Aboriginal isolates from the Alice Springs regions, Northern Territory 
(Figures 6.1, 5.1, and 6.3, Appendix A.5) Twelve isolates from non-Aboriginal 
patients with Hib disease were obtained from the Alice Springs region. They included 2 
pairs of indistinguishable isolates recovered from the blood and cerebrospinal fluid of 2 
patients. One of each of these was removed for the analysis. Eight types were found 
among the 10 remaining isolates including 1 that was indistinguishable from the 
predominant Aboriginal type and 2 that were indistinguishable from the predominant 
non-Aboriginal type. The predominant non-Aboriginal type was clonally related to one 
other type representing one isolate. The range of similarity among the types was 13-
96%. Two isolates were indistinguishable from the most diverse type found in the 
Aboriginal subset that represented 5 isolates from the Alice Springs region. The 
distribution of isolates among types was: 
Non-Aboriginal Alice Springs region isolates ( n= 10) 
Smal-RFLP type Number of isolates/type 
NT6a NT9a 2 
' NT8b NTllb 2 
' NT4c 1 
NT12, NTl, NTlO, NT2, NT7 1 each 
aindistinguishable from the predominant non-Aborginal type 
\ndistinguishable from the most diverse Aborginal type 
cindistinguishable from the predominant Aborginal type 
Sydney isolates not associated with meningitis or epiglottitis (Figures 4.3-6 and 6.3, 
Appendix A.5) Fifteen isolates associated with cellulitis (n=2) and invasive disease not 
meningitis or epiglottitis (n=13) were obtained from the Sydney region. Eight Smal-
RFLP types were found among them. They shared 4 types with the 
1neningitis/epiglottitis subset from Sydney and added 4 new types. Eight of the isolates 
were indistinguishable from the predominant non-Aboriginal type. The range of 
similarity among the types was 55-96%. The distribution of isolates among types was: 
Sydney region isolates associated with cellulitis or invasive 
disease not meningitis or epiglottitis ( n= 15) 
Smal-RFLP type Number of isolates/type 
Sl a 8 
all othersb (n=7) 1 each 
aindistinguishable from the predominant non-Aborginal type; included 
S1 , S3, S4, S23, S26, S31 , S33, and S34 
bincluded S10, S13, S15, S19, S21, S27, S32 
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Non-Aboriginal Western Australian isolates not associated with meningitis or 
epiglottitis (Figures 4.7-8, 6.3, Appendix A.4) Six isolates associated with Hib 
disease not meningitis or epiglottitis were obtained from Western Australia. Five were 
from metropolitan Perth and one was from a rural region. All the isolates except one 
from metropolitan Perth were indistinguishable from the predominant non-Aboriginal 
type. 
Townsville isolates (Figures 6.2 and 6.3, Appendix A.5) Two isolates from patients 
with Hib meningitis each represented an RFLP type. One type was indistinguishable 
from the non-Aboriginal predominant type. The other type was distinct from it at an F 
= 0.50. Both of these isolates were collected after in 1993 sometime after July. 
All the isolates combined Note: the names of RFLP types have now been assigned 
according to their position in the dendrogram that represents 213 isolates. How the 
types are named is explained in section 6.3.3 and is based on the major cluster and 
clonal grouping into which a type fell. What has been referred to as RFLP type Smal-
A 1, the predominant Aboriginal type, is now known as type F2a and Smal-M5 , the 
predominant non-Aboriginal type, is now known as type A8b. 
Well-resolved patterns of 13 to 17 Smal fragments of approximately 8-650 kb 
representing 69 RFLP types were found among the 213 isolates. A total of 78 distinct 
fragments was observed on the gels. Only of these fragments ( ,__,43 kb corresponding to 
fragment 8.13 of HS008) was present in the RFLP patterns of all the isolates. It did not 
carry the cap locus and the P2 gene was found on a 43 kb fragment in only one of the 
94 isolates typed with the P2 probe. Forty-eight (70%) of the RFLP types were 
represented by single isolates and 22 (32%) types had multiple isolates. The two most 
numerous types, one predominating in the Aboriginal subset (n=37) and one 
predominating in the non-Aboriginal subset (n=55), represented 43% of the sample. 
The remaining 19 types with multiple members were represented by two to eight 
isolates . 
Nineteen types were found among the isolates from Aboriginal children (n=76) and 55 
types were found among those from non-Aboriginal children and adults (n= 13 7). The 
ratio of isolates to type was 4: 1 and 2.5: 1 among the Aboriginal and the non-Aboriginal 
populations, respectively, with only 5 types shared by both population groups. For the 
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most part, within each of the 5 shared types, the Aboriginal and non-Aboriginal isolates 
were from the same geographic region. 
Type F2a accounted for 35 (46%) of the Aboriginal isolates but only 2 (1 %) of non-
Aboriginal isolates (Table 6.1). Type A8b accounted for 53 (39%) of the non-
Aboriginal isolates and 2 (3%) of the Aboriginal isolates (Table 6.2). 
Table 6. 1 Distribution of Hib Smal-RFLP type F2a (n=37) that accounted for 46% of 
the Aboriginal isolates 
Group and geographic location 
Canberra region 
Victoria 
Sydney region 
Perth, Wes tern Australia 
Townsville, Queensland 
Alice Springs region 
Bathurst Island 
Rural W estem Australia 
Total 
Meningitis 
A n-A 
3 
4 
4 
1 1 
1 
1 
Number of isolates 
Epiglottitis Other 
A n-A A n-A 
1 
0 1 14 0 
Carrier 
A n-A 
4 
6 
10 0 
Total 
A n-A 
1 
3 
22 1 
6 
4 
35 2 
aThese isolates were associated with pneumonia (n=5), gastroenteritis (n=3), acute lower respiratory tract infections 
(n=3) , cellulitis (n= 1), bronchiolitis (n= 1), and failure to thrive (n= 1). 
Table 6. 2 Distribution of Hib Smal-RFLP type A8b (n=55) that accounted for 29% of 
the non-Aboriginal isolates 
Number of isolates 
Group and geographic location 
Meningitis Epiglottitis Other Carrier Total 
A n-A A n-A A n-A A n-A A n-A 
Canberra region 4 1 5 
Victoria 4 7 1 1 
Sydney region 1 1 fJ1 17 
Perth, Western Australia 1 4 4 4 l 12 
Townsville, Queensland 1 1 
Alice Springs region 1 2 1 2 
Bathurst Island 
Rural Wes tern Australia 3 1 1 5 
Total 2 27 0 13 0 13 0 0 2 53 
alnasive isolates ( diagnosis unknown) 
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6.3.2 Genetic relationships determined by numerical analysis 
F values ranged from 0.07 to 1, corresponding to a similarity range from 7-100%. An F 
value of 1, determined when all fragments between a pair were shared, corresponded to 
identical fragment patterns on the gels. Thus, when F = 1 the members of the pair are 
considered to be the same RFLP type. The smallest F value found, 0.07, corresponded 
to pairs where only 2 of the 14 and 15 fragments of the isolate pair were shared. A 
similarity matrix based on pairwise comparison of F for all RFLP types was used to 
calculate a dendrogram (Figure 6.3) as described in Methods. 
The isolates fell into seven major clusters, designated Groups A-G, at an F value< 0.5. 
There were 41 branches at an F value > 0.9 corresponding to a genetic distance of 
greater than 90% similarity that are referred to as clonal groups. A single type or a 
cluster of closely related types whose members differ by 3 or fewer fragments 
represented each of the clonal groups. For comparative purposes each RFLP type was 
given a three character name according the major cluster (A, B, C, D, E, F, or G) in 
which it fell, the clonal group of which it was a member in that cluster (numbered from 
1) and its unique type in the clonal group (lettered from a). Appendix C shows the 
distribution of types and isolates among the clusters and clonal groups found in 
dendrogram seen in Figure 6.3. 
Two highly divergent groups ( designated F and G) comprising 7 types represented 50 
(66%) of the Aboriginal isolates and 6 (4%) of the non-Aboriginal isolates. A single 
genetically distinct group (designated A) comprising 39 types represented 7 (9%) of the 
Aboriginal isolates and 106 (77%) of the non-Aboriginal isolates. 
The largest major cluster, group A, included 113 isolates and comprised 39 types in 15 
clonal groups, 11 of which comprised multiple types. Type A8b that comprised 26% of 
the sample and 39% of the non-Aboriginal isolates fell in group A. Distribution of 
RFLP types among Groups B to E is shown in Figure 6.3. Group F had 48 members 
among 6 types in 4 clonal groups including type F2a that comprised 20% of the sample 
and 46% of the Aboriginal isolates. Group G included a single type, G 1, comprised of 6 
Aboriginal isolates and 2 Caucasian isolates from the Alice Springs region. G 1 was the 
most highly divergent type in the sample with less than 15% similarity to either of the 
two predominant types, F2a and A8b (F = 0.13 and 0.14, respectively). 
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Figure 6.1 Smal restriction fragments obtained by PFGE of the genomic DNAs of 11 
non-Aboriginal Hib isolates from the Alice Springs region. Lanes labelled 8, A and A-H 
contain fragment standards. 
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Figure 6.2 SmaI restriction fragments obtained by PFGE of the genomic DNAs of 2 
Hib isolates from 1neningitis patients from Townsville, 3 from Sydney, and 3 from 
Canberra. Lanes labelled 8 and A contain fragment standards. 
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Figure 6.3 Dendrogram showing the clustering of 69 Smal RFLP types of 213 Hib 
isolates obtained from Aboriginals and non-Aboriginals from rural and urban regions 
around Australia. The dendrogram was generated using the mathematical model of Nei 
and Li and distances were calculated by the neighbor-joining method. The distance 
between any two taxa is the sum of the horizontal lines between them. The bar indicates 
an F value of 0.10 or 10% similarity. The isolates fall into seven major clusters 
designated A through G. There are 41 branches or clusters at F > 0.90. Only types Gl , 
F2a, A4b, A8b, and C3 share both Aboriginal and non-Aboriginal members. 
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The largest genetic distance estimate was between two members of Group A (types A2b 
and Al0) and the members of Group G. They were separated by genetic distances of F 
= 0.07 with only 2 of 29 fragments shared between pairs. 
6.3.3 Genetic diversity and correlation to epidemiology 
Clustering of RFLP types was not associated with disease type. Isolates from patients 
with meningitis and epiglottitis, as expected, were each represented by a diverse range 
of types and no single type was associated with a particular diagnosis or carriage. In 
addition, no association was found between age, sex, date of collection or geographic 
location. A strong association, however, between both the origin of isolates from 
Aboriginal children and RFLP type F2a and the origin of isolates from non-Aboriginal 
children and RFLP type A8b (chi square, p < 0.001) was found and 3 other RFLP types 
(F3, G 1, and C7a) with multiple members were composed of predominantly Aboriginal 
isolates. 
Type F3 comprised 7 isolates and fell in the same clonal group as type F2a. It accounted 
for 5 isolates from Aboriginal children living in the Alice Springs region and 2 isolates 
from Aboriginal children living in rural W estem Australia. Type G 1 included 6 
Aboriginal isolates and 2 non-Aboriginal isolates from the Alice Springs region. Eight 
isolates from Aboriginal children shared RFLP type C7 a that fell in a group comprised 
of 13 Aboriginal isolates and 11 non-Aboriginal isolates. The association of type C7a 
with Aboriginality or geographic location is not statistically significant, however, 7 of 
the 8 isolates in type C7a were from Bathurst Island in the Northern Territory, as was 
the single member in a clonally related type, C7b. 
6.3.4 Numerical index of the discriminatory ability of the typing system 
Simpson's index of diversity (D) was 0.90 when applied to the data to determine the 
discriminatory power of SmaI among the entire sample of 213 Hib isolates. 
6.4 Discussion 
The sample of 213 Hib isolates comprised 69 different types of SmaI-RFLP patterns 
with 17 or fewer fragments that were well resolved by PFGE. Closely related and more 
distantly related genomic types were easily discriminated. 
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When Simpson's index of diversity was applied to the system an index of D = 0.90 was 
calculated. This indicates that the system demonstrates good discriminatory power for 
typing based on the probability of two unrelated strains being characterised as the same 
type. An index greater than 0.90 is considered desirable if the typing results are to be 
interpreted with confidence but assessment of other factors such as typability and 
reproducibility affect the usefulness of a typing system. Cost, level of technical skill 
required and time requirements will also affect whether a system is used or not. 
The Smal RFLPs fell into 7 major clusters in a tree-like dendrogram that is consistent 
with a clonal population structure, as is the presence of 2 predominant types among the 
69 types found. The two predominant types, F2a and A8b, accounted for 43% of the 
sample and included almost one-half of the Aboriginal isolates and well over one-third 
of the non-Aboriginal isolates, respectively. Not surprisingly, the results described a 
heterogenous clonal population structure and extend the geographical range over which 
the clonality of Hib has been demonstrated. 
Differences and similarities between Hib isolates were readily visualised from the 
CHEF patterns and a general grouping of the isolates could be established in this way. 
However, a more quantitative approach can be derived by subjecting the data to the 
analytical procedures described by Nei and Li. In an attempt to describe what are 
otherwise qualitative differences in fragment patterns among a large body of 
comparative data, we estimated DNA similarities on the basis of the fraction of 
common fragments generated by the endonuclease. The value generated is referred to as 
the F value. 
It has been suggested by Tenover that, in the context of analysing outbreak strains using 
one endonuclease, a 1-3 fragment difference can occur between closely related strains 
and possibly related strains can be found among those that differ by 4-6 fragments 
(Tenover et al., 1995). It has also been reported that closely related strains of E. faecalis 
can differ by up to six bands and that patterns have been shown to differ by up to seven 
bands and still be clonally related (Thal et al., 1997). Furthermore, using hybridization 
analysis and PFGE in the investigation of insertion mutations in the transferrin binding 
systems of Hib, Curran et al. found 5 different changes of 0-3 bands between Smal 
fragments of 5 insertion mutants. These results remind us that several different 
chromosomal mutations could generate the same phenotype. 
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Thus, the values of F obtained should not be seen as precise estimates of genetic 
distance but summary values indicative of overall similarities and differences between 
isolates and a means to illustrate relationships within a large body of comparative data. 
F values >O. 9 representing pairs of isolates that differ by up to 3 fragments were used to 
determine closely related isolates in this study and we describe such closely related 
isolates as a clonal group. However, pairs of isolates that are closely related can be 
found as n1embers of different clonal groups as well as within clonal groups so the 
number of branches is not an absolute representation of all closely related pairs. For 
example, the predominant RFLP type, A8b, is found within a clonal group comprised of 
2 other closely related types. It is also closely related (F > 0.9) to 16 types found in 10 
other clonal groups within Group A. 
Despite the wide diversity of the strains studied, including clinical and non-clinical 
isolates, it was not possible to detect an obvious correlation between a given genotype 
and the specific disease it can cause or a healthy state of the host. After subjecting the 
data to statistical analyses (averages distances and chi square analysis) no association 
between RFLP type and age, sex, date of collection, or disease manifestation was 
revealed. Because of the lack of Aboriginal isolates from urban areas and non-
Aboriginal isolates from rural areas the association between geographic location and 
type was not found to be significant in this sample. The genetic distance separating the 
important major lineages ranged from a similarity of 20% to 50% yet there is apparently 
an equivalent ability to cause disease among the lineages. One of the patterns of Hib 
disease in Australia was a significant difference in the incidence of epiglottitis among 
urban populations . The incidence of epiglottitis in Victoria (Gilbert et al. , 1990) and the 
Australian Capital Territory (McGregor et al., 1992) was twice that of Sydney 
(McIntyre et al. , 1991) and Western Australia (Hanna et al., 1992). Another pattern of 
Hib disease in Australia was the lack of epiglottitis among Aboriginal children, similar 
to the epidemiology of Hib disease among other high-risk indigenous populations 
(Hanna, 1992). The possibility that differences in the incidence of epiglottitis among 
different population groups are related to differences in the strains of Hib has not been 
demonstrated in this study and the patterns of the incidence of epiglottitis in Australia 
remain unexplained. Other restriction enzymes which sample different areas of the 
genome may detect molecular differences that demonstrate clonal disease specificity but 
we did not detect such a relationship among the Smal RFLP types in this sample. 
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Analysis of isolates from Aboriginal children living in geographically isolated regions 
of Australia revealed a relatively small number of genetically distinct RFLP types . A 
strong association was found between the origin of isolates from Aboriginal children 
and one of these types. Isolates from non-Aboriginal populations were more diverse and 
genetically distinct from most Aboriginal isolates; and, one of these types found in a 
cluster of closely related isolates was strongly associated with the origin of isolates from 
non-Aboriginal children. The data support the hypothesis described by Musser et al. 
(1990) that a causal relationship exists between the degree of ethnic mixing of human 
populations and the degree of diversity in clonal composition of Hib populations. 
According to this hypothesis, a large component of the current geographic variation in 
clonal composition of Hib reflects an older pattern of differentiation that evolved in 
relative geographic isolation before the Age of Exploration (beginning about 450 years 
ago) and has not been completely obscured by recent demographic changes (Musser et 
al., 1990). It explicitly predicts that isolates from Aboriginal populations largely belong 
to a distinctive set of clones, as described in this study. 
If Hib had been present in Aboriginal populations before European settlement, the 
striking difference between the predominant Aboriginal type and the predominant non-
Aboriginal type suggests separate evolution of strains. The time span since permanent 
European settlement began on the East coast of Australia in 1788 does not support a 
long history of differentiation that may be needed for such a deep divergence between 
types. Therefore, it is more likely that urban non-Aboriginal types have been recently 
introduced from other areas of the world rather than derived from the Aboriginal types . 
Nonetheless, more extensive analysis is needed to provide data to support the 
explanation of the phylogenetic relationship between the Hib types described here. 
Prior to the introduction of vaccination, the incidence of Hib disease in Aboriginal 
populations was reported to be extremely high and varied among communities. The 
estimated annual incidence among Aboriginal children under five in Central Australia 
(an area corresponding to the Alice Springs region in this study) was 991 cases per 
100,000, with a high proportion of cases of meningitis and a case-fatality rate of 8.3% 
(Hanna, 1990). The corresponding rate among non-Aboriginal children in Central 
Australia was 215 per 100,000 which was significantly higher than that in other areas of 
the Northern Territory and four times higher than that in Melbourne (Hanna, 1992). It 
was concluded that environmental factors and cultural factors were responsible for the 
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very high incidence in Aboriginal communities (Hanna, 1990). However, this does not 
explain the increased incidence in non-Aboriginal children. An alternative explanation, 
that the strains circulating among Aboriginal children and affecting some non-
Aboriginal children in the same geographic area are more virulent than urban strains has 
not been investigated. 
Our data show that a few distinct types are responsible for Hib disease among 
Aboriginal populations; and, the high incidence of disease in very young children 
indicates very high transmission rates associated with environmental factors. According 
to Ewald's cultural vector hypothesis increased transmission rates and repeated passage 
through human hosts may lead to selection of more rapidly multiplying and virulent 
strains (Ewald, 1994). If so, such strains of Hib in Aboriginal populations are also likely 
to spread to non-Aboriginal children in the same geographic area and result in an 
increased diversity of strains in this group as well as an increased incidence of disease. 
Differences found between Aboriginal and non-Aboriginal Hib types using PFGE 
demonstrate its practical discriminatory power for analysing large numbers of Hib 
isolates. Analysis of the huge similarity matrices required for large samples has been 
facilitated by the availability of computer programs and, with standardisation of PFGE 
methods, would allow inter- and intra-laboratory comparison of results in a common 
database. This would improve surveillance by increasing the capacity to detect new 
strains of Hib and monitor the presence of old strains. The usefulness of the system was 
shown when 2 isolates of Hib recently recovered in a nursing home outbreak in the 
Sydney region (Heath et al., 1997) were analysed, and both were shown to have patterns 
identical to that of Smal type A8b. This suggested that these isolates were not a new 
genotype since they were identical to the predominant type found in Sydney in the pre-
vaccine era. This system will be useful for monitoring future Hib isolates from children 
in whom the vaccine has failed, unimmunised children, and adults . Further, the 
genotyping of clinically significant and carrier Hib isolates may help to elucidate 
transmission routes in community infections, endemicity, and the reasons for vaccine 
failures. 
CHAPTER 7 
ERIC-PCR and OMP26 Hybridisation Studies 
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7. 1 Introduction 
The development and extensive use of high resolution molecular typing systems based 
on direct analysis of genomic polymorphisms have greatly improved the understanding 
of the epidemiology of infectious disease. These systems exploit genetic variation and 
analyse DNA variation. As all genetic differences between individual bacterial cells are 
related to the primary sequence of their genomic DNA, the most direct method of 
identifying an individual isolate would be to determine this sequence for the whole 
genome. This is currently not feasible. The panoply of molecular typing methods that 
are in use vary in their ability to provide the answers to the questions sought and 
comparative studies using a combination of systems is often recommended (Struelens, 
1998) (van Belkum et al., 200 l ). 
PFGE is now the "gold standard" for epidemiological typing and calculation of 
restriction pattern similarity coefficients and graphical display of pattern relatedness as 
dendrograms is also useful for interpretation, particularly for large scale studies 
(Struelens, 1998). Although this analysis has been criticised as invalid for phylogenetic 
inferences because DNA restriction fragment pattern variation is not due to independent 
events, it is supported by population analysis, e.g., of Pseudomonas aeruginosa 
(Struelens, 1998). For Hib, the DNA restriction polymorphisms detected by PFGE 
reflected evolutionary divergence with that identified by MLEE (Arbeit et al. , 1990). Its 
discriminatory power has been shown to be better than MLEE, ribotyping, and RAPD-
PCR methods and is best used to identify the micro-variation that is required to 
distinguish between strains; it is suitable for typing both highly clonal and less clonal 
populations (Struelens, 1998). However, like other electrophoretic methods, it is not 
known what each fragment represents, i.e., the genetic basis of differences in band 
patterns is not known. To better understand the usefulness of interpreting PFGE 
fragment patterns for phylogenetic relationships characterisation of the fragments is 
warranted, as well as, comparison with other genetic methods. 
To comparatively evaluate the data provided by PFGE two other molecular tests were 
applied to a selection of isolates from this study. 
ERIC Enterobacterial repetitive intergenic consensus (ERIC) sequences are conserved 
regions of DNA dispersed throughout the genomes of Gram-negative enteric bacteria. 
ERIC sequences are highly conserved at the nucleotide sequence level, but their 
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chromosomal locations differ between species or strains (Gomez-de-Leon et al. , 2000). 
These elements have been successfully used to differentiate strains of Bartonella, 
Bacillus subtilis, Citrobacter diversus, methicillin resistant Staphylococcus aureus , 
Streptococcus pneumoniae, Neisseria gonorrhoeae and Neisseria meningitidis and other 
bacterial genomes (Olive and Bean, 1999). And, ERIC-specific primers have been used 
to produce genetic fingerprints H injluenzae strains (van Belkum et al., 1994; Smith-
Vaughan et al., 1998; Gomez-de-Leon et al., 2000; Pettigrew et al., 2002). The largest 
practical application of ERIC-PCR to capsulated and unencapsulated strains of H. 
injluenzae demonstrated the ability of this method to detect genetic diversity when 69 
fingerprint patterns were found among 92 isolates recovered from Mexican children 
(Gomez-de-Leon et al., 2000). Intriguingly, the results of this study show that some of 
the strains grouped according to the type of infection (i.e., meningitis strains versus 
other disease isolates). Further study is required to determine whether meningitis 
isolates present specific characteristics related to ERIC motifs and if these, in tum, may 
be recognised as having some involvement in the pathogenesis of Hib meningitis strains 
(Gomez-de-Leon et al., 2000). In the present study genomic DNA amplified by PCR 
with primers for the ERIC sequences* was used to genotype Hib isolates and the 
discriminatory power of ERIC-PCR was compared with PFGE. 
*True ERIC sequences are not present in the fully sequenced H. injluenzae Rd so it is 
likely that ERIC fingerprints reflect random hybridisation of the primers (Pettigrew et 
al., 2002). 
OMP26 OMP26 is a major outer membrane protein of approximately 26-kDa isolated 
and purified from NTHi strain 289. It has been investigated for its suitability as a 
vaccine candidate against NTHi infection for which it shows significant potential (Kyd 
and Cripps, 1998; El-Adhami et al., 1999). DNA sequences encoding OMP26 were 
previously cloned by PCR amplification using oligonucleotide primers designed from 
the equivalent gene of H injluenzae Rd (El-Adhami et al., 1999). The PCR product of 
about 618 bp was digested and ligated into pQE-30 to give pP26/l. Ligated DNA 
transformed into E. coli XL-1 Blue was kindly provided by Dr Adam Smith, Canberra 
Centre for Mucosal Immunology. 
When the pP26/1 construct was originally prepared hybridisation analysis of 19 
different isolates ofNTHi and a capsule deficient type b strain was performed. Genomic 
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DNA of all strains hybridised with the probe indicating similar OMP26 genes existed in 
all these strains (El-Adhami et al. , 1999). A BLAST® search for sequences deposited in 
public sequence databases that produced significant alignments with that of the NTHI-
289 OMP26 gene (accession no. AF109085) returned 24 matches (at an effective value 
of 0) of previously characterised genes from H. influenzae isolates. Homology ranged 
from 96% to 99%. No other significant alignments were returned. 
In this study a probe prepared from p26/l was used to detect the location of the OMP26 
gene among the DNA fragments produced by PFGE of Hib DNA digested by the 
restriction endonuclease Smal. The purpose of this was to confirm that fragments with 
similar migration profiles on the electrophoretic gels carry similar genetic information. 
7.2 Methods 
7 .2.1 Bacterial isolates 
ERIC-PCR Twenty-nine isolates were selected from the collection of Hib strains that 
had been previously characterised by PFGE. Six isolates from each of the two 
predominant Smal-RFLP types, F2a and A8b, were included in the selection. The other 
17 isolates represented all the major groups delineated by the Smal PFGE and types 
closely related to the predominant types as listed in Table 7 .1. The number of RFLP 
types among the sample was 19. Isolate information can be found in the appendices. 
OMP26 hybridisation Forty-nine isolates from the collection of Hib strains that had 
been previously characterised by PFGE were analysed for the presence of the OMP26 
gene. Southern blots prepared from the electrophoretic gels seen in Figures 4.2, 4.3, 4.5, 
4.8, and 5.8 that had been previously used for cap and P2 hybridisation studies were 
used in this study. The selection included 23, and 6 isolates, respectively, from the 
predominant Smal-RFLP types, A8b and F2a. One other type had multiple isolates 
(n=4) and 15 types were represented by one isolate. The isolates are listed in Table 7.2. 
Four NTHi including NTHi-289, also previously characterised by PFGE and probed for 
the cap locus, were used as controls. 
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7.2.2 ERIC-PCR 
DNA preparation Total chromosomal DNA was harvested using the Genomic Tip 
20/G kit (Qiagen) from overnight sBHI broth cultures inoculated with a single colony. 
The DNA concentration was estimated by comparing a small DNA sample with known 
amounts of bacteriophage lambda DNA on an ethidium bromide stained electrophoretic 
gel. The DNA was dissolved at a concentration of ~20 ng/µl in TE. 
ERIC-PCR and amplification conditions PCR and amplifications conditions are 
described in Chapter 2. The results were analysed only if control samples without 
extraneous DNA failed to yield amplified product. To check for reproducibility and to 
optimise performance 3 strains were typed on three or more separate occasions from 
independent DNA preparations. All isolates were fingerprinted at least twice. 
ERIC-PCR patterns and analysis The numbers and size of fragments were 
determined by visual examination of the digitised photographs of the stained gels. 
Because template concentration and run parameters affect product, bands that were 
present on two analyses were included. The range of similarity or genetic distance, 
identification of clonal and the most diverse relationships among types and construction 
of a dendrogram was determined from a matrix produced using the mathematical model 
of Nei and Li as previously described for PFGE. A matrix of F values for all pairs of 
isolates was constructed and a dendrogram computed using the NJTREE program and 
the companion TDRA W program. 
7.2.3 OMP26 typing 
Southern blotting and hybridisation Smal digested DNA fragments separated by 
PFGE were transferred onto nylon membranes as described in Chapter 2. Membranes 
were stored at 4°C until used. Extraction of purified plasmid pQE-30/OMP26 was 
accomplished using the Quantum Prep® Plasmid Miniprep Kit (Biorad). A digoxigenin-
labeled probe was prepared, hybridised to the target filter under standard conditions, and 
the probe-positive bands were visualised by an immunochemiluminescent detection 
system according to the manufacturer's instructions (DIG-High Prime DNA Labelling 
and Detection Kit, Boehringer Mannheim). 
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7.3 Results 
General characteristics and diversity of ERIC-PCR types ERIC-PCR produced 
banding patterns of 6-10 fragments that were not too complex to analyse. Two invariant 
fragments were found in each pattern. Another fragment was found in all the samples 
except NT8. Seven ERIC types (designated I-VII) were found among the 29 isolates. 
Two types accounted for 23 of the closely related isolates and the other 5 types 
represented each of the more diverse isolates. Table 7 .1 shows the comparison of ERIC-
types with PFGE groups, the source and the diagnosis of each isolate. The major 
divisions of Hib among the predominant PFGE types was found among the ERIC types 
though different PFGE types had the same ERIC type. Each of the A8b PFGE types and 
clonally or closely related types fell into ERIC-III. Each of the F2a types and their 
related types fell into ERIC-II, a type that is distinctly different from ERIC-ill. The 
other isolates representing PFGE types selected from genetically diverse groups fell into 
different ERIC types. 
Relationships among ERIC-types compared to PFGE groups The distance matrix 
constructed using ERIC fragment profiles is in table 7 .2 and the dendrogram 
constructed from it is in Figure 7.1. The polymorphism obtained with ERIC-PCR 
allowed the 29 Hib isolates to be distributed in to a dendrogram into 2 groups at a 
genetic distance of F< 0.50; the isolate NT8 (PFGE type G 1 and ERIC type I) was in 
one group and all the other isolates fell into the other group. The larger cluster formed 4 
smaller clusters including one in which included 2 types related to PFGE-A8b/ERIC-ill 
at a genetic distance of F> 0.90. The clustering of isolates was in agreement with that 
found among PFGE types (see Figure 6.3) although the genetic distance between the 
two predominant types, F2a and A8b, is not as distinct among the ERIC-PCR types as 
among the PFGE types. The F value determined using PFGE RFLPS between Ml5 (an 
isolate representing ERIC type II) and MS (an isolate representing ERIC type ill) is 
0.4687 (see Table 3.11 in Appendix B) while the F value between ERIC type II and ill 
is 0.6250 indicating greater similarity. When the distance matrix of a representative 
PFGE isolate for each ERIC type was calculated and compared to the ERIC type 
distance matrix by the program Diploma a correlation of 0.90 was obtained. Simpson 's 
index of diversity was calculated to be D = 0.89. 
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Figure 7. 1 ERIC-PCR fingerprinting patterns of Hib 
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The image was digitally acquired by using Bio-Rad GelDoc 1000 
and Microsoft Powerpoint and annotated with Corel Draw and 
Microsoft Word. A size standard (GeneRuler™ 1kb DNA ladder) 
is in the lane marked 1 kb. 
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Figure 7. 2 ERIC-PCR fingerprinting patterns of Hib 
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The image was digitally acquired by using Bio-Rad GelDoc 1000 
and Microsoft Powerpoint and annotated with Corel Draw and 
Microsoft Word. 
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Table 7. 1 Distance matrix of the F values of 7 ERIC-PCR types 
IV 0.3750 
V 0.4286 0.8889 
VI 0.5000 0.7500 0.8571 
VII 0.5000 0.7000 0.8888 0.7500 
II 0.3077 0.5882 0.7777 0.6158 0.4706 
III 0.4000 0.9474 0.9412 0.8000 0.7368 0.6250 
I IV V VI VII II 
Table 7. 2 Comparison of ERIC-PCR types with PFGE typing groups 
Isolate Source Diagnosis PFGE Group ERIC-PCR 
Type 
NT8 bld . 
. GI I mvas1ve 
M13 bld/csf meningitis Fl II 
Al bld meningitis F2a II 
ASO nk gastro F2a II 
B6 naso earner F2a II 
NT4 bld/csf meningitis F2a II 
S37 bld epiglottitis F2a II 
WA4 csf meningitis F2a II 
A34 bld/csf meningitis F2b II 
BS naso earner F2c II 
A23 bld febrile F3 II 
NT12 bld mvas1ve F4 II 
M7 bld/csf meningitis El III 
Vl nk meningitis E2 III 
M3 bld/csf meningitis Ala III 
NT2 bld meningitis A4b III 
WA42 bld epiglottitis A8a III 
A22 csf meningitis A8b III 
MS csf meningitis A8b III 
WAI csf meningitis A8b III 
V2 nk meningitis A8b III 
E12 bld epiglottitis A8b III 
S3 bld . . A8b III mvas1ve 
S27 bld . . A8c III mvas1ve 
Ml 1 bld/csf meningitis A8d III 
M8 bld/csf meningitis A9a IV 
S IS bld . . B7 V mvas1ve 
A4S nk pneumo C7a VI 
A2 bld meningitis Dla VII 
Abbreviations : bld-blood, csf-cerebrospinal fluid , naso-nasopharynx, nk- not known 
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I-G1 
II-F2a*,F1 ,F2b,F2c,F3,F4 
IV-A9a 
- III-A8b*,E1 ,E2,A 1 a,A4 b,A8a,A8c,A8d 
- V-87 
-
VI-C?a 
VII-D1 a 
Figure 7. 3 Dendrogram showing the clustering of 7 ERIC types found among 29 
isolates selected from the major PFGE groupings. The dendrogram was generated 
using the mathematical model of Nei and Li. Distances were calculated by the 
neighbour-joining method and the TDRA W program was used to produce the 
appropriate tree. The genetic distance between types is found in Table 7 .2. 
*this PFGE type represents 6 isolates all of which were the same ERIC type 
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Table 7. 3 Hybridisation patterns of the OMP26 probe among 50 Hib isolates 
Group Isolate OMP26 Gel 
fragments** 
A5b S 11 29 Figure 4.3 
A8b Sl * " 
A8b S6 13 " 
A8b S17 13 " 
A8b S18 13 " 
Al Ob S2 13 " 
Al lb S13 13 " 
Al5a S8 13 " 
Cla S14 13 " 
B7 S16 13 and 77 " 
A l b S21 13 and 50 Figure 4 .5 
A8b S23 13 " 
A8b S24 * " 
A8b S25 13 " 
A8b S26 13 " 
A8c S27 * " 
A8b S30 13 " 
A8b S28 13 " 
B4 S29 13 " 
C l a Sl9 * " 
A l a WA25 13 and 50 Figure 4 .8 
A8h WA22 13 " 
A8b WA23 13 " 
A8b WA27 13 " 
A8b WA28 13 " 
A8b WA30 13 " 
A8b WA37 13 " 
Al lb WA31 13 " 
Al lb WA34 13 " 
Al lb WA35 13 " 
A l 3b WA24 13 " 
C3 WA36 13 " 
A3d V14 13 and 52 Figure 4.2 
A8b Vl 1 13 " 
A8b Vl2 13 " 
A8b V13 13 " 
A8b Vl5 13 " 
A8b Vl6 13 " 
A8b Vl7 13 " 
A8b V20 13 " 
A8b S34 13 " 
Al Sb Vl9 13 " 
BS Vl8 13 " 
Al6 WAS 15 Figure 5.8 
F2a (n=6) WA6-10, Al 4 " 
* An asterisk means that residual DNA in the loading well hybridised indicating a positive result but no 
fragments hybridised because the larger fragments 'washed out ' in the PFGE run (this is an unexplained 
artifact of the procedure that occun-ed occasionally in some lanes on some gels ; on repeat runs the 
presence of the large fragments were confirmed) 
**numbers refer to one of the 81 marker fragments in the Smal database 
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Presence of OMP26 gene in Hib strains Genomic DNA of all the strains (n=50) 
hybridised with the probe. Either one (n=46) or two (n=4) fragments per isolate 
hybridised. Of the 50 isolates all but 8 carried the OMP26 gene on the same size 
fragment. This fragment (number 13 in Table 7.3) corresponds to the 256 kb fragment 
of the Hib size standard, HS008, depicted in Table 2.3 and seen in each of the figures in 
the lane labelled 8. The fragment numbers used in Table 7.3 correspond to one of the 81 
Smar different sized fragments (listed numerically in the reference database) that were 
found among 213 Hib isolates. That is, a total of 81 different sized fragments were 
found among the entire collection used in the larger PFGE study. In total, in this sample 
of 50 isolates, seven different sized fragments hybridised with the probe. 
The OMP26 hybridisation patterns were as follows: 
1) one fragment, fragment 13, of all the isolates that fell into type A8b (n=22 not 
including S 1 and S24) hybridised with the OMP26 probe, 
2) the 4 isolates for which two fragments hybridised, one of which was fragment 13 , 
belonged to 4 other RFLP types, 
3) fragment 4 of all 6 isolates that fell into type F2a hybridised with the probe and, 
4) two other different sized fragments hybridised in one of 2 other distinct types in 
which only one fragment hybridised. 
7a4 Discussion 
ERIC-PCR The bacterial strains selected for ERrC-PCR typing represented the genetic 
diversity found among Hib using PFGE. They included 6 isolates representing each of 
the two predominant PFGE RFLPs found in a sample of 213 Hib isolates. The findings 
from ERrC-PCR are in agreement with those derived from the PFGE RFLP analysis , 
and a correlation of 0.9 was found when a representative distance matrix 'derived from 
PFGE data was compared to that derived from the ERrC-PCR data. Calculation of 
Simpson's index of diversity showed that Smar digestion using PFGE was more 
discriminating. D = 0.974 for PFGE, indicates a very high power of discrimination. The 
D value of ERIC-PCR at 0.890 is considered to be less desirable but is just within the 
range where results can be interpreted with confidence. No correction factor was used 
for a small sample and it is best that typing schemes be validated with larger samples 
(n>J00). 
205 
The major clusters estimated with PFGE were revealed with ERIC-PCR but fewer types 
were found among them. ERIC-PCR detected a smaller genetic distance between the 
two most predominant types than revealed with PFGE. The F value found from a 
pairwise comparison of F2a and A8b was 0.6250 for PFGE and 0.3448 for ERIC-PCR. 
This was the largest discrepancy seen in the data. Further investigation into the genetic 
relationship of these two isolates is warranted. 
The overall high level of concordance between the two systems validates the usefulness 
of PFGE for typing Hib and does not contradict the use of quantitative analysis of PFGE 
for revealing phylogenetic relationships among the strains. The results of ERIC-PCR do 
not show that some strains group according to diagnosis. 
OMP26 The bacterial strains selected for OMP26 hybridisation represented the 
predominant RFLP types, A8b (n=24) and F2a (n=6), and 20 other isolates that fell into 
the major clusters designated A (n=12), B (n=3) and C (n=3). Genomic DNA of all 
strains hybridised with the probe, the majority hybridising to the same size fragment. In 
every case where more than one isolate was representing a type the same size fragment 
hybridised. This indicates that the OMP26 gene exists in all these strains and suggests 
that it is found in the same chromosomal region. The results revealed the location of 
homologous DNA ( ,..__,615 bp) on same size fragments generated by Smal digestion of 
Hib DNA and suggest that fragments of the same size may represent the same region of 
the chromosome. Similar results seen with the cap probe and P2 probe ( data not shown) 
when identical (but different for each probe) size fragments hybridised with the majority 
of isolates is further evidence of homologous DNA on same size fragments. 
Concluding remark The results of the work described here do not contradict the 
overall genetic relationships revealed among the Hib isolates by quantitative analysis of 
PFGE RFLPs. 
CHAPTER 8 
Examination of 
Isolates from the Post-vaccine Era 
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8. 1 Introduction 
One of the goals of the work presented in this thesis is to develop a database of Hib 
genotypes found in Australia before the introduction of conjugate vaccines and to use it 
to monitor Hib isolates recovered after widespread vaccination. The database has been 
developed by the identification of 69 genotypes (SmaI genotypes) among 213 Hib 
isolates from different population groups and different geographic areas in Australia. In 
this study we use the database in the examination of isolates recovered after the 
introduction of vaccination. 
In collaboration with Heidi C. Smith-Vaughan of the Menzies School of Health 
Research, it was proposed to subject isolates collected in the years 1996-1998 to PFGE 
to study the impact of Hib vaccines on Hib genotypes endemic in a remote Aboriginal 
community. Isolates recovered from this same population group in the two years prior 
to vaccine introduction are included in the pre-vaccine database of Hib genotypes and, 
thus, are available for direct comparison with the post-vaccine isolates. The PFGE 
results of these pre-vaccine isolates are in Chapter 5 in this thesis. They comprise 19 
isolates collected for a longitudinal study examining the relationship between bacterial 
colonisation of the nasopharynx and the onset of otitis media in Aboriginal infants 
(Leach et al., 1994). 
Prior to the introduction of the Hib conjugate polysaccharide vaccine, PRP-OMP, in 
mid-1993, the cumulative incidence of Hib in the infants under study was at least 42.8% 
by age 6 months (Smith-Vaughan et al., 1998). Widespread vaccination initially 
resulted in a sharp decline in Hib carriage during the first six months of vaccine usage 
and reached zero in 1994, however, Hib carriage rates in infants subsequently rose and 
Hib continues to be circulated in the community (Smith-Vaughan et al., 1998). This is 
of potential concern, particularly, since high carriage rates and a re-emergence of Hib 
disease has been reported among Native Alaskans (Galil et al. , 1999). 
Temporal shifts in the subtype distribution of Hib causing invasive disease have been 
demonstrated (Barenkamp et al., 1983; Hampton et al. , 1983; Leaves and Jordens, 
1994); and, it is not clear what effect vaccine usage will have on the selection of Hib 
clones in a population that experiences continued high carriage rates. If vaccination 
levels fall , existing Hib clones could spread more widely. It is also theoretically possible 
that the uptake of capsule gene sequences by potentially invasive NCHi clones during 
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concurrent carriage of Hib and NCHi strains could generate new Hib strains and cause a 
recurrence of Hib disease (Smith-Vaughan et al., 1998). 
Studies on the temporal trends of subtypes of Bordetella pertussis have led to some 
intriguing observations. Bordetella pertussis, like Hib, is a uniquely human pathogen 
that was a major cause of childhood illness and infant death before the introduction of 
vaccination programs in industrialised countries. There has been a resurgence of 
pertussis (whooping cough) since the early 1980s in countries with high vaccination 
rates, such as , the USA, The Netherlands, Canada and Australia (Mooi et al., 1998; 
Cordova et al., 2000; Hardwick et al., 2002). Pertussis vaccine was introduced in the 
1940s and coverage has been continuously high in developed countries since then. The 
shift in epidemiology may be a consequence of a number of factors but one explanation 
involves changes in the circulating B. pertussis population leading to increased 
virulence or resistance to vaccine induced immunity. To investigate this, Hardwick and 
co-workers used PFGE to subtype recently and previously circulating B. pertussis 
isolates in the USA. They found several major trends: different types circulated and 
predominated at different times, the relatedness among PFGE types was consistent with 
a relatively homogenous population, the more frequent profiles were more highly 
related to each other then to less common types, and genetic diversity decreased over 
the study period (1935-1999) (Hardwick et al., 2002). 
The observed tendency of different types of B. pertussis circulating in pre- and post-
vaccination periods was also demonstrated in the Netherlands where 83% of DNA types 
were limited to single periods and only one type was cultured in all successive periods 
(Mooi et al., 1998). In particular, in the Hardwick study, PFGE types from the pre-
vaccine era (before 1946) were highly divergent from the post-vaccination types . 
However, the role of vaccine selection in the divergence observed remains speculative 
because of the low number of isolates from the archival period (Hardwick et al., 2002). 
Both of these studies provide data about the distribution of types over an extended 
period of time and demonstrate shifts in genetic types suggesting that the population 
structure of B. pertussis may be distinct in vaccinated and unvaccinated populations. 
Though the role vaccination plays in subtype selection remains equivocal, the need for 
continued surveillance of the genetic diversity of B. pertussis to explain these 
observations is unquestioned. 
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The question can be raised as to whether the introduction of vaccines will affect the 
types of Hib circulating in vaccinated populations in Australia, particularly those with 
high carriage rates. In the Aboriginal population under study a shift in ~-lactamase 
production among Hib isolates has been observed. That is, ~-lactamase production was 
found in 43 % of pre-vaccine isolates compared to 19% of post-vaccine isolates and, if 
cases of possible longitudinal carriage are removed, the rate of ~-lactamase production 
fell from 45% to 15% (personal communication, Heidi C. Smith-Vaughan). It has not 
been determined whether this is due to chromosomal or plasmid mediated changes in 
the bacteria. 
Prior to the introduction of vaccines 19 Hib isolates from infants in this remote 
Aboriginal community were separated into 6 subtypes in two distinct lineages by PFGE 
typing. Here we present the results of an investigation into the possible change in the 
types of Hib circulating in this community since vaccination was introduced in mid-
1993. 
8.2 Methods 
Preparation of DNA, restriction endonuclease digestion, PFGE conditions, staining and 
visual determination of the numbers and mobilities of fragments were performed as 
previously described. The gel images were captured using the Gel Doc 1000 DNA gel 
analysis and photodocumentation system (Bio-Rad Laboratories, Hercules, CA). The 
images were then pasted into Microsoft Powerpoint® for illustration and subsequent 
publication. 
8.2.1 Bacterial isolates 
Twenty Hib isolates were obtained from a collection held at the Menzies School of 
Health Research, Darwin, Northern Territory. They were collected in 1996-1998 as part 
of the longitudinal study on otitis media. They were previously identified by their 
requirement for X and V factor and serotyping. Serotyping was confirmed by PCR. The 
sample includes: 2 isolates collected from an infant and its mother on the same day 
(B22-23), 2 isolates from an infant and its sibling collected six months apart (B27-28), 2 
isolates from the same infant collected 1 ½ years apart (B29-30), 4 isolates collected 
from an infant and its sibling on the same day and from this infant on two other 
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occasions (B3 l-32, B33-B34) and, 4 isolates collected from an infant and its sibling on 
two different occasions (B36-37 and B38-39). The other 6 isolates are from unrelated 
infants or siblings (B24-26, B35 , B4 l and B46). Table 8.1 describes the isolates. 
Table 8. 1 Post-vaccine carriage isolates recovered from Aboriginal infants, siblings, 
and a mother from Bathurst Island 
Code ID Lab# Relation DOC Age ~- PFGE typea 
(PEM) (MSHR) (MSHR) (days) lacta-
mase Group Bathurst Is. 
Subset 
B22 A04 4411 infant 09/02/98 644 neg F2a B6 
B23 A04 4411 mother 09/02/98 na neg F2a B6 
B24 Al 1 4139 sibling 18/09/96 na pos C7a B2 
B25 A14 4269 infant 24/04/97 38 neg C7ab B25 
B26 A15 4438 infant 06/05/98 1021 neg F2a B6 
B27 Al9 4354 infant 14/10/97 69 neg Bl Bl 
B28 A19 4420 sibling 08/04/98 na neg Blc B28 
B29 A21 4022 infant 22/04/96 286 neg .. d C7a ·· B29 
B30 A21 4358 infant 14/10/97 658 neg F2a B6 
B31 A25 4313 infant 06/08/97 53 pos C7b B13 
B32 A25 4313 sibling 06/08/97 na pos cs B8 
B33 A25 4322 infant 18/08/97 65 pos C5 B8 
B34 A25 4338 infant 15/09/97 93 pos C7a B2 
B35 A28 4374 infant 10/11/97 198 neg F2a B6 
B36 A29 4115 infant 27 /08/96 168 neg F2a B6 
B37 A29 4115 sibling 27/08/96 na neg F2a B6 
B38 A29 4167 infant 15/10/96 217 neg F2a B6 
B39 A29 4142 sibling 19/09/96 na neg F2a B6 
B40 A31 4272 infant 24/04/97 559 neg Bl B l 
B41 A33 4082 sibling 09/07/96 na neg F2a B6 
Shading is used to highlight associated isolates, i.e., B22-23 , B27-28, B29-30, B3 l-34, and B36-39. 
aThe PFGE type is shown for the entire database grouping scheme (Group) and the subset of Bathurst Island isolates 
(Bathurst Is. Subset) as determined by SmaI RFLPs. Group and Subset designation for each isolate refer to the same 
RFLP. The designations are used in Figure 5.10 and Figure 6.3, the dendrograms showing the clustering of SmaI 
RFLPs in the Bathurst Island subset and the entire database, respectively. 
bThe RFLP for this isolate was not found among the pre-vaccine isolates but it is closely related to group C7a from 
which it differs by three fragments . 
cThe RFLP for this isolate was not found among the pre-vaccine isolates but it is closely related to group B 1 from 
which it differs by two fragments . 
dThe RFLP for this isolate was not found among the pre-vaccine isolates but it is clonally related to group C7a from 
which it differs by two fragments . 
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8.3 Results 
All the isolates produced well-resolved patterns when digested with Smal and ApaI (see 
Figures 8.1-8.4). Eight Smal-RFLP types were found. Five of them were 
indistinguishable from types found in the Hib database. The other 3 types were clonally 
or closely related to a type in the database. One type that was indistinguishable from the 
most common Aboriginal type in the Hib database, F2a, predominated in this sample 
accounting for one half of the isolates compared to 32% in the pre-vaccine sample. 
After removal of possible longitudinal carriage isolates this type accounts for 38% of 
the isolates in the post-vaccine sample compared to 24% in the pre-vaccine sample. 
Another type, C7a, accounts for 2 (10%) of the post-vaccine isolates and 7 (37%) of the 
pre-vaccine isolates. After removal of possible longitudinal carriage isolates there was 
no change in distribution among the post-vaccine isolates and 4 (26%) of the pre-
vaccine isolates are type C7a. Table 8.1 lists the overall group type and the Bathurst 
Island subset type described previously in this thesis for each of the isolates. 
The distribution of isolates among the types in both the post-vaccine and pre-vaccine 
samples was: 
Northern Territory Bathurst Island post-vaccine isolates ( n=20) compared to pre-
vaccine isolates ( n = 19) by Smal-RFLP type 
(Pre-vaccine) Number of isolates per type 
Smal-RFLP type 
Number of isolates per type 
after removal of possible 
Bathurst Is. Subset type / longitudinal carriage isolates 
Group type Post-vaccine Pre-vaccine Post-vaccine Pre-vaccine 
number(%) number(%) number(%) number(%) 
Bl / Bl 2 ( 10) 1 
B2 I C7a 2 ( 10) 7 (37) 2 (10) 4 (25) 
BS I F2c 0 1 
B6 I F2a 10 (50) 6 (32) 6 (38) 4 (24) 
B8 / C5 2 ( 10) 3 (16) 
Bl3 / C7b 1 l 
B25 I new a 1 0 
B28 / new b 1 0 
B29 I new a 1 0 
aThe RFLP of this isolate was not found in the pre-vaccine sample but is closely related to 
pre-vaccine type C7a. 
bThe RFLP of this isolate was not found in the pre-vaccine sample but is clonally related to 
pre-vaccine type B 1. 
The use of the restriction enzyme Apal revealed seven Apal-RFLP types in 3 clonal 
groups. The 10 isolates indistinguishable from Smal-RFLP F2a were broken in to 3 
Apal-RFLP types that differed from each other by 1 fragment. 
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B22 B23 B24 B25 B26 B27 B28 8 B29 B30 B31 B32 B33 B34 
kb 
250.0 
80.0 
30.0 
Figure 8. 1 Smal restriction fragment patterns of post-vaccine isolates 
Smal restriction fragments obtained by PFGE of the genomic DNAs of 13 Aboriginal 
Hib isolates from Bathurst Island that were collected after the introduction of 
widespread vaccination. The lane labelled 8 contains fragment size standards. (Note: Lane 
B22 has been cut and pasted into this picture from an image of another gel run. ) 
B35 B36 B37 8 B38 B39 B40 B41 
kb 
250 .0 
80.0 
30.0 
Figure 8. 2 Smal restriction fragment patterns of post-vaccine isolates 
Smal restriction fragments obtained by PFGE of the genomic DNAs of 7 Aboriginal 
Hib isolates from Bathurst Island that were collected after the introduction of 
widespread vaccination. The lane labelled 8 contains fragment size standards. 
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B23 B24 B25 B26 B27 B28 8 B29 B30 B31 B32 B33 B34 
kb 
250.0 
80 .0 
30.0 
Figure 8. 3 Apal restriction fragment patterns of post-vaccine isolates 
ApaI restriction fragments obtained by PFGE of the genomic DNAs of 12 Aboriginal Hib 
isolates from Bathurst Island that were collected after the introduction of widespread 
vaccination. The lane labelled 8 contains fragment size standards. 
B22 B28 B35 B36 B37 8 B38 B39 B40 B41 
kb 
250.0 
80 .0 
30.0 
Figure 8. 4 Apal restriction fragment patterns of post-vaccine isolates 
ApaI restriction fragments obtained by PFGE of the genomic DNAs of 9 Aboriginal Hib isolates 
from Bathurst Island that were collected after the introduction of widespread vaccination. The 
lane labelled 8 contains fragment size standards. (Note: The smallest fragments are shown to 
better advantage in the section appended to the bottom of this depiction.) 
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8.4 Discussion 
There has been a resurgence of Hib carriage in a remote Aboriginal community since 
widespread vaccination introduced in the early 1990s initially caused a sharp decline in 
its carriage. Because this resurgence may represent changes in the carriage isolates, we 
determined the PFGE profiles of 20 isolates circulating in the population in this 
community after the introduction of Hib vaccines and compared them to PFGE profiles 
of Hib isolates recovered in the same community before the introduction of vaccines. 
We looked for any trends with potential epidemiologic significance. 
We found that the same PFGE types were circulating during the pre-vaccine era and 
several years after the introduction of vaccines. Of 8 Smal-RFLP types found among the 
post-vaccine isolates 5 are indistinguishable from types found in the pre-vaccine isolates 
from the Bathurst Island community under study. The same type (indistinguishable 
from Group F2a) predominates in both the pre- and post-vaccine samples and there is 
no evidence of displacement of types in the post-vaccine sample. Three of the post-
vaccine types are not found in the pre-vaccine sample from the community nor from the 
Australia wide sample but they are clonally (differed by 1 fragment) or closely (differed 
by 2-3 fragments) related to two of the other 5 post-vaccine types. 
The divergence among these 3 types in the post-vaccine sample compared to the pre-
vaccine sample may suggest a shift in population structure but because of the relatively 
low number of isolates in each sample it cannot be ruled out that less frequent types 
were not recovered in the pre-vaccine sample. 
PFGE is particularly suited to detecting micro-evolutionary changes and the results 
found in this small sample suggest that the Hib genomic types circulating several years 
after the introduction of vaccines are similar to those circulating before immunisation. 
Because of the pre-vaccine sample size the data does not suggest that new variants of 
Hib are present after the resurgence of carriage in this population but the detection of 3 
new closely related types warrants investigation. Examination of a larger sample of 
isolates and further characterisation of isolates using other molecular methods that 
reveal the DNA sequences within fragments may reveal the significance of these 
variants. 
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Hib carriage is a dynamic process. It was shown in another sample of isolates from this 
same population that ERIC-PCR typing split the Hib isolates into two groups with the 
apparent replacement of one variant by the other during several episodes of Hib carriage 
(Smith-Vaughan et al., 1998). It is not clear whether the two variants of Hib were 
transmitted, and thus , carried together, taking turns as the dominant strain, or whether 
there were separate episodes of colonisation in infants who do not develop a strong 
immune response to the Hib polysaccharide capsule following natural exposure. 
PFGE also revealed the dynamics of Hib carriage. In this study: 
1) the same PFGE type was recovered from a mother (B22) and her infant (B23) on the 
same day, 
2) the same PFGE type was recovered from an infant (B36, B37) and its sibling (B38, 
B30) on two occasions within a 2 month period, 
3) a type recovered from its sibling (B28) was closely related to a isolate recovered 
from an infant (B27) six months previously, 
4) three closely related types were recovered from an infant (B3 l, B33, B34) and its 
sibling (B32) over a period of 2 months and each of the types was carried by the 
infant at different times and, 
5) two genetically distinct types collected a year and a half apart were recovered from 
the same infant (B29, B30). 
Thus, our results show that both concurrent carriage of the same or closely related Hib 
types among relatives occurs over a period of at least two months and that an individual 
may harbor closely related or distinctly different types at different points in time. It is 
not clear whether the subsequent presence of a closely related type represents 
colonisation from a newly introduced strain or is a strain carried concurrently and not 
previously recovered due to sampling methods or is a recent variant of the previously 
identified isolate to which it is related. The recovery of distinctly different types from an 
infant and its sibling implies that the Hib isolates were from different origins and that 
older siblings were not the source of the infant Hib isolate. 
Although the Smal restriction profiles of B27 and B28 that were recovered from an 
infant and its sibling were almost identical they differed by two fragments. When the 
genomic DNAs of B27 and B28 were digested with Apal a two fragment difference was 
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also observed. Since the difference observed with Smal could also be observed with 
Apal, this meant that the band differences are not simply due to a point mutation that 
modified the Smal restriction site. This may indicate that the strains isolated from these 
siblings were of different origins. 
Concluding remark This work demonstrates the usefulness of the PFGE database 
developed during the course of the larger study for the evaluation of Hib isolates 
recovered after the introduction of vaccines. 
CHAPTER 9 
Concluding Remarks 
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Before the introduction of conjugate vaccines in 1992, Haemophilus influenzae type b 
(Hib) disease was a major cause of morbidity and mortality in Australian children 
particularly among Aboriginal populations in whom the incidence of Hib disease was 
among the highest in the world. Overall 600-700 cases of invasive Hib disease occurred 
each year in Australia. While the incidence of Hib disease has dropped dramatically 
since vaccination policies have been in place, invasive disease due to Hib still occurs. 
Between July 1993 and June 1996, 412 cases, including 18 deaths, were reported to the 
Hib Case Surveillance Scheme. Thirty-four cases met the Australian case definition of 
a vaccine failure. However, a further 24 cases would meet the United Kingdom vaccine 
failure definition that includes cases occurring after just two rather than three doses of 
vaccine when the first dose is given before the age of 7 months (Herceg, 1997). That 
Hib continues to circulate in an Aboriginal island community 6 years after the 
introduction of the Hib conjugate polysaccharide vaccine is a cause for concern, 
particularly if vaccination rates fall (Smith-Vaughan et al., 1998). Thus, despite the 
introduction of effective vaccines in 1992 there is a public health need to monitor Hib 
and other invasive H. influenzae populations in Australia. 
The overall purpose of this project was to characterise the population structure of Hib in 
Australia using PFGE, determine whether RFLP types correlated with the epidemiology 
of disease, and assess the usefulness of PFGE as the basis of a database of genetic types 
to monitor Hib isolates in the post-vaccine era. This has been accomplished. 
The ultimate collection of isolates made available for this study is the result of 
professional networking rather than any well laid out plan that would ensure an ideal 
selection. Many of the isolates had been collected for a nationwide multi-city study on 
antimicrobial resistance but others came from contacts who collected Hib for a variety 
of purposes. Clinical and non-clinical isolates were obtained. The history that was 
available for each isolate varied considerably and though all isolates could be separated 
into carrier or disease associated types, in some cases, for a few invasive isolates a 
specific diagnosis was not able to be obtained. Missing data were always thoroughly 
investigated with the source person from whom I obtained isolates. Sometimes it was 
just not available. It should be noted that the isolates were collected over a period of a 
few years as I became acquainted with the microbiology community in Australia. The 
point is, I did not have immediate access to isolates recovered in most of the varied 
geographic regions that were ultimately included in this study. I was responsible for 
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locating and obtaining all the isolates except the Canberra and Sydney strains that are 
stored at the Canberra Hospital. The quality of the sample did not suffer too much from 
. 
this ad hoc collecting. A particularly sorry point, though, is that I was not able to obtain 
Aboriginal isolates from urban areas and thus could not directly address a very 
important question, namely, are Hib clones like those described elsewhere associated 
with specific geographic areas? 
The work reported here established the usefullness of PFGE for examining the genetic 
diversity of Hib in Australia. The practical applicability of this for surveillance was 
shown when 2 isolates of Hib recovered in 2 fatal cases in a nursing home outbreak in 
the Sydney region (Heath et al. , 1997) were analysed, and both were shown to have 
patterns identical to that of Smal type A8b. The database was also helpful in confirming 
the identity of a nontypeable H. influenzae from the cerebrospinal fluid and blood of a 
child with a past history of Hib meningitis and subsequent immunisation (Moor and 
Kelly, 1995). Medical and laboratory evaluation failed to find an immunological or 
anatomical predisposition for this child to suffer recurrent invasive infection. Southern 
blot analysis confirmed the lack of an intact capsulation (cap) locus within the 
chromosome showing that this isolate was not a capsule deficient type b. RFLP analysis 
using PFGE further confirmed the strain was not closely related to known Hib isolates 
previously typed by this method. The unusual presentation was also notable for the 
recovery of a serologically typed Hib isolate from a nasal swab taken at the time of the 
NTHi meningitis. Unfortunately, this isolate was not available for analysis. 
PFGE and the Australia wide database is now being applied to the examination of Hib 
carrier strains found in the Bathurst Island Aboriginal community after the introduction 
of vaccines. The emergence of multiresistant Hib in Papua New Guinea (PNG) is of 
some concern (Michael et al. , 1997). Five new types were found among 7 isolates sent 
to me from patients at Goroka Base Hospital PNG to evaluate for genetic diversity. The 
data revealed that the isolates were not the result of the clonal spread of a single type. 
The widespread introduction of vaccines against Haemophilus influenzae type b (Hib) 
increases the importance of the precise identification of isolates infecting both 
immunised and non-immunised patients. There is an increasing need to more precisely 
characterise the genetic characteristics of NTHi as they become more prominent in the 
infections caused by H. injluenzae. Preliminary work has begun on a PFGE RFLP 
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database of NTHi modeled on this system (Webb-Wagg, 1997) and a project using 
other molecular typing methods in conjunction with PFGE to characterise NTHi in 
Australia is under development. 
Since the commencement of this project others have reported using CHEF PFGE to 
study smaller collections of Hib isolates (Tarasi et al., 1998; Mitsuda et al. , 1999; Saito 
et al. , 1999) and their results have also confirmed the effectiveness of PFGE for 
studying the genetic diversity of Hib. As noted, what was an almost experimental 
technique when I began this study is now the gold standard of typing. 
There is real concern about making phylogenetic inferences with RFLP data and it must 
be emphasised that the values of F obtained should not be seen as precise estimates of 
genetic distance but summary values indicative of overall similarities and differences 
between isolates and a means to illustrate relationships within a large body of 
comparative data. The results of the cap locus, P2 and OMP26 hybridisation studies 
showed that similar size fragments carried the same genetic information. Thus, the 
results of these tests did not contradict the inferences made by RFLP analysis and 
revealed homologous DNA was carried on same sized fragments. By definition Hib 
isolates carry the cap locus but the analyses also showed that the P2 and OMP26 genes 
are highly conserved among the different isolates. 
The results described in this thesis are based largely on the RFLPs of a single enzyme 
that was shown to correlate very well with a second rare cutting endonuclease. The use 
of more than one enzyme would allow sampling of other parts of the genome and would 
theoretically result in a more powerful analysis. Other enzymes may detect molecular 
differences that demonstrate clonal disease specificity that was not found with Smal or 
Apa!. This should continue to be investigated. Not only, to more carefully examine the 
diversity of Hib, but to better understand the RFLP data generated by PFGE. 
PFGE is currently considered the most reliable and practical tool for molecular 
epidemiologic analyses of bacterial infections and it is particularly well suited to 
detecting microevolution. But, we agree that additional analysis using other genotyping 
techniques should be used in conjunction with RFLP data. Rapid amplified polymorphic 
DNA (RAPD) analysis was shown to improve the subtyping of 30 Hib strains 
characterised by PFGE in a recent Japanese study (Mitsuda et al., 1999). Evaluation of 
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other genotyping systems and combinations of them with PFGE should be explored. 
Polymerase chain reaction-based typing systems, particularly RAPD RFLP analysis are 
now widely used for bacterial typing and have been compared to PFGE (Chachaty et 
al., 1994; Farber and Addison, 1994; Sandery et al., 1994; Renders et al., 1996). The 
results of ERIC-PCR used in this study were highly correlated with the PFGE results 
and did not contradict the phylogenetic inferences made with PFGE. Further evaluation 
of the purported relationships should be explored. 
Long PCR-ribotyping was found to be as informative for typing nontypeable H. 
injluenzae as conventional ribotyping and subsequently has been used to type Hib 
isolates (Smith-Vaughan et al., 1995; Smith-Vaughan et al., 1998). Although sampling 
a highly conserved region of the genome, PCR ribotyping may also provide further 
informative genetic characterisation of Hib among a large diverse sample of isolates. 
The availability of molecular genetic technologies like DNA sequencing, and physical 
and genetic map construction would also permit a clearer insight into the local 
population structures of Hib. 
Prior to the widespread use of molecular techniques to characterise bacteria, phenotypic 
methods, such as, OMP typing and multilocus enzyme electrophoresis (MLEE), were 
used extensively in the study of Hib. Examination of the sample studied here with these 
two typing systems ( a formidable task in the case of MLEE) would allow an invaluable 
comparison with isolates previously typed by these methods, as well as, increase the 
resolution of the overall analysis. MLST represents the newest generation of molecular 
technology and in companion with PFGE may provide the most readily available 
window on population structures. 
The visual analysis of the gel patterns becomes laborious and immensely time 
consuming when more than a few isolates are compared. However, the development of 
computerised gel scanning and pattern analysis methods have made it possible to create 
reference databases in a fraction of the time (Gerner-Smidt et al., 1998). 
The analyses described in this thesis have given us a better understanding of the 
population structure of Haemophilus injluenzae type b in Australia. OMP subtyping 
revealed that a small number of OMP subtypes caused most Hib disease but OMP 
subtyping is not very discriminatory and did not reveal the diversity seen with PFGE. 
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The data confirmed that the population structure of Hib in Australia is clonal and 
revealed that two different types, designated A8b and F2a, predominated among 
Aboriginal versus non-Aboriginal children. A deep divergence in the genetic relatedness 
of Aboriginal and non-Aboriginal isolates was revealed. Because of the increased 
incidence of Hib disease in Aboriginal populations it is tempting to speculate on 
whether this large genetic difference is associated with increased virulence among the 
Aboriginal I-lib types. According to what I call Musser et al.' s ( 1990) 'geographic 
isolation' hypothesis these isolates may represent an older pattern of differentiation that 
has not been obscured by human migration patterns of the last few hundred years. The 
data was in agreement with the prediction based on this hypothesis that within a native 
population a few distinct clones would be found. 
Important information about the dynamics of Hib strain diversity in the pre- and post-
vaccine periods was revealed. Pre-vaccine PFGE types were found to be circulating 
several years after the introduction of vaccines in a remote Aboriginal community. Of 8 
SmaI-RFLP types found among 20 post-vaccine isolates 5 are indistinguishable from 
types found among the pre-vaccine isolates. The same type (F2a) predominates in both 
the pre- and post-vaccine samples. The three post-vaccine types not found in the pre-
vaccine sample are closely related to two of the pre-vaccine types. This divergence may 
suggest a shift in population structure but because of the relatively low number of 
isolates studied it cannot be ruled out that less frequent types were not recovered in the 
pre-vaccine sample. 
It is vital to be able to predict the likely effects of public health interventions on the 
biology of the pathogens against which they are directed. Understanding the structure 
and dynamics of microbial populations will permit the design of effective public health 
policies that minimise the possibilities for microbial evolution to neutralise them. The 
genotypic database compiled in this study is unique in its scope and can be used in a 
broader national surveillance system to support this aim. No other study has examined 
the genotypic diversity of such a wide-ranging collection of Australian isolates and 
provided information on the dynamics of Hib diversity in the pre- and post-vaccine era. 
The results of this work can be applied to the continued study of the epidemiology of 
Hib and to elucidating the genetic virulence determinants of its ability to cause disease. 
APPENDICES 
A p p e n d i x  A . 1 :  H i b  I s o l a t e s  R e c o v e r e d  f r o m  t h e  C a n b e r r a  R e g i o n  
C o d e  
I D #  
L o c a t i o n  
H o s p i t a l  
D i a g n o s i s  S p e c i m e n  D O C  
D O B  A g e ( y . m . )  
S e x  R a c e  
S e r o t y p e  
B i o t y p e  B
0
L a c t a m a s e  
p U 0 8 2  " b "  
M l  
H S 0 3 5 8  
C a n b e r r a  
W V H  
m e n i n g i t i s  b l d / c s f  
2 - A u g - 8 8  n o t  k n o w n  
3  m  
N  
b  
I  
p o s i t i v e  
p o s i t i v e  
M 2  
H S 0 3 5 9  
C a n b e r r a  
W V H  
m e n i n g i t i s  b l d / c s f  l - S e p - 8 8  
n o t  k n o w n  
2 . 2  f  
N  
b  
I  p o s i t i v e  
p o s i t i v e  
M 3  
H S 0 3 6 0  
C a n b e r r a  
W V H  
m e n i n g i t i s  b l d / c s f  
l  l - J u n - 8 9  n o t  k n o w n  
2 7  
m  N  
b  
I  
p o s i t i v e  
p o s i t i v e  
M 4  
H S 0 3 6 3  
C a n b e r r a  
W V H  
m e n i n g i t i s  b l o o d  2 0 - D e c - 8 8  
n o t  k n o w n  4 5  
f  N  
b  I  
p o s i t i v e  
p o s i t i v e  
M S  
H S 0 3 9 2  
C a n b e r r a  
W V H  
m e n i n g i t i s  c s f  1 8 - S e p - 8 0  
n o t  k n o w n  
1 . 4  f  
N  
b  
I  n e g a t i v e  
p o s i t i v e  
M 6  
H S 0 4 8 5  
C a n b e r r a  
W V H  
m e n i n g i t i s  b l d / c s f  
2 5 - F e b - 8 9  n o t  k n o w n  
1 . 5  
m  N  
b  
I  p o s i t i v e  
p o s i t i v e  
M 7  
H S 0 4 8 6  C a n b e r r a  
W V H  
m e n i n g i t i s  
b l d / c s f  5 - J u n - 8 9  n o t  k n o w n  
1 . 5  
m  N  
b  
I  
p o s i t i v e  
p o s i t i v e  
M 8  
H S 0 4 8 8  
C a n b e r r a  
W V H  
m e n i n g i t i s  
b l d / c s f  l  7 - J u n - 8 9  n o t  k n o w n  
1 . 9  
f  
N  b  
I I  n e g a t i v e  
p o s i t i v e  
M 9  
H S 0 4 9 4  C a n b e r r a  
W V H  
m e n i n g i t i s  c s f  l  1 - A p r - 8 9  n o t  k n o w n  
1 . 2  m  
N  b  
I I  n e g a t i v e  
p o s i t i v e  
M I O  
H S 0 4 9 5  C a n b e r r a  
W V H  
m e n i n g i t i s  b l d / c s f  l  5 - N o v - 8 9  
n o t  k n o w n  
0 . 3  m  
N  
b  I  p o s i t i v e  
p o s i t i v e  
M l  l  
H S 0 4 9 7  C a n b e r r a  
W V H  
m e n i n g i t i s  b l d / c s f  8 - J a n - 9 0  
n o t  k n o w n  
2 . 1  
f  N  
b  I  n e g a t i v e  
p o s i t i v e  
M l 2  
H S 0 5 0 1  
C a n b e r r a  W V H  
m e n i n g i t i s  b l d / c s f  2  l - F e b - 9 0  
n o t  k n o w n  
1 . 1  m  
N  
b  I  n e g a t i v e  
p o s i t i v e  
M l 3  
H S 0 5 1 4  G o u l b o u r n  
W V H  
m e n i n g i t i s  b l d / c s f  1  O - M a y - 9 0  
n o t  k n o w n  
1 . 7  
f  N  
b  I  n e g a t i v e  
p o s i t i v e  
M l 4  H S 0 5  l  5  
Q u e a n b e y a n  W V H  
m e n i n g i t i s  c s f  
2 5 - M a y - 9 0  n o t  k n o w n  
2 . 7  
f  N  
b  I  p o s i t i v e  
p o s i t i v e  
M l 5  
H S 0 5 5 0  
C a n b e r r a  W V H  
m e n i n g i t i s  
b l d / c s f  7 - J u n - 9 0  n o t  k n o w n  
0 . 6  
m  N  
b  I I  n e g a t i v e  
p o s i t i v e  
M l 6  
H S 0 5 5  l  
C a n b e r r a  W V H  
m e n i n g i t i s  
b l d / c s f  l  1 - J u n - 9 0  n o t  k n o w n  
0 . 5  
m  N  
b  I  n e g a t i v e  
p o s i t i v e  
M 1 7  
H S 0 5 5 3  
C a n b e r r a  W V H  
m e n i n g i t i s  
b l d / c s f  2 5 - J u n - 9 0  
n o t  k n o w n  2 . 9  
f  N  
b  I  n e g a t i v e  
p o s i t i v e  
M 1 8  
H S 0 5 9 3  C a n b e r r a  
W V H  
m e n i n g i t i s  
b l d / c s f  l  7 - J u l - 9 0  
n o t  k n o w n  
0 . 6  m  N  
b  I  n e g a t i v e  
p o s i t i v e  
M 1 9  
H S 0 5 9 4  C a n b e r r a  W V H  
m e n i n g i t i s  b l d / c s f  
3 0 - J u l - 9 0  n o t  k n o w n  
1 . 5  f  N  
b  I  p o s i t i v e  
p o s i t i v e  
M 2 0  H S 0 5 9 8  
C a n b e r r a  
W V H  m e n i n g i t i s  
b l d / c s f  2 1 - S e p - 9 0  n o t  k n o w n  
2 . 6  
f  N  b  I  p o s i t i v e  
p o s i t i v e  
E l  H S 0 3 5 4  
C a n b e r r a  W V H  e p i g l o t t i t i s  b i d  2 3 - J u n - 8 8  
n o t  k n o w n  
2 . 5  m  N  b  I  n e g a t i v e  
p o s i t i v e  
E 2  H S 0 3 5 7  
C a n b e r r a  W V H  
e p i g l o t t i t i s  
b i d  2 - A u g - 8 8  n o t  k n o w n  
2 . 9  f  
N  b  I  n e g a t i v e  
p o s i t i v e  
E 3  H S 0 3 6 2  
C a n b e r r a  W V H  e p i g l o t t i t i s  b i d  
l  8 - D e c - 8 8  n o t  k n o w n  4 . 6  
f  N  b  I  p o s i t i v e  
p o s i t i v e  
E 4  
H S 0 3 6 6  
C a n b e r r a  W V H  
e p i g l o t t i t i s  
b i d  1 4 - M a r - 8 9  n o t  k n o w n  
4 . 2  m  
N  b  I  p o s i t i v e  
p o s i t i v e  
E S  
H S 0 3 6 7  C a n b e r r a  
W V H  e p i g l o t t i t i s  
b i d  1 8 - M a r - 8 9  n o t  k n o w n  
2 . 8  f  N  
b  
I  n e g a t i v e  
p o s i t i v e  
E 6  H S 0 3 6 9  
C a n b e r r a  W V H  
e p i g l o t t i t i s  
b i d  1 6 - M a r - 8 9  n o t  k n o w n  
2 . 7  m  N  b  I  p o s i t i v e  p o s i t i v e  
E 7  H S 0 4 8 9  C a n b e r r a  
W V H  e p i g l o t t i t i s  
b i d  l  2 - J u l - 8 9  n o t  k n o w n  
2 . 4  m  N  
b  
I I  n e g a t i v e  
p o s i t i v e  
E 8 i s S 3 7  H S 0 4 9 0  C a m p b e l l  t o w n  
W V H  e p i g l o t t i t i s  
b i d  l  4 - J u l - 8 9  n o t  k n o w n  
2 . 6  
m  N  b  I  
n e g a t i v e  
p o s i t i v e  
E 9  
H S 0 5 0 4  C a n b e r r a  W V H  
e p i g l o t t i t i s  
b i d  2 - M a r - 9 0  n o t  k n o w n  
0 . 4  
m  N  b  I  
n e g a t i v e  
p o s i t i v e  
E l O  
H S 0 5 5 2  C a n b e r r a  
W V H  e p i g l o t t i t i s  
b i d  l  3 - J u n - 9 0  n o t  k n o w n  
3  m  
N  
b  I  
n e g a t i v e  
p o s i t i v e  
E l  I  H S 0 5 5 4  C a n b e r r a  
W V H  e p i g l o t t i t i s  
b i d  2 3 - J u n - 9 0  n o t  k n o w n  
2 . 2  
f  N  b  
I  n e g a t i v e  p o s i t i v e  
E l 2  H S 0 5 9 5  C a n b e r r a  
W V H  e p i g l o t t i t i s  
b i d  1 7 - A u g - 9 0  n o t  k n o w n  
3 . 5  m  N  
b  
I  
n e g a t i v e  
p o s i t i v e  
t i  
E 1 3  
H S 0 5 9 6  C a n b e r r a  
W V H  e p i g l o t t i t i s  
b i d  2 6 - A u g - 9 0  n o t  k n o w n  
3 . 8  m  N  b  I  
p o s i t i v e  
p o s i t i v e  
E l 4  H S 0 5 9 9  C a n b e r r a  
W V H  e p i g l o t t i t i s  
n k  2  l - S e p - 9 0  
l  6 - F e b - 6 0  3 0  
?  N  b  
I  n e g a t i v e  p o s i t i v e  
~ 
E 1 5  H S 0 6 0 1  C a n b e r r a  W V H  e p i g l o t t i t i s  
n k  1 4 - D e c - 9 0  2 4 - D e c - 8 7  2 . 1 1  
m  N  b  
I  p o s i t i v e  p o s i t i v e  
C o d e  
I D #  
S l  
H S 0 0 8 3  
S 2  
H S 0 0 8 4  
S 3  
H S 0 5 1 3  
S 4  
H S 0 0 8 7  
S 5  
H S 0 0 9 6  
S 6  
H S 0 l  1 6  
S 7  
H S 0 l  1 7  
S 8  
H S 0 l  1 8  
S 9  
H S 0 1 6 5  
S I O  
H S 0 2 0 7  
S I  1  
H S 0 2 0 8  
S l 2  
H S 0 2 0 9  
S 1 3  
H S 0 2 1 0  
S l 4  
H S 0 2 1  I  
S l 5  
H S 0 2 1 2  
S l 6  
H S 0 2 1 3  
S l 7  
H S 0 2 1 5  
S l 8  
H S 0 2 3 5  
S 1 9  
H S 0 2 3 6  
S 2 0  
H S 0 2 3 7  
S 2 1  H S 0 2 3 8  
S 2 2  
H S 0 2 3 9  
S 2 3  
H S 0 2 4 0  
S 2 4  
H S 0 2 7 0  
S 2 5  H S 0 2 7  l  
S 2 6  
H S 0 2 7 2  
S 2 7  H S 0 2 7 3  
S 2 8  H S 0 2 7 4  
S 2 9  
H S 0 2 7 5  
S 3 0  
H S 0 2 7 6  
A p p e n d i x  A . 2  ( p a g e  1  o f  2 ) :  H i b  I s o l a t e s  R e c o v e r e d  f r o m  t h e  S y d n e y  R e g i o n  a n d  T o w n s v i l l e  
L o c a t i o n  
H o s p i t a l  
D i a g n o s i s  
S p e c i m e n  
D O C  
D O B  
A g e  ( y . m )  S e x  R a c e  
S e r o t y p e  
B i o t y p e  B ~ L a c t a m a s e  
S y d n e y  
S y d  C h i l d r e n ' s  
c e l l u l i t i s  b i d  2 6 - S e p - 8 8  n o t  k n o w n  
0 . 7  f  N  
b  
I  n e g a t i v e  
S y d n e y  
S y d  C h i l d r e n ' s  
m e n i n g i t i s  
c s f  5 - D e c - 8 8  n o t  k n o w n  
5  
m  N  
b  
I  n e g a t i v e  
S y d n e y  
B l a c k t o w n  
m v a s 1 v e  b i d  2 3 - O c t - 8 9  n o t  k n o w n  
4 . 3  m  N  
b  I  n e g a t i v e  
S y d n e y  
S y d  C h i l d r e n ' s  
c e l l u l i t i s  
b i d  
1 7 - N o v - 8 8  n o t  k n o w n  
1  
m  N  
b  I  
p o s i t i v e  
S y d n e y  
N e p e a n  
m e n i n g i t i s  c s f  
n o t  k n o w n  
n o t  k n o w n  
1 . 7  f  N  
b  
I  n e g a t i v e  
S y d n e y  S t .  G e o r g e  
m e n i n g i t i s  b i d  1 5 - M a r - 8 9  n o t  k n o w n  
3  m  
N  
b  I  n e g a t i v e  
S y d n e y  N e p e a n  
m e n i n g i t i s  c s f  8 - A p r - 8 9  n o t  k n o w n  
1 6  m  
N  
b  I  n e g a t i v e  
S y d n e y  N e p e a n  
m e n i n g i t i s  
c s f  1 3 - A p r - 8 9  n o t  k n o w n  
5  
m  N  
b  I  n e g a t i v e  
S y d n e y  S t .  G e o r g e  
m e n i n g i t i s  
c s f  4 - M a y - 8 9  n o t  k n o w n  
1  
m  N  
b  I  n e g a t i v e  
S y d n e y  B l u e  M o u n t a i n s  
m v a s 1 v e  b i d  
l  l - J u l - 8 9  n o t  k n o w n  
2 . 5  
f  N  
b  I  p o s i t i v e  
S y d n e y  S t .  G e o r g e  
m e n i n g i t i s  c s f  
l  3 - J u l - 8 9  n o t  k n o w n  
1 . 5  ?  N  
b  I  p o s i t i v e  
S y d n e y  B a n k s t o w n  
m e n i n g i t i s  c s f  
l  7 - J u l - 8 9  
n o t  k n o w n  
1 . 7  ?  N  
b  I  p o s i t i v e  
S y d n e y  S t .  G e o r g e  
m v a s 1 v e  b i d  
3 - J u ; - 8 9  
n o t  k n o w n  
5 . 9  f  N  
b  I  n e g a t i v e  
S y d n e y  S u t h e r l a n d  
m e n i n g i t i s  c s f  l  5 - A u g - 8 9  n o t  k n o w n  
1 . 8  f  N  
b  I  n e g a t i v e  
S y d n e y  H a w k e s  b u r y  
m v a s 1 v e  b i d  1 5 - A u g - 8 9  n o t  k n o w n  
4 . 1  m  N  
b  I  p o s i t i v e  
S y d n e y  H a w k e s  b u r y  
m e n i n g i t i s  c s f  1 6 - A u g - 8 9  n o t  k n o w n  
1 . 4  f  
N  b  I  p o s i t i v e  
S y d n e y  W e s t m e a d  
m e n i n g i t i s  c s f  2 1 - A u g - 8 9  n o t  k n o w n  
0 . 2  m  
N  b  I  n e g a t i v e  
S y d n e y  W e s t m e a d  
m e n i n g i t i s  c s f  1 8 - A u g - 8 9  n o t  k n o w n  
0 . 5  m  
N  b  I  n e g a t i v e  
S y d n e y  M o n a  V a l e  m v a s 1 v e  b i d  2 1 - A u g - 8 9  n o t  k n o w n  4 . 8  
m  N  b  I  n e g a t i v e  
S y d n e y  
B l a c k t o w n  m e n i n g i t i s  c s f  2 3 - A u g - 8 9  n o t  k n o w n  
0 . 7  m  N  b  I  n e g a t i v e  
S y d n e y  B l a c k t o w n  
m v a s 1 v e  
b i d  
l  5 - A u g - 8 9  
n o t  k n o w n  2  m  N  
b  
I I  p o s i t i v e  
S y d n e y  
M t .  D r n i t t  m e n i n g i t i s  c s f  3 0 - A u g - 8 9  n o t  k n o w n  
0 . 6  f  N  b  I  
p o s i t i v e  
S y d n e y  S t .  G e o r g e  
m v a s 1 v e  
b i d  
l - S e p - 8 9  
n o t  k n o w n  
0 . 8  m  
N  
b  
I  n e g a t i v e  
S y d n e y  W e s t m e a d  m e n i n g i t i s  c s f  1 2 - A p r - 8 9  n o t  k n o w n  
0 . 2  ?  N  b  I  
n e g a t i v e  
S y d n e y  G o s f o r d  
m e n i n g i t i s  
c s f / b l d  
1 4 - A p r - 8 9  
n o t  k n o w n  
0 . 5  f  
N  
b  
I  n e g a t i v e  
S y d n e y  
B a n k s t o w n  
m v a s 1 v e  b i d  8 - A p r - 8 9  n o t  k n o w n  
4 . 7  f  N  b  I  
n e g a t i v e  
S y d n e y  W e s t m e a d  m v a s 1 v e  b i d  2 9 - A p r - 8 9  n o t  k n o w n  
n o t  k n o w n  f  N  b  I I  
n e g a t i v e  
S y d n e y  
G o s f o r d  
m e n i n g i t i s  c s f  1 6 - M a y - 8 9  n o t  k n o w n  
1  f  N  b  I  
n e g a t i v e  
S y d n e y  
N e p e a n  
m e n i n g i t i s  c s f  2 9 - M a y - 8 9  n o t  k n o w n  
1 . 9  f  N  b  I  
n e g a t i v e  
S y d n e y  
N e p e a n  
m e n i n g i t i s  c s f  6 - J u n - 8 9  n o t  k n o w n  
I  
f  
N  b  I  
n e g a t i v e  
p U 0 8 2  " b "  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
p o s i t i v e  
t - J  
N  
U \  
A p p e n d i x  A .  2  ( p a g e  2  o f  2 ) :  
H i b  I s o l a t e s  R e c o v e r e d  f r o m  t h e  S y d n e y  R e g i o n  a n d  T o w n s v i l l e  
C o d e  
I D #  
L o c a t i o n  
H o s p i t a l  
D i a g n o s i s  S p e c i m e n  
D O C  D O B  A g e ( y . m . )  S e x  R a c e  
S e r o t y p e  B i o t y p e  B ~ L a c t a m a s e  
p U 0 8 2  " b "  
S 3 1  
H S 0 2 7 7  
S y d n e y  
W e s t r n e a d  
m v a s 1 v e  
b i d  I  0 - J u n - 8 9  
n o t  k n o w n  2 . 6  
f  N  
b  I  n e g a t i v e  
p o s i t i v e  
S 3 2  
H S 0 2 7 8  
S y d n e y  
B a n k s  t o w n  
m v a s 1 v e  b i d  
9 - J u n - 8 9  n o t  k n o w n  
1 . 8  f  
N  
b  
I  n e g a t i v e  
p o s i t i v e  
S 3 3  
H S 0 3 9 1  
S y d n e y  
N e p e a n  
m v a s 1 v e  b i d  
5 - S e p - 8 9  
n o t  k n o w n  
0 . 8  f  N  
b  I  n e g a t i v e  
p o s i t i v e  
S 3 4  
H S 0 5 0 5  
S y d n e y  
W e s t r n e a d  
m v a s 1 v e  
b i d  
1 4 - O c t - 8 9  n o t  k n o w n  4 . 4  
m  N  b  
I  n e g a t i v e  
p o s i t i v e  
S 3 5  
H S 0 5 1 0  
S y d n e y  
W e s t m e a d  
m e n i n g i t i s  
c s f  2 3 - S e p - 8 9  
n o t  k n o w n  
0 . 5  f  N  
b  I  n e g a t i v e  
p o s i t i v e  
S 3 6  
H S 0 5 1 2  
S y d n e y  
H o r n s b y  
m e n i n g i t i s  c s f / b l d  
1 5 - O c t - 8 9  n o t  k n o w n  3 . 8  f  N  
b  I  n e g a t i v e  
p o s i t i v e  
S 3 7  
H S 0 4 9 0  
C a m p b e l l  t o w n  
W V H  
e p i g l o t t i t i s  b i d  
1 4 - J u l - 8 9  n o t  k n o w n  2 . 6  
m  N  b  I  n e g a t i v e  
p o s i t i v e  
T l  
T o w n s v i l l e  
T ' v i l l e  G e n  H o  
m e n i n g i t i s  
c s f / b l d  
a f t e r  J u l y  9 3  
n o t  k n o w n  
n k  n k  N  
b  n k  n k  p o s i t i v e  
T 2  
T o w n s v i l l e  
T ' v i l l e  G e n  H o  
m e n i n g i t i s  c s f / b l d  
a f t e r  J u l y  9 3  n o t  k n o w n  n k  n k  N  
b  n k  n k  p o s i t i v e  
~ 
C ' -
A p p e n d i x  A . 3 :  
H i b  I s o l a t e s  R e c o v e r e d  f r o m  t h e  M e l b o u r n e  R e g i o n  
C o d e  
I D #  
L o c a t i o n  H o s p i t a l  
D i a g n o s i s  S p e c i m e n  D O C  
D O B  
A g e  ( y . m )  S e x  
R a c e  S e r o t y p e  
p U 0 8 2  " b "  
V l  
1  
M e l b o u r n e  R C H  
m e n i n g i t i s  n o t  k n o w n  1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  
N  b  
p o s i t i v e  
V 2  
7  
M e l b o u r n e  
R C H  
m e n i n g i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  
n k  
N  b  p o s i t i v e  
V 3  
8  
M e l b o u r n e  
R C H  
m e n i n g i t i s  n o t  k n o w n  1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  
N  
b  p o s i t i v e  
V 4  
1 5  
M e l b o u r n e  
R C H  m e n i n g i t i s  
n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  
n k  N  
b  p o s i t i v e  
V 5  
3 5  
M e l b o u r n e  
R C H  
m e n i n g i t i s  
n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  
N  b  p o s i t i v e  
V 6  
4 6  
M e l b o u r n e  
R C H  
m e n i n g i t i s  n o t  k n o w n  1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  
N  
b  p o s i t i v e  
V 7  
4 1  
M e l b o u r n e  
R C H  m e n i n g i t i s  
n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  
n k  N  
b  p o s i t i v e  
V 8  6 8  
M e l b o u r n e  
R C H  
m e n i n g i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  p o s i t i v e  
V 9  9 5  
M e l b o u r n e  R C H  
m e n i n g i t i s  n o t  k n o w n  1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  p o s i t i v e  
V l 0  
1 2 1  
M e l b o u r n e  
R C H  m e n i n g i t i s  n o t  k n o w n  1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  
N  b  p o s i t i v e  
V I  1  
4  
M e l b o u r n e  
R C H  e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  p o s i t i v e  
V l 2  
2 4  
M e l b o u r n e  R C H  
e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  
p o s i t i v e  
V l 3  
1 2  
M e l b o u r n e  
R C H  e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  
N  b  p o s i t i v e  
V l 4  1 6  
M e l b o u r n e  
R C H  e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  
p o s i t i v e  
V l 5  6 5  
M e l b o u r n e  R C H  
e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  
p o s i t i v e  
V l 6  2 0  
M e l b o u r n e  R C H  
e p i g l o t t i t i s  
n o t  k n o w n  1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  
p o s i t i v e  
V l 7  2 9  
M e l b o u r n e  R C H  
e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  
p o s i t i v e  
V l 8  4 2  
M e l b o u r n e  R C H  
e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  
p o s i t i v e  
V l 9  
5 3  
M e l b o u r n e  R C H  e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  N  
b  
p o s i t i v e  
V 2 0  
7 0  
M e l b o u r n e  
R C H  e p i g l o t t i t i s  n o t  k n o w n  
1 9 8 7 - 1 9 9 0  
n o t  k n o w n  
n k  n k  
N  b  
p o s i t i v e  
~ 
- N  
- . : . i  
A p p e n d i x  A . 4  ( p a g e  1  o f  1 ) :  
C o d e  
I D #  
L o c a t i o n  
W A I  
8 8 : 2 0 4  
M e t r o p o l i t a n  P e r t h  
W A 2  
8 9 : 0 2 3  
S E  
W A 3  
8 9 : 1 3 9  
S E  
W A 4  
9 4 : 2  
M e t r o p o l i t a n  P e r t h  
W A S  
9 4 : 5  
M i d l a n d s  
W A 6  
9 4 : 6  
S E  
W A 7  
9 4 : 3  
C e n t r a l  
W A 8  
9 4 : 1  
M e t r o p o l i t a n  P e r t h  
W A 9  8 4 : 5 0  
K i m b e r l y  
W A I 0  8 4 : 7 2  
C e n t r a l  
W A I i  
n o n - v i a b l e  
l y o p h i l i z e d  s a m p l e  
W A 1 2  
8 5 : 3 4  
M e t r o p o l i t a n  P e r t h  
W A 1 3  
8 6 :  1 7 6  
M e t r o p o l i t a n  P e r t h  
W A 1 4  
8 7 : 5 7  
M e t r o p o l i t a n  P e r t h  
W A I S  
8 7 : 6 1  
M e t r o p o l i t a n  P e r t h  
W A 1 6  
8 7 : 1 2 5  
M e t r o p o l i t a n  P e r t h  
W A 1 7  
8 8 :  1 1  
M e t r o p o l i t a n  P e r t h  
W A 1 8  
8 8 : 2 0 7  
M e t r o p o l i t a n  P e r t h  
W A 1 9  
8 8 : 6 6  
M e t r o p o l i t a n  P e r t h  
W A 2 0  
8 7 :  1 6 3  M e t r o p o l i t a n  P e r t h  
W A 2 1  8 8 : 8  
M e t r o p o l i t a n  P e r t h  
W A 2 2  
8 8 : 2 1 6  
M e t r o p o l i t a n  P e r t h  
W A 2 3  8 7 :  1 7 2  
M e t r o p o l i t a n  P e r t h  
W A 2 4  8 7 :  1 8 9  
M e t r o p o l i t a n  P e r t h  
W A 2 5  8 8 :  I  8 0  
M e t r o p o l i t a n  P e r t h  
W A 2 6  
8 7 :  1 9 5  
M e t r o p o l i t a n  P e r t h  
W A 2 7  
8 8 :  1 1 7  M e t r o p o l i t a n  P e r t h  
W A 2 8  8 7 :  I O I  
M e t r o p o l i t a n  P e r t h  
W A 2 9  8 7 :  1 2 1  R u r a l  
W A 3 0  8 4 : 7 9  R u r a l  
H i b  I s o l a t e s  R e c o v e r e d  f r o m  M e t r o p o l i t a n  P e r t h  a n d  R u r a l  W e s t e r n  A u s t r a l i a  
H o s p i t a l  D i a g n o s i s  S p e c i m e n  D O C  D O B  A g e  ( y . m . )  
S e x  
R a c e  
S e r o t y p e  
p U 0 8 2  " b "  
P r i n c e s s  M a r g a r e t  
m e n i n g i t i s  c s f  S e p - 8 8  1  l - O c t - 8 7  
0 . 1 1  
n k  
A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  J a n - 8 8  2 2 - M a y - 8 8  
0 . 8  n k  
A  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  
m e n i n g i t i s  
c s f  
M a y - 8 9  
l  9 - F e b - 8 8  
1 . 3  n k  
A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  J a n - 9 0  3  l - A u g - 8 9  
0 . 5  n k  
A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  M a r - 9 0  
2 3 - J u n - 8 9  0 . 9  
n k  A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  
m e n i n g i t i s  
c s f  A u g - 9 0  4 - A p r - 9 0  
0 . 4  n k  A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  D e c - 9 0  1 8 - A p r - 9 0  
0 . 8  n k  
A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  F e b - 9 1  l - A u g - 9 0  
0 . 7  
n k  A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  A p r - 8 4  7 - N o v - 8 3  
0 . 6  
n k  A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  M a y - 8 4  1 4 = N o v - 8 3  
0 . 7  n k  A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
c s f  A u g - 8 5  2 3 - M a r - 8 5  
0 . 5  n k  A  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f / b l d  O c t - 8 6  
2 3 - A p r - 8 6  
0 . 6  n k  A  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
c s f / b l d  A p r - 8 7  4 - N o v - 8 6  
0 . 6  n k  
N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
c s f / b l d  M a y - 8 7  2 6 - J u l - 8 6  1 0  m o n t h s  
n k  N  b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  
m e n i n g i t i s  c s f / b l d  S e p - 8 7  2 3 - J u n - 8 6  
1 . 3  n k  N  b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  
m e n i n g i t i s  
c s f / b l d  J a n - 8 8  2 5 - S e p - 8 6  1 . 4  
n k  N  b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i  t i s  b i d  S e p - 8 8  3 - F e b - 8 5  
3 . 8  n k  
N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i t i s  b i d  A p r - 8 8  1 5 - J a n - 8 6  2 . 4  
n k  
N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i t i s  b i d / t h r o a t  O c t - 8 7  1 6 - A p r - 8 4  
3 . 7  n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  
e p i g l o t t i t i s  b i d  J a n - 8 8  5 - D e c - 8 6  1 . 2  n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  O c t - 8 8  8 = A p r - 8 7  
1 . 6  n k  
N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  
o t h e r  b i d  O c t - 8 7  3 - A p r - 8 7  
1 . 6  
n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  
m e n i n g i t i s  
c s f  N o v - 9 7  l  6 - D e c - 8 6  
I . I  n k  
N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  b i d  S e p - 8 8  2 4 - J u n - 8 4  4 . 3  n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i t i s  
b i d  
D e c - 8 7  2 6 - J u l - 8 4  
3 . 5  n k  N  b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  b l d / c s f  M a y - 8 8  6 - J u l - 8 6  I . I  n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i t i s  b i d  J u n - 8 7  1 4 - J u l - 8 1  
5  . 1 1  n k  
N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  c s f  
A u g - 8 7  
4 - F e b - 8 7  
0 . 7  n k  
N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  
-
m e n i n g i t i s  c s f  M a y - 8 4  4 - O c t - 8 3  
0 . 6  
n k  N  
b  
p o s i t i v e  
l ' . J  
~ 
D O  
A p p e n d i x  A . 4  ( p a g e · 2  o f  2 ) :  
C o d e  
I D #  
L o c a t i o n  
W A 3 1  
8 4 :  1 1 3  
M e t r o p o l i t a n  P e r t h  
W A 3 2  
8 7 : 6 2  
M e t r o p o l i t a n  P e r t h  
W A 3 3  
8 7 :  1 2 2  
M e t r o p o l i t a n  P e r t h  
W A 3 4  
8 7 :  1 0 6  
M e t r o p o l i t a n  P e r t h  
W A 3 5  
8 7 : 7 8  
M e t r o p o l i t a n  P e r t h  
W A 3 6  8 6 : 3 1  
R u r a l  
W A 3 7  
8 7 : 2 0 6  
R u r a l  
W A 3 8  8 7 :  1 9 6  
M e t r o p o l i t a n  P e r t h  
W A 3 9  
8 7 :  1 9 7  
M e t r o p o l i t a n  P e r t h  
W A 4 0  8 7 :  1 9 8  
M e t r o p o l i t a n  P e r t h  
W A 4 1  8 7 : 1 6 8  
R u r a l  
W A 4 2  
8 6 :  1 6 3  R u r a l  
W A 4 3  
8 4 : 3 5  M e t r o p o l i t a n  P e r t h  
W A 4 4  8 6 :  1 2 3  R u r a l  
W A 4 5  8 8 :  1 7 0  R u r a l  
W A 4 6  8 8 : 3 8  R u r a l  
W A 4 7  8 7 :  1 0 6  M e t r o p o l i t a n  P e r t h  
H i b  I s o l a t e s  R e c o v e r e d  f r o m  M e t r o p o l i t a n  P e r t h  a n d  R u r a l  W e s t e r n  A u s t r a l i a  
H o s p i t a l  
D i a g n o s i s  
S p e c i m e n  D O C  
D O B  
A g e  ( y . m . )  
S e x  
R a c e  S e r o t y p e  
p U 0 8 2  " b "  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
b l d / c s f  A u g - 8 4  
2 7 - F e b - 8 4  
0 . 6  
n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  o t h e r  
b i d / e y e  s w a b  M a y - 8 7  
l - J u l - 8 6  
0 . 1 1  
n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  o t h e r  
b i d  A u g - 8 7  2 4 - A u g - 8 1  
6  n k  
N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
b i d  J u l - 8 7  
1 2 - A u g - 8 6  
0 . 1 1  
n k  N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i  t i s  b i d  
M a y - 8 7  4 - S e p - 8 0  
6 . 8  n k  
N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i t i s  
b i d  M a r - 8 6  7 - J u l - 8 4  
1 . 8  n k  
N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  
o t h e r  b i d  
D e c - 8 7  9 - N 0 v - 8 7  
0 . 1  
n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  
o t h e r  b i d  
N o v - 8 7  1 - S e p - 8 1  
6 . 2  
n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  o t h e r  b i d / e y e  s w a b  
D e c - 8 7  3 1 - J u l - 8 7  
0 . 5  
n k  N  
b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i  t i s  
b i d  N o v : - 8 7  2 4 - M a r - 8 5  
2 . 8  
n k  N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
b l d / c s f  O c t - 8 7  3 0 - A u g - 8 4  
3 . 2  
n k  N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t t i t i s  
b i d  A u g - 8 6  1 5 - F e b - 8 5  
1 . 6  n k  N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
c s f  F e b - 8 4  2 7 - O c t - 8 2  
1 . 4  
n k  N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
b l d / c s f  J u l - 8 6  1  0 - D e c - 8 3  
2 . 7  
n k  N  
b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t i t t i s  
b i d  A u g - 8 8  1 6 - O c t - 8 5  
2 . 1  
n k  N  b  
p o s i t i v e  
P r i n c e s s  M a r g a r e t  e p i g l o t i t t i s  
b i d  F e b - 8 8  1 4 - J u n - 8 6  
1 . 8  n k  N  b  p o s i t i v e  
P r i n c e s s  M a r g a r e t  m e n i n g i t i s  
b i d  J u l - 8 7  1 2 - A u g - 8 6  
0 . 1 1  n k  N  
b  p o s i t i v e  
I " '  
' N  
- . . \ . )  
Appendix A.5 (page 1 of 2): Hib Isolates Recovered from the Alice Springs Region 
Code ID# Location Hospital Diagnosis Specimen DOC DOB Age(y.mo) Sex Race Serotype pU082 "b" Al QI Ngukurr ASH meningitis bld l 6-Apr-93 25-Nov-92 0.5 m A b positive 
A2 Q2 Santa Teresa ASH meningitis bld 8-Apr-93 l 9-Dec-92 0.4 m A b positive 
A3 Q3 Kintore ASH pneumo111a bld 27-Feb-93 3-Mar-92 I f A b positive A4 Q4 Alice Springs ASH cellulitis bld 8-Feb-93 2-Sep-92 0.5 m A b positive 
AS QS Emabella ASH pneumo111a bld 28-Jan-93 92 < I m A b positive A6 Q6 Katherine ASH meningitis csf 13-Jan-93 22-May-92 0.8 f A b positive A7 Q7 Alice Springs ASH meningi tis bld 21 -Dec-92 l 7-Jul-92 0.5 m A b positive A8 Q8 Papunya ASH gastro bld 20-Dec-92 17-Jun-92 0.6 m A b positive A9 Q9 Yarralin ASH pneumo111a bld 28-Nov-92 2-Jun-92 0.6 f A b positive AIOisNTIO QlO duplicate 
Al I Ql I Alice Springs region ASH well npa not known 28-Jul-90 nk f A b positive Al2 Q12 Alice Springs region ASH well npa not known l 2-Jul-90 nk m A b positive Al3 Q13 Alice Springs region ASH well npa not known 2 l-Feb-92 nk m A b positive Al4 Ql4 Alice Springs region ASH well npa not known 3-Apr-91 nk m A b positive Al5 Ql5 Alice Springs region ASH well npa not known 2 l-Feb-92 nk m A b positive Al6 Ql6 Alice Springs region ASH well npa not known 4-Mar-9 I nk f A b positive Al7 Ql7 Alice Springs region ASH ALRI npa not known 91-Apr-l nk m A b positive 
Al8 Ql8 Alice Springs region ASH ALRI npa not known 3-Apr-91 nk m A b positive 
Al9 Q19 Alice Springs region ASH ALRI npa not known 2-Dec-90 nk f A b positive 
A20 Q20 Alice Springs region ASH ALRI npa not known 2-Dec-90 nk A b positive 
A21 pair Q21 Hennannsburg ASH meningitis blood not known 3 l-May-92 0.4 f A b positive 
A22 pair Q22 see A21 - diff. RFLP ASH meningitis csf not known 3 l-May-92 0.4 f A b positive 
A23 Q23 Katherine ASH febrile bid 5-Sep-92 5-Feb-92 0.7 f A b positive 
A24 is NT9 Q24 duplicate 
A25 is NTHi Q25 Hermanns burg ASH heart/resp failure bid 30-Aug-92 20-Dec-90 1.8 f A b/c NEGATIVE 
A26 Q26 Alice Springs area ASH bronchiolitis bid l l-Aug-92 6-Mar-92 0.5 m A b positive 
A27 Q27 Yambah ASH pneumo111a bid 3-Aug-92 I 1-Feb-92 0.6 m A b positive 
A28 Q28 Fregon, SA ASH gastro bid 26-Jul-92 31-Aug-9 l I. I m A b positive 
A29 pair Q29 Tennant Creek ASH pneumo111a bid l l -Jul-92 20-Feb-92 0.5 m A b positive 
A30 pair Q30 see A29 - same RFLP ASH see A29 pleural fluid see A29 see A29 see A29 see A29 see A29 b positive 
A31 Q31 Kintore ASH pneumo111a bid 9-Jul-92 18-Sep-9 l !Omo. m A b positive 
~ 
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Appendix A.5 (page 2 of 2): Hib Isolates Recovered from the Alice Springs Region 
Code ID# Location Hospital Diagnosis Specimen D OC DOB Age(y.mo) Sex Race Serotype pU082 "b" A32 Q32 Ernabella, SA ASH gastro bld 30-May-92 9-Aug-92 10 months f A b positive 
A33 Q33 Mt. Davis ASH gastro bld I l -May-92 6-May-92 I m A b positive 
A34 pair Q34 Alice Springs region ASH meningitis b ld 13-May-92 12-Dec-91 0 .5 f A b positive 
A35 pair Q35 see A34 - diff. RFLP ASH see A34 csf see A34 see A34 see A34 see A34 see A34 b positive 
A36 Q36 Katherine ASH meningitis bld 26-May-92 24-Mar-91 1.2 f A b positive 
A37 Q37 Mt. Allen ASH meningitis bld I-May-92 3 l -Jan-92 0.3 m A b positive 
A38 Q38 Kintore ASH gastro bld 5-Apr-92 16-Jul-91 0.9 m A b positive 
A39 Q39 Ali Curang ASH failure to thrive bid l l -Jan-92 8-Dec-90 0.1 f A b positive 
A40 Q40 Katherine ASH pneumoma bid 8-Jan-92 17-Feb-91 0 .11 f A b positive 
A41 SCI Alice Springs region ASH meningitis not known 8-Jan-89 not known nk f A b positive 
A42 I0CI Alice Springs region ASH eye not known 17-Jul-85 not known nk m A b positive 
A43 23Cl Alice Springs region ASH gastro not known 10-May-90 not known nk m A b positive 
A44 24Cl Alice Springs region ASH gastro & pneumo not known 27-Mar-89 not known nk f A b positive 
A45 25CI Alice Springs region ASH pneumo not known 8-May-90 not known nk m A b positive 
A46 26CI Alice Springs region ASH gastro & ? pneumo not known 89 not known nk f A b positive 
A47 pair 27CI Alice Springs region ASH otitis media & men not known 19-Nov-89 not known nk f A b positive 
A48 pair 28CI see A47 - same RFLP see A47 see A47 see A47 see A47 not known nk see A47 A b positive 
A49 30CI Alice Springs region ASH gastro & septic not known 8-Jan-89 not known nk m A b positive 
A50 31 CI Alice Springs region ASH gastro & entero not known 7-Apr-90 not known nk m A b positive 
NT! ASH - tourist ASH meningitis csf 7-Jul-89 4-Nov-88 0.8 m N b positive 
NT2 Alice Springs region ASH meningitis bld/csf l 2-Jan-9 1 19-Nov-89 0.2 f N b positive 
NT3isNT2 Alice Springs region ASH meningitis bld/csf see NT2 see NT2 see NT2 as above N b positive 
NT4 Alice Springs region ASH meningitis bld/csf l-Apr-91 4-Nov-88 2.5 f N b positive 
NT5isNT4 Alice Springs region ASH meningitis bld/csf see NT4 see NT4 see NT4 as above N b positive 
NT6 Tourist from Sydney ASH mvas1ve bid l l-Apr-9 1 14-Jan-54 37.3 f N b positive 
NT7 Alice Springs region ASH mvas1ve bid l 5-Aug-9 1 5-Oct-90 10 mo. m N b positive 
NT8 Alice Springs region ASH mvas1ve bid 2 1-Aug-9 l 4-Dec-89 1.9 m N b positive 
NT9 Alice Springs region ASH mvas1ve bid 2-Sep-92 17-Oct-90 1.11 m N b positive 
NTl0 Katherine ASH mvas1ve bid 7-Oct-92 30-Aug-90 2.1 f N b positive 
NT! I Katherine ASH mvas1ve bid 13-Nov-92 Feb-92 0 .9 m N b positive 
NTI2 Katherine ASH mvas1ve bid 21 -May-93 20-Feb-47 46 .3 f N b positive 
N 
UJ 
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Appendix A.6: Hib Isolates Recovered from Bathurst Island 
Code ID# Location Hospital Diagnosis Specimen D OC DOB Age(y.m.) Sex Race Serotype Biotype pU082 "b" 
Bl 909-1 Nguiu, Bathhurst Is . MSHR earner nasopharynx 24-Mar-92 not known 0.2 nk A b II positive B2 911-1 Nguiu, Bathhurst Is. MSHR earner nasopharynx 14-Apr-92 not known 0.2 nk A b ill positive 
B3 911-2 Nguiu, Bathhurst ls. MSHR earner nasopharynx 14-Apr-92 not known 0.2 nk A b IV positive B4 911-4 Nguiu, Bathhurst Is . MSHR earner nasopharynx 14-Apr-92 not known 0.2 nk A b II positive B5 9 13- 1 Nguiu, Bathhurst Is. MSHR earner nasopharynx 20-May-92 not known 0.3 nk A b l positive B6 9 14- 1 Nguiu, Bathhurst Is . MSHR earner nasopharynx 21-Jul -92 not known 0.4 nk A b ill positive B7 914-3 Nguiu, Bathhurst Is. MSHR earner nasopharynx 2-Dee-92 not known 0.8 nk A b I positive B8 923- 1 Nguiu, Bathhurst Is. MSHR earner nasopharynx 21-Jul-92 not known 0.1 nk A b I positive B9 non-viable on receipt 
B IO 925-1 Nguiu, Bathhurst Is . MSHR earner nasopharynx 21-Jul-92 not known 0.08 nk A b I positive B 11 926-2 Nguiu, Bathhurst Is . MSHR earner nasopharynx 1-Dec-92 not known 0.4 nk A b I positive B12 928-1 Nguiu, Bathhurst Is . MSHR earner nasopharynx 5-Jan-93 not known 0.5 nk A b I positive B13 931-1 Nguiu, Bathhurst Is. MSHR otitis media? ear discharge 28-Apr-93 not known 0.7 nk A b II positive B14 934-1 Nguiu, Bathhurst Is. MSHR earner nasopharynx 2-Dee-92 not known 0.1 nk A b I positive 
B IS 934-3 Nguiu, Bathhurst Is. MSHR earner nasopharynx I 0-Feb-93 not known 0.3 nk A b I positive B16 935-1 Nguiu, Bathhurst Is. MSHR earner nasopharynx 3-Mar-93 not known 0.4 nk A b l positive 
B l 7 non-viable on receipt 
Bl8 943-3 Nguiu, Bathhurst Is. MSHR earner nasopharynx 1 0-Aug-93 not known 0 .3 nk A b I positive 
Bl 9 943-2 Nguiu, Bathhurst Is. MSHR earner nasopharynx 20-Sep-93 not known 0.4 nk A b II positive 
B20 947- 1 Nguiu, Bathhurst ls . MSHR earner nasopharynx 5-Oct-93 not known 0.4 nk A b I positive 
B2 1 950-1 N guiu, Bathhurst Is. MSHR earner nasopharynx 2 l-Sep-93 not known 0.3 nk A b I positive 
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APPENDIX B: Table 3.7 Distance matrix of the 1-Fvalues* of 16 Smal-RFLP types found among 20 meningitis isolates 
Ml 0.0000 
M2 0.1429 0.0000 
M3 a 0.2143 0.2143 0.0000 
M5 b 0.1852 l®llll1 !filiftlififll 0.0000 
M6 0.2414 0.2414 
~JfB~fil 0.1429 0.0000 
M7 0.6000 0.5333 0.6000 0.5862 0.5484 0.0000 
MB 0.2414 0.1724 0.1724 :llli i1ili1 0.1333 0.5484 0.0000 
M9 0.6552 0.5862 0.5862 0.5714 0.5333 0.3548 0.5333 0.0000 
Ml0 0.2414 0.2414 iQ:,;r~~l~ri!i 0.1429 0.1333 0.6129 0.2000 0.6000 0.0000 
Mll 0.2414 0.1724 t@.;l'.;!l fl~till l l 1liii~l~t 0.2000 0.6129 0.1333 0.6000 0.1333 0.0000 
M13 0.7 2 41 0.6552 0.7241 0.6429 0.6667 10. 80 651 0.6000 0.6667 0 .7333 0.6667 0.0000 M14 0.3333 0.3333 0 . 2667 0.2414 0.2258 0.6250 0.2258 0.4839 0 .2 903 0.2903 0.5484 0 . 0000 M15 0.3571 0.2857 0.2857 0.2593 0.2414 0.5333 0. 2 414 0.5172 0 . 3103 0.3103 0.6552 0.2667 0.0000 Ml 7 0.2593 0.1852 0.1852 l l!il~lflll 0.2143 0.6552 0.1429 0.5714 0.2143 0.1429 0.6429 0.3103 0.3333 0.0000 M19 0.2143 0.2143 l lllltl!l 'l lru 0.6000 0.1724 0.5862 l 1l~1lffll;~;'.ey;:I 0.1724 0.7 2 41 0.2667 0.2857 0.185 2 0.0000 M20 0.2143 0.2143 0.1852 0.2414 0.6000 0.2414 0.6552 0.2414 0.2414 0.7 2 41 0.3333 0.3571 0. 2 59 3 0. 2143 Ml M2 M3 a M5 b M6 M7 MB M9 Ml0 Mll M13 Ml4 M15 M17 M19 
The lightly shaded nu1nbers represent the F values >0.9 (1-the shaded value) that indicate clonally related pairs of isolates that have a one to three fragment difference. The boxed number is the 1-F value of the most diverse pair of isolates, M 13 -M7, that had an F value of 0 .19. This pair shared only 3 of the 28 different fragments found between the1n. 
*The F value is 1 1ninus the value found in this matrix because the RAPDistance Package program used for constructing the matrix has been designed to subtract the F value from 1. Therefore, the lowest values in this matrix represent the most closely related pairs of isolates and the highest values represent the 1nost diverse pairs of isolates. The zero values shown in this matrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a 0.0000 value in a 1natrix generated using the RAPDistance Package. 
· 
a SmaI-M3 included isolates M3 and M4. 
6SmaI-M5 included isolates MS , Ml2, Ml6, and Ml 8. 
N 
w 
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APPENDIX B: Table 3.8 Distance matrix of the 1-Fvalues* of 12 Smal-RFLP types found among 14 epiglottitis isolates 
El 0.0000 
E2 a 0.3333 0.0000 
E3 0.3548 0.1724 0.0000 
E4 0.4000 0.2143 ,,,,,,. 0.0000 
ES 0.4000 0.4286 0.4483 0.5000 0.0000 
E6 0.3750 0.1333 0.1613 0.2000 0.4667 0 . 0000 
E7 0.3548 0.2000 0. 2 414 0.3793 0 .2258 0.0000 
E9b 0. 3 7 93 0.2143 0.1852 0.4815 0 .2 414 0.0000 
Ell 0.3793 0.3333 0.3571 0.4074 :~:~iff~lm•; i; 0.3793 0 . 2857 0.3846 0 . 0000 
E12 0.3103 
~,fff&.~21!~'f~ 0.1429 0.1852 0.4074 0.1724 0 . 3077 0.0000 E13 0.3548 0.1724 0.1333 0.1724 0.4483 ti;1irl£!ll1&:1 0.2000 0.2143 0 . 357 1 0.1429 0 . 0000 ElS 0.4194 0 .1 724 0.2667 0.3103 10. 51721 0.2258 0.2667 0.2857 0 . 4286 0.2143 0. 2667 0.0000 El E2 a E3 E4 ES E6 E7 E9b Ell E12 E13 ElS 
The lightly shaded numbers represent the F values >0.9 (1 -the shaded value) that indicate clonally related pairs of isolates that have a one to three fraginent difference. The boxed number is the 1-F value of the most diverse pair of isolates, E5 -E 15, that had an F value of 0.48. This pair shared only 7 of the 22 different frag1nents found between them. 
*The F value is 1 minus the value found in this matrix because the RAPDistance Package program used for constructing the matrix has been designed to subtract the F value from 1. Therefore, the lowest values in this matrix represent the most closely related pairs of isolates and the highest values represent the most diverse pairs of isolates. The zero values shown in this matrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a 0.0000 value in a 1natrix generated using the RAPDistance Package. 
3Smal-E2 included isolates E2 and E14. 
bSmaI-E9 included isolates E9 and El 0. 
N 
w 
+:>,. 
APPENDIX B: Table 3.9 Distance matrix of the 1-Fvalues* of26 Smal-RFLP types found among 34 meningitis and epiglottitis isolates 
Ml 0.0000 
M2 0.1429 0.0000 
M3 a 0.2143 0.2143 0.0000 
MS b 0.1852 (~t,1,-~tl~~ l1(~~ili t1 0 . 0000 
M6 0.2414 0.2414 :11;i iltllJ 0.1429 0.0000 
M7 0.6000 0.5333 0.6000 0.5862 0.5484 0.0000 
M8 c O. 2414 0.1724 0.1724 0.1333 0.5484 0.0000 
M9 0.6552 0.5862 0.5862 0.5714 0.5333 0.3548 0.5333 0.0000 
MlO 0.2414 0.2414 i.l:¼J~if;~; 0.1429 0.1333 0.6129 0.2000 0.6000 0 . 0000 
Mll 0.2414 0.1724 IJl~Jlli !l [i 11i 0 . 2000 0.6129 0.1333 0.6000 0.1333 0.0000 
M13 0.7241 0.6552 0.7241 0.6429 0.6667 10. 8 0 651 0.6000 0.6667 0.7333 0.6667 0.0000 Ml4 0.3333 0.3333 0.2667 0.2414 0.2258 0.6250 0.2258 0.4839 0.2903 0.2903 0.5484 0.0000 MlS 0.3571 0.2857 0.2857 0.2593 0.2414 0.5333 0.2414 0.5172 0.3103 0.3103 0.6552 0.2667 0.0000 Ml7 0.2593 0.1852 0.1852 0 . 2143 0.6552 0.1429 0.5714 0.2143 0.1429 0.6429 0.3103 0.3333 0.0000 M19 0.2143 0.2143 0.6000 0.1724 0.5862 0.1724 0.7241 0.2667 0.2857 0.1852 M20 'fw:;%~11411 0.2143 0.2143 0.1852 0.2414 0.6000 0.2414 0.6552 0.2414 0.2414 0.7241 0.3333 0.3571 0.2593 El 0.4000 0.3333 0.3333 0.3103 0.3548 0.6250 0.3548 0.6129 0.3548 0.3548 0.5484 0.4375 0.3333 0.2414 E2d 0.2143 0.1429 0.1429 0.1724 0.5333 0.5172 0.1724 0.6552 0.2667 0.2857 E3 0.2414 0.2414 0.1429 0.1333 0.5484 0.2000 0.5333 0.1333 0.7333 0.2903 0.3103 0.2143 E4 0.2857 0.2857 0.1429 0.1852 0.1724 0.5333 0.2414 0.5172 0.1724 0.2414 0.7931 0.3333 0.3571 0.2593 ES 0.5000 0.4286 0.4286 0.4074 0.3793 0.6000 0.3793 0.5172 0.4483 0.4483 0.5862 0.4000 0.1429 0.4074 E6 0.2667 0.2667 0.1333 0.1724 0.5625 0.2258 0.5484 0.1613 0.2258 0.7419 0.3125 0.3333 0.2414 E9e O. 2593 0.1852 0.1852 0.2143 0.5862 0.5714 0.2143 0 .14 29 0.7143 0.3103 0.3333 0.1538 Ell 0.4074 0.3333 0.3333 0 .30 77 0.2857 0.5172 0.2857 0.5000 0.3571 0.3571 0.6429 0.3103 0.3846 E13 0.2414 0.2414 0.1429 0.6129 0.2000 0.6000 0.1333 0.2000 0.7333 0.2903 0 . 3103 0.2143 £15 :~1:iii:~:~~tl; 0.2414 0.2414 0 .2 143 0.2667 0.4839 0.2667 0.6000 0.2667 0 . 2667 0.7333 0.3548 0.3793 0 .28 57 Ml M2 M3 a MS b M6 M7 M8 c M9 MlO Mll M13 M14 MlS Ml 7 
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APPENDIX B: Table 3.9 continued 
M20 0.2143 0.0000 
El 0.3333 0.4000 0.0000 
E2 d 0.1429 0.2143 0.3333 0.0000 
E3 ;JJ,lll!tl 0.2414 0.3548 0.1724 0.0000 
E4 0.1429 0.2857 0.4000 0.2143 0.0000 
ES 0.4286 0.5000 0.4000 0.4286 0.4483 0.5000 0.0000 
E6 r~;IIIZt[tl 0.2667 0.3750 0.1333 0.1613 0.2000 0.4667 0 . 0000 
E9e 0 .1852 0.2593 0.3793 
~fw;~l ?ll3 0. 2 143 0.1852 0.4815 0 . 2 414 0.0000 
Ell 0.3333 0.4074 0.3793 0.3333 0.3571 0.4074 0 .3 793 0.3846 0.0000 El3 1l l lfll ~il 0.2414 0.3548 0.1724 0.1333 0.1724 0.4483 0.2143 0 .3571 0.0000 El5 0.2414 i iilll'i 0.4194 0.1724 0.2667 0.3103 0.5172 0 . 22 58 0.2857 0.4286 0.2667 0.0000 Ml9 M20 El E2d E3 E4 ES E6 E9e Ell El3 El5 
The lightly shaded numbers represent the F values >0.9 (1-the shaded value) that indicate clonally related pairs of isolates that have a one to three fragment difference. The boxed number is the 1-F value of the most diverse pair of isolates, Ml 3- M7, that had an F value of 0.19. This pair shared only 3 of the 28 different fraginents found between them. 
*The F value is 1 minus the value found in this matrix because the RAPDistance Package program used for constructing the matrix has been designed to subtract the F value from 1. Therefore, the lowest values in this matrix represent the most closely related pairs of isolates and the highest values represent the most diverse pairs of isolates. The zero values shown in this matrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a 0 value in a matrix generated using the RAPDistance Package. 
aSmal-M3 included isolates M3 and M4. 
bSmal-M5 included isolates M5 , Ml 2, M16, M18, and E12. 
cSmal-M8 included isolates MS and E7. 
dSmaI-E2 included isolates E2 and E14. 
eSmal-E9 included isolates E9 and El0. 
N 
v-.) 
0\ 
APPENDIX B: Table 3.10 Distance matrix of the 1-F values* of 15 Apal-RFLP types found among 20 meningitis isolates 
Ml 0 . 0000 
M2 ~1;ifJi1i~1 0.0000 
M3 0 . 1351 0.222 2 0 . 0000 
M4 0.1892 0. 2222 0.1579 0.0000 
M5 a O .14 29 0.1176 0.1667 r!llfi!II~ 0 . 0000 
M7 0 . 3 143 0.2941 0.3333 0.3333 0 .2353 0.0000 
M8 0.2000 0.1765 0.2222 0.1667 '.i ii~1i~l!ri ii 0.1765 0.0000 
M9 0 . 3 158 0.297 3 0.3333 0.2821 0.189 2 0.4054 0.2432 0 . 0000 
MlO 0.1351 0.22 22 ~;;j c,@1-~ ~jf~1rl ~tirl l 0.3333 0.1667 0 . 282 1 0.0000 
M1 3 10 . 5 67 61 0.555 6 0.5263 0.4211 0 . 4444 0.4444 0.4444 0 . 3846 0.4737 0 . 0000 
M14 0.3846 0.3684 0.3500 0.3000 0. 3158 0.4737 0.3158 0.1220 0.3000 0.4000 0.0000 M15 0.3514 0.3 333 0 . 3158 0.2105 0. 2222 0.2778 0. 2778 0 . 3333 0.2632 0.3684 0.4000 0 . 0000 Ml 7 0.2000 0.1765 0.2222 0.1667 l !f~(~~;l [~;[i ; 0.2353 0.1176 0 .2 432 0.1667 0.4444 0.3684 0.2778 0.0000 M19 0.1667 0.1429 0 .1 35 1 0.1351 t~r1il~~~1~t~ 0.2571 WAi~l~l~'f!I 0 . 2 105 1il]ll ll l !I 0.4595 0.3333 0. 2 432 ;~iJIIIAi 0.0000 M2 0 @ ''0'55"6 
. ·':t :/~i,· .-..,/~;. ::;:)\~~;:, ~l~!~ti!Jil~ 0 .1 35 1 0.1892 0.14 29 0 . 3143 0.2000 0 . 3158 0.1351 10. 5 67 61 0.3846 0.3514 0 . 2000 'Qtt; £''.:fr l d.. :: ·~ Yit :=:, ~;·,' \-... ~::~ %~:\{:. ? ' ' --~: ,-.':,. Ml M2 M3 M4 M5 a M7 M8 M9 MlO M13 M14 M15 M17 M19 
The lightly shaded numbers represent the F values >0.9 (1-the shaded value) that indicate clonally or closely related pairs of isolates that have a one to three fragrnent difference. The boxed nu1nber is the 1-Fvalue of the 1nost diverse pairs of isolates, Ml - M13 and M13- M20, that had an Fvalue of0.43. These pairs each shared only 8 of the 29 different frag1nents found between the1n. 
*The F value is 1 1ninus the value found in this 1natrix because the RAPDistance Package program used for constn1cting the matrix has been designed to subtract the F value fro1n 1. Therefore, the lowest values in this 1natrix represent the 1nost closely related pairs of isolates and the highest values represent the most diverse pairs of isolates. The zero values shown in this 1natrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a 0 value in a 1natrix generated using the RAPDistance Package. 
aApal-MS included isolates M5, M6, Ml 1, Ml 2, M16, and M18. 
N 
w 
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APPENDIX B: Table 3.11 Distance matrix of the 1-Fvalues* of9 Apal-RFLP types found among 14 epiglottitis isolates 
El 0.0000 
E2 0. 2 7 2 7 0 .0000 
E3 0. 3 714 0.1667 0.0000 
E4 0. 3529 0 .14 29 0.1351 0.0000 
E5a 0. 2000 0 .1 66 7 0.2632 0.1 892 0 .0000 
E6b 0. 3333 0.1176 liffitllfllJ ;1sii~1~r~;~· 0.2222 0.0000 
E7 0. 3333 0.1765 0.1667 tllri ;~!i:fl; 0.2778 l ~i il:ll1m1~ 0.0000 
El3 0. 3529 0 .14 29 0.1351 :~)0~{©1~:r~!@ 0.2432 ~;;!t1~~rffl fl~. 0.0000 
El5 10. 4 7 0 61 0.2571 0.1892 0.1667 0.3514 0 . 1429 0.2000 l!:)''-f~~i jl !,:1il 0 . 0000 El E2 E3 E4 E5 a E6b E7 El3 El5 
The lightly shaded numbers represent the F values >O. 9 ( 1-the shaded value )that indicate clonally or closely related pairs of isolates that have a one to three fragment difference. The boxed nmnber is the 1-F value of the most diverse pair of isolates, El - E15, that had an F value of 0.53 . This pair shared only 9 of the 25 different fragments found between them. 
*The F value is 1 minus the value found in this matrix because the RAPDistance Package program used for constructing the 1natrix has been designed to subtract the F value fro1n 1. Therefore, the lowest values in this matrix represent the most closely related pairs of isolates and the highest values represent the most diverse pairs of isolates. The zero values shown in this matrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a O value in a 1natrix generated using the RAPDistance Package. 
3Apal-E5 included isolates ES and El L 
bApal-E6 included isolates E6, E9, ElO, El2, and E14. 
N 
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APPENDIX B: Table 3.12 Distance matrix of the 1-Fvalues* of20 ApaI-RFLP types** found among 34 meningitis and epiglottitis isolates 
Ml 0 . 0000 
M2 ,,, ·'''''-i ii'fr&i ~@li~tti~,:~; . 0 .0000 
M3 0.1351 0.2222 0.0000 
M4 0.1892 0.2222 0.1579 0.0000 
M5 a 0.1429 0.1176 0.1667 10ww; r;f '{lr ~ -~ f ~ill ~:n ~h-; <t; t1 \ .. /c_.f.,:,.J:::·.,;.i.. .. -t~,.: 0.0000 
M7 0.3143 0.2941 0.3333 0.3333 0.2353 0.0000 
M8b 0. 2000 0.1765 0.2222 0.1667 rm1t1,11 0 .17 65 0.0000 
M9 0.3158 0.2973 0.3333 0.2821 0.1892 0.4054 0.2432 0 . 0000 
MlO 0.1351 0.2222 !I I![ifl~I '.~1IAtm1~i~: l~M~ggf;~ 0.3333 0.1667 0 .282 1 0.0000 
M13 10. 5 67 61 0.5556 0.5263 0.4211 0.4444 0 .4444 0.4444 0.3846 0.4737 0.0000 
M14 0.3846 0.3684 0.3500 0.3000 0.3158 0.4737 0.3158 0.1220 0.3000 0.4000 0.0000 
M15 c O. 3514 0.3333 0.3158 0 . 2105 0.2222 0. 2 778 0.2778 0.3 333 0.2632 0. 368 4 0.4000 0.0000 
Ml 7 0.2000 0.1765 0.2222 0.1667 :m:!,,~~e;~;~ 0. 23 53 0.1176 0. 2 432 0.1667 0.4444 0.3684 0. 2 778 0 . 0000 
M19 0.1667 0.1429 0.1351 0.1351 :1:::s;1~:M~$JfS 0.2571 WJ,1:1;1~11 0.2105 ;ffi ;;t:;@;1;1u.1 0.4595 0.3333 0.243 2 :i!t1rii[i1!i;ii 0.0000 
M2 oct ;gf:~Qlit~:8 :l;:i!til~l~I 0.1351 0.1892 0.1429 0.3143 0.2000 0.3158 0.1351 10. 5 6 7 61 0 . 3846 0.3514 0 .2 000 11' 
El 0.4706 0.4545 0.4286 0.3143 0.3333 0.3333 0.3333 0.4444 0.3714 0.4286 0.4595 0.2000 0 . 2727 0.3529 
E2 0 . 25 71 0.2353 0.2222 0.1176 0.3529 0.1765 0. 29 73 0.1667 0.5000 0.3684 0.1667 0.1765 0.1429 
E3 0.1351 0. 2222 0.3333 0.1667 0.28 2 1 0.4737 0.3000 0.263 2 0 .1 667 0.1351 
E4 0 .1 667 0.1429 0.1892 0.1351 0.2000 i,@~l!,~ii(i~i1 0.2105 0.1351 0.4054 0.3333 0.189 2 ;~;iil@l$l[t 6 
E13 ;g:F,;~l~ll1u1 0.1892 0.1351 0.2571 \@J:;JID;:ffl;'fqiW:S 0.2105 0.1351 0.4595 0.3333 0. 2 43 2 (~l!ill[i ~i ,fl3 
E15ct 0. 0556 0.0857 0.1351 0.189 2 0.1429 0.3143 0.2000 0.3158 0.1351 0.5676 0.3846 0.3514 0 .20 00 0.1111 
Ml M2 M3 M4 M5 a M7 M8b M9 MlO M13 Ml4 Ml5c M17 M19 
El 0 . 0000 
E2 0.2727 0.0000 
E3 0 . 371 4 0.1667 0.0000 
E4 0.3529 0.1429 0.1351 0.0000 
E1 3 0.3529 0.1429 0.1351 0.0000 
E15d 0.4706 0 . 25 71 0.1892 0.1667 0.1111 0.0000 
El E2 E3 E4 E13 E15 ct 
0 . 0000 
0.4706 
0.2571 
0 . 189 2 
0.1667 
0.1AL11 
. . ;~ . 
0.0000 
M2 0ct 
N 
v,.) 
\0 
APPENDIX B: Table 3.12 continued 
The lightly shaded numbers represent the F values >0.9 (1 -the shaded value) that indicate clonally or closely related pairs of isolates that have a one to three fragment difference. The boxed number is the 1-F value of the most diverse pairs of isolates, Ml - M13 and M13-M20, that had an F value of 0.43. These pairs each shared only 8 of the 29 different fragments found between them. 
*The F value is 1 minus the value found in this matrix because the RAPDistance Package program used for constructing the matrix has been designed to subtract the F value from 1. Therefore, the lowest values in this matrix represent the most closely related pairs of isolates and the highest values represent the most diverse pairs of isolates. The zero values shown in this matrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a 0 · value in a matrix generated using the RAPDistance Package. 
aApal-M5 included isolates M5, M6, Ml 1, M12, M16, Ml 8, E6, E9, El0, E12, and E14. 
bApal-M8 included isolates M8 and E7. 
cApal-Ml5 included isolates M15 , E5, and El 1. 
dApal-M20 and included isolates M20 and E15. [Both M20 and E15 are included in the matrix rather than only one representative isolate per type because the NJTREE progra1n would not compute if one of the isolates was omitted.] 
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APPENDIX B: Table 3.13 Distance matrix of the 1-F values* of 17 SmaVApaI-RFLP types found among 20 meningitis isolates 
Ml 0.0000 
M2 llj!ICBffl: 0.0000 
M3 0.1692 0.2188 0.0000 
M4 0.2000 0.2188 t~s•,1~1®t~ 0.0000 
M5 a 0. 1613 0.1148 0.1429 0.0000 
M6 0.1875 0.1746 0.1385 1~111 111:11 0.0000 
M7 0.4462 0.4063 0.4545 0.4545 0.3968 0.3846 0.0000 
M8 0.2188 0.1746 0.2000 0.1692 m111,~r,~1~~il l 0.3538 0 . 0000 
M9 0.4627 0.4 2 42 0.4412 0.4118 0.3538 0.34 33 0.3824 0.3731 0.0000 
Ml0 0.1818 0.2308 l)lfJ~;i ~tl 0.1250 0.1 212 0.4627 0 . 1818 0.4203 0.0000 
Mll 0.1875 0.1429 0.1385 0.4154 IW.i;~l liti1\I 0.3731 0.1212 0 . 0000 Ml3 0.6364 0.6000 0.6119 0.5522 0.5313 0.5455 0.6119 0.5152 0.5072 0.5882 0 .5 455 0.0000 Ml4 0.3623 0.3529 0.3143 0.2857 0.2836 0.2754 0.5429 0.2754 0.2778 0.2958 0 .3 043 0.4648 0.0000 Ml5 0.3538 0.3125 0.3030 0.2424 0.2381 0.2308 0.3939 0.2615 0.4118 0.2836 0.2615 0.4925 0.34 29 0.0000 Ml7 0.2258 0.1803 0.2063 0.1746 0.1290 0.4286 0 . 1290 0.3846 0.1875 ,!\t~~~lll!i! 0.5313 0.3433 0.3016 0.0000 Ml9 0.1875 0.1746 ti[!1l1i,EtBl 0.4154 0.1250 0.3731 ~,,;;1.lt~l,l ~l 0.5758 0.3043 0 . 2615 0.1290 0 . 0000 M20 l&~l~~l~I~'. 0.1429 0.1692 0.2000 0.1613 0.1875 0.4462 0 .2 188 0.4627 0.1818 0 .18 75 j0. 63641 0.36 23 0.3538 0 . 2258 0.1563 Ml M2 M3 M4 M5 a M6 M7 M8 M9 Ml0 Mll Ml3 Ml4 Ml5 Ml7 Ml9 
The lightly shaded numbers represent the F values >0.9 (1 -the shaded value) that indicate clonally related pairs of isolates that have a one to three fragment difference. The boxed number is the 1- F value of the most diverse pair of isolates, Ml3 - M20, that had an F value of 0.36. This pair shared only 12 of the 54 different fragments found between them. 
*The F value is 1 minus the value found in this matrix because the RAPDistance Package program used for constructing the matrix has been designed to subtract the F value from 1 Therefore, the lowest values in this matrix represent the most closely related pairs of isolates and the highest values represent the most diverse pairs of isolates. The zero values shown in this 1natrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a 0 value in a 1natrix generated using the RAPDistance Package. 
aSmaI!ApaI-M5 included isolates M5, Ml2, Ml 6, and Ml8. 
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APPENDIX B: Table 3.14 Distance matrix of the 1-F values* of 13 SmaVApaI-RFLP types found among 14 epiglottitis isolates 
El 0.0000 
E2 0.3016 0.0000 
E3 0.3636 0.1692 0.0000 
E4 0.3750 0.1746 0.1212 0.0000 
ES 0.2923 0.2813 0.3433 0.3231 0.0000 
E6 0.3538 0.1250 0.1343 
~l~fE~llki 0 . 3333 0 . 0000 
E7 0.3438 0.1429 0.1818 0.1563 0 . 3231 0.1385 0.0000 
E9a 0. 3548 0.1148 0.1563 ;{lffll l;.~l!i 0.3333 :1;;r!l1IIU!! ;l!;fJlfl :l;I; 0.0000 Ell 0.2813 0.2381 0.3030 0.2813 '.p;:~;Q,i;t~)~; 0 .2 923 0.2813 0. 2903 0.0000 
E12 0.3226 111t11,i 0.1250 ~2,ri11ll,1i 0.3016 ;Wr1¥&l tl~tf.i1: l ,, .. ,,1;15¥1'1 i,.;~ .f~'.~~!\!~.I:i:2;:: ::7~ :-·::: 0.2581 0.0000 E1 3 0.3538 0.1563 0.1343 IJ~iflf1i'I  0.3333 rlJli(l!lii!~ 0.1385 0.2923 0 . 0000 E14 0.3438 11t~li !iS1 0.1515 0.1250 0.3231 ~-f11i~!llf®1 0.2813 0.0000 E15 10. 4 4 621 0.2188 0.2239 0.2308 0.424 2 0.1818 0.2308 0. 2 063 0.3846 0.1746 0 .2 121 0.1692 0.0000 El E2 E3 E4 ES E6 E7 E9a Ell El2 E13 E14 El5 
The lightly shaded numbers represent the F values >0.9 (1 -the shaded value) that indicate clonally related pairs of isolates that have a one to three fraginent difference. The boxed number is the 1- Fvalue of the most diverse pair of isolates, El - E15, that had an Fvalue of0.56. This pair shared only 18 of the 65 different frag1nents found between them. 
*The F value is 1 minus the value found in this matrix because the RAPDistance Package program used for constructing the matrix has been designed to subtract the F value fro1n 1. Therefore, the lowest values in this matrix represent the most closely related pairs of isolates and the highest values represent the most diverse pairs of isolates. The zero values shown in this 1natrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a O value in a matrix generated using the RAPDistance Package. 
aSmaVApaI-E9 included isolates E9 and ElO. 
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APPENDIX B: Table 3.15 Distance matrix of the 1-Fvalues* of28 Smal/Apal-RFLP types found among 34 meningitis and epiglottitis isolates 
Ml 0.0000 
M2 ll!!l1i1' 0.0000 
M3 0.1692 0.2188 0.0000 
M4 0.2000 0.2188 :~,-~,;;~ti, 0.0000 
M5a O. 1613 0.1148 0.1429 0.0000 
M6 0.1875 0.1746 0.1385 lliliilllli 0.0000 
M7 0.4462 0.4063 0.4545 0.4545 0.3968 0.3846 0 . 0000 
M8b 0.2188 0.1746 0.2000 0.1692 l ll9!l~tfl1 ~il!l~:la:§: 0.3538 0.0000 
M9 0.4627 0.4242 0.4412 0.4118 0.3538 0.3433 0.3824 0.3731 0.0000 
MlO 0.1818 0.2308 l@ftf'I;J~trli 1!l 0.1250 0.1212 0.4627 0.1818 0.4203 0 . 0000 Mll 0.1875 0.1429 0.1385 ,:::r;m:1t111 ,a,:;:tfra:a::a11m 0.4154 f:1~!l ltlfiJ 0.3731 0 . 1212 0.0000 Ml3 10.6 3641 0.6000 0.6119 0.5522 0.5313 0.5455 0.6119 0.5152 0.5072 0 . 5882 0.5455 0.0000 Ml4 0.3623 0.3529 0.3143 0.2857 0.2836 0.2754 0.5429 0.2754 0.2778 0 . 2958 0.3043 0.4648 0.0000 Ml5 0.3538 0.3125 0.3030 0.2424 0.2381 0.2308 0.3939 0.2615 0.4118 0 . 2836 0.2615 0 .4 925 0.3429 0 .0 000 Ml7 0.2258 0.1803 0. 2063 0.1746 :(ilii\\~IIJili 0.1290 0.4286 0.1290 0.3846 0.1875 l1l!l~mm~fJll 0.5313 0.3433 0 . 3016 M19 0.1875 0.1746 \@1-1~~l ;1l~lil1 0.4154 0.1250 0.3731 ,l iI:[111:11, 1:1)~~~,-~; 0.5758 0.3043 0 . 2615 M20 llI!1(figli~I 0.1429 0 . 1692 0.2000 0 . 1613 0.1875 0.4462 0.2188 0.4627 0 . 1818 0.1875 10. 63641 0.3623 0.3538 El 0.4375 0.3968 0.3846 0.3231 0.3226 0.3438 0.4769 0.3438 0.5224 0 . 3636 0.3438 0.4848 0.4493 0.2615 E2 0.2381 0.1935 0 . 1875 0.1250 1111;1~:StiI 0.1429 0.4375 0.1429 0.3939 0.1692 0.1111 0.5692 0.3235 0 . 2188 E3 0.1818 0. 2 308 0 . 1250 0.1212 0.4328 0.1818 0.3913 ,~ai• t,,1~, 0.1212 0.5882 0. 2 958 0 . 2836 E4 0.2188 0.2063 0.169 2 0.1385 \@ll;~li !l ll ~  1;~;t1@l1~ffl;~; 0.3538 0.1563 0.3433 0 . 1515 0.1250 0.5758 0.3333 0.2615 ES 0.4154 0.3750 0. 3 636 0.3030 0 . 3016 0.2923 0.4242 0.3231 0.4118 0.3433 0.3231 0.4627 0.4000 E6 0. 2 000 0.1875 0.1515 0.1212 
~{t~:l~l111' 0 . 3939 0.1385 0.3529 0 . 1343 0.5821 0.3143 0.2727 E9c 0.1935 0.1475 0.1746 0.1429 fflllll~11~1r;i 0.3968 0.3538 0.1563 0.5625 0.3134 0.2698 Ell 0.3750 0.3 3 33 0 .323 1 0.2615 0 . 2581 0.2500 0.3846 0.2813 0.4030 0 . 3030 0.2813 0.4848 0.36 2 3 
~fiJ~t~1~:~¥1' E13 0.1692 0.156 3 0.1515 0.1212 ;l !,i!lll!,; : 0 . 4242 0.1385 0.3824 0.1343 0 . 5821 0.3143 0 . 2727 El4 0.1746 0 .1 2 90 0.1563 0.1250 
~i fii1tl%1m:;,1 0.3750 0.3333 0 . 1385 0 . 5385 0 . 2941 0.2500 El5 i1511l~1~fi;i~~: 0.156 3 0.1818 0.2121 0 . 1746 0.2000 0.3939 0.2308 0.4412 0 . 1940 0.2000 0.6418 0 . 3714 0 . 3636 Ml M2 M3 M4 MS a M6 M7 M8 b M9 MlO Mll M1 3 M14 MlS 
t'-.J 
+::,.. 
w 
APPENDIX B: Table 3.15 continued 
M19 0.1290 0 . 0000 
M20 0.2258 0.1563 0.0000 
El 0.2581 0 . 3438 0.4375 0.0000 
E2 0.1475 0.1429 0.2381 0.3016 0.0000 
E3 0.1875 0.1875 0.1212 0.2121 0.3636 0.1692 
E4 0.1613 lillil i ilill 0.2188 0 . 3750 0.1746 0.1212 0.0000 
ES 0.3333 0.3231 0.4154 0 . 2923 0.2813 0.3433 0.3231 0.0000 
E6 0.1429 \~l;J~tl~li[I 0.2000 0.3538 0.1250 0.1343 0.3333 0.0000 
E 9 c !llfiliill i1lillill~1i ,: 0.1935 0.3548 0.1148 0.1563 0.3333 0.0000 
Ell 0.3226 0.2813 0.3750 0.2813 0.2381 0.3030 0.2813 lffl!l~11l l l!~1l l 0. 2 923 0.2903 0.0000 E13 0.1429 @:;~::~1~:1:~1 0.1692 0.3538 0.1563 0.1343 0.3333 0. 2 92 3 0 . 0000 E14 ;~1,r,:i§l@l~ ~~r~Jfi '.wt~~ 0.1746 0.3333 0.1385 0.3125 0. 2 698 @l~111!:~f$; 0.0000 E15 0.2381 0.1692 ;~;J.½i\t1;1; 0 . 4462 0.2188 0.2239 0.2308 0.4242 0 . 1818 0.2063 0.3846 0 . 1818 0.1563 0 . 000 0 Ml 7 M19 M20 El E2 E3 E4 ES E6 E9c Ell El3 El4 E15 
The lightly shaded numbers represent the F values >0.9 (1-the shaded value) that indicate clonally or closely related pairs of isolates that have a one to three 
fragment difference. The boxed numbers are the 1-F values of the most diverse pairs of isolates, Ml - M13 and M13- M20, that had an F value of 0.36. These pairs 
shared only 12 of the 54 different fragments found between them. 
*The F value is 1 minus the value found in this matrix because the RAPDistance Package program used for constructing the matrix has been designed to subtract the 
F value fro1n 1. Therefore, the lowest values in this matrix represent the most closely related pairs of isolates and the highest values represent the most diverse pairs 
of isolates. The zero values shown in this matrix are the values relating to the comparison of identical pairs that would yield an F value of 1 represented by a 0 value in a 1natrix generated using the RAPDistance Package. 
aSmal/Apal-M5 included isolates M5, M12, M16, Ml8 and E12. 
bSmal/ApaI-M8 included isolates M8 and E7. 
cSmal/ApaI-E9 included isolates E9 and El0. 
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APPENDIX C : 245 
Distribution of 213 Hib isolates among 69 Smal-RFLP types by group and 
Aboriginality in 7 major genetic distance clusters found using the mathematical 
model of Nei and Li and the programs, NJTREE and TDRAW 
Repre-
- Page 1 of 2 senta- C'O Group C: -IC tive C, -IC 
- *refer to Appendices A.1-A.6 for key to code name "C Name C'O "i: -(l) Smal C: 0 C'O **a black box indicates a type was found among both I.. ... 
.c 0 C'O 
RFLP C, <( ~ Aboriginal and non-Aboriginal isolates .c "i: en I type* 0 C: 
.c 0 
<X: z 
G1 NT8 6 2 8 NT8, NTl l, A5, A 7, Al 6 , Al 9, 
A37, A40 
F1 M13 0 1 1 Ml3 
F2a S3l 35 2 37 S37, Al, A4 , A6 , A9 , All, Al3, Al4, Al 5 , 
Al 7 , Al 8 , A20, A2 6, A27, A29 , A31, A35, 
A36 , A38 , A39 , A43 , A4 6 , A5 0, WA4, WA6, 
WA7 , WA8 , WA9 , WA l O, WA13 , B6 , B7 , Bll, 
B1 4 , B15, B2 1, NT4 
F2b A34 1 0 1 A34 
F2c 85 1 0 1 B5 
F3 A23 l 0 7 A23 , A28 , A33 , A4 4 , A4 9 , WA2 , WA3 
F4 NT12 0 1 1 NT12 
E1 Ml 0 1 1 M7 
E2 V1 0 2 2 Vl, V9 
E3 M9 0 1 1 M9 
E4 T1 0 1 1 Tl 
A1a M3 0 4 4 M3 , M4 , WAl 6 , WA25 
A1b M10 0 2 2 Ml O, S21 
A1c S10 0 1 1 Sl O 
A2a E3 0 1 1 E3 
A2b E4 0 i 1 E4 
A3a M6 0 1 1 M6 
A3b M19 0 1 1 Ml 9 
A3c E13 0 1 1 E l3 
A4a VB 0 1 1 V8 
A4b NT2 1 1 2 NT2, A47 I 
A3d V14 0 1 1 Vl4 
A3e WA46 0 1 1 WA46 
A5a F6 0 1 1 E6 
A5b S11 0 1 1 Sll 
A5c NT10 0 1 1 NTlO 
A6a M1 0 1 1 Ml 
A6b M20 0 1 1 M20 
A6c E15 0 1 1 El5 
Ala M2 0 2 2 M2, S32 
Alb A42 1 0 1 A42 
Ale A21 1 0 1 A21 
Ald V10 0 1 1 VlO 
A16 WMS 1 0 1 WAS 
A8a WA42 0 2 2 WA42 , NTl 
continued on page 2 
APPENDIX C : 246 
Distribution of 213 Hib isolates among 69 5mal-RFLP types by group and 
Aboriginality in 7 major genetic distance clusters found using the mathematica l 
model of Nei and Li and the programs, NJTREE and TDRAW 
Repre-
- Page 2 of 2 senta- rn Group C: -!( 
tive -j,; 
-
O'l 
*refer to Append ices A .1-A.6 for key to code name -0 Name rn 'i: -Q,) Smal C: 0 Cil **a black box indicates a type was found among both ,._ ... C'tl O'l .0 0 
.c:: RFLP 
'i: <2: I- Aboriginal and non-Aboriginal isolates en ! type* 0 C: Shaded isolates are epiglottitis iso lates 
.0 0 
<2: z Underlined iso lates are those not meningitis or epiglottitis 
A8b M5 2 53 55 MS , Ml2 , Ml 6 , Ml 8 , E,t2 , V2 , V3 , V4 , V6 , 
Vl); , Vif:2:, Vl3', VT5 
. . ' 
\716 , VI7 , V20, Sl, 
S3, S4, S 6, Sl7, Sl8, S23, S24, S2S, S2 6, 
S28 , S30, S31, S33, S34, S3S, S3 6 , WAl, 
WA14, WATS, WA22, WA23, WA26, WA27, WA28, 
WA29, WA30 , WA32, WA37, WA38, WA39, WA40 , 
WA44 , WA4 S, WA4 7 , NT6 , NT9, T2,A22 
A8c S27 0 1 1 S27 
A8d M11 0 1 1 Mll 
A9a MS 0 2 2 M8 , E7 
A9b E9 0 3 3 E9 , ElO , WA20 
A10a M17 0 1 1 Ml7 
A10b S2 0 1 1 S2 
A 11 a V5 0 1 1 ' vs 
. A 11 b S13 0 8 8 Sl3 , S20 , WA1S , WA19 , WA31 , WA34 , WA3S , WA43 
A12 A8 1 0 1 A8 
A13a S5 0 1 1 ss 
A13b WA24 0 2 2 WA24 , WA41 
A14 WA33 0 1 1 WA33 
A15a E2 0 3 3 E2 , El 4 , S8 
A15b V1 9 0 1 1 Vl9 
B1 8 1 1 [ 0 1 Bl 
B2 E1 a I. 1 1 El 
B3 V? 0 1 1 V7 
B4 S29 0 1 1 S29 
B5 V18 0 1 1 Vl8 
B6 M14 0 1 1 Ml4 
B7 S15 0 3 3 SlS , Sl 6, S22 
C1a M15 0 3 3 MlS, Sl4, Sl9 
C2 ES 0 1 1 ES 
C1b E11 0 4 4 Ell, S7, S 9, NT7 
C3 WA17 1 2 3 WAl 7, WA36, WA12 
C4 WA2 1 0 1 1 WA21 
C5 B8 3 0 3 B8 , BlO, Bl2 
C6 S12 0 1 1 Sl2 
C7a A45 8 0 8 A4S, B2, B3, B4, Bl 6 , Bl8 , Bl 9, B20 
C7b B13 1 0 1 Bl3 
D1a A2 3 0 3 A2 , Al2, A32 
O1b A4 1 1 0 1 A41 
02 A3 1 0 1 A3 
Totals 41 76 137 213 
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